0001213900-14-008252.txt : 20141114 0001213900-14-008252.hdr.sgml : 20141114 20141114161856 ACCESSION NUMBER: 0001213900-14-008252 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141114 DATE AS OF CHANGE: 20141114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arista Power, Inc. CENTRAL INDEX KEY: 0001424640 STANDARD INDUSTRIAL CLASSIFICATION: ENGINES & TURBINES [3510] IRS NUMBER: 000000000 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53510 FILM NUMBER: 141224437 BUSINESS ADDRESS: STREET 1: 1999 MOUNT READ BLVD CITY: ROCHESTER STATE: NY ZIP: 14615 BUSINESS PHONE: 585-243-4040 MAIL ADDRESS: STREET 1: 1999 MOUNT READ BLVD CITY: ROCHESTER STATE: NY ZIP: 14615 FORMER COMPANY: FORMER CONFORMED NAME: WindTamer Corp DATE OF NAME CHANGE: 20081126 FORMER COMPANY: FORMER CONFORMED NAME: Future Energy Solutions Inc DATE OF NAME CHANGE: 20080123 10-Q 1 f10q0914_aristapowerinc.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2014

 

OR

 

   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number: 001-53510

 

ARISTA POWER, INC.

(Exact name of Registrant as specified in its charter)

 

New York   16-1610794
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
     
1999 Mount Read Blvd    
Rochester, New York   14615
(Address of principal executive offices)   (Zip Code)

 

(585) 243-4040

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x    No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant has been required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ☐ Accelerated filer
       
Non-accelerated filer (Do not check if a smaller reporting company)  ☐ Smaller reporting company ☒ 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨   No x

 

As of November 14, 2014 the Registrant had outstanding 20,979,877 shares of common stock, $0.002 par value per share and 1,360 shares of Series A Convertible Preferred Stock, $0.002 par value per share.

 

 

 

 

  

ARISTA POWER INC.

TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION  
   
Item 1. Financial Statements   2
     
  Unaudited Condensed Balance Sheets as of  September 30, 2014 and December 31, 2013   3
     
  Unaudited Condensed Statements of Operations for the Three Months Ended September 30, 2014 and 2013 and the Nine Months Ended September 30, 2014 and 2013   4
     
  Unaudited Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2014 and 2013   5
     
  Unaudited Statement of Stockholders' Deficit through September 30, 2014   6
     
  Notes to Unaudited Condensed Financial Statements   7
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
     
Item 3. Quantitative and Qualitative Disclosure about Market Risk 21
     
Item 4.  Controls and Procedures 21
     
PART II. OTHER INFORMATION  
     
Item 1. Legal Proceedings 21
     
Item 1A. Risk Factors 21
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 21
     
Item 3. Defaults Upon Senior Securities 22
     
Item 4. Mine Safety Disclosures 22
     
Item 5. Other Information 22
     
Item 6. Exhibits 22
     
Signatures 23
     
Exhibits  

 

2
 

 

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements and Notes

ARISTA POWER, INC.

Condensed Balance Sheets (Unaudited)

   September 30,
2014
   December 31,
2013
 
         
         

ASSETS

 
Current assets        
Cash  $353,166   $297,385 
Accounts Receivable (less allowance for doubtful accounts of $0 at September 30, 2014 and December 31,2013)   143,103    265,245 
Prepaid expenses and other current assets   101,717    232,570 
Inventory   496,313    496,313 
Deferred debt discount   820,750    820,750 
Total current assets   1,915,049    2,112,263 
Other assets   139,344    172,362 
Intangible assets, net   23,796    25,305 
Property and equipment, net   19,080    69,555 
Total assets  $2,097,269   $2,379,485 
           
Current liabilities          
Accounts payable  $487,192   $1,175,221 
Borrowings under line of credit, net of debt discount   941,248    684,994 
Customer deposits   18,850    19,000 
Accrued payroll   54,763    146,465 
Deferred revenue   318,977    63,311 
Accrued warranty costs   142,504    140,074 
Accrued liabilities   442,640    496,011 
Accrued loss contract   542,842    519,092 
Accrued dividends   63,675    0 
Derivative liabilities, short term   0    13,200 
Current portion of long term debt   277    11,782 
Total current liabilities   3,012,968    3,269,150 
Long term liabilities          
Long term debt   0    16,169 
Derivative liabilities   556,070    762,396 
Total long term liabilities   556,070    778,565 
Total liabilities   3,569,038    4,047,715 
           
Stockholders' (deficit)          
Preferred stock, 5,000,000 shares authorized, $0.002 par value; 1,415 and 0 issued and outstanding at September 30, 2014 or December 31, 2013   3    0 
Common stock, 500,000,000 shares authorized, $0.002 par value; 19,892,264 and 17,993,694 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively   39,784    35,987 
Additional paid-in capital   23,923,613    25,330,474 
Deficit accumulated   (25,435,169)   (27,034,691)
           
Total stockholders' (deficit)   (1,471,769)   (1,668,230)
Total liabilities and stockholders' deficit  $2,097,269   $2,379,485 

 

3
 

 

ARISTA POWER, INC.

Condensed Statements of Operations (Unaudited)

   Three Months
Ended
September 30,
2014
   Three Months
Ended
September 30,
2013
   Nine Months
Ended
September 30,
2014
   Nine Months
Ended
September 30,
2013
 
                 
Sales  $250,231   $578,689   $541,675   $1,015,949 
Cost of Goods Sold   423,487    1,219,094    654,038    1,740,939 
Gross Margin/(Loss)   (173,256)   (640,405)   (112,363)   (724,990)
Operating Expenses:                    
Research and development expenses   0    63,639    0    320,341 
Selling, general and administrative expenses   341,237    463,492    

1,190,233

    1,828,753 
Total expenses   341,237    527,131    

1,190,233

    2,149,094 
Loss from operations   (514,493)   (1,167,536)   

(1,302,596

)   (2,874,084)
Non-operating revenue/(expense)                    
Interest expense   (111,900)   (112,498)   (336,419)   (518,428)
Unrealized gain (loss) on change in fair value of derivative liabilities   1,149,696    237,538    3,240,052    218,968 
Net loss before income taxes   523,303    (1,042,496)   1,601,037    (3,173,544)
Income taxes (credits)   (360)   (0)   1,515    (103,471)
Net income (loss)  $523,663   $(1,042,496)  $1,599,522   $(3,070,073)
Less preferred stock dividends   (32,288)   0    (86,557)   0 
Net Income (loss) available to common shareholders   491,375    (1,042,496)   1,512,965    (3,070,073)
Net income (loss) per common share – basic  $0.02   $(0.06)  $0.08   $(0.21)
Weighted average number of common shares
outstanding – basic
   19,892,264    17,793,694    19,352,887    14,462,909 
Net income (loss) per common share – diluted  $0.02   $(0.06)  $0.06   $(0.21)
Weighted average number of common shares
outstanding – diluted
   29,248,946    17,793,694    24,354,789    14,462,909 

 

4
 

 

ARISTA POWER, INC.

Condensed Statements of Cash Flows (Unaudited)

   Nine Months
Ended
September 30,
2014
   Nine Months
Ended
September 30,
2013
 
Operating activities        
Net income (loss)  $1,599,522   $(3,070,073)
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization and depreciation expense   33,076    48,769 
Stock-based compensation   171,141    650,505 
Amortization of prepaid warrants for rent, non-cash   33,018    0 
Amortization of prepaid warrants for consulting, non-cash   157,593    0 
Stock issued for rent and services   0    92,470 
Amortization of debt discount   256,254    441,228 
Impairment of intangible assets   0    3,699 
Issuance of warrants for services   0    137,496 
Change in derivative liability   (3,240,052)   (218,968)
Gain on sale of equipment   (5,592)   0 
         20,486 

Increase in lower of cost or market reserve

Changes in operating assets and liabilities :

          
           
(Increase) in prepaid expenses and other current assets   (26,740)   (92,351)
Decrease (increase) in trade accounts receivable   122,142    305,482 
Decrease in inventory   0    57,133 
Increase in customer deposits   (150)   81,028 
Increase (Decrease) in deferred revenue   255,666    (28,900)
Increase (Decrease) in accrued loss contract   23,750    638,850 
Increase (Decrease) in trade accounts payable and accrued liabilities   (714,673)   (90,919)
Net cash provided by/(used in) operating activities   (1,335,045)   (1,024,065)
           
Investing activities          
Proceeds from sale of truck   18,500    0 
Net cash provided by investing activities   18,500    0 
           
Financing activities          
Proceeds from issuance of common stock, net of placement costs   0    1,245,000 
Proceeds from issuance of preferred stock   1,500,000    0 
Stock offering costs paid   (100,000)   0 
Borrowings on line of credit   0    270,000 
Payments on debt   (27,674)   (8,705)
Net cash provided by financing activities   1,372,326    1,506,295 
           
Increase/(decrease) in cash   55,781    482,230 
           
Cash - beginning of period   297,385    78,253 
           
Cash - end of period  $353,166   $560,483 
           
Supplemental Information:          
Income Taxes Paid/(Tax credits received)  $1,515   $(103,471)
Interest Paid  $3,409   $1,402 
Non-cash investing and financing activities:          
Warrant derivative liability incurred with preferred stock offering  $3,020,526   $0 
Issuance of warrants with Preferred stock  $(2,868,750)  $0 
Additional warrants issued for anti-dilution clause  $(151,776)  $0 
Stock issued for accounts payable and accrued expenses  $110,000   $157,903 
Application of deferred debt discount  $0   $270,000 
Warrants issued for prepaid rent  $0   $746,332 
Payment of accrued dividend with common stock  $22,881   $0 
Transfer of property for accounts payable  $6,000   $0 

5
 

 

ARISTA POWER, INC.

Statement of Stockholders’ (Deficit)
(Unaudited)

   Number of Shares   Par Value   Additional
Paid-In
   Accumulated   Total
Stockholders'
 
   Common   Preferred   Common   Preferred   Capital   Deficit   Deficit 
Balance, December 31, 2013   17,993,694    0   $35,987   $0   $25,330,474   $(27,034,691)  $(1,668,230)
Issuance of convertible preferred stock for cash        1,500         3    1,499,997         1,500,000 
Stock offering costs                       (100,000)        (100,000)
Issuance of warrants with private placement                       (2,868,750)        (2,868,750)
Issuance of common stock and warrants for antidilution clause   1,255,000         2,510         (154,286)        (151,776)
Issuance of shares for legal services   440,000         880         109,120         110,000 
Conversion of Preferred shares to Common Shares   560,237    (85)   1,120         21,761         22,881 
Stock options and stock compensation   10,000         20         171,121         171,141 
Retirement of Shares   (366,667)        (733)        733         0 
Declared Dividend on Preferred Shares                       (86,557)        (86,557)
Net income for nine months                            1,599,522    1,599,522 
Balance, September 30, 2014   19,892,264    1,415   $39,784   $3   $23,923,613   $(25,435,169)  $(1,471,769)

 

6
 

 

ARISTA POWER, INC.

 

Notes to the Financial Statements

Nine-Month Period ended September 30, 2014

(Unaudited)

 

Note 1 – Description of Business and Summary of Significant Accounting Policies

 

Description of Business

 

Arista Power, Inc. (the “Company”) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions, Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power, Inc. The name change more accurately reflects the broadening of the Company’s focus beyond the WindTamer® brand and entry into areas within the energy storage and power management industries.

 

The Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer of solar energy systems.  The Company’s patented Power on Demand system utilizes inputs from multiple energy sources including solar, wind, fuel cells, generators, and/or the grid, in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy users. The Company also designs, sells and installs residential and commercial solar PV systems. 

 

Basis of Preparation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q.  Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.

 

In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.  Operating results for the three-month and nine-month periods ended September 30, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.  These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Company’s Form 10-K for the fiscal year ended December 31, 2013.

 

Method of Accounting

 

The accompanying financial statements have been prepared in accordance with GAAP.  Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.  The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.  The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.

 

7
 

 

Accounts Receivable

 

Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.  We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.  As of September 30, 2014 and December 31, 2013, the allowance for doubtful accounts was $0.

 

Inventory

 

Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (“PV”) systems, and is stated at the lower of cost or market value.  The Company capitalizes applicable direct and indirect costs incurred in the Company’s manufacturing operations to bring its products to a sellable state.  The inventory as of September 30, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.  Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.  As of September 30, 2014 and December 31, 2013, no reserve was necessary.

 

Fixed Assets

 

Fixed assets are recorded at cost.  Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.  Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.  Expenditures for renewals and betterments are capitalized.  Expenditures for minor items, repairs and maintenance are charged to operations as incurred.  Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.

 

Intangible Assets

 

Intangible assets consist of costs associated with the application and acquisition of the Company’s patents.  Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three and nine months ended September 30, 2013, trademark costs totaling $0 and $3,396, respectfully relating to the Company’s WindTamer® trademark were impaired, while no intangible assets were impaired for the three and nine months ended September 30, 2014.    

 

Impairment of Long-Lived Assets

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.  Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.   For the three and nine months ended September 30, 2014 and 2013, no assets were impaired.

 

Fair Value of Financial Instruments

 

The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.

 

8
 

  

Revenue Recognition

 

Revenue is recognized when all of the following conditions are satisfied:  (1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.  Amounts collected prior to satisfying our revenue recognition policy are reflected as customer deposits.

 

For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.  The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.

 

The Company uses contract accounting for Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.

 

At September 30, 2014, the Company had costs of uncompleted contracts in excess of related billings totaling $296,008 ($0 as of September 30, 2013). This amount was netted with the accrued loss contract on the Company’s balance sheet.

 

Research and Development Costs

 

All costs related to research and development are expensed when incurred. Research and development costs consist of expenses associated with the development of the Company’s Power on Demand system and the Mobile Renewable Power Station.  Specifically, these costs consist of labor, materials, and consulting.

 

Warranty Costs

 

The Company’s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.  Several warranties have specific additional terms and conditions.  The Company provides for estimated cost of warranties at the time the revenue is recognized.  Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer’s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.

 

Stock-Based Compensation

 

The Company accounts for stock option awards granted under the Company’s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.  Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.  The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option’s expected term and the price volatility of the underlying stock.

 

The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.  Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant’s or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.  This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.  Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.  Deferred income tax expense represents the change in net deferred assets and liability balances.

 

9
 

 

Basic and Diluted Loss Per Share

 

Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.  Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.  In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.

 

As of September 30, 2014, 1,415 shares of our Series A Convertible Preferred Stock, convertible into 7,075,000 shares of common stock, 2,455,191 stock options and 18,292,916 warrants were outstanding which, upon exercise, could dilute future earnings per share. Diluted Weighted Average Shares reflect the Company’s total weighted average shares outstanding during the period, which includes the conversion of the Series A Convertible Preferred Stock as well as any stock options or warrants in which the exercise price is below the Company’s stock trading price, less the stock that can be repurchased with funds received from such exercise.

 

Note 2 - Going Concern

 

The financial statements have been prepared assuming that the Company will continue as a going concern.  Since its formation, the Company utilized funds generated from private placement offerings and debt to fund its product development and operations and has incurred a cumulative net loss of $25,435,169 as of September 30, 2014.  The recurring losses from operations and current liquidity raise substantial doubt about the Company’s ability to continue as a going concern.  Continuation of the Company is dependent on achieving sufficiently profitable operations and obtaining additional financing.

 

Note 3 – Debt

 

On September 4, 2012, the Company entered into an unsecured loan agreement with TMK-ENT, Inc. that provided for a $500,000 working capital revolving line of credit.  Advances under the line of credit bear interest at 10% per year, payable annually. On November 13, 2012, the Company amended its loan agreement to increase the revolving line of credit from $500,000 to $750,000, and on December 21, 2012 amended its loan agreement to increase the revolving credit from $750,000 to $1,250,000.  The note matures on December 21, 2014. Borrowings under the line of credit amount to $1,018,500 as of September 30, 2014 and December 31, 2013. In conjunction with the line of credit facility, the Company issued 1,250,000 warrants to purchase the Company’s common stock at varying prices from $1.38 to $1.62 per share. The warrants vested one year from issuance and have a ten year term. The fair market value of the warrants at grant date was determined utilizing the Black Scholes option pricing model and amounted to $1,839,250. The difference between the fair market value of the warrants and draws on the line of credit is $820,750 as of September 30, 2014 and December 31, 2013, which is recorded as deferred debt discount.  The deferred debt discount will be recognized and recorded as debt discount as the Company continues to borrow against the line of credit. Debt discount costs will be recognized as the Company draws down the available line of credit, and will be amortized over the remaining term of the loan. As a result of the amortization of the debt discount, the Company expensed $256,254 and $441,228, respectively, for the nine months ended September 30, 2014 and 2013 and $85,732 and $86,674 for the three months ended September 30, 2014 and 2013.

  

Annual maturities of debt are as follows:

 

2014 (includes TMK-ENT, Inc. line of credit repayment)  $1,018,777 

 

10
 

 

Note 4 – Stockholders’ Equity

 

On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company’s common stock at a conversion price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. Stock offering costs for the private placement amounted to $100,000. Each share of Preferred Stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly. The Preferred Stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of Preferred Stock outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally, until September 30, 2015, each investor has the right to invest an amount equal to the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment provision. The warrants associated with this transaction were valued at their date of issue utilizing the Black-Scholes option pricing model, which amounted to $2,868,750.  The difference between the warrants valuation of $2,878,560 and the net proceeds received by the Company of $1,400,000 results in a deemed dividend of $1,468,750, which has been charged to additional paid-in-capital, as the Company has no retained earnings from which to declare a dividend.

 

On March 31, 2014, in conjunction with the full ratchet and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional 1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the exercise price for the 3,060,000 warrants outstanding that were associated with this transaction were reduced from $0.30 to $0.25 per share.

 

Note 5 – Stock Based Compensation

 

The Company has established the 2008 Equity Incentive Plan, which is a shareholder-approved plan that permits the granting of stock options and restricted stock to employees, directors and consultants.   The 2008 Equity Incentive Plan provides for the issuance of up to 3,550,000 shares of common stock of which 50,000 shares are available for grant as Incentive Stock Options.  The exercise price for options awarded is no less than 100% of the fair market value of the common stock on the day of grant.  The options generally vest either immediately on the date of grant or one to three years from the date of grant.

 

For the three and nine months ended September 30, 2014, the Company recorded compensation costs for options and warrants of $59,147 and $171,141 respectively, as compared to $111,114 and $650,505 for the nine and three months ended September 30, 2013. For the nine months ended September 30, 2013, compensation costs relating to the issuance of options and warrants amounted to $539,926 and the Company recorded an expense of $110,579 associated with the repricing of options and warrants held by a former consultant/outside counsel who is now an employee of the Company, while for the nine months ended September 30, 2014, there was no expense associated with the repricing of options or warrants.

 

11
 

 

The Company has valued the options at their date of grant utilizing the Black Scholes option pricing model.  Prior to the fourth quarter of 2009, there was not a public market for the Company shares.  Accordingly, the fair value of the underlying shares was determined based on recent transactions by the Company to sell shares to third parties and other factors determined by management to be relevant to the valuation of such shares.  Beginning in the fourth quarter of 2009, the quoted price for the Company’s shares on the OTCBB or the OTCQB, as applicable, was used to value the underlying shares.  Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry.  The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options depending on the date of the grant and expected life of the options.  The expected life of options used was based on the contractual life of the option granted.  The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.  The following weighted-average assumptions were utilized in the fair value calculations for options granted:

 

   Nine Months
Ended
   Nine Months Ended 
   September 30, 2014   September 30, 2013 
         
Expected dividend yield   0%   0%
Expected stock price volatility   112%    105-108%
Risk-free interest rate   3.63 %   2.68-3.44%
Expected life of options   .14-9.78 years     .4-9.9 years 

 

The following table summarizes the status of the Company’s aggregate stock options granted:

 

   Number of Shares Remaining Options   Weighted Average Exercise  Price   Weighted- Average Remaining Contractual Term  Aggregate Intrinsic  Value 
                
Outstanding at January 1, 2014    1,386,108   $.61         
Options granted during 2014    1,365,000   $.19    9.8 years  $   
Options cancelled or expired during 2014    (295,917)  $.56         
Outstanding at September 30, 2014    2,455,191   $.34   8.7 years   $0 
Exercisable at September 30, 2014    725,191   $.60   6.7 years   $0 

 

For the nine and three months ended September 30, 2014, the Company recorded compensation costs for options granted under the plan of $139,010 and $45,553, as compared to $190,861 and $20,800 for the nine and three months ended September 30, 2013. Stock option grants amounted to 1,365,000 for the nine months ended September 30, 2014 (1,655,208 for the nine months ended September 30, 2013) while 251,250 options vested during that period (166,858 options vested for the nine months ended September 30, 2013). There were 295,917 options cancelled or expired for the nine months ended September 30, 2014, while 23,000 options were cancelled for the nine months ended September 30, 2013. No options were exercised for the nine months ended September 30, 2014 or September 30, 2013.

 

The weighted average fair value of options granted during the nine months ended September 30, 2014 was $0.19 per share, compared to $0.45 per share for the nine months ended September 30, 2013. 

 

For the nine months ended September 30, 2013, the Company recorded expenses totaling $13,575 associated with the repricing of 25,000 options awarded to a former consultant/outside counsel who is now an employee of the Company. No such expense was recorded for the nine months ended September 30, 2014.

 

On December 13, 2010, the Board of Directors approved a restricted stock grant award to certain employees in lieu of future salary cash payments.  The employees forfeited salary over a twelve-week period to purchase common shares, which were valued at fair market value as of the date of grant.  The Compensation Committee of the Company’s Board of Directors have approved a change in the vesting date for restricted stock held by certain employees from April 1, 2011 to April 1, 2015. A total of 55,969 shares vested on April 1, 2011, and 118,378 shares remain outstanding and are scheduled to vest on April 1, 2015.

 

On March 31, 2014, Adeeb Saba was named Chief Operating Officer and the Company awarded him 250,000 shares of restricted common stock pursuant to the Company’s 2008 Equity Incentive Plan, which will vest one half each on the first and second anniversary of the award. Compensation costs associated with this award amount to $72,500 and will be recognized over the vesting period of the stock. On May 28, 2014, the Company awarded an employee 100,000 shares of restricted common stock pursuant to the Company’s 2008 Equity Incentive Plan, which will vest one half each on March 31, 2015 and March 31, 2016. Compensation costs associated with this award amount to $15,000 and will be recognized over the vesting period of the stock. On June 16, 2014, Stephen Brown was named as the acting Chief Financial Officer and the Company awarded him 50,000 shares of restricted common stock pursuant to the Company’s 2008 Equity Incentive Plan, of which 10,000 shares vested immediately and the remaining 40,000 shares shall vest on December 16, 2014. Compensation costs associated with this award amount to $9,000 and will be recognized over the vesting period of the stock.

 

12
 

 

The following table summarizes the status of the Company’s restricted common stock awards:

 

 

Restricted Shares

  Number of
Restricted Shares
   Weighted Average
Fair Value at
Grant Date
 
Non-vested at September 30, 2014   118,378   $2.80 
Awarded during 2014   400,000   $.23 
Cancelled or expired   (138,296)  $.36 
Non-vested at September 30, 2014   380,082   $.39 

 

The compensation expense related to these grants were $30,026 for the nine months ended September 30, 2014. There was no expense for the nine months ended September 30, 2013. 

 

Note 6 – Warrants

 

The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model.  The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life.  The expected life of warrants used was based on the term of the warrant.  The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.  The following weighted-average assumptions were utilized in the fair value calculations for warrants granted:

 

   Nine Months Ended   Nine Months Ended 
   September 30, 2014   September 30, 2013 
Expected dividend yield   0%   0%
Expected stock price volatility   134%   93-98%
Risk-free interest rate   1.73-1.75%   .14–2.60%
Expected life of warrants   4.1-8.8 years    35-9.3 years

 

The following table summarizes the status of the Company’s warrants granted:

 

   Number of Shares Remaining Warrants   Weighted Average Exercise Price   Weighted- Average Remaining Contractual Term  Aggregate Intrinsic Value 
Outstanding at January 1, 2014    7,671,267   $1.51         
Warrants granted during 2014    11,862,000   $.25         
Warrants expired during 2014    (1,240,351)  $.50         
Outstanding at September 30,2014    18,292,916   $.78   5.1 years   $0 
Exercisable at September 30,2014    18,139,250   $.75   5.4 years   $0 

 

The weighted average fair value of warrants issued during the nine months ended September 30, 2014 and 2013 was $.25 and $.41, respectively.  During the nine months ended September 30, 2014, 11,878,000 warrants vested (4,302,625 vested for the nine months ended September 30, 2013), and 1,240,351 warrants expired. No warrants expired for the nine months ended September 30, 2013.

 

For the nine months ended September 30, 2014 and 2013, respectively, the Company recorded compensation costs of $4,962 and $349,065 for warrants issued to a former consultant/outside counsel (now an employee) of the Company.  The warrants have a ten year life, a $1.20 exercise price, and vest from nine months to three years from grant date.

 

For the nine months ended September 30, 2013, the Company recorded expenses totaling $62,623 associated with the repricing of 423,125 outstanding warrants awarded to a former consultant/outside counsel who is now an employee of the Company.  No such expense was recorded for the nine months ended September 30, 2014.

 

13
 

 

Note 7 – Derivative Liabilities

 

Certain warrants issued by the Company do not have fixed settlement provisions because their exercise prices may be lowered if the Company issues securities at lower prices in the future, are classified as derivative liabilities, and are revalued at each reporting date. These warrants include (1) warrants issued to 1999 Mt RB, LLC in conjunction with our lease modification on February 4, 2013, which expired on February 4, 2014 (2) warrants issued in conjunction with the Company’s strategic advisory agreement with Sunrise Financial Group, Inc. on May 21, 2013, which were cancelled on June 19, 2014 and (3) warrants issued in conjunction with the Company’s private placements on July 31, 2013, August 6, 2013 and March 31, 2014. The reset provisions protect the warrant holders from the potential dilution associated with future financings.

 

The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model. Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry, or if applicable based upon the term of the warrant, based upon the Company’s historical volatility. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life. The expected life of warrants used was based on the term of the warrant. The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future. The following weighted-average assumptions were utilized in the fair value calculations for warrants granted and subsequent revaluation: 

 

   Nine Months Ended   Nine Months
Ended
 
   September 30, 2014   September 30, 2013 
Expected dividend yield   0%   0%
Expected stock price volatility   142-148%   90-172%
Risk-free interest rate   1.62-178%   .08-1.41%
Expected life of warrants   2.9-4.5 years     .35-4.84 years  
Number of warrants   14,922,000    4,300,351 
Fair value of warrants  $556,070   $1,232,676 

 

The fair value of these warrant liabilities was $556,070 at September 30, 2014. The change in fair value for the nine months ended September 30, 2014 was $3,240,052 and is reported in our statement of operations as an unrealized gain on the change in fair value of the derivative liabilities. For the nine months ended September 30, 2013, we recorded an unrealized loss on the change in fair value of the derivative liabilities totaling $218,968. The fair value of the derivative liabilities are re-measured at the end of every reporting period and upon the exercise of the warrant.

  

Fair Value Measurement

 

Valuation Hierarchy

 

ASC 820, “Fair Value Measurements and Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

 

The following table provides the liabilities carried at fair value measured on a recurring basis as of September 30, 2014:

 

       Fair Value Measurements at
September 30, 2014
 
   Total
Carrying
Value at
September 30,
2014
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Derivative liabilities  $556,070   $-   $-   $556,070 

 

14
 

 

The derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors, and are classified within Level 3 of the valuation hierarchy.

 

The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:

 

   Nine Months Ended September 30,
2014
 
Beginning balance January 1, 2014  $775,596 
Issuance of derivative financial instruments in 2014   3,020,526 
Net unrealized (gain) loss on derivative financial instruments   (3,240,052)
Ending balance as of September 30, 2014  $556,070 

 

Note 8- Recent Accounting Pronouncements

 

In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-15, Presentation of Financial Statements - Going Concern. The new standard required management of public and private companies to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, disclose that fact. Management will also be required to evaluate and disclose whether its plans alleviate that doubt. The new standard is effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early adoption is permitted. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.

 

In May 2014, the "FASB" issued ASU 2014-09 Revenue from Contracts with Customers, which will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The standard's core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. We are carefully evaluating our existing revenue recognition practices to determine whether any contracts in the scope of the guidance will be affected by the new requirements. The effects may include identifying performance obligations in existing arrangements, determining the transaction price and allocating the transaction price to each separate performance obligation. We will also establish practices to determine when a performance obligation has been satisfied, and recognize revenue in accordance with the new requirements. The new standard is effective for us on January 1, 2017. Early adoption is not permitted. The standard allows for either "full retrospective" adoption, meaning the standard is applied to all of the periods presented, or "modified retrospective" adoption, meaning the standard is applied only to the most current period presented in the financial statements. We are currently evaluating the transition method that will be elected.

 

In June 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2014-12 Compensation - Stock Compensation ("ASU 2014-12"). ASU2014-12 is intended to resolve diverse accounting treatment for share based awards in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The standard is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015 and may be applied prospectively or retrospectively. The Company does not expect adoption of this standard will have a significant impact on the Company's consolidated financial statements.

 

15
 

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with the unaudited historical financial statements and the related notes and the other financial information included elsewhere in this report and in the Company’s annual report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2014. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of any number of factors, including those set forth under “Information Concerning Forward-Looking Statements” and under other captions contained elsewhere in this report.

 

Company Overview

 

During 2013, we continued our product development, with most of such efforts directed at our Power on Demand system and Mobile Renewable Power Station. We continued further development and product enhancement on our products in 2014, primarily our Power on Demand system, and expect to continue to do so during the remainder of 2014 and 2015. In 2013 and 2014, we continued to sell solar PV systems to residential and commercial customers and also perform development services for the U.S. Army.

 

In May 2013, we entered into an Agreement with City Lights at Queens Landing, Inc. pursuant to which City Lights has agreed to purchase a Power on Demand system for installation and use at City Lights’ 43-story, 525-unit, cooperative building located in Long Island City, New York. The City Lights Building is managed by Rose Associates, Inc., a New York-based full service real estate firm. Separately, City Lights intends to purchase and has installed a combined heating and power co-generation system at the City Lights Building. The Power on Demand system will consist of a micro-grid that will include the integration of the newly installed solar PV, the newly installed CHP co-generation system, energy storage and power distribution.  This represents the Company’s first sale of a Power on Demand system to be installed in the New York City area.  We expect the Power on Demand system to be installed in the first quarter of 2015. We continue to market the Power on Demand system, primarily in the New York City market.

 

Since 2012, we have been awarded $1.8 million in U.S. Army contracts to be the prime contractor to complete Phase One and Phase Two activities to develop an Intelligent Micro-Grid for the Renewable Energy for Distributed Under-Supplied Command Environments (“REDUCE”) program under the guidance of the U.S. Army Communications-Electronics Research, Development and Engineering Center. In the latter half of September 2012, we completed Phase One activities. Work commenced on Phase Two late in 2012, which was completed in the second quarter of 2014. In September 2013, the Company was awarded a single vendor contract valued at $625,000 to continue development under this contract, which followed the completion of Phase Two beginning in the second quarter of 2014. The Company believes that the micro-grid that it is developing for the U.S. Army will complement the development of the products that it will sell to commercial, military and governmental customers.

 

In November 2013, we partnered with EaglePicher Technologies by integrating the EPT’s Power Pyramid™ system into the Power on Demand system to be installed at the City Lights building in Long Island City, NY.

 

16
 

 

Results of Operations

 

Results of Operations for Quarter Ended September 30, 2014 Compared to Quarter Ended September 30, 2013.

 

Revenues

 

During the quarter ended September 30, 2014, we reported revenues of $250,000 as compared with revenues of $579,000 for the quarter ending September 30, 2013.  The decrease in sales is due to the increased sales and marketing efforts on our Power on Demand products which typically have a larger sales cycle than our solar products. We have received deposits from customers for solar PV systems totaling approximately $19,000 as of September 30, 2014. We expect to realize sales associated with these deposits during the next several quarters, as we obtain permits and zoning approvals from customers’ town officials and NYSERDA for solar PV installations, complete site assessments, and complete installations and inter-connection agreements, although there can be no assurance that we will be able to meet this schedule.

 

Gross Margin (loss)

 

For the quarter ended September 30, 2014, gross margin amounted to a loss of $173,000 as compared to a loss of $640,000 for the quarter ended September 30, 2013.  The gross loss resulted from the recognition of an expected loss relating to the Power on Demand installation expected to be commissioned in the first quarter of 2015. The gross margin on other projects continue to be small due to the costs associated with maintaining an operations staff, responsible for not only solar products and Power on Demand systems, but also for troubleshooting customer issues, inventory management, and maintaining day–to-day operations. Gross margin improved mostly due to the recognition of the majority of the expected loss in 2013 and to a lesser extent to the reduction of staff in 2014. We recognized an additional expense of $200,000 for the loss on the Power on Demand project in the third quarter of 2014.

 

Research and Development

 

Research and development costs for the quarter ended September 30, 2014 totaled $0 as compared to $64,000 for the quarter ended September 30, 2013. These costs have ceased due to the staff reductions.

 

Selling, General and Administrative

 

Selling, general and administrative expenses amounted to $341,000 for the quarter ended September 30, 2014, as compared to $463,000 for the quarter ended September 30, 2013.  The decrease over the prior year was related primarily to the reduced salary and headcount related expenses as compared to 2013.

 

Depreciation and Amortization

 

Depreciation and amortization charges were $9,000 for the quarter ended September 30, 2014, compared to $15,000 during the quarter ended September 30, 2013 due to a lower depreciable asset base in 2014.

 

Other Income (Expense)

 

Interest expense for the quarter ended September 30, 2014 was $112,000, as compared to an expense of $112,000 for the quarter ended September 30, 2013.

 

In 2013, we recorded derivative liabilities associated with the issuance of warrants for (1) a lease modification with our existing landlord, (2) an advisory agreement with Sunrise Financial Group, LLC and (3) in conjunction with our private placement funding which occurred during the third quarter of 2013 and in the first quarter of 2014. In June 2014 the advisory agreement with Sunrise Financial Group was terminated and its accompanying warrants were cancelled. The warrants do not have a fixed settlement provision because their exercise prices may be lowered if the Company issues securities at lower prices in the future. Accordingly, the Company revalues these derivative liabilities each quarter, and the financial statements reflect a gain on the revaluation of the derivative liabilities for the third quarter of 2014 of $1,150,000, as compared to $238,000 for the quarter ended September 30, 2013.

 

The Company made no tax payments during the quarters ending September 30, 2014 and 2013.

 

17
 

 

Net Income/(Loss)

 

We reported net income of $524,000 for the quarter ended September 30, 2014 and a net loss of $1,042,000 for the quarter ended September 30, 2013.  Operating losses of amounted to $514,000 and $1,168,000 for the quarter ended September 30, 2014 and 2013 respectively due to decreased operating expenses for the quarter ended September 30, 2014 as compared to the quarter ended September 30, 2013. Increases in net income for the three months ended September 30, 2014 compared to the quarter ended September 30, 2013 were due to recording an unrealized gain of $1,150,000 on the change in fair value of derivative liabilities for the quarter ended September 30, 2014, as compared to an unrealized gain of $238,000 for the quarter ended September 30, 2013.

 

Results of Operations for the Nine Months Ended September 30, 2014 Compared to the Nine Months Ended September 30, 2013.

 

Revenues

 

During the nine months ended September 30, 2014, we reported revenues of $542,000 as compared with revenues of $1,016,000 for the nine months ending September 30, 2013.  The decrease in sales is due to the increased sales and marketing efforts to market our Power on Demand products which typically have a larger sales cycle than our solar products. We have received deposits from customers for solar PV systems totaling approximately $19,000 as of September 30, 2014. We expect to realize sales associated with these deposits during the next several quarters, as we obtain permits and zoning approvals from customers’ town officials and NYSERDA for solar PV installations, complete site assessments, and complete installations and inter-connection agreements, although there can be no assurance that we will be able to meet this schedule.

  

Gross Margin/Loss

 

For the nine months ended September 30, 2014, gross margin amounted to a loss of $112,000 as compared to a loss of $725,000 for the nine months ended September 30, 2013.  The gross loss resulted from the recognition of an expected loss relating to the Power on Demand installation expected to be commissioned in the first quarter of 2015. The gross margin on other projects continue to be small due to the costs associated with maintaining an operations staff, responsible for not only solar products and Power on Demand systems, but also for troubleshooting customer issues, inventory management, and maintaining day-to-day operations. Gross margin improved mostly due to the recognition of the majority of the expected loss in 2013 and to a lesser extent to the reduction of staff in 2014. We also recognized an additional expense of $200,000 for the loss on the Power on Demand project in 2014.

 

Research and Development

 

Research and development costs for the nine months ended September 30, 2014 totaled $0 as compared to $320,000 for the nine months ended September 30, 2013. This decrease results from lower salaries due to reduced headcount.

 

Selling, General and Administrative

 

Selling, general and administrative expenses amounted to $1,190,000 for the nine months ended September 30, 2014, as compared to $1,829,000 for the nine months ended September 30, 2013.  The decrease over the prior year was related primarily to reduced salary and headcount related expenses partially offset by higher consulting and legal expense in 2014 as compared to 2013.

 

Depreciation and Amortization

 

Depreciation and amortization charges were $33,000 for the nine months ended September 30, 2014, compared to $49,000 during the nine months ended September 30, 2013 due to a lower depreciable asset base in 2014.

 

Other Income (Expense)

 

Interest expense for the nine months ended September 30, 2014 was $336,000, as compared to an expense of $518,000 for the nine months ended September 30, 2013. The decrease is due to the amortization of deferred debt discount relating to the Company’s line of credit over an extended period as of September 30, 2014 due to the deferral of the loan due date in May 2013 to December 2014 from December 2013.

 

In 2013, we recorded derivative liabilities associated with the issuance of warrants for (1) a lease modification with our existing landlord, (2) an advisory agreement with Sunrise Financial Group, LLC and (3) in conjunction with our private placement funding which occurred during the third quarter of 2013 and in the first quarter of 2014. In June 2014 the advisory agreement with Sunrise Financial Group was terminated and its accompanying warrants were cancelled. The warrants do not have a fixed settlement provision because their exercise prices may be lowered if the Company issues securities at lower prices in the future. Accordingly, the Company revalues these derivative liabilities each quarter, and the financial statements reflect a gain on the revaluation of the derivative liabilities for the nine months ended September 30, 2014 of $3,240,000, as compared to $219,000 for the nine months ended September 30, 2013.

 

The Company paid $1,500 in tax payments during the nine months ending September 30, 2014 and received a net tax credit of $103,000 in the nine months ended September 30, 2013. 

 

18
 

 

Net Income (Loss)

 

We reported net income of $1,600,000 for the nine months ended September 30, 2014 and a net loss of $3,070,000 for the nine months ended September 30, 2013.  Operating losses of amounted to $1,303,000 and $2,874,000 for the nine months ended September 30, 2014 and 2013, respectively, due to decreased operating expenses, mostly resulting from the reduction of our staff, as well as better gross margins for the nine months ended September 30, 2014 as compared to the nine months ended September 30, 2013.  Increases in net income for the nine months ended September 30, 2014 compared to the nine months ended September 30, 2013 were due to recording an unrealized gain of $3,240,000 on the change in fair value of derivative liabilities for the nine months ended September 30, 2014, as compared to $219,000 for the nine months ended September 30, 2013, as well as the improved net operating loss.

 

Liquidity and Capital Resources

 

As of September 30, 2014, our accumulated deficit totaled $25 million.

 

We had a working capital deficit of approximately $1,098,000 as of September 30, 2014 as compared to working capital deficit of $1,157,000 as of December 31, 2013. The decrease in working capital relates to the operating loss for the nine months ended September 30, 2014 offset by the proceeds received from the March 2014 private placement which provided the company working capital of $1.4 million.

 

On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company’s common stock at a conversion price of $0.20 in stated value per share, and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. The Company received a total of $1,400,000 in net proceeds from the sales.  Each share of preferred stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly.  The preferred stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of preferred stock outstanding on March 31, 2017 automatically converting into common stock.  The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015.  In addition, the investors received “most favored nation” protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding.  Additionally, until September 30, 2015, each investor has the right to invest the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment provision.

 

We believe that we will require additional funding of approximately $2.0 million to satisfy our operating cash needs and our anticipated growth for the next twelve months.

 

Due to the uncertainty of our ability to meet our current operating expenses, in their report on our audited annual financial statements as of and for the years ended December 31, 2013 and 2012, our independent auditors included an explanatory paragraph regarding concerns about our ability to continue as a going concern. Our financial statements contain additional note disclosures describing the circumstances that led to this disclosure by our independent auditors. There is substantial doubt about our ability to continue as a going concern as the continuation and expansion of our business is dependent upon obtaining further financing, successful and sufficient market acceptance of our products, and achieving a profitable level of operations.

 

The issuance of additional equity securities by us may result in a significant dilution in the equity interests of our current shareholders. Obtaining commercial loans, assuming those loans would be available, will increase our liabilities and future cash commitments. There is no assurance that we will be able to obtain further funds required for our continued operations or that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due and we will be forced to scale down or perhaps even cease our operations.

 

Operating Activities

 

Our operating activities used net cash of $1,335,000 for the nine months ended September 30, 2014, as compared to $1,024,000 for the nine months ended September 30, 2013.  For the nine months ended September 30, 2014, cash used in operations resulted from net income of $1,600,000, offset by non-cash adjustments which consist of an increase of $3,240,000 gain in fair value of derivative liabilities and reduced by $651,000 consisting primarily of $171,000 of stock based compensation, the amortization of debt discount of $256,000, and $171,000 from the issuance of warrants for services. Net changes to working capital amounted to negative $340,000 and were primarily due to payments of accounts payable and accrued liabilities. For the nine months ended September 30, 2013, cash used in operations resulted from a net loss of $3,070,000 reduced by non-cash expenses of $1,815,000 consisting primarily of $651,000 of stock based compensation, stock and warrants issued for rent and services of $230,000 and the amortization of debt discount of $441,000.  Net changes to working capital for the nine months ended September 30, 2103 amounted to $231,000 due primarily to decreases in trade accounts receivable and increases in customer deposits offset by decreases in accounts payable and accrued expenses.

 

19
 

 

Investing Activities

 

The Company received $18,500 from a sale of a truck for the nine months ended September 30, 2014 and did not utilize any funds for investing activities for the nine months ended September 30, 2013.

 

Financing Activities

 

Our financing activities provided $1,391,000 and $1,506,000 for the nine months ended September 30, 2014 and 2013, respectively. In 2014, the Company raised $1,500,000 in the sale of convertible preferred stock, with offering costs amounting to $100,000.  For the nine months ended September 30, 2013, the Company raised $1,245,000 of net proceeds from issuance of common stock and drew $270,000 from its line of credit. Repayments on long term debt were $28,000 and $9,000, respectively for the nine months ended September 30, 2014 and 2013.

  

Off-Balance Sheet Arrangements

 

We have no significant off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to shareholders.

 

Critical Accounting Policies

 

As of September 30, 2014, the Company’s critical accounting policies and estimates have not changed materially from those set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, filed on March 31, 2014 with the Securities and Exchange Commission.

 

In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-15, Presentation of Financial Statements - Going Concern. The new standard required management of public and private companies to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, disclose that fact. Management will also be required to evaluate and disclose whether its plans alleviate that doubt. The new standard is effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early adoption is permitted. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.

In May 2014, the "FASB" issued ASU 2014-09 Revenue from Contracts with Customers, which will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The standard's core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. We are carefully evaluating our existing revenue recognition practices to determine whether any contracts in the scope of the guidance will be affected by the new requirements. The effects may include identifying performance obligations in existing arrangements, determining the transaction price and allocating the transaction price to each separate performance obligation. We will also establish practices to determine when a performance obligation has been satisfied, and recognize revenue in accordance with the new requirements. The new standard is effective for us on January 1, 2017. Early adoption is not permitted. The standard allows for either "full retrospective" adoption, meaning the standard is applied to all of the periods presented, or "modified retrospective" adoption, meaning the standard is applied only to the most current period presented in the financial statements. We are currently evaluating the transition method that will be elected.

In June 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2014-12 Compensation - Stock Compensation ("ASU 2014-12"). ASU2014-12 is intended to resolve diverse accounting treatment for share based awards in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The standard is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015 and may be applied prospectively or retrospectively. The Company does not expect adoption of this standard will have a significant impact on the Company's consolidated financial statements.

 Information Concerning Forward-Looking Statements

 

All statements in this Form 10-Q, future filings by the Company with the Securities and Exchange Commission (“Commission”), the Company’s press releases and oral statements by authorized officers of the Company, other than statements of historical facts, that address future activities, events or developments are “forward-looking statements.”

 

These forward-looking statements include, but are not limited to, statements relating to our anticipated financial performance, business prospects, new developments, new merchandising strategies and similar matters, and/or statements preceded by, followed by or that include the words “believes,” “could,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “projects,” “seeks,” or similar expressions. We have based these forward-looking statements on certain assumptions and analyses made by us in light of our experience and on our assessment of historical trends, current conditions, expectations, and projections about expected future developments and events, as well as on other factors we believe are appropriate under the circumstances and other information currently available to us. These forward-looking statements are subject to risks, uncertainties and assumptions, including those described under the heading “Risk Factors” in Item 1A of Part I of the Company’s 10-K filed with the Commission, for the fiscal year ended December 31, 2013, that may affect the operations, performance, development and results of our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date hereof.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties. All forward-looking statements and reasons why results may differ contained herein are made as of the date hereof, and we assume no obligation to update any such forward-looking statement or reason why actual results might differ. All of the forward-looking statements contained herein are qualified by these cautionary statements.

 

20
 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

None.

 

Item 4. Controls and Procedures

 

The Company’s management has established disclosure controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within time periods specified in the SEC rules and forms. Such disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.

 

Based on the evaluation of the effectiveness of our disclosure controls and procedures, our Chief Executive Officer and Acting Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2014.

 

There can be no assurance, however, that our disclosure controls and procedures will detect or uncover all failures of persons within the Company to disclose material information otherwise required to be set forth in our periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in the Company’s internal control over financial reporting that occurred during the nine months ended September 30, 2014 that has materially affected, or is likely to materially affect, the Company’s internal control over financial reporting.

 

Part II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

There were no reportable events during the quarter.

 

Item 1A. Risk Factors

 

Smaller reporting companies are not required to provide the information required by this item.

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

 

On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000, that are convertible into shares of the Company’s common stock at a conversion price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. Stock offering costs for the private placement amounted to $100,000. Each share of preferred stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly. The preferred stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of preferred stock outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally, until September 30, 2015, each investor has the right to invest the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment provision.

 

On March 31, 2014, in conjunction with the full ratchet and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional 1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the price for the 3,060,000 warrants outstanding that were associated with this transaction were reset from $0.30 to $0.25 per share.

 

We registered the resale of the securities sold in the March 31, 2014 private placement pursuant to a registration statement on Form S-1 that was filed with the Securities and Exchange Commission on April 30, 2014 and was declared effective on May 13, 2014.

 

21
 

 

The terms of sales of unregistered sales of securities by us are described in Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities under the captions “Recent Unregistered Sales of Securities”.

 

The securities referenced above were issued in reliance upon the exemption from securities registration afforded by the provisions of Section 4(2) of the Securities Act of 1933, as amended (“Securities Act”), and/or Regulation D, as promulgated by the U.S. Securities and Exchange Commission under the Securities Act, based upon the following: (a) each of the persons to whom the securities were issued (each such person, an “Investor”) confirmed to the Company that it or he is an “accredited investor,” as defined in Rule 501 of Regulation D promulgated under the Securities Act and has such background, education and experience in financial and business matters as to be able to evaluate the merits and risks of an investment in the securities, (b) there was no public offering or general solicitation with respect to the offering of such units, (c) each Investor was provided with certain disclosure materials and all other information requested with respect to the Company, (d) each Investor acknowledged that all securities being acquired were being acquired for investment intent and were “restricted securities” for purposes of the Securities Act, and agreed to transfer such securities only in a transaction registered under the Securities Act or exempt from registration under the Securities Act and (e) a legend has been, or will be, placed on the certificates representing each such security stating that it was restricted and could only be transferred if subsequently registered under the Securities Act or transferred in a transaction exempt from registration under the Securities Act.

 

Item 3.  Defaults Upon Senior Securities

 

None.

 

Item 4.  Mine Safety Disclosures

 

Not Applicable.

 

Item 5.  Other Information

 

None

 

Item 6.

 

(a)   Exhibits:  
       
    31.1 Certification of the Chief Executive Officer Pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
       
    31.2 Certification of the Acting Chief Financial Officer Pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
       
    32.1 Certification Pursuant to 18 U.S.C. Section 1350 by the Chief Executive Officer, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
       
    32.2 Certification Pursuant to 18 U.S.C. Section 1350 by the Acting Chief Financial Officer, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

22
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ARISTA POWER, INC.
     
November 14, 2014    
  By: /s/ William A. Schmitz
    William A. Schmitz
    President and Chief Executive Officer
     
  By: /s/ Stephen Brown
    Stephen Brown
    Acting Chief Financial Officer,
Principal Financial Officer and
Principal Accounting Officer

 

 

 

23


 

 

 

EX-31.1 2 f10q0914ex31i_aristapowerinc.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 Exhibit 31.1

 

Certification of Chief Executive Officer

as required by Rule 13a-14 Or 15d-14 of the Securities Exchange Act of 1934, 

 as adopted pursuant to Section 302 of The Sarbanes-Oxley Act of 2002

 

I, William A. Schmitz, certify that:

 

1.      I have reviewed this quarterly report on Form 10-Q of Arista Power, Inc.;

 

2.      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.      The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.      The registrant 's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant 's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

  Date:  November 14, 2014
   
  /s/ William A. Schmitz
  William A. Schmitz
  President and Chief Executive Officer

EX-31.2 3 f10q0914ex31ii_aristapower.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER

Exhibit 31.2

 

Certification of Chief Financial Officer

as required by Rule 13a-14 Or 15d-14 of the Securities Exchange Act of 1934,

as adopted pursuant to Section 302 of The Sarbanes-Oxley Act of 2002

 

I, Stephen Brown, certify that:

 

1.      I have reviewed this quarterly report on Form 10-Q of Arista Power, Inc.;

 

2.      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.      The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.      The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

  Date: November 14, 2014
   
  /s/ Stephen Brown
 

Steven Brown,

Acting Chief Financial Officer

EX-32.1 4 f10q0914ex32i_aristapower.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

Exhibit 32.1

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of Arista Power, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William A. Schmitz, as Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 to the best of my knowledge, that:

 

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

  Date:  November 14, 2014
   
  /s/ William A. Schmitz
  William A. Schmitz
  President and Chief Executive Officer

EX-32.2 5 f10q0914ex32ii_aristapower.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

Exhibit 32.2

 

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of Arista Power, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen Brown, as Acting Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 to the best of my knowledge, that:

 

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

  Date: November 14, 2014
   
  /s/ Stephen Brown
  Stephen Brown
  Acting Chief Financial Officer

EX-101.INS 6 aspw-20140930.xml XBRL INSTANCE FILE 0001424640 2011-12-31 0001424640 2012-09-04 0001424640 2012-09-01 2012-09-04 0001424640 2012-09-30 0001424640 2012-11-13 0001424640 2012-12-21 0001424640 2012-12-18 2012-12-21 0001424640 2012-12-31 0001424640 us-gaap:CommonStockMember 2012-12-31 0001424640 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001424640 us-gaap:RetainedEarningsMember 2012-12-31 0001424640 2013-03-31 0001424640 2013-06-30 0001424640 2013-07-01 2013-09-30 0001424640 2013-01-01 2013-09-30 0001424640 us-gaap:WarrantMember 2013-01-01 2013-09-30 0001424640 us-gaap:StockOptionMember 2013-01-01 2013-09-30 0001424640 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-09-30 0001424640 us-gaap:WarrantMember 2013-01-01 2013-09-30 0001424640 us-gaap:WarrantMember aspw:ConsultantMember 2013-01-01 2013-09-30 0001424640 2013-09-30 0001424640 us-gaap:WarrantMember 2013-09-30 0001424640 2013-12-31 0001424640 us-gaap:CommonStockMember 2013-12-31 0001424640 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001424640 us-gaap:RetainedEarningsMember 2013-12-31 0001424640 us-gaap:WarrantMember 2013-12-31 0001424640 us-gaap:EmployeeStockOptionMember 2013-12-31 0001424640 us-gaap:RestrictedStockMember 2013-12-31 0001424640 us-gaap:PreferredStockMember 2013-12-31 0001424640 us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0001424640 us-gaap:ChiefOperatingOfficerMember 2014-01-01 2014-03-31 0001424640 us-gaap:CommonStockMember 2014-03-31 0001424640 us-gaap:AdditionalPaidInCapitalMember 2014-03-31 0001424640 us-gaap:RetainedEarningsMember 2014-03-31 0001424640 us-gaap:PreferredStockMember 2014-03-31 0001424640 aspw:EmployeeMember 2014-05-01 2014-05-28 0001424640 aspw:StephenBrownMember 2014-06-01 2014-06-16 0001424640 aspw:StephenBrownMember aspw:VestingPeriodTwoMember 2014-06-01 2014-06-16 0001424640 2014-07-01 2014-09-30 0001424640 2014-01-01 2014-09-30 0001424640 us-gaap:CommonStockMember 2014-01-01 2014-09-30 0001424640 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-09-30 0001424640 us-gaap:RetainedEarningsMember 2014-01-01 2014-09-30 0001424640 us-gaap:WarrantMember 2014-01-01 2014-09-30 0001424640 us-gaap:StockOptionMember 2014-01-01 2014-09-30 0001424640 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0001424640 us-gaap:WarrantMember 2014-01-01 2014-09-30 0001424640 us-gaap:WarrantMember aspw:ConsultantMember 2014-01-01 2014-09-30 0001424640 us-gaap:RestrictedStockMember 2014-01-01 2014-09-30 0001424640 us-gaap:PreferredStockMember 2014-01-01 2014-09-30 0001424640 us-gaap:FairValueMeasurementsRecurringMember 2014-01-01 2014-09-30 0001424640 us-gaap:DirectorMember 2014-01-01 2014-09-30 0001424640 aspw:SecuritiesPurchaseAgreementMember 2014-01-01 2014-09-30 0001424640 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0001424640 us-gaap:WarrantMember 2014-01-01 2014-09-30 0001424640 us-gaap:PrivatePlacementMember aspw:SecuritiesPurchaseAgreementMember 2014-01-01 2014-09-30 0001424640 us-gaap:ConvertiblePreferredStockMember aspw:SecuritiesPurchaseAgreementMember 2014-01-01 2014-09-30 0001424640 us-gaap:ConvertiblePreferredStockMember 2014-01-01 2014-09-30 0001424640 aspw:VestingPeriodOneMember 2014-01-01 2014-09-30 0001424640 aspw:VestingPeriodThreeMember 2014-01-01 2014-09-30 0001424640 us-gaap:MaximumMember 2014-01-01 2014-09-30 0001424640 us-gaap:MinimumMember 2014-01-01 2014-09-30 0001424640 2014-09-30 0001424640 us-gaap:CommonStockMember 2014-09-30 0001424640 us-gaap:AdditionalPaidInCapitalMember 2014-09-30 0001424640 us-gaap:RetainedEarningsMember 2014-09-30 0001424640 us-gaap:WarrantMember 2014-09-30 0001424640 us-gaap:EmployeeStockOptionMember 2014-09-30 0001424640 us-gaap:WarrantMember 2014-09-30 0001424640 us-gaap:WarrantMember aspw:ConsultantMember 2014-09-30 0001424640 us-gaap:RestrictedStockMember 2014-09-30 0001424640 us-gaap:PreferredStockMember 2014-09-30 0001424640 us-gaap:FairValueMeasurementsRecurringMember 2014-09-30 0001424640 aspw:SecuritiesPurchaseAgreementMember 2014-09-30 0001424640 us-gaap:ConvertiblePreferredStockMember 2014-09-30 0001424640 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0001424640 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0001424640 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0001424640 2014-11-14 0001424640 us-gaap:ConvertiblePreferredStockMember 2014-11-14 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure Arista Power, Inc. 0001424640 false --12-31 10-Q 2014-09-30 2014 Q3 Smaller Reporting Company 20979877 1360 297385 353166 265245 143103 232570 101717 496313 496313 820750 820750 2112263 1915049 172362 139344 25305 23796 69555 19080 2379485 2097269 1175221 487192 684994 941248 19000 18850 146465 54763 63311 318977 140074 142504 496011 442640 519092 542842 0 63675 13200 0 11782 277 3269150 3012968 16169 0 762396 556070 778565 556070 4047715 3569038 0 3 35987 39784 25330474 23923613 -27034691 -25435169 24813 24038807 -23761751 -1668230 35987 25330474 -27034690 0 38497 23778389 -27786979 3 -1471769 39784 23923613 -25435169 3 2379485 2097269 0 0 5000000 5000000 0.002 0.002 0 1415 0 1415 500000000 500000000 0.002 0.002 17993694 19892264 17993694 19892264 578689 1015949 250231 541675 1219094 1740939 423487 654038 -640405 -724990 -173256 -112363 63639 320341 0 0 463492 1828753 341237 1190233 527131 2149094 341237 1190233 -1167536 -2874084 -514493 -1302596 112498 518428 111900 336419 237538 218968 1149696 3240052 -1042496 -3173544 523303 1601037 -0 -103471 -360 1515 -1042496 -3070073 523663 1599522 1599522 0 0 32288 86557 -1042496 -3070073 491375 1512965 -0.06 -0.21 0.02 0.08 17793694 14462909 19892264 19352887 -0.06 -0.21 0.02 0.06 17793694 14462909 29248946 24354789 48769 33076 111114 650505 59147 171141 0 33018 0 157593 92470 0 86674 441228 85732 256254 3699 0 137496 0 0 5592 20486 92351 26740 -305482 -122142 -57133 0 81028 -150 -28900 255666 638850 23750 -90919 -714673 -1024065 -1335045 1245000 0 0 1500000 0 -100000 -100000 270000 0 -8705 -27674 1506295 1372326 0 18500 0 18500 482230 55781 371132 55533 78253 56199 501 560483 297385 353166 -103471 1515 1402 3409 0 3020526 0 -2868750 0 -151776 157903 110000 270000 0 746332 0 0 22881 0 6000 12406633 17993694 0 19248694 1500 19892264 1415 1500000 1499997 3 1500 -2868750 -2868750 -151776 2510 -154286 1255000 110000 880 109120 440000 22881 1120 21761 560237 -85 171141 20 171121 10000 0 -733 733 -366667 -86557 -86557 <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Note 1 &#8211; Description of Business and Summary of Significant Accounting Policies</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Description of Business</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Arista Power, Inc. (the &#8220;Company&#8221;) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions, Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power, Inc. The name change more accurately reflects the broadening of the Company&#8217;s focus beyond the WindTamer&#174; brand and entry into areas within the energy storage and power management industries.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer of solar energy systems.&#160;&#160;The Company&#8217;s patented Power on Demand system utilizes inputs from multiple energy sources including solar, wind, fuel cells, generators, and/or the grid, in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy users.&#160;The Company also designs, sells and installs residential and commercial solar PV systems.&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Basis of Preparation</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q.&#160;&#160;Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.&#160;&#160;Operating results for the three-month and nine-month periods ended September 30, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.&#160;&#160;These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Company&#8217;s Form 10-K for the fiscal year ended December 31, 2013.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Method of Accounting</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The accompanying financial statements have been prepared in accordance with GAAP.&#160;&#160;Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Use of Estimates</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Cash and Cash Equivalents</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.&#160;&#160;The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.&#160; The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Accounts Receivable</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.&#160;&#160;We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.&#160;&#160;As of September 30, 2014 and December 31, 2013, the allowance for doubtful accounts was $0.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Inventory</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (&#8220;PV&#8221;) systems, and is stated at the lower of cost or market value.&#160;&#160;The Company capitalizes applicable direct and indirect costs incurred in the Company&#8217;s manufacturing operations to bring its products to a sellable state.&#160;&#160;The inventory as of September 30, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.&#160;&#160;Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.&#160;&#160;As of September 30, 2014 and December 31, 2013, no reserve was necessary.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Fixed Assets</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Fixed assets are recorded at cost.&#160;&#160;Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.&#160;&#160;Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.&#160;&#160;Expenditures for renewals and betterments are capitalized.&#160;&#160;Expenditures for minor items, repairs and maintenance are charged to operations as incurred.&#160; Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Intangible Assets</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Intangible assets consist of costs associated with the application and acquisition of the Company&#8217;s patents.&#160;&#160;Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three and nine months ended September 30, 2013, trademark costs totaling $0 and $3,396, respectfully relating to the Company&#8217;s WindTamer&#174; trademark were impaired, while no intangible assets were impaired for the three and nine months ended September 30, 2014.&#160;&#160;&#160;&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Impairment of Long-Lived Assets</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.&#160;&#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.&#160;&#160;Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.&#160;&#160; For the three and nine months ended September 30, 2014 and 2013, no assets were impaired.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Fair Value of Financial Instruments</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Revenue Recognition</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Revenue is recognized when all of the following conditions are satisfied:&#160;&#160;(1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.&#160;&#160;Amounts&#160;collected prior to satisfying our revenue recognition policy are reflected as customer deposits.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.&#160;&#160;The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company uses contract accounting for Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">At September 30, 2014, the Company had costs of uncompleted contracts in excess of related billings totaling $96,008 ($0 as of September 30, 2013). This amount was netted with the accrued loss contract on the Company&#8217;s balance sheet.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Research and Development Costs</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">All costs related to research and development are expensed when incurred.&#160;Research and development costs consist of expenses associated with the development of the Company&#8217;s Power on Demand system and the Mobile Renewable Power Station.&#160;&#160;Specifically, these costs consist of labor, materials, and consulting.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Warranty Costs</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company&#8217;s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.&#160;&#160;Several warranties have specific additional terms and conditions.&#160;&#160;The Company provides for estimated cost of warranties at the time the revenue is recognized.&#160;&#160;Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer&#8217;s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Stock-Based Compensation</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company accounts for stock option awards granted under the Company&#8217;s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.&#160;&#160;Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.&#160;&#160;The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option&#8217;s expected term and the price volatility of the underlying stock.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company&#8217;s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.&#160;&#160;Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i)&#160;the date at which a commitment for performance by the consultant or vendor is reached or (ii)&#160;the date at which the consultant&#8217;s or vendor&#8217;s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Income Taxes</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.&#160;&#160;This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.&#160;&#160;Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.&#160;&#160;Deferred income tax expense represents the change in net deferred assets and liability balances.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><b>&#160;</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Basic and Diluted Loss Per Share</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.&#160;&#160;Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.&#160;&#160;In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">As of September 30, 2014, 1,415 shares of our Series A Convertible Preferred Stock, convertible into 7,075,000 shares of common stock, 2,455,191 stock options and 18,292,916 warrants were outstanding which, upon exercise, could dilute future earnings per share. Diluted Weighted Average Shares reflect the Company&#8217;s total weighted average shares outstanding during the period, which includes the conversion of the Series A Convertible Preferred Stock as well as any stock options or warrants in which the exercise price is below the Company&#8217;s stock trading price, less the stock that can be repurchased with funds received from such exercise.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Note 2 - Going Concern</b></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The financial statements have been prepared assuming that the Company will continue as a going concern.&#160;&#160;Since its formation, the Company utilized funds generated from private placement offerings and debt to fund its product development and operations and has incurred a cumulative net loss of $25,435,169 as of September 30, 2014.&#160; The recurring losses from operations and current liquidity raise substantial doubt about the Company&#8217;s ability to continue as a going concern.&#160;&#160;Continuation of the Company is dependent on achieving sufficiently profitable operations and obtaining additional financing.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Note 3 &#8211; Debt</b></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">On September 4, 2012, the Company entered into an unsecured loan agreement with TMK-ENT, Inc. that provided for a $500,000 working capital revolving line of credit.&#160;&#160;Advances under the line of credit bear interest at 10% per year, payable annually. On November 13, 2012, the Company amended its loan agreement to increase the revolving line of credit from $500,000 to $750,000, and on December 21, 2012 amended its loan agreement to increase the revolving credit from $750,000 to $1,250,000.&#160;&#160;The note matures on December 21, 2014. Borrowings under the line of credit amount to $1,018,500 as of September 30, 2014 and December 31, 2013. In conjunction with the line of credit facility, the Company issued 1,250,000 warrants to purchase the Company&#8217;s common stock at varying prices from $1.38 to $1.62 per share. The warrants vested one year from issuance and have a ten year term. The fair market value of the warrants at grant date was determined utilizing the Black Scholes option pricing model and amounted to $1,839,250. The difference between the fair market value of the warrants and draws on the line of credit is $820,750 as of September 30, 2014 and December 31, 2013, which is recorded as deferred debt discount.&#160;&#160;The deferred debt discount will be recognized and recorded as debt discount as the Company continues to borrow against the line of credit. Debt discount costs will be recognized as the Company draws down the available line of credit, and will be amortized over the remaining term of the loan. As a result of the amortization of the debt discount, the Company expensed $256,254 and $441,228, respectively, for the nine months ended September 30, 2014 and 2013 and $85,732 and $86,674 for the three months ended September 30, 2014 and 2013.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Annual maturities of debt are as follows:</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px; text-align: left;">2014 (includes TMK-ENT, Inc. line of credit repayment)</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">1,018,777</td><td style="width: 15px; text-align: left;">&#160;</td></tr></table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Note 4 &#8211; Stockholders&#8217; Equity</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company&#8217;s common stock at a conversion price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. Stock offering costs for the private placement amounted to $100,000. Each share of Preferred Stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly. The Preferred Stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of Preferred Stock outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally, until September 30, 2015, each investor has the right to invest an amount equal to the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a &#8220;full ratchet&#8221; anti-dilution adjustment provision. The warrants associated with this transaction were valued at their date of issue utilizing the Black-Scholes option pricing model, which amounted to $2,868,750.&#160;&#160;The difference between the warrants valuation of $2,878,560 and the net proceeds received by the Company of $1,400,000 results in a deemed dividend of $1,468,750, which has been charged to additional paid-in-capital, as the Company has no retained earnings from which to declare a dividend.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">On March 31, 2014, in conjunction with the full ratchet and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional 1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the exercise price for the 3,060,000 warrants outstanding that were associated with this transaction were reduced from $0.30 to $0.25 per share.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Note 5 &#8211; Stock Based Compensation</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company has established the 2008 Equity Incentive Plan, which is a shareholder-approved plan that permits the granting of stock options and restricted stock to employees, directors and consultants.&#160;&#160; The 2008 Equity Incentive Plan provides for the issuance of up to 3,550,000 shares of common stock of which 50,000 shares are available for grant as Incentive Stock Options.&#160;&#160;The exercise price for options awarded is no less than 100% of the fair market value of the common stock on the day of grant.&#160;&#160;The options generally vest either immediately on the date of grant or one to three years from the date of grant.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">For the three and nine months ended September 30, 2014, the Company recorded compensation costs for options and warrants of $59,147 and $171,141 respectively, as compared to $111,114 and $650,505 for the nine and three months ended September 30, 2013. For the nine months ended September 30, 2013, compensation costs relating to the issuance of options and warrants amounted to $539,926 and the Company recorded an expense of $110,579 associated with the repricing of options and warrants held by a former consultant/outside counsel who is now an employee of the Company, while for the nine months ended September 30, 2014, there was no expense associated with the repricing of options or warrants.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company has valued the options at their date of grant utilizing the Black Scholes option pricing model.&#160;&#160;Prior to the fourth quarter of 2009, there was not a public market for the Company shares.&#160;&#160;Accordingly, the fair value of the underlying shares was determined based on recent transactions by the Company to sell shares to third parties and other factors determined by management to be relevant to the valuation of such shares.&#160;&#160;Beginning in the fourth quarter of 2009, the quoted price for the Company&#8217;s shares on the OTCBB or the OTCQB, as applicable, was used to value the underlying shares.&#160;&#160;Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry.&#160;&#160;The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options depending on the date of the grant and expected life of the options.&#160;&#160;The expected life of options used was based on the contractual life of the option granted.&#160;&#160;The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.&#160;&#160;The following weighted-average assumptions were utilized in the fair value calculations for options granted:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;" colspan="2">Nine Months<br />Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;" colspan="2">Nine Months Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30, 2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30, 2013</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;" colspan="2">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;" colspan="2">&#160;</td> <td style="font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1050px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected dividend yield</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 236px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 188px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected stock price volatility</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">112</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;105-108</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Risk-free interest rate</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">3.63&#160;</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2.68-3.44</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected life of options</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">.14-9.78 years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">.4-9.9&#160;years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The following table summarizes the status of the Company&#8217;s aggregate stock options granted:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;" colspan="2">Number of Shares Remaining Options</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;" colspan="2">Weighted Average Exercise &#160;Price</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">Weighted- Average Remaining Contractual Term</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;" colspan="2">Aggregate Intrinsic &#160;Value</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;" colspan="2">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;" colspan="2">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;" colspan="2">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 847px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">Outstanding at January 1, 2014</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">1,386,108</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">.61</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 141px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 141px; font-size: 10pt; text-align: right; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Options granted during 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">1,365,000</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">.19</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px; text-align: right;">&#160;9.8&#160;years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">Options cancelled or expired during 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: right; text-indent: 0px;">(295,917</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">)</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: right; text-indent: 0px;">.56</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: left; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: right; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: left; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">Outstanding at September 30, 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: right; text-indent: 0px;">2,455,191</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">.34</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px; text-align: right;">8.7 years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">0</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">Exercisable at September 30, 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: right; text-indent: 0px;">725,191</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">.60</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px; text-align: right;">6.7 years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">0</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 4pt;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">For the nine and three months ended September 30, 2014, the Company recorded compensation costs for options granted under the plan of $139,010 and $45,553, as compared to $190,861 and $20,800 for the nine and three months ended September 30, 2013. Stock option grants amounted to 1,365,000 for the nine months ended September 30, 2014 (1,655,208 for the nine months ended September 30, 2013) while 251,250 options vested during that period (166,858 options vested for the nine months ended September 30, 2013). There were 295,917 options cancelled or expired for the nine months ended September 30, 2014, while 23,000 options were cancelled for the nine months ended September 30, 2013. No options were exercised for the nine months ended September 30, 2014 or September 30, 2013.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The weighted average fair value of options granted during the nine months ended September 30, 2014 was $0.19 per share, compared to $0.45 per share for the nine months ended September 30, 2013.&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">For the nine months ended September 30, 2013, the Company recorded expenses totaling $13,575 associated with the repricing of 25,000 options awarded to a former consultant/outside counsel who is now an employee of the Company. No such expense was recorded for the nine months ended September 30, 2014.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">On December 13, 2010, the Board of Directors approved a restricted stock grant award to certain employees in lieu of future salary cash payments.&#160;&#160;The employees forfeited salary over a twelve-week period to purchase common shares, which were valued at fair market value as of the date of grant.&#160;&#160;The Compensation Committee of the Company&#8217;s Board of Directors have approved a change in the vesting date for restricted stock held by certain employees from April 1, 2011 to April 1, 2015. A total of 55,969 shares vested on April 1, 2011, and 118,378 shares remain outstanding and are scheduled to vest on April 1, 2015.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">On March 31, 2014, Adeeb Saba was named Chief Operating Officer and the Company awarded him 250,000 shares of restricted common stock pursuant to the Company&#8217;s 2008 Equity Incentive Plan, which will vest one half each on the first and second anniversary of the award. Compensation costs associated with this award amount to $72,500 and will be recognized over the vesting period of the stock. On May 28, 2014, the Company awarded an employee 100,000 shares of restricted common stock pursuant to the Company&#8217;s 2008 Equity Incentive Plan, which will vest one half each on March 31, 2015 and March 31, 2016. Compensation costs associated with this award amount to $15,000 and will be recognized over the vesting period of the stock. On June 16, 2014, Stephen Brown was named as the acting Chief Financial Officer and the Company awarded him 50,000 shares of restricted common stock pursuant to the Company&#8217;s 2008 Equity Incentive Plan, of which 10,000 shares vested immediately and the remaining 40,000 shares shall vest on December 16, 2014. Compensation costs associated with this award amount to $9,000 and will be recognized over the vesting period of the stock.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The following table summarizes the status of the Company&#8217;s restricted common stock awards:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px;"><b>Restricted Shares</b></p> </td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of&#160;<br />Restricted Shares</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average&#160;<br />Fair Value at&#160;<br />Grant Date</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Non-vested at&#160;September 30, 2014</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">118,378</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">2.80</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Awarded during 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">400,000</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">.23</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">Cancelled or expired</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(138,296</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">)</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">.36</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Non-vested at September 30, 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">380,082</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">.39</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The compensation expense related to these grants were $30,026 for the nine months ended September 30, 2014. There was no expense for the nine months ended September 30, 2013.&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Note 6 &#8211; Warrants</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model.&#160; The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life.&#160;&#160;The expected life of warrants used was based on the term of the warrant.&#160;&#160;The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.&#160;&#160;The following weighted-average assumptions were utilized in the fair value calculations for warrants granted:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center; text-indent: 0px;" colspan="2">Nine Months Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center; text-indent: 0px;" colspan="2">Nine Months Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-indent: 0px;" colspan="2">September&#160;30, 2014</td> <td style="padding: 0px; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-indent: 0px;" colspan="2">September&#160;30, 2013</td> <td style="padding: 0px; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Expected dividend yield</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">0</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">0</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Expected stock price volatility</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">134</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">93-98</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Risk-free interest rate</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1.73-1.75</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">.14&#8211;2.60</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Expected life of warrants</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">4.1-8.8&#160;years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;"></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;35-9.3&#160;years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;"></td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The following table summarizes the status of the Company&#8217;s warrants granted:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: center;" colspan="2">Number of Shares Remaining Warrants</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: center;" colspan="2">Weighted Average Exercise Price</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: center;">Weighted- Average Remaining Contractual Term</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: center;" colspan="2">Aggregate Intrinsic Value</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 847px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">Outstanding at January 1, 2014</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">7,671,267</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">1.51</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 141px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 141px; font-size: 10pt; text-align: right; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Warrants granted during 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">11,862,000</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">.25</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: right; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">Warrants expired during 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: right; text-indent: 0px;">(1,240,351</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">)</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: right; text-indent: 0px;">.50</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: left; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: right; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: left; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">Outstanding at September 30,2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: right; text-indent: 0px;">18,292,916</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">.78</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: center;">5.1 years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">0</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">Exercisable at September 30,2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: right; text-indent: 0px;">18,139,250</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">.75</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: center;">5.4 years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">0</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The weighted average fair value of warrants issued during the nine months ended September 30, 2014 and 2013 was $.25 and $.41, respectively.&#160;&#160;During the nine months ended September 30, 2014, 11,878,000 warrants vested (4,302,625 vested for the nine months ended September 30, 2013), and 1,240,351 warrants expired. No warrants expired for the nine months ended September 30, 2013.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">For the nine months ended September 30, 2014 and 2013, respectively, the Company recorded compensation costs of $4,962 and $349,065 for warrants issued to a former consultant/outside counsel (now an employee) of the Company.&#160;&#160;The warrants have a ten year life, a $1.20 exercise price, and vest from nine months to three years from grant date.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">For the nine months ended September 30, 2013, the Company recorded expenses totaling $62,623 associated with the repricing of 423,125 outstanding warrants awarded to a former consultant/outside counsel who is now an employee of the Company.&#160;&#160;No such expense was recorded for the nine months ended September 30, 2014.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Note 7 &#8211; Derivative Liabilities</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Certain warrants issued by the Company do not have fixed settlement provisions because their exercise prices may be lowered if the Company issues securities at lower prices in the future, are classified as derivative liabilities, and are revalued at each reporting date. These warrants include (1) warrants issued to 1999 Mt RB, LLC in conjunction with our lease modification on February 4, 2013, which expired on February 4, 2014 (2) warrants issued in conjunction with the Company&#8217;s strategic advisory agreement with Sunrise Financial Group, Inc. on May 21, 2013, which were cancelled on June 19, 2014 and (3) warrants issued in conjunction with the Company&#8217;s private placements on July 31, 2013, August 6, 2013 and March 31, 2014. The reset provisions protect the warrant holders from the potential dilution associated with future financings.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; line-height: 15.3333320617676px; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model. Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry, or if applicable based upon the term of the warrant, based upon the Company&#8217;s historical volatility. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life. The expected life of warrants used was based on the term of the warrant. The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future. The following weighted-average assumptions were utilized in the fair value calculations for warrants granted and subsequent revaluation:&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;" colspan="2">Nine Months Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;" colspan="2">Nine Months&#160;<br />Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30, 2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30, 2013</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected dividend yield</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected stock price volatility</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">142-148</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">90-172</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Risk-free interest rate</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1.62-178</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">.08-1.41</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected life of warrants</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2.9-4.5&#160;years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">.35-4.84 years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Number of warrants</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">14,922,000</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">4,300,351</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Fair value of warrants</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">556,070</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">1,232,676</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The fair value of these warrant liabilities was $556,070 at September 30, 2014. The change in fair value for the nine months ended September 30, 2014 was $3,240,052 and is reported in our statement of operations as an unrealized gain on the change in fair value of the derivative liabilities. For the nine months ended September 30, 2013, we recorded an unrealized loss on the change in fair value of the derivative liabilities totaling $218,968. The fair value of the derivative liabilities are re-measured at the end of every reporting period and upon the exercise of the warrant.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Fair Value Measurement</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><i>Valuation Hierarchy</i></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><i>&#160;</i></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221; establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company&#8217;s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The following table provides the liabilities carried at fair value measured on a recurring basis as of September 30, 2014:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td> <td style="font-size: 10pt;" colspan="2">&#160;</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair Value Measurements at<br />September 30, 2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total&#160;<br />Carrying&#160;<br />Value at&#160;<br />September&#160;30,<br />2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Quoted&#160;<br />Prices in&#160;<br />Active&#160;<br />Markets&#160;<br />(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Significant&#160;<br />Other&#160;<br />Observable&#160;<br />Inputs&#160;<br />(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Significant&#160;<br />Unobservable&#160;<br />Inputs&#160;<br />(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 815px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Derivative liabilities</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">556,070</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">-</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">-</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">556,070</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors, and are classified within Level 3 of the valuation hierarchy.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: left;">The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Nine Months Ended September&#160;30,<br />2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1379px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Beginning balance January 1, 2014</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">775,596</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Issuance of derivative financial instruments in 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">3,020,526</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">Net unrealized (gain) loss on derivative financial instruments</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">(3,240,052</td> <td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">Ending balance as of September 30, 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">556,070</td> <td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Note 8- Recent Accounting Pronouncements</b></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"></p><p style="font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in; color: #252525; background-color: white;">In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU")&#160;<b>2014-15</b>,&#160;<i>Presentation of Financial Statements - Going Concern</i>&#160;. The new standard required management of public and private companies to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, disclose that fact. Management will also be required to evaluate and disclose whether its plans alleviate that doubt. The new standard is effective for annual periods ending after&#160;December 15, 2016, and interim periods within annual periods beginning after&#160;December 15, 2016. Early adoption is permitted. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.</p><p style="font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in; color: #252525; background-color: white;">&#160;</p><p style="font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in; color: #252525; background-color: white;">In May 2014, the "FASB" issued ASU 2014-09&#160;<i>Revenue from Contracts with Customers</i>&#160;, which will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The standard's core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. We are carefully evaluating our existing revenue recognition practices to determine whether any contracts in the scope of the guidance will be affected by the new requirements. The effects may include identifying performance obligations in existing arrangements, determining the transaction price and allocating the transaction price to each separate performance obligation. We will also establish practices to determine when a performance obligation has been satisfied, and recognize revenue in accordance with the new requirements. The new standard is effective for us on&#160;January 1, 2017. Early adoption is not permitted. The standard allows for either "full retrospective" adoption, meaning the standard is applied to all of the periods presented, or "modified retrospective" adoption, meaning the standard is applied only to the most current period presented in the financial statements. We are currently evaluating the transition method that will be elected.</p><p style="font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in; color: #252525; background-color: white;">&#160;</p><p style="font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in; color: #252525; background-color: white;">In June 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No.&#160;2014-12&#160;<i>Compensation - Stock Compensation&#160;</i>("ASU 2014-12"). ASU2014-12&#160;is intended to resolve diverse accounting treatment for share based awards in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The standard is effective for annual periods and interim periods within those annual periods beginning after&#160;December 15, 2015&#160;and may be applied prospectively or retrospectively. The Company does not expect adoption of this standard will have a significant impact on the Company's consolidated financial statements.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Description of Business</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Arista Power, Inc. (the &#8220;Company&#8221;) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions, Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power, Inc. The name change more accurately reflects the broadening of the Company&#8217;s focus beyond the WindTamer&#174; brand and entry into areas within the energy storage and power management industries.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer of solar energy systems.&#160;&#160;The Company&#8217;s patented Power on Demand system utilizes inputs from multiple energy sources including solar, wind, fuel cells, generators, and/or the grid, in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy users.&#160;The Company also designs, sells and installs residential and commercial solar PV systems.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Basis of Preparation</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q.&#160;&#160;Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.&#160;&#160;Operating results for the three-month and nine-month periods ended September 30, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.&#160;&#160;These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Company&#8217;s Form 10-K for the fiscal year ended December 31, 2013.</p> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Method of Accounting</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">The accompanying financial statements have been prepared in accordance with GAAP.&#160;&#160;Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Use of Estimates</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Cash and Cash Equivalents</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.&#160;&#160;The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.&#160; The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Accounts Receivable</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.&#160;&#160;We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.&#160;&#160;As of September 30, 2014 and December 31, 2013, the allowance for doubtful accounts was $0.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Inventory</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (&#8220;PV&#8221;) systems, and is stated at the lower of cost or market value.&#160;&#160;The Company capitalizes applicable direct and indirect costs incurred in the Company&#8217;s manufacturing operations to bring its products to a sellable state.&#160;&#160;The inventory as of September 30, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.&#160;&#160;Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.&#160;&#160;As of September 30, 2014 and December 31, 2013, no reserve was necessary.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Fixed Assets</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">Fixed assets are recorded at cost.&#160;&#160;Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.&#160;&#160;Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.&#160;&#160;Expenditures for renewals and betterments are capitalized.&#160;&#160;Expenditures for minor items, repairs and maintenance are charged to operations as incurred.&#160; Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.</p></div> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Intangible Assets</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Intangible assets consist of costs associated with the application and acquisition of the Company&#8217;s patents.&#160;&#160;Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three and nine months ended September 30, 2013, trademark costs totaling $0 and $3,396, respectfully relating to the Company&#8217;s WindTamer&#174; trademark were impaired, while no intangible assets were impaired for the three and nine months ended September 30, 2014.&#160;&#160;&#160;&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Impairment of Long-Lived Assets</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.&#160;&#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.&#160;&#160;Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.&#160;&#160; For the three and nine months ended September 30, 2014 and 2013, no assets were impaired.</p> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Fair Value of Financial Instruments</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.</p></div> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Revenue Recognition</b></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Revenue is recognized when all of the following conditions are satisfied:&#160;&#160;(1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.&#160;&#160;Amounts&#160;collected prior to satisfying our revenue recognition policy are reflected as customer deposits.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.&#160;&#160;The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">The Company uses contract accounting for Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">At September 30, 2014 the Company had costs of uncompleted contracts in excess of related billings totaling $96,008 ($0 as of September 30, 2013). This amount was netted with the accrued loss contract on the Company&#8217;s balance sheet.</p> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Research and Development Costs</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">All costs related to research and development are expensed when incurred.&#160;Research and development costs consist of expenses associated with the development of the Company&#8217;s Power on Demand system and the Mobile Renewable Power Station.&#160;&#160;Specifically, these costs consist of labor, materials, and consulting.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Warranty Costs</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company&#8217;s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.&#160;&#160;Several warranties have specific additional terms and conditions.&#160;&#160;The Company provides for estimated cost of warranties at the time the revenue is recognized.&#160;&#160;Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer&#8217;s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Stock-Based Compensation</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">The Company accounts for stock option awards granted under the Company&#8217;s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.&#160;&#160;Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.&#160;&#160;The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option&#8217;s expected term and the price volatility of the underlying stock.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">The Company&#8217;s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.&#160;&#160;Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i)&#160;the date at which a commitment for performance by the consultant or vendor is reached or (ii)&#160;the date at which the consultant&#8217;s or vendor&#8217;s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><b>Income Taxes</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.&#160;&#160;This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.&#160;&#160;Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.&#160;&#160;Deferred income tax expense represents the change in net deferred assets and liability balances.</p></div> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>Basic and Diluted Loss Per Share</b></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.&#160;&#160;Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.&#160;&#160;In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">As of September 30, 2014, 1,415 shares of our Series A Convertible Preferred Stock, convertible into 7,075,000 shares of common stock, 2,455,191 stock options and 18,292,916 warrants were outstanding which, upon exercise, could dilute future earnings per share. Diluted Weighted Average Shares reflect the Company&#8217;s total weighted average shares outstanding during the period, which includes the conversion of the Series A Convertible Preferred Stock as well as any stock options or warrants in which the exercise price is below the Company&#8217;s stock trading price, less the stock that can be repurchased with funds received from such exercise.</p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px; text-align: left;">2014 (includes TMK-ENT, Inc. line of credit repayment)</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">1,018,777</td><td style="width: 15px; text-align: left;">&#160;</td></tr></table> <div>&#160;</div> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center; text-indent: 0px;" colspan="2">Nine Months Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center; text-indent: 0px;" colspan="2">Nine Months Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-indent: 0px;" colspan="2">September&#160;30, 2014</td> <td style="padding: 0px; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-indent: 0px;" colspan="2">September&#160;30, 2013</td> <td style="padding: 0px; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Expected dividend yield</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">0</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">0</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Expected stock price volatility</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">134</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">93-98</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Risk-free interest rate</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1.73-1.75</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">.14&#8211;2.60</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Expected life of warrants</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">4.1-8.8&#160;years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;"></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;35-9.3&#160;years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;"></td> </tr> </table> <div>&#160;</div> <div>&#160;</div> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;" colspan="2">Nine Months<br />Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;" colspan="2">Nine Months Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30, 2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30, 2013</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;" colspan="2">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt;" colspan="2">&#160;</td> <td style="font-size: 10pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1050px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected dividend yield</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 236px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 188px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected stock price volatility</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">112</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;105-108</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Risk-free interest rate</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">3.63&#160;</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2.68-3.44</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected life of options</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">.14-9.78 years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">.4-9.9&#160;years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <div>&#160;</div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: center;" colspan="2">Number of Shares Remaining Warrants</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: center;" colspan="2">Weighted Average Exercise Price</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: center;">Weighted- Average Remaining Contractual Term</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: center;">&#160;</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: center;" colspan="2">Aggregate Intrinsic Value</td><td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 847px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">Outstanding at January 1, 2014</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">7,671,267</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td><td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">1.51</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="width: 15px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td><td style="width: 141px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td><td style="width: 15px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td><td style="width: 15px; font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td><td style="width: 141px; font-size: 10pt; text-align: right; padding: 0px; text-indent: 0px;">&#160;</td><td style="width: 15px; font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Warrants granted during 2014</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">11,862,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">.25</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; text-align: right; padding: 0px; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">Warrants expired during 2014</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: right; text-indent: 0px;">(1,240,351</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">)</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: right; text-indent: 0px;">.50</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; text-align: left; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; text-align: right; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td><td style="font-size: 10pt; text-align: left; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">Outstanding at September 30,2014</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: right; text-indent: 0px;">18,292,916</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">.78</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: center;">5.1 years</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">0</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">Exercisable at September 30,2014</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: right; text-indent: 0px;">18,139,250</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">.75</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: center;">5.4 years</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">0</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td></tr></table><div>&#160;</div> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"></p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;" colspan="2">Number of Shares Remaining Options</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;" colspan="2">Weighted Average Exercise &#160;Price</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">Weighted- Average Remaining Contractual Term</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: center;" colspan="2">Aggregate Intrinsic &#160;Value</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;" colspan="2">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;" colspan="2">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;" colspan="2">&#160;</td> <td style="font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 847px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">Outstanding at January 1, 2014</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">1,386,108</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">.61</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 141px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 141px; font-size: 10pt; text-align: right; padding: 0px; text-indent: 0px;">&#160;</td> <td style="width: 15px; font-size: 10pt; text-align: left; padding: 0px; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">Options granted during 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">1,365,000</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;">.19</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px; text-align: right;">&#160;9.8&#160;years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: right; text-indent: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px; text-align: left; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">Options cancelled or expired during 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding-left: 0px; text-align: right; text-indent: 0px;">(295,917</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">)</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: right; text-indent: 0px;">.56</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 1.5pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: left; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: right; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> <td style="font-size: 10pt; text-align: left; padding: 0px 0px 1.5pt; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">Outstanding at September 30, 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: right; text-indent: 0px;">2,455,191</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">.34</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px; text-align: right;">8.7 years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">0</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">Exercisable at September 30, 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-top: 0px; padding-right: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; padding-left: 0px; text-align: right; text-indent: 0px;">725,191</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">.60</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px; text-align: right;">6.7 years</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-indent: 0px;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: left; text-indent: 0px;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding: 0px 0px 4pt; text-align: right; text-indent: 0px;">0</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 4pt;">&#160;</td> </tr> </table> <div>&#160;</div> <div>&#160;</div> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px;"><b>Restricted Shares</b></p> </td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of&#160;<br />Restricted Shares</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average&#160;<br />Fair Value at&#160;<br />Grant Date</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Non-vested at&#160;September 30, 2014</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">118,378</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">2.80</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Awarded during 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">400,000</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">.23</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">Cancelled or expired</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(138,296</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">)</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">.36</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Non-vested at September 30, 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">380,082</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">.39</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <div>&#160;</div> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;" colspan="2">Nine Months Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;" colspan="2">Nine Months&#160;<br />Ended</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30, 2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">September&#160;30, 2013</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected dividend yield</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected stock price volatility</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">142-148</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">90-172</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Risk-free interest rate</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1.62-178</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">.08-1.41</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Expected life of warrants</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2.9-4.5&#160;years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">.35-4.84 years</font></td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Number of warrants</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">14,922,000</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">4,300,351</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Fair value of warrants</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">556,070</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">1,232,676</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"></p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td> <td style="font-size: 10pt;" colspan="2">&#160;</td> <td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair Value Measurements at<br />September 30, 2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total&#160;<br />Carrying&#160;<br />Value at&#160;<br />September&#160;30,<br />2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Quoted&#160;<br />Prices in&#160;<br />Active&#160;<br />Markets&#160;<br />(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Significant&#160;<br />Other&#160;<br />Observable&#160;<br />Inputs&#160;<br />(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Significant&#160;<br />Unobservable&#160;<br />Inputs&#160;<br />(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 815px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Derivative liabilities</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">556,070</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">-</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">-</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">556,070</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Nine Months Ended September&#160;30,<br />2014</td> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1379px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Beginning balance January 1, 2014</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">775,596</td> <td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Issuance of derivative financial instruments in 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">3,020,526</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">Net unrealized (gain) loss on derivative financial instruments</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">(3,240,052</td> <td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">Ending balance as of September 30, 2014</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">556,070</td> <td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td> </tr> </table> 346014 150299 0 0 0 3396 0 0 1500 1415 7500000 7075000 2455191 18292916 0 96008 1018777 500000 500000 750000 0.10 750000 1250000 2014-12-21 1018500 1018500 1250000 1.38 1.62 P1Y P10Y P10Y P5Y 1839250 820750 820750 1500000 0.20 11250000 0.25 100000 0.09 2868750 2878560 1400000 1468750 1255000 1.20 1.20 0.30 0.25 4300351 14922000 423125 3060000 612000 0.00 0.00 0.00 0.00 1.34 1.12 0.93 1.05 0.90 1.42 0.98 1.08 1.72 1.48 0.0363 0.0014 0.0268 0.0008 0.0173 0.0162 0.0260 0.0344 0.0141 0.0175 1.78 P3Y6M P4M24D P4Y1M6D P1M21D P9Y3M18D P9Y10M24D P8Y9M18D P9Y9M11D 7671267 1386108 18292916 2455191 11862000 1365000 23000 -1240351 295917 -295917 18139250 725191 1.51 0.61 0.78 0.34 0.45 0.25 0.19 0.19 0.50 0.56 0.75 0.60 P9Y9M18D P5Y1M6D P8Y8M12D P5Y4M24D P6Y8M12D 0 0 0 0 118378 380082 2.80 0.39 400000 0.23 138296 0.36 1655208 1365000 166858 251250 Either immediately on the date of grant or one to three years from the date of grant. 110579 Employees forfeited salary over a twelve-week period to purchase common shares 10000 55969 40000 118378 250000 100000 50000 30026 3550000 50000 No less than 100% of the fair market value of the common stock on the day of grant. 539926 72500 15000 9000 20800 190861 45553 139010 13575 25000 0.41 0.25 4302625 11878000 349065 4962 <div>Vest from&#160;nine months to three years from grant date.</div> 62623 0.00 0.00 P4M6D P2Y10M24D P4Y10M2D P4Y6M 1232676 556070 556070 556070 775596 775596 556070 3020526 -3240052 EX-101.SCH 7 aspw-20140930.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Statement of Shareholders' (Deficit) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Description of Business and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Stock Based Compensation link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Derivative Liabilities link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Debt (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Debt (Details Textual) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Stock Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Stock Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Stock Based Compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stock Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Warrants (Details Textual) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Derivative Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Derivative Liabilities (Details 1) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Derivative Liabilities (Details 2) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Derivative Liabilities (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 aspw-20140930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 aspw-20140930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 aspw-20140930_lab.xml XBRL LABEL FILE EX-101.PRE 11 aspw-20140930_pre.xml XBRL PRESENTATION FILE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`=?[]DX`$``+H6```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F-UNVC`8AL\G[1XBGT[$ MV-FZMB+T8#^'&]+8!;CQ!XE(;,MV.[C[.8&B"E$J5*2^)T00^WL?K.B1\D[N MUEV;/9(/C34E$_F8960JJQNS+-G?^<_1-VIC]6*>?MR2>VL"R;]N%?5;)E'-M4ZF82/FCT0:<:\\1](G]8'/AP$1<&Z?_?,/A,#@G"48!P M?`;A^`+"<07"\16$XQJ$XP:$0XQ10%",*E"4*E"<*E"D*E"L*E"T*E"\*E#$ M*E#,*E',*E',*E',*E',*E',*E',*E',*E',*E',*E',6J"8M4`Q:X%BU@+% MK`6*68OW,FM,S2#QX?/MC^DPYI5J*L1-2^'"KY/;H:\EU\J3_A-]ZE`O#O!\ M]BF.U##.O'4A=:V>SC^%IS*UWSUR:1#YV-"^3CU62^X34T][?N!!+TI]$ZQ) M'\GF0_,\_0\``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)? M]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBR MBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'% M#U1?````__\#`%!+`P04``8`"````"$`Z,')Y]\!``"K%0``&@`(`7AL+U]R M96QS+W=OZP*4BK!91/-)I(=U;FZ,[TGD^N;C\VZ>/,AKKJV-#29FL*W55>O MVF5IGI_N3BY,$9-K:[?N6E^:K8_F9GY\=/W@UR[E'\5FU<_;?&?1A8U+>1F6MG?5BUMZR]/IS(:?9YCYP9G%?5V:<%^3F.)I MV^='_W]XMUBL*G_;5:\;WZ9?GF'?N_`2&^]3/M2%I4^E&;:BW=TAF63-QOXA M)_NA*^<"R>&9LAR>03FD+8>0'#E5EB.G2,ZYLIIS)(9860TQE*-M#D%W^$S9 M'3Y#[HAV"`H,01DU!&/C@J\?4\C,B=GVKUP^V$;F:# MK='?2)N5$)6DK8:@'-8F-T-R\ZCD'D:G?;<,6U_3%,/Q148-O92G3K^7LEO: MW16&"VDSDB`C29N1!!DIVB006"QM$$`.:%<*%HJTK2'H#6LSDB$C>51&#BFW M3YMAZSOXX'PIVIDC,'-$&YH"H:D-*^YWAXG*S*KQ74)I+,?;#HX'O@4AEQL7SV'^8WWXY]3UMF,A8 M(06,_3?0_N7D\Z>+M50O"RE?/!00>NSGQI3G0:#3'%9,'\D2!-Y92K5B!I?J M.="E`I;I',"LBB`:#(Z#%>/"WRJF\+W"J;-3<8-9&-_A$NYAM8%5957%2_P[ED\B/U@ MTA1YK[P,EJPJS!S+VZFC7]$PBH[MD]:*1PYKO0^R2V_SQ$4FU_91M/:M6<68 MP+J^]<0SD^/]P6#07/L._#DWNXLH'Q#]VD'SI$$.Y7<",/-6W(G MMNYSB2VTKM]A9:'OJ7..?]1=%MK$JJTER`UG7/ M9A51B:G,23>9;Q*',\%>I:!P>O9NGI#-3[M14UA0TV*L^[#,R/3EUV) M-W\JQ(EN=$9BPT%O,!)D.;J6*SP(=#V?1&&(L]#L'CHPNFT]SF^%:!44L-`A;.=_3P*4 ML;`'LKXV],A0^D('O\,N8B<;YNVAVH"$B\Z!UAH5G%7#>$&IB"A5N.B$UTWH MB:(L13TL8NO^125SV)B*XS@BM;7P>M=!P4&T8[^EORUR'SFYD M0GV(Z:ZXZ!CJQ+I\C"B3<0^3O2/F5A%32G'1R:3_Q-RAUBJ)`AL[P!X6HJT= MM3)RH#TL1%MK/YZ:J<<%EA;4?<>OHI05*7ZNV1_[O5-W(-A]K$[^`@``__\# M`%!+`P04``8`"````"$`*I^7`1$&``#7%P``&````'AL+W=OFO9KMRO+W@&%0[=R=WU_ M7"X67;$KZ[R;-\?R`'AA4[Q>",7]1Y]7!-0K+=HI& ML]E419DVQ6M='GHCTI;[O(?Y=[OJV)W4ZF**7)VW7U^/LZ*ICR#Q4NVK_L<@ MZCIUL?R\/31M_K('W]^YRHN3]O#E2KZNBK;IFDT_![F%F>BUYV@1+4#I^6E= M@0.][$Y;;E;N1[[,A'07ST_#`OU;E6^=];_3[9JWW]IJ_:4ZE+#:$"<=@9>F M^:K1SVM]"08OKD9_&B+P9^NLRTW^NN__:MY^+ZOMKH=P>^!(&UNN?Z1E5\"* M@LQ<>%JI:/8P`?ATZDJG!JQ(_GWX^U:M^]W*E?[<"YCD@#LO9==_JK2DZQ2O M7=_4_QF(CU)&1(PB,&(4X6(N0H][_F.5A9G18##-^_SYJ6W>',@:>&9WS'4. M\B4HGYR9>9R]WK(*'K7(1ZVR,0BLL]2F_`]Q21Y1F8#/%`LDC?, MP8Z?;D[#Q-Q%=EC5V"#&W(P'4G@T+Q'A*Z88W7>(X%Q(GY2B#!&!4%'$SHN, M8@=[:+H]#>-M%UYDC3V#W-MV#XGT(9'=(Y`]W9Y8M?]^D=0PCEY(=E5L$#FD M)K&>F'LFLCZ$A$0^O3,VL\=*P:2Z/!CYB;`?_2Z3\*Z_[TL/(KY(G8X-8N8. M#Q>2;CD;4+Y4$5%(;8##EA22YB0B0A$&WH5`)CDXFAZU@2;V+L(F*T?FCC]$ M>"+@M*"FB'C?(4($5Z@P88OZK3XY,;GI`>P70D@J7CPR8V'QN%(1684$(UR7 M?$F*3TH8R807$2;##`12,6LZV*=N`*;[-.T"[.[SBR\DM2_FAKE781XCZ6,D MNXM@D[H+F&[2]`PHF&2%8VZ8,9A<9QNM-A2!&D_><2E&I/05)S4IPXC'0R4N M*MBD;@U-FYAQIB">)"O2\4GC0OF, M,UJF,X3,)/07GKI4"AQ0W2-,=VDZ"A1(DDPQ-XQY.\ZD?Y6R]GUR,QT'C^;@ M)]^Y7QF6,$/W88&D"FZ\([GN#J8;,[V$;N4M1&9I(%C%F_,G'X=,LPW:5I,)#+R_*-+NTF9":%"$D:)]P0 M[[8_Z7AS7(+0]SRRT;,;P[$MW258MB:6&=-;('MD;6-N&/.3244_Z>&0BTZG.&5F-!-V?L3FCQ08! M<)_D0H;N@X"XI!,*J""=SD2+UQT/_8T7#\JG/<>C,!+"O]2Z(:<3S`1!)'VJ MDV(FDAXD/DU=S"CE"^CMSNF##4,6_GP&"SV*Q)0D5CPRMV-J-,S]=V-J`];+TT/ M!ZK#OSLX0"_A6)'-`=XT37_ZH@\/ST?RS_\#``#__P,`4$L#!!0`!@`(```` M(0#SI:19LP,``&4,```9````>&PO=V]R:W-H965TF)2<5$F-G%FML7*5&2\W"7VOW\>;N:VI30M,YJ+ MDB7V"U/VY_4_GU9'(1_5GC%M`4.I$GNO=;5T797N64&5(RI6PB];(0NJX5+N M7%5)1K/Z4)&[WFP6N07EI8T,2WD-A]AN>$YUR\UJ6T5Z?+[KA22;G+(^YD$-&VYZXL3^H*G4BBQ MU0[0N2CT-.>%NW"!:;W*.&1@;+D;GMKE>U0?]Q=E2#SY;:B^-7 MR;,?O&3@-M3)5&`CQ*.!?L_,5W#8/3G]4%?@E[0RMJ6'7/\6QV^,[_8:RAU" M1B:Q9?9RSU0*C@*-XX6&*14Y"(!7J^"F-<`1^ER_'WFF]XGM1TX8SWP"<&O# ME'[@AM*VTH/2HO@?0:2A0A*O(8'WAL3SG<`+X_D5+"XJJA.\IYJN5U(<+>@: MB*DJ:GJ0+(&YS0QU=+E>2A5R-"2WAB6Q(]N"+!34YVD=$G_E/H&G:8.Y0PR\ M=AC2(5Q0TTD"&4-)YTUN(QNPB6Q,-U+N\(MA&.]\&/\]80PXL8&[$^_'O7R, MC!AX[3#1^>?#U1<]@%Z9*GC;`W-HK"`D0<>/"A"#"@B91S`J9QUD MU&?@Y5#"Z_8;\#1TV/%B:,1@Z!OB!3,_['MD%-H\&"9WW=O^FT-C"4&PF$A` M3)/]W%MX"]*7:"1A<2KA[0*80Q,)8>\NNH"85@+Q%]X`,I)`H.FG-KRMH3XU M%='[C"(:T*)N1.)*RL5![/)$9#:?=MMF;=>O2=V/\"25]$=^TGECI?*RMD6CLZ< M&(HN<4W$"RVJ>M7:"`WK7?UQ#^L\@X5EY@!X*X1N+\PBVOU!6/\%``#__P,` M4$L#!!0`!@`(````(0!0NDJ3>0,```L+```9````>&PO=V]R:W-H965T+E)R)_? MSX,[XBA-RXSFHF0)>6>*W,\_?YKMA7Q16\:T`PZE2LA6ZVKJ>2K=LH(J5U2L MA"=K(0NJX5)N/%5)1K-Z49%[H>^/O(+RDAB'J;S%0ZS7/&6/(MT5K-3&1+*< M:N!76UZI@UN1WF)74/FRJP:I*"JP6/&.EL1)=TJ+XI\1!8V5,0D;DPCHS?,P#*;@?(C,<+2Q7@H58D23!W1)R(@X$(6"^KS.8S^> M>:^0T[31+$XU@:U8'A18"L!K&2'R+N/YK!]04(PH6`5D6Y@;X-VRA;WWGBK& M1WB+!#)T.PF*$P+F[8MC?V2_>F$T\-EJ>HKE-87%-K39L)+#BSUZR!8N2LBX M\_YHW$O/PFBN,5Y36(S`\^WD+B\\M(B@9V\G0G&? M:&B_=&$T#5'@1KWGR^9Y)^/'BEMD4)0N&=837"_L.8=ZXB*;]G\((SF M6CT;19-5=Q*U,5J$>+SU]HZ/"7%1G_"8`4-H--<(&T5+>'>><&(37M\Y4-PG M&[>^ALQHVNJ.PXGU]S3H->BRMV#X-+B0S`!JV\WF==9:W8<])L'`-J(C;>QW M_\)36GM%Z,96=)-)=X75"@'NW9U>^(#>[/3VUMA/=6T)/=_YI<1^+\3E6=&D M+9K-B/O\[8SF5+`8@]X.LX"A`WO&8@Q.CK5SHF.?&$8S>YBCN6!RPY8LSY63 MBAW.%2'L;^W==N9YJ$>>WOT%SD+U--,^@%&DHAOV@\H-+Y63LS58^NX8]D=I MAAESH455#P0KH6$(J;]N8>AD<(KZ+HC70NC#!9[1.$35$\7\/P```/__`P!0 M2P,$%``&``@````A`#4/6S'="```.S@``!D```!X;"]W;W)K&ULI)O;;NK($H;O1YIW0-P/T(`Y*G]2X_9/?=7UG1_?/A]]_N/O+C]^(URTX=\G`H M[KNOI]/;HM\O-J_9?EWT\K?L0+\\Y\?]^D1?CR_]XNV8K9_*D_:[_G`PF/3W MZ^VAJSPLCK?XR)^?MYO,SC?O^^QP4DZ.V6Y]HO(7K]NWHO:VW]SB;K\^?G]_ M^V.3[]_(Q>-VMSW]*IUV._O-(G@YY,?UXX[J_5.,UYO:=_FEX7Z_W1SS(G\^ M]=Y?]XG3P]W3UNJ@6SVSC%[ON]^$XMT..[V'^[*!OKO-OLHKCYW MBM?\PSMNG^+M(:/6IGZ2/?"8Y]\E&CQ)$YW<;YSMECWPU['SE#VOWW>G?^4? M?K9]>3U1=UM4(UFQQ=,O.RLVU*+DIC>TI*=-OJ,"T/_.?BNE02VR_ED>/[9/ MI]?[[FC2LZ:#D2"\\Y@5)W:'CUXM"A2[K0\?_HRB3R@L=*R]#:H$;6V-:G4S'\\F]J1C,1]/; MFY3&9UD/.GZ],>:5$SK63D1O9EGCR>P311$D2J41J?KI$X2XT^U`TS M_K361"TV^:%V,_U\:4BKJE(7N0UO%VU?#:-R5-KKT_KA[IA_="C44=V*M[4, MG&(AR'4]'M7H.8_0?QJ@-#*EEV_2S7V7Y$=CKZ"H\N-A/!W>]7]0)-A4S++) M3,ZE7[LV7/P*_12G)NI37&[PN,'GAD`9Z/^Y]+QD81,93T=Z4:+: M[\7-:&[I3%PS=7&3VG`YB=4PK0DZI4^]=NXZTI/6=>TAM.XA2JB^\K`V7 M"[,.6S6)*:N.W428$Z=)<">N0JB:Y^9G3CQ(^)`(FL1X.M5[)U3,2"@%B^F, M`5&+D]E`=Q+?P"1-AE4Y;1)7[:;I@"+#)W0@:4T'W+#B!IL;'&YPE>&Z!\=\ M!'EM#).3W\9,].8-VIB9SH1MS%QGHA9FQH9>?`.3M#$L,J1F1NM-BL&?Z$U) M:[W)#2MNL+G!X097&=22249ACQM\;@BX(>2&B!OBVG`9]>,9&P1)S=1!*[TR M:*U&"Y5/M)JD[[NTWCD'G/&,345+Q5#'G1DFQ!4D;$@XD'`AX4'"AT0`B1`2 M$21B2"202$V$)@E:C&B2D"N;$:T(S=.D/.N^2\'WW.UCBZERJ1B3-"!A0\*! MA`L)#Q(^)`)(A)"((!%#(E'$O)R:!SW!PGFJ_SR^S"R:*&C,:Z(PBT'23`RS MB^-RA;I4C$D,D+`AX4#"A80'"1\2`21"2$20B"&1*,(JQ3"<6W/!%FJI!HP& M@\LB3=.#3"M=W_Z8]2!IK@%!PH=$`(D0$A$D8D@D MBE!Z$*.)==WAY3A--6)B68 M@T5Y&I?&Y1)J]J@@DS8P8K<@XQF;()T6B,4N%R,>1GR,!!@),1)A),9(@I'4 MB&C!0R8-&UK!J\[R-*:5.=/KLH*,6E&Y(@-BMW@1@MWW.A4T*^=7(0;6E*G) M;7'#U.1AQ,=(@)$0(Q%&8HPD&$F-B"X5F>&Y7GO<&%948DB[0YFS_EO*7#-- M2P8=K#!B8\3!B(L1#R-^"S*>LQNSH`5BH@PQ$F$DQDB"D=2(Z%JAGM2T`J8> MB?-PPG)22Z$@HT8@8F,O#D;<"E&3M67-)RS<>-B'CY$`(R%&H@JI%INTTF2! M.L8^$HRD1D17A\R*\4ARPZ2CDFEZ).%I,/E,"$42B-C8BX,1%R->A51](V:C M*5MQ^=A)@)$0(Q%&X@I1I1TWE91@'ZD1T64B4V?7,@%!1&7:='GP[(=\=(_D M`1$;>W$PXF+$PXB/D:!"5+?1?44C`H0:(23`8D2D$2TN8ER.!".I$='5(1-H MU^JX+5\J5-Y-5PF;=)<59)QJE!\#8E=>5+-32F?(+N/@R[@8\3#B8R3`2(B1 M"",Q1A*,I$9$UXG,K'U!)RHAI^N$)TK$==9N9+4,BU6%&'4"O3C8BXL1#R,^ M1@*,A!B),!)C),%(:D1TI4HC)UNE+8++X4U^F\5ITHP*@3X,.I+F+P MX6+$PXB/D0`C(48BC,0823"2&A%=)3(-QU5R0W9-9>]TE;"[AJ50D*$#5QBQ M6Q!2G/XV@=,"L>G)Q8B'$1\C`49"C$08B3&28"0U(II6ACP3:U[!EKA^&RP& M/%5206I500^2QFQ26FD`I=55Y/O+5L#1"C^4"P]G1T8CZ835B<<2O" M($(/(SY&`HR$&(DP$F,DP4AJ1'2-4-M]12/R-*X1)H'E4$&&WEEAQ&Y!F@]P M*JAZ@#.RKMX=+1\\NBU>V'K%PXB/D0`C(48BC,0823"2&A%=*5_+NM+FFJ92 MV(IB64%&I>"L*_;B5(@*6V4J2X_A+O;A8<3'2("1$",11F*,)!B1>Z1D-[;W MD-*)V@.E=EOLL^-+MLIVNZ*SR=_E_B;Y(MO9>MY[]:W<>L7L2[&@G1'T#BRS MVV)!>QF:]D@L:)]!TY[0WJXV^W*X6+9==S5EN_9,GZ^+(]%)U=]DQ5'_3D;IZCVOREOISRMW(ORF-^HDU;Y<=7 MVJ27T=O'@Q[!SWE^JK_("YRW_3W\#0``__\#`%!+`P04``8`"````"$`\LEV M@!\#``!:"0``&0```'AL+W=O?/F MS>.(H_GU4U.31ZZTD&U&0R^@A+>Y+$2[RNCO7_=7$TJT86W!:MGRC#YS3:\7 M'S_,-U(]Z(IS0X"AU1FMC.EFOJ_SBC=,>[+C+3PII6J8@4NU\G6G."OZH*;V MHR`8^0T3+46&F3J'0Y:ER/F=S-<-;PV2*%XS`_IU)3J]8VOR<^@:IA[6W54N MFPXHEJ(6YKDGI:3)9U]7K51L64/=3V'"\AUW?_&"OA&YDEJ6Q@,Z'X6^K'GJ M3WU@6LP+`158VXGB949OPMEM&%%_,>\-^B/X1A^<$UW)S6`VK)-= M@:64#Q;ZM;"W(-A_$7W?K\`/10I>LG5M?LK-%RY6E8'E3J$B6]BL>+[C.@=' M@<:+4LN4RQH$P)$TPK8&.,*>^O^-*$R5T7CDI>,@#@%.EER;>V$I*B($JA"P_H\+I)1,OAY#3[Y=J`W*Z/B`/1[M^5$!8LY0`%UW:/%Y"FS0T(.A`L2D?0N$X20> M3UZW`%KE<@$V:"A@[/C1`L1,>P&1=R([N'B8_6WC+7B8=<^+61\>!_3E9 M1RMO!\+@;?O_RMN@H8"IXT.C]-/WI+=!@_3C?7F8'C';98\G MT73?%T<"0FCSRPWHHX82]IL'2MB"=A;$IQ38;>CB)0AQ\SI^__<9M@H0A"[$ MDR"8G-AY8%2]1P/N;,<:ANW?4V?4N;#O$UP'''$X`1JN5OP3KVM-&PO=V]R:W-H965T:_Q#YODF<+P@BC-JMNCO2CC1:[;1/R\[^GNSFQI&)5Q@I1\82\ M<4F^KK[\L3R(YEGN.%<6.%0R(3NEZH7CR'3'2R9M4?,*GFQ$4S(%M\W6D77# M6=8.*@O'<]W(*5E>$718-+=XB,TF3_FC2/UW>I*&NP6.=%KMY:4V*5Z>+;MA(-6Q<0]RL-6-I[MS-D**C;+! MSD'0TYAC)W;`:;7,ZE$^1M%M+-"$Z\S@??.Q//MP`MG\QM<'"1J`WQDBJV6C3A84#4P MIZR9KD&Z`.<^,N088KT4*L2H3>ZU2T(B8D$4$M;G914$X=)Y@9RFG>8!-7`= M-'10.$`S(`'&,=+Y)/62==HSS@%\?3>.>G\3\RC18G!+P'>'\^'WQQ M9M3`==!$@\((,#!GUCGWH2;?#U0/2LCLR-V/XL$?"5!S`P%4W7&*-4%PL9[[ M5.M!9@Z"8(P0"5`3MB5`_7E$W3%+1@Z@5J8$UW.@!TT)9I,% M00"I_#B!'C0E&"/$'*`&">Z\.(SIR&@0Z)^'R=Z[O@IZT)1@6@>H00(O"$,: M7]AJ\2G!]570@R8$X9ACS`%JD&#F70:@4/?3'%PG:$=-$<80$:$3Q6TMNG8T M/C<6@>J^-%F%&PBPFQTWA"`<&TU'@**>@([+9!+HEO5Q`FQT)H$_E'I'@**> M((Q@-QR]QA9M`NE.]G$@['\F4#`%0E$/Y(_/38)/M4B*_<\D&&/L4H*BGF!L M8";`F0YY0U6<:9'A.$,'@*+C+AV$%SH$_52;;$=-M\>T2W4B$^-2A7ZJ5](S MS3*:-HI.9&!8(<'T9U%Z#YU>\4:)NSX!KH>#0H#CP_$Y-Y>[N'\K52<5%F9#`]8G# MRE1DO-PEY/>OI[LI<92F949S4;*$O#-%[I=?_E@\:T`PRE2LA>ZVKN M>2K=LX(J5U2LA#M;(0NJX53N/%5)1K-Z49%[H>^/O8+RDAB&N;R%0VRW/&6/ M(CT4K-2&1+*<:M"O]KQ2+5N1WD)74/ERJ.Y2451`L>$YU^\U*7&*=/Z\*X6D MFQSV_1;$-&VYZY,S^H*G4BBQU2[0>4;H^9YGWLP#IN4BX[`#M-V1;)N0AV"^ M#B+B+1>U07]S=E2]WX[:B^.?DF??>,G`;<@)$]@(\8+0YPPOP6+O;/53G<`/ MZ61L2P^Y_BF.?S&^VVN(>P0[PHW-L_='IE)P%&C<<(1,J6);Z9Q3/[JFUZI)HN%U(<':@]4*XJBI41+*AJ6N<$TB@(W@(;?^PQ+OD'W_#_E;^F$B/HZ M,5UXQH4^UJ:+BVR]<72J;%.!!G,MW09A/(9WY8G!4HBOS$$G^5PA+AHJ/#E@ M%!K,-84-HE-XJF!+X+V/(-A6%L9#90;39!VYXW!F?;[>#5UKC;;%QM'$_C>L&M`U'UN(,3)TQ]->Z?I^T-^0Y6R`K;L7_B=R3:/O M=\8X.F5F4J\IH<@_]*J&K%N(D0NOU/BR0.SQ/8&W_7\"\V:PA7!]A1,@7O>Z&S"`573'OE.YXZ5R&ULG)K;CJ,X$(;O5]IW0-QOB($<.NKT:`A':5=:K?9P M31.2H`DA`GIZYNVWC`V-BXPKF;D8.L['C_U3+ES!SY^^E6?C:UXW1779FFPV M-XW\DE7[XG+MP8H M7)JM>6K;Z\:RFNR4EVDSJZ[Y!;XY5'69MO"Q/EK-M<[3?7=2>;;L^7QIE6EQ M,87"IKY'HSHNWNPT2^++*Z:JI#.P,Y2W1T.N8G MZ\D"I9?G?0$CX+8;=7[8FI_9)K%MTWIY[@SZM\C?F]'?1G.JWJ.ZV/]>7')P M&^X3OP.O5?6%H\F>-\')UN3LL+L#?];&/C^D;^?VK^H]SHOCJ87;O8`1\8%M M]M_]O,G`49"9V0NNE%5GZ`#\;Y0%#PUP)/W6'=^+?7O:FLYRMEC-'0:X\9HW M;5AP2=/(WIJV*O\3$)-20L26(G"4(LR>V>L%6RP?4'&D"AQ[E:?9>K%PE^O5 M_7UQI0H'1!X"QD_ M;=.7Y[IZ-V`>PEULKBF?U6P#PGVLB#L[1,^/@@>BAHM\YBI;DES6QPT!;@AQ0X0;8MR0C!HL,&%P`B)U[,3M MV=(/F,-\P'U7O;[APP$;C4X033)&/P2BN MPLP=N\KCRX&,IG>7GZ2XBQMVHF%LILM MQCW3SY^D;[A]DC)TR,3CH>M#B<-;$Y+V,.M-W/0$H_.;)'R2"$@B%,2B M>UXQEZ'<$"E?+^9S-6IB4C_1$8K3$)YCI_41S6'589<]J7WS!*-SF"1\D@A( M(B2)2!!K<0_`9/BGCB4F-1(=H?C,*YS18D?O,X>1SS;JFR<8G<\DX9-$0!(A M242">.I\AG4_\I@\/]$1BL>PB!Q[S+.&"RE'[S4_2?7:67\\^$26%HS.:Y+P M22(0A,@)JUOQ&"K$O&-4-R/R*C%))#I"\9O!:FILN-[HCE:==AF.:@F-K789 M6JOL;D`HS_LT$MQ`7!M=*KP!H4M%-!+32*)%5-=Y%3%*)?<]')FH/<9/1]=& M<]&3T-A]--H=C?@T$DA$/O^@N)\FWY"6B6@DII%$BZC6\]KC<>M%Q:):CY;Q M'A.0UGH2\6F50")#.D9+CY"6B&@DII%$BZBV@RL_83L_"^4;&Q5J'A.0UG82 M\6F5@$9"&HEH)*:11")R]JD+']5X7AH]'N^BH%+C'869QP2D-9Y$?%HEZ)&Y M7'_,T8(U[(%1W8"27D0C,8TD6D3UG1=*C_LNRBO5=S04C_\:"[-"ZSN)^+1* M(!$19/::_VJ*'O8AK1+12$PCB191G>>%T\AY8DDCRBS5<;QX9+I:K%M?[FC$ MIY%`(KWCJ_5B.7&<[$M$7RBFD42+J([S$FKD^)W+&5%XJ<[C'U>8KCJ3SI.( M3ZL$$I$)U54S:G>AD%:):"2FD42+J,[SPFKD/!'KH@Q3'4>YU&.Z6DTZ3B(^ MK1)(1!;OW3N92:R3%XKH"\4TDF@1U7%>6HT&KZ`/1+7])C_D=;'XM(8Y_P`EYK/ M^$:$6NRR$!_:ZMJ]5W^M6M@=T?UY@MTP.;S1GL\`/E15VW^`#EG#_IJ7_P$` M`/__`P!02P,$%``&``@````A`/X0$+9!!```3P\``!D```!X;"]W;W)K&ULE)?;CJ,X$(;O1]IW0-QWP!QR4I)12*MW1IJ15JL] M7!/B)*@!1YATNM]^JB@'L$DSR4VZ@9_?GZO*9;SX^IYGUALO92J*I7F:VI:LXF(79Z+@2_N#2_OKZH\OBXLH7^61\\H"AT(N[6-5 MG>:.(Y,CSV,Y$B=>P).]*/.X@LORX,A3R>-=_5*>.9[KCIT\3@N;'.;E/1YB MOT\3_BR2<\Z+BDQ*GL45\,MC>I)7MSRYQRZ/R]?SZ2D1^0DLMFF65A^UJ6WE MR?S[H1!EO,U@WN\LB).K=WW1L\_3I!12[*L1V#D$VI_SS)DYX+1:[%*8`8;= M*OE^::_9?,-FMK-:U`'Z+^47V?G?DD=Q^;-,=S_2@D.T(4^8@:T0KRC]OL-; M\++3>_NESL!?I;7C^_B<57^+RS>>'HX5I#N$&>'$YKN/9RX3B"C8C+P0G1*1 M`0#\6GF*I0$1B=^7M@<#I[OJN+3]\2B8JQ!MD:()FMT6=ICVX)92,C/VRKTW(7S!C%-E";J:YBNV%P5F`K`:Q@A;%W& MVU&_HJ`843`+R!;1#?!NV#QCW+YB$C82C00B=#\)BI?VI#-PZ!E3CD@#OPW< MN!FYQM\,*32VX!$V%-?UV(P;,#-AI.FR!G#_UK>`W@2WK\0L\H M^H@TLWJQ8MLRRDY_'+31U^AP@^MTCV$J%)M4OCYL1)JPIF)L.IFZKE&6FZXD M\%T/NE]CHL'-'H%#L0D7-+[424@SE%924%#9J`VYQL4@?_='K58;9*R=,9$I M$<7MB7F!ZX=MRF@Y*,UM?!T0&W$GK?<5':/V#V*^IL#VT7K+]?A%[KK')+HFF]>(/9N"U_!==][@UV]3-:$WU4>/&*ENCZX2K(P@(8W19X3&SG%GBZ'>#Z3-UQVC6UVL MT)OI[!LE@OR:GY9P:G@D4C=V"=_8GZ+:$G;I3A!8[[M)B6BMC&$/:S="*C0Z MB]"G>L[+`]_P+)-6(LYXS@A@C35WFS/0VL/Y&?&PO=V]R:W-H965TU MC?'JZUM56J^L%06O$^+9+K%8G?&\J/<)^?[MZ6Y.+"%IG=.2URPA[TR0K^LO M?ZQ.O'T1!\:D!0ZU2,A!RF;I."([L(H*FS>LAI8=;RLJX;+=.Z)I&XNKNRK(FNYX#MI@YVC0*_G MO'`6#CBM5WD!,\#8K9;M$G+O+3=>0)SUJ@OH1\%.8O3?$@=^^K,M\K^+FD': M4">LP);S%Y0^YW@+.CM7O9^Z"OS;6CG;T6,I_^.GOUBQ/T@H=P0SPHDM\_<' M)C)(%&QL/T*GC)<``-]65>#2@$3H6_=[*G)Y2$@PLZ/8#3R06ULFY%.!EL3* MCD+RZJ<2>6*?3>#W;.*'=NA'\?PS+L'9!7XO+L%D%T?-JXOI@4JZ7K7\ M9,':`W+14%S)WA*<+_FHV?2)_2HP2`I-[M$E(3-B018"JORZC@)OY;Q"9;*S M)KW6&(K-18$%!;R>$7(;,WYCZ^6G=$> M#_@:'[XG1]O'[<6&8I,KUL=-E:;GFGD+[?-X-X`H4*W#W';U3_AX%_8C:.2+ MSY"CV"0W$DN5IB>/C?:-T1YZX[EH:!XLP.FI=FH=+G+-6,^B\4,7/E.;3!ZQN.:GD4ZXU`]5>X/1<.SI^>(&_MT1O4:T/9K_XI1B:)N MO_'"A0_G.4.S\<::,'#=(!JV?1T0-_?I@*C60PS\P5EM.W"80M%.DZI%3RP;N_VQ_C[GU\Y1KW4SS> MX7VG;X#354/W[!_:[HM:6"7;@:5KQ[!9M^I\IBXD;[K3R99+.%=U?P]PCF;P M2G=M$.\XEY<+'*`_F:__!P``__\#`%!+`P04``8`"````"$`;LRAC-0"```L M"0``&0```'AL+W=OP%#R$TA5:NJNY5VI6JUEV<'3+`"&-E.T_[]'F-""6D"?0DAF3-G9HZQ6=V^ M%CEZ85)Q44:8.!Y&K(Q%PLMMA/_\?KR98Z0T+1.:BY)%^(TI?+O^^F5U$'*G M,L8T`H9213C3NEJZKHHS5E#EB(J5\$\J9$$UW,JMJRK):%(7%;GK>][4+2@O ML658RC$<(DUYS!Y$O"]8J2V)9#G5H%]EO%)'MB(>0U=0N=M7-[$H*J#8\)SK MMYH4HR)>/FU+(>DF!]^O9$+C(W=]>**S"`=3)YQY`0$XVC"E'[FAQ"C>*RV*?Q9$&BI+XC%9BB",\P:A4$ ML[X"BPDZF'?$B0*`=!5<[VS`$0;NMG,8S%IG=3[W%C.WR813;^:U@)/&D]/& M)OQAZZ:H+V#>\EL!%C/".HRZ:WV<`E,T%+[%C%`P/55P/7P#[GOOAV\QWO2GJ:UBT_#9_B^EJN+#TS`G1>_R&5X`I&LK?8D8H6)PJN)Z_ M`?>]]_.WF&[GB_D3>,X_;[^NZJF8O#]A=@(-J"OCP@C(!UO@\`SJJJ$A-*`Q M(GJ[X/4QP%DW/(<&=&47LN>=/0XJNF4_J=SR4J&&4JK]F\%;"X$SP'`"G0NCCC3E/V_><]7\```#__P,`4$L#!!0`!@`( M````(0!R(W3O'08``.@9```8````>&PO=V]R:W-H965T&UL MG)G;;J-($(;O5]IW0-R/31^!*,YH()K=D7:EU6H/UP3C&,48"\ADYNVWFNH8 MNK`9LSUZ)IR_JX\=DJ\+WBF-?;\OB\\?_^Z_.' MR/?:+CMNLT-]+#;^]Z+U/S[\_-/]6]V\M/NBZ#R(<&PW_K[K3G?K=9OOBRIK M5_6I.,(WN[JIL@X^-L_K]M04V;:_J#JL>1#H=9651Q\CW#6WQ*AWNS(O'NO\ MM2J.'09IBD/6@?YV7Y[:]VA5?DNX*FM>7D\?\KHZ08BG\E!VW_N@OE?E=U^> MCW63/1U@W=^8S/+WV/V'2?BJS)NZK7?="L*M4>ATS?$Z7D.DA_MM"2LP:?>: M8K?Q/[&[5(3^^N&^3]`_9?'6CG[VVGW]]DM3;G\KCP5D&^ID*O!4UR\&_;(U MOX*+UY.K/_<5^*/QML4N>SUT?]9OOQ;E\[Z#E[^6O;U=6_ M"#$;"H-P&T2`>OL]7_%(,:5_'&6-BOH%/F9=]G#?U&\>=`W'1!HB49]3 MH0335-D8X'$HHBLYDZXP4U?]P[J:BXC`B`A$1/4"F10L$"Z0C@&N%9=7!$+C MCS-W6^.9BXC`V+U_@H@5&+"0D12G8X`+#MOP',$IK78%SG>=@5UA8@B+78<( M"I.Q%HQF;@9PA$%OCS,W+\S`1!@[KQ>%(8+"(AZ$BBA/9P!'F+&[T2R9%V9@ M(HP388C84L9,!9(4.QT3G#'.]9!41UJ\1)J!B;0A+.8,$2M-Q$*2^93.B650&Q=A3$>("R@17-FAC'C#?#U[FD@;`F/6+/-> MT2"BG>8`.E9JB.!FS0SHFUN-X3@?#UY!DI)8QF8MB$.N:;.Y""167AN^;)$M M]+1K68(,K<0R$/?L'60%Z2SB9H^8PP\*.W4%05V!C:>^C$(6#^W>ESYU",9" MQ?DPAUQU_\L9S.,8W;2D@(EEL,:Q9%R2=:0.H2,9Q\/NPJ4E(:A*6L265'`S,=;B4$$$0 M#H0CCB^RB9YV9S$UJ,0R*$Y*KFE'IBX1Z^!:YO@BH^AI(FYH%^PXRZ`X)7E$ MZYZZ!(N#T<1Q,[?(*OC4*B09M(EE4)P6.B3J4PN(_B'YRB[EBRRBITG.2)\G MEJ%WQ1UJO[2M*.#\X-R);K8660.?6@,=J8EE4!:?[$[[M17&PFC8X*XPX@KS MGF5>B(D;T&?'Q#)X9Q$P'FMJ!RX"3P3P#'HE;XO\@*,?P-0\N_DHL-T"R,PY MO@US&7&S9P;TS<]+',?Y^'E)#4/3RD/F2K?AE[:HFHT>I5Q9B^R`3^U`#=UB M92&#=U9*!Z.W.[L3QD2HN1@]'[OB%OD!G_J!HGY@F3EQ&`6),(S4-2,U9S2W M%[2GW?&A!J/!S%D&;RV4C@/ZE)<03;CL=$5-O4-0;+(/;@M0_=;Z\,D@$R!\7UD@+89K-S[O^ M*E)@Z@^6L06.PXAT0.H"*HZ&"&[V%GF$F'J$(G,VL0Q*@QT)K\N3TQ&744)` M_PTK<`4N\@HQ]0I%WQPL@P(_<"6%&@\UVW\8Z!V"XUT)CG'9+\0BO^AIM[QZ MZ!^[0=`O[-V9A(.OT=BU"EU&ZXB/CJG<'!+'N.U\#@[AJ>_J(0-6*#)XQLDO MOFG;,!:Y^*:-9_5XE'W*GHO?L^:Y/+;>H=C!C@E69L\T>%*/'[KZU!]9/]4= MG+#W/^[A+RH%G&<'*X!W==V]?S!_"SC_C>;A/P```/__`P!02P,$%``&``@` M```A`)`"B8+]`@``P0D``!@```!X;"]W;W)K0X->OGW..XY/Y[7/;>$^$"\JZ'$5^B#S2%:RDW29'OW\]W$R1)R3N2MRP MCN3HA0ATN_CX8;YC_%'4A$@/'#J1HUK*?A8$HJA)BX7/>M+!2,5XBR7<\DT@ M>DYPJ2>U31"'81JTF';(.,SX-1ZLJFA![EFQ;4DGC0DG#9;`+VK:BU>WMKC& MKL7\<=O?%*SMP6)-&RI?M"GRVF+V==,QCM<-Q/TS'W0%?G"O)!7>-O(GVWTA=%-+*'<"$:G` M9N7+/1$%9!1L_#A13@5K``"^O9:JK0$9P<_Z=T=+6>=HE/K))!Q%(/?61,@' MJBR15VR%9.U?(](1'4SBO#'G;.?!KH$U M18_5'HQFX*PB&T%^SD<&(:DY=VJ2G@IJ`>5X6J3Q/'B"#!9[R?)4XBA69Q3) MP20`O`,C1/Z6<9A-B7,T0=Z1;72PU?A+(X%HCQ);L1I26&A@'"5V<(X%,)DRDD3C)*'^.%!#"@L--OKUF5)B M!RVU%UX:2:;1XD\W3HU7%X.=6UB&#C M7I\F)7:(I@Z1D5PD,L.#1*J)O3DAAI\^)7:(,H?(2*P]%;I;?5AC)2Q[#YX2 MVW@39^FED5S<5Q>'+:@(CM#KDZ;5#E;D9&VOV1>I(WYSA?[C7#@,9GKSD/:)JPZ5$]WI#OF&]H)[R&5'!LAOX$ MGFQN6K"YD:S7O6C-)+1.?5G#JQ*!1A7Z(*X8DZ\WJLD?7KX6_P```/__`P!0 M2P,$%``&``@````A`.C\F8@]1```B.0``!0```!X;"]S:&%R9613=')I;F=S M+GAM;.R=VVY8=U@0&)@"FA2;9R:.-RA*]%9B6XI(Q]C8F(MF]R+9 M<;.;Z=4MF;G*.\S5`#.`GF`>0H^2)YG?__NJ:AV;!SOQQ<8`V]EBKUI57WWG M4]7Z\M]^NIED'_)Y,9Y-?_^LO[GU+,NGP]EH/+WZ_;/OST\W#I]EQ6(P'0TF MLVG^^V=W>?'LW[[Z[__MRZ)89+P[+7[_['JQN/WMBQ?%\#J_&12;L]M\RI/+ MV?QFL.#/^=6+XG:>#T;%=9XO;B8OMK>V]E_<#,;39]EPMIPN6/=@;^]9MIR. M_[K,3_RGO=V#9U]]68R_^G+QU:O9<'F33Q<9<&2OIXOQXBY[,_4%@/O+%XNO MOGRAH3[\*/MV-EU<%PP=Y:/FT[/\=C/;V>IEVUO]W>;#[V8?-K/^;O?#L/+[ M_&I<+.8#X/EN<),WI_CB>,[C0?9N]C&?]X!SN-D:TOPAS'S"'N>#">^,\I^R M/^9WS7%?;&T!]/;N_NY6\]$Q"!H9DDXG@ZOFTR\N!Y.B!>K)QT7`Q9 M]C_RP5PXRUX-%JVQ7VQL]+A.`-% MC#AFVBE2NAA?3/+LW3R_S*'->#B:#Z3!G M022PR-:_GPZ6H_$B'SWGWV>OLK7GS7=?Y4.DI&^"T,)-Y)M!43!=\]6307'= M_.UX:))>@*AA/OXPT#;6)WE19.!O]M&`0YZST6QYL;A<3K)!?&%VF:UM98-% MAMPN;)])>$T=`&CXM=^##79:.P%;MX/Q*,M_0B\5(%-*9+:XAFK#P/_=^W@# MQJ>+#JJ_BN@?Y1>+;(3P2&4UMWP^6R!3]R_QUL!8M3QJ]\H([@-ZV31OK?)N MCKJ=HP^UJ_ROR_&M=$#G4`>H>[%(TC!8YQ%NV@(RO?QS,I<#O,$#%ZD7NQX;!,9G!PT/,S7PP;!$GKC8: M?Q@CB:,63E\AWA\&B_&''&PES/>RXAIMDBWR^4US@Y%0IF[0)"`4PWQE8PVU MS1?J;%A9I3GPFS3-HP:)C,TINK?3'.40E5#?LUP86J*F.9#A>=.F`H#%A+VG>O1Z65/^!:M/!@^4"G(__EH]ZZ)O-K:UM6&R>?1A, MEOGOLGYOM[]G(K:5C8M"#&A:I%3<*S04*JVJH.1SM+6IVX0(FH=' MV[WM_5V#J7_0.SK:Z>T?[<:M/0E@;:L%<2_#3-WF0S'JI&7:CD>(-VX8VDZ* M=F,\S8:#VS':KTDMI%/DD7)?WBPG&-51_Z;?-6=[G!0'#\-J$;H2]G5O.%LWR" M3W#5RZ[R*3C%R4/9#$8WXZG%4V8&HY?6?-=%?=53;2&[G,]N,GE#3JWF#-_- MIAOA*;L*_L&+]3!E"P%OIIC?'$R&`<9OEX-Q,"'N^'09^^:\W^4++#K;N!Q\&XXFY](L9OI#+O8/^?CJ&JN1#0B&!B!YNE3D(^Q6URTJ8KYJJD!L6*RTA+5%8#"J.R4X.A1>J>45PP/I.OTX$=_P;UVQ0:EYCE^ MZY#X5G&%\QR_ZM]#+;U4X`@3ES)3SMS2!<I7IL<4C.S173!B4?R<;-DJ`E[$')!_[.F`!W%.Z[G;D\P_C85M(F]#?&_^\(7DPGEL:AXV.IXT0L+FM-_BB%CLSN(:- M8@4P)TDWX3$W0X^69_>U%)N,.&9&,I;BRQ8<4Y0/=!2_P+%1(F6'YMG-8/XC M3(4R!:A61/;%YT^?/S7G#%H1\JYX#1_\X0!VQ;L-)(2$@*$V3;LZ9I/F-0US.Y_)QHRRB[L7ZT'= M8$'=@F.C2WW31*Y2,X6EVU:/(3,RS',\(/,+(@LOYLOAC\WINB`RHCVTQNEX MBOBA,.Z!M0Z'_.LHL=%D>4@JQ2OE-AF0T$*9H1([4A.K9X/3JS%NG.48:A*[*WP3S9.NO-<(!TQB?CS5(S,? M[8C0MZLVSBKM- M'BPD6I2Q>##3;Y%5<_*32IVB^:RDO=&H^?BX3.Z02;*$3W/(RR2K,75"?A^C MMKKBT'I#.5)/W#WP9I6'KI<+,EQO28=>'6G5.72I,2[)HQ4O$U/AE=X MZ1LY#-DU,A-X`E/:+S+$^(?Q='3.O^<(M$."S&_BO@'+G6HNU+$%0X"\%?DMM=7*784$F%$4*F_MB/B,RC`YH9;5__/U_*4-!>(>/ M>D=)WH8GD#__W^P"%X"4%O_A7,"6A/VS#)$#05+^`8'*F8(DE(=EOC3\UD+M MF\&45)B%#."!*%(M`ZV>$VTF[G^,&.`+6<96/2HLF%^QJ1G_UKR%G.!QB.(M M+-T8Y062`H%;:Q9W!=GRPM\F`8/OIT7J"Y1\FH^9B!TP('X MRW)*@@U(S"X/0MA>XN=BL"!Q7-(I0"J@!WB1LUNHLY#R*5!!"RG%,>L)JD4^ MO)[.)C.(O+C&(9KG$^54BK@/?IJAS^@XR?A??H=+T,M+^CH8.83LU-9"1=NT M+D@F11K0C(L]+T!R!<7T7A2S0"8V7`@'56(IBBE4N%Z,65,[0*$C9:3UL-A& MPW=_#J30U$T=\I(4KI50WBEA!W^!MN88@2-/UU2*L+",#JN0S=I*#H;X1ZN6 MI9EK%:F_AQS\ M9=K*8*>O"L0.LG4TW]?'Q^],[0?W`*#: M*:UQF5JCC.EE=N;BR\F=J:D[NF!(9"YX30P+?B8328W/Q-*TU8D!YTK':=L7 M=YD@A( M/-/1H(3!$"7CAL=@"*5C$2G<&X@:5X0S+I!7ZFU#\:``\$QE9+6X7H",/BD1 MV'KW[BC%V4;.KR%N%]D+=94L)[!+#NL,#&"C&QD&4T>F M*(+F*"JB+6-R,_@1]HN+&K/3+;:\":&+&:4!"<0AK4E```XI^H#$P8TG9@## MN\OLU4J.WOY6GQR%3?E[#!3CH!=00RO?\55&("`*2N7.;ME MK]*@XJ(1.X2OY7AD$HCHW%[DN*YD3Q%4$GBF?J$\"(1-<*NG>%Z5F(_D,MU+ M&:)N`^*7)%JC)8NJOR%6B>3.&BCF.LB4PJ9SUQL7(=;M2=FP[>4M.@@^F%&> M3-)J+:)QFZ#UOB9(M M6O^:%%*MR=J`I;/DZZA7`KT\ES&'33`D(A3K%DOP76#.8$`O2ML9@%;8`IN[ M]WQ[/5O,/LPF&):A.9CO_FSN92VD@H?-ZX5R2`486U5@M5[%EDB&5CR+D@:> M#5?S]0C/$3TNL.60V!]>$\*G4EMTIT5'"):7E-Q<@59<,BD*4ZJRCD0Y1"7\ M0V2UL,(8Q':1X)->"5%$YLTY)68X%+=59<-ZA41#>X*>53C/;,S'L2+%:,)1,<4N=KV M)]2\F,<'$\!",/2TM08(7D'XV9$(*+7&&[ MFTE-5(K-J/MM%!@;(EA4ZD/NY%BFF)G,!N:J"Z,G-1,)TBNP`#M5!`:FKT"7 M'6-KK(U,2%+WE^EL+UJKMR6E=&4(-)/Q7#'DK!9\)_:U5!3+1+.`U2+`0T#8 MKL50X8'[.49,M`[84 M$`=%9&&L<#88XE30[A\B3K%6-9#P-)#SR3MFDM/HJLS>".O4J6:TP#-56Q)+ MPVO.E!TL>YD<3%\H>B&A31$USVKSV4_NC%L`X%6+R?@RWU0T;^BT0-&6K:2[ M5\6&.]@DM9)@1U0*D%59Z,"(**;S+B!E;:>W<[2?>J\5[2GGB$P%O==$4S6G M6$Y.-PXL8GU%:F['P5+'UPQ&:3079;61*69[TK9V35BZ6GKJG4TZ;+#QC0KD M*Q28#9`V@3E"WP_;2%I:RL3W9'E/23O<3$Y1+&T*R'.VYB8-QW/ZS3$_"(M^ ML/A;WDY-EUCIH3'5&-B"7!%AK._%:<2/*&2GGA=J)S64^DO`\,IKST7+G:1)9L MH;#HD9G-R[[$*2`/$5,'#D'(9C(FN*T&GQ*9,1$J:ZULJ0RK#C*9-XX0VO[> MD*A=RADO\6_"/8*A3)VQR9*OM(,*11P"61WJ*Q+`!@(T/*`;X-SK7X$$&^HP M>"C@"?=ZD-!P_MNS/TP6[QB8Z&J*^PXCOFC2V-+-M\,\ZG2+V.?66FH%:5I1J M-#O6=&3/NWE,_$-BS[,158^^\N-]+1=FY%2LX`2(/,NH8,VK`UNT0%=(%>R7 M_^['G$(_$`K9%L-ED05K.&"@SN1I#:&?(+J MTGP^%HDL+93_SOAG?=?G&K)97/N**34WPF*"OSW\R@! M],*2$4M@N-R)-75B:(Q@*-HE#@"Q8%XI*;:.).27&`D*+)X^=+DWKTHCW8S" M!M?C6Y'5+7#TR+1GRSL%@IEE3HRM,@B=K3R3#C?/WZ@:0-W$=>$Q)1GW)EW; MIHB+1GF5V5(HTS/7Y%H)60=")D/]Z_`W=+ARZ?PWOT`E0%$3U+`1M M4S=5H,1F1HZ`]R4NYCXH@V+>K)E:".@&2J@S5/._1K?!%;DGQY:)KM!I[TD. MY[,+,[E-T1<:8LX'$UN>PHRZ3%PA/Z$["+>FYF(S>^4.M2VI?!);*P\5\&N! MEO`*):#B,)1)9*5^4#*\$-A%KII+AHE94D?)YFB1R#,BMQ,WLBA;G^<8PSB) M&"&P!%*5D+TD<3HQM*4)1)G`BB/W1^,C$=TB/DM>.W'4$".B>W`&[*#8.V4O M'H#)-HFX%Y@<7& M+V%>RFY4\.'O2CN98R/D`ZL/]+Z!%SPZ3TUK,R[&X-VLM"EV*1LK*LN5DHHR M[QM1HK(;L9B(8PYD*6T1:W%!`Q&8W68,[/1$3'R3J%S4%Y1!B)`B;$]8SV!\ MNGR91$=>4.@O]"JS:O]X4,2.NT[=U]/0UTEO_3P$(CLQZB'648/'NL(?4VVM ME-#.\TU2O7![\!R5L8.(]="RJZ\].FY!7UAUZB+JK.YX>8RD%*\XW7S*W2B9%%#OYW!IW*\E"&14^?CST+-6,[26_8VU\IZ6TGS[',HYDAHU9X+8 MC#@TU,"Q2V:"/I"@-]5*^I)#F;7$O/#-DLJ8"ACWQL[@.(H=<6/*)YOA*;/J MY:%KY:T`EKW`',&[38Y"(+IK?J`W<**+[O9%O!00J'6:6B*:HYI-L_E/<*=2&$S4D`20L3>OD"W^!2QB.,0E6M.39@)#?$H1'68_HYGYL,IY6@>_G.K3+R3AF4A;IKAJ`22S"0^@"FY,JQ6W-8 M6[E?85./EKZI:C60^6'R$V2?D$1Z<$@K_CNAF)B_95K:T?GYUD!_W#3=IL)"7A3Z=WA#/JM:J'8B"%DX+$HL&Q MMF#5O=B4WC/4D$G$:_,C<*&P6P;^`MZVX[Y!)38->M*W;!Q>Q1\B1"`X6Q:6 MA0O>L_S+)94,6N!0)17$1:F`AQASF9MC:2(D9UR8A,'C(X*PEL"B.MQC?XE8 M_+AQ-B0WSB^!+(KFQ"$WLQ'=:X(B!H3Z55N,_$;AM,R%:&`5EV&K5C^MK^,3 MIT8!S2AE)K:NM`1XWB8N[5Y%93E&MU>KYI\TK>_(^*C,7Z'23*-I@$>NE,F0 MNYAI,WC$0Q/3J[9*2Q+.>;G*ID'*3!%[N"I\J)X-\TK3A\0)3IM=\8%@RMR2 M((/Y7[(FSG41)20>G(,L]#Y5UZE##(%M?..JK?)5*4[G"4R-$E"<05<,2@\VQ]W#V]%BQ?-Z*G M*>ROZG),"3`685LSK[V,7A,.5V^\3C7W5A^!.-]`BMF20I%UU8(5R,5`*60E M?J=-"Z&V$<$^@X1X?LOK+2W>1%>FXV--;_(<)`6^K6MFW$2]9'P2WI%Q(06 M2H\9;U,/(P6C?@1OF/$'5-<^*A/F%*QEVUVN]$#3>:8!N&J9Y\K.`"VH2K@C MY'92%S!5-_,P\`MIR>#F+IN3.ABP26*]=REN1RUS^KE,/G<#+S\@;=W\>E/A MII^NL';,35?L2"6NN(1XT'K&;=V2;%2Q!8OI?@-68F;[>15/(P6*=$/Q$=ZUN$\_&P&]`<:*#YK%['T=I`K\(>:` MG;"&WJ)B-$W'RK52XJFXEPK][B"QW477[E#'95&["(-?^;4+V3>JA+Y#M,YT MR*0I)CX>(JKIWA*V?B8,X*P8:MRF9@7YT[MY>KW_4;WAV8I7^(7TDV[VC_GZ,G7#LE0:JDLXT2R^(^T]JG"]` M6^PGU-4BT<5OXY[,9)""=-O(,1O0I2=GCLPJFY]4O''/5K?3)LO6'CYTOFN;\^JU%YJSG8/DLL=0 MYBRDQTL5@?XESF4W*-DES2CR^H.7%_#D@29\3[\`26[1`3]5(_E->S!M<0:M M*7CAWZ(5/+2M9_B"=26.,(R5167K1P3S]8.I^$J7"*0TLN1DI"LR41QZV5:) MJ8YJ@LIT+QQHVLG?4_$,R+P33:=L[+XXZ4!9&--NR.O:]EYO=P<9W3_2_OBE ME3-41X+%-S@^X2R"WH:W&_=%&;BVH*4=B`K(I9"-5RU8K7U*-IGJM3M*,\HX M2W>JJVSI=SCB=UCH<"_B820]=XT,Y.+;2#G8WHO."@$4A0^OZ6D5Z8KEI8Y4 M\SLZ%EQ>$G35UB)9L@LUJ^N%BL4)'#6]:K'VJ\[+'*'<`P<5=\)!Q?95 MD&^YY#:=AT!Q4]W>KO,56T!?RE2"+(1TB2,)^OEE,N//Y&"[N)Y_^\>-U]^= MAY.!QNH65(T8+W,VR-;VPHV.RL89E_LEA(@^L:,AKWZ9A;'_\>B#MX7`G\&' MKX]">9B;*&#)6R%B_:W?R"7(Y#_V*K<1Z+S-Y&XS8^OIR*)*^NVM8SU9S>6A ML5EP`=NKG.Z6=A7PSKUIS[RV=D!OHVZU-$:&:5(;[+9?X[M-VOQGK!LZI$U: MXAKB[S7NV_45#9%265,=7K5R/N+5`<'N9E:Y760EQD-VW]?8PM)"V97B;;M- M6XTW%EN\B)JKG]:3B#6H2S>K)17JO!FYOVU\9(;9DX?))H:,DDJX%J88]@65MQ4BX68)!OC\ M4Q^A.-4GL6!7?64H2FMAB>%KFAW8*ADP55$JJ0+7]Q(@H`CP&3B$7V_QDL=M$-+KAUN;_5@_">R1XR*F:%: M"$^!BUFMV"&4V+O[<@<[:$0(M7:XW]L_V$VS><.CWU:PJGVS MG*YE2S\3)C;]N6,_C&FJ,9VX,30H:H0?0K*P=:D/`.^23/.#H$56MX)URH'X MD!IOW3FTUH3G3"HJW,[X1?;:,J"/&?.0/[!K_D!U=A3CBODQD]_Z30%NGG`2 MJE*A4AC6E3,MZ#QS(764``?!\9>4^X6," M18L.6$M.=^@!U&28N^A@F/?AX7XCIBS7JFRETS:H`50OV^TDGN'6(EN;V]PP MK6MS*ZO+V;"9L_6#!$2Y5-7L/'?YO41`-LQP1)T?-5XP+"QAIT9/?BJB_QXM%OHAYK$:3N_:53(V[R.A;$!UW2A#/7J2%I'6J9(]VXH+^=%2JY MB17XK4J#&*Q>5M`O#TB(\[:B<4\A=."FFK_`A:N)Z$'&->DS!8EDDRIPXRN8 M%U_E1$=$HBO:R2]$RSA^>(W%8NE+CDSHFH/+)1V*AI3RF6JXQ#FW;CB,7:WG M-L4P-D-%RH@?%O1%U>#=,SL]2)7ZBJ!630!>LG&3 M*7OGP2GTBEVD;$-`1#&S7=PF=O,L!9(Y-:TFC3"BJ8F%*U%4"43T,P3#7.Q"8/8-HU8!EN: M#Y3;N`MJ&QNV(:7RI.*HH!*[`S/%#39Z?8/PV:W MM$@\$D+-S_4N4E45*HE#IJY226^A^RGX>QXA,IH;3PN%=7N-J3U&4*E:<-BN M,6%Y34$I7`YD`HA\2^,\"^JDBA5+`YKC/0IU-UJ@D76S2199A'M+:C[VO17> MJ+UKRFZ[=[A_*.>W=%#MC++H5/.T$^AEY0`RK?'^`;'5OI\V$;&56@&EW@R8 M!!;6T,/HKNI5OH<0@FWW]BR)IRME2%/ALZ>+HGRH0QGWD-JBA^B@<#`JBBC\ MJ>Y#G=\+!["P9W4_5J_;$;EP[T#*G%J(%!*).KEGMU9ACR(T+4?M;4.[X8#` MT,AV.VBL,HV)>(L-*^5=(>L/RZ#FCY=72[2+.9YMXP4NJSJ3A!JIR;I!AP;;9)35>^7]&8R8#<)^6B(8G^R'ZRSM5US?65[U&QTNY(:"\Q M(0IKJ$$]FN*=WM:^?T(CS5^U'>8DF2@\3F#0O=QD0S)'IYR!96=+JJH!5(N& MYFKR>2.E=<6@L8FDTYGM&/>00[M7.K0=;S=7.:^(B?@4EX;DW)@.0_0FS^P" M*_>V&\TR43A0);B>)1-L6!U7IZ#HCI)&QL7"'=2Y=YO1PGCI$>COQL;;*=Q. M*6,%S>3'^D,P2HUP,KO+U4[EQW[5SB#=">/'5@=3*)8T70VQZ\?84:;=13=2 ML+CSN-/;\PQ1Q=^H\1TC76+KPRPH2@&J&,[3%:#T#V$G_UB^G2"JP M@UD31N!3R[J9`@FU`I#:WR*A!R3:P\JD1!ULMXTCSH;QGL&6`(BKE8<'Y=EF M-`#1)5Q6BE$/V"\M&2V#;Y&]*NEC5EH7,LC-#*FCUN"6-)R&>/AI1_;J<5=* M6[#C)$XPA[(,HD3<7\U(@X6UO:->?QTA5 M=N[<=,T8[Y'Q.MK>M^V+4"=>D`,#\9R%.H:$4',#UOI]MGN@JD73F[!:56CO M`J^=2]O90NPR5R=1M(&O2N%](27L9T>449\@8/B"8OF/`)?$/S)\@-/T#V4$ M45C@/P*+'J^3OE#^$(L<=_?H';%4M!PM3CZOH%":-+A3`BTA9"%(*ZZ5"]!3 MTY6AN]RBTC5=,J9+ MVF(J$M&2*K]82G$$/?@$R039@%9S;,(*+2\B:,QZLJWYRFE;!2.J69^I@ M\#'<0J>B:1A'L<:V\&N@OH[G90G."?NLN1!1<5Q;:F30[ARIM!177H-+;G,3 M1+7%JA^A[+A9UEC_&' M)->E.Y(0W::R[R.3!N1YX+1'/:;Y@_I/?>(7?.4@MP<_OE3 MGT[=_M9A\\'[;K%M#MO9W-]IUP.V-_;PQ-TD=^#A#3';?9W-XXV M#P[=/VP]U<.CSY_,>6P^E*B4O.3=`W`_9LSN"!+[*=FY;";83!V7^75'7Q3@ MEMMH`XPL;6>R/*MMT;ZYJ*-B MIY7*.TS='*)[S'Q01$ MYD0$VWM6`4K^0"@@I?983TCH.][K_?W]WN'>87/HDU:U9*O<;(HQ6>#B-&&G M&#QA>I@D;(KD%92*VLL6*R=_PHP$GM_I7BYG6;Y; M%0Q1)M:D4<\,&K?X:3^YJK2'*K^>T@7FF1)^+#5C./Y!T4X6T*JGL6B:O-64 M9A06P_&W\((=EJ%SB>Y@2DN<"_E1G"8-PL*M_+2Y#2:W5'1-P"RJ8Q.JV1'^ MA_C;8SWT,P!J_S%,L8TEL,0Z,4>>VL(C:RK[&K$T;N9;T/L87G02'HB]<5'^@E'GL["U@T>='M+R&X#BH M9`+!ZAMX)C*>??KG=G`4P]AVP=%&*>-:Z/#6,M3$+6G9F'&OB_UJ!5<4[#%% MH(OL;'!!Z`PU]/T$4O.TKZ8OZ8*CMVIB)5IVZUY*=!2_:^Y5CVT'`7!V74'H ML-IJURR+5\FX.H&=>$K'<<-VN;5K,.%PF;H'V+S(ZD5J`4K9EKHO,$_)9\[M M^O+`-P:V[GVI,)YS"Y\C]6R1W^IFR9=S-=*5#`ZGBUE4%X>]G=U/TZ5@7D M7\#M3.FU%C+/E<)A4![I"%NH6VHWKBNTH=W:*TAD*3(5^Q.P]`N(AL>M5M]? M(`=-[^)<(IRN_WIBM+M*($R]H!C%QB"V/>)4 MQLY"4TQ?^_'7.J&?O2+5U%J5.ZP#E?5BR\ML1:3'H5!V3X!YTA&0-M==[^_H MD-1^\W=]Y##!TW9Z6^"(A.C[TFY'-ZIRUPKL2F'%;'U(@:V16]JB(/,D]THU M3P4?,EQE1>,)4^QT.+@_^.4DK4MCXN\/U:#WK08=1S>Q*>P$@V<]0,$[@H1B M"(Q-LTSR\SI0V)>?HNE.>ZG"5,O=_LK9ZK3=>]/5OG6I%_@%:1(CI<1W\A%K MO\K;2I-WIZG5R10]R#`TS14I\_]STO%;33KPXX[5/3GIA'&3Z(ZD]-'.QE$K M)=O?/-C9X'_VFC)"MI0/JI%TW6H^>5WE@"JMFP-W-_L;AROS=*2I]TBYDNG] MYZ=<'\1%LBKQ8&B9__QAE>J)QZ%CRC0E63M3K%UI4K-$32S%]1Z3]TQCD;<' M\YGDH/!!=O;ZS17O2V!V94;W-OM/SU]V3[3;/9$4\@,IFD124T@TS-'5CI>% M4GI4X=T<)&#:,4.UIK8MZ;2U34Y)*$A*+1>FAEX];7+.6/>M,5">6`(TV.OU MW=[.UG9OGQ7#+T^QC:$Y/=&RG#ZP@&5*TIJ1+YZR1"M"/7U\=FDWX;6.Q7HH ME?(V-9?$HSULQ=HND7DX5[*SBS^[OV2Y,A20R`>2S=;0@)B>]XNX9`E'2V^ZJ71\`Z)TWE0XDT\:6X/@E>'Y" M%F]?O+;S"?S^R]*Z[TB'\:Q M:K6Y?3/V,\6T%#1U7_>HA]S)`W,GN]]MKG`2TH`)EX%[:1*1LDK>C7^OSEC/ M;R@NN)71+\"%T]+=1Q?Y4)_ZUKOF??F-",Z+^A@5EX.$SYN0,^+>B^H:MC(- M].41(#Q;ZNEDD:R&FVKGGIV$M7'DF_?5)JS&BW+`J@N!1G/65I4_2RU:"H@3 M53K_!C,IJ6>E":`OD1&^SZ=[H\L?T]U1_:.CH^S;1?:>)I5OOCGI;"[6_17^ M>0PNW++OT%IC/;FGT_R"[X617R65(UT?TU51*[:'<%",RZB;@.!MD;9JMS0' MVGF3C5KF:9T?TF),([,NSDG'JKR/Y&PYI4\EKUPT_O5\MKP-Q[&!Q7)/7@Q- MH#;**HSR;`J]5+*HIFYU`_;/`1F:U^\=(/&K^4E?Q#/`Y"*]^=KS$JB19GZ) M\\CGL#$FTQO?8Q-W.%9@_!>`RV)3MJ5JQ9CILA/:-_R[M2T]%1+EY9F5EMK4 M\E&**GUN"2/_K.@M>QT=W;+5H8S9_L6M3G9%%N)YS M=P"_MT9O;AT2`.^VHJ3MS:.-W'I)L'K[N;ABGBF#"_C[IO06&;23&>5 M'YNCI.KJE6HDOS2GMYP`WSH@'=S53>(\/$P5N,K,3X@7=K$]K+1C MT>76GOOMI++<\,L)X>LLF&@[_6E7(N+B5YO^R*_IYA):+_4=ZE'XAI,G.#J! MXWTIO%'IX%539+9$-CUU=`6."]E@&M9,6_ M]=5$IB;O*5GA[9S_SF?-=>K\KCE$EW+J,@F=$>R>5+36W73Q,Z9%3^<'"9[" M&1^>5SJCJ7CZ0A;^Z>X':++$RPP;"E\L)RB1Y#APEE_DEX"WBK@(__!E.2G^ M#V>']6TKKSR%Z>P8KL=M]D%ZG$O.7@!9NF)@,_M&/V5]>-N^F2[/M]J&763K M?(/;OO&J#*'8*6#Y/KN.\^+%EI!(7V5Z]B*0T]D2' M.83>RB0=2_-.Q)O=.2UTHGSG'ZSM+`J^35>%B+,GX?R-'WG2X1O-E/X"8[/E MU77L)>#(!E^=X!I+.>-^S43]$*LXU,X$5JUK[Y*-B-B)<`O;RVD% MZ+"?6O*\ZNJHSLB&0GMRV=L>>60%[E":I4I4[T`)71L]%@3$6&GHO*CV\9"I M+;D.%JRX"S68%8J11S!^\\VBZ(""5ZK?6[6T0LT0A(U(;%O2;4JG4;VS>%+G MSD2$*KOH"DO[,DEUZU&6[.R$^EZX0<*2;0`/:,@%\M@NB;5J>RM50DO7G*L' MJ6W?3X!.=Q6WGT@Y43KNJ.DEN*P-NJFQ_F1G)]KS60I7X7#[T;%)BC2@M0Q+!1XF(:62TH0Z`D*)2;[>=5)3$N%=29DO**@R" M(%\GPE`JC*J0F4Q+B:U`#$%X2\I:PE1QA/V(0"F!G9Q>'BF*'^UXH/WZ3;PI MBSU5B%MNJ=30AHFN!/]WY`0JGMVZ/@;QG(P35TRRR8=F;;+9>O(QFT\X1"%/ M*^YLE49JOO;>SX'I;-D24\P,[^:S*?\>^E613QW_4-KP<"-[VI+SK[Y5B_?];O/^.OX6R"Z4<0;G)^TB_S4PX)^)`3 MO'@^8ZQ?+P=<4W'G/V_K!W7'V367??M6/+VR5Q5?BGXU^J#M6UO\UUNYU M['LL@'^%?;]3ZHQ;;3QI6?T.(?2,=Y9VWG7Z*R/I\R>/8/01#QQV_VI,N!/= M[N*)!QY1&+=+.]E#BW/RZX6*3A&LZI&D]@WS( M.)S5Y+Q?.&&=(-5>TB01;/M4-[<*`!)'2S[8_>6V@%UPVH$O=NA7J"L:D+-- M*Z2NE/'X37^,+P7+UYCJ@FPT M?99HM56SZ8XG?6Q^,`HG)H"..:VAEX^@\26ZD5VE-,&'VM.O+K6QZF$L M7BPA,$=[_7RD:$\;8OX3-_Z(4<4EOG9CYM)N=[5SLE\?'[]SYHZ* M`*$DXM-U6MP5-+[ET`N\Y(Z.-9[I^FH#@.C!FW+38O[U+EJL=!R;.\;L>X4W M]O58_R0(4J+XU"X`E<1'?"('B$-J`I9<<\F2/MSI@8U8CB#;0U`QJ?=NBFM= M&=V%[B6&F]R;?E'S-A/7/DVRN)Z196M!8R(B1XZP29]N!YU!70B9<@3OQ2S? MR"66T+6F+)]B0J!TE6C?/DJL%.+(8DCJ+/JVB32QX]D_(,4&+KRX*%4=-+1B MP\)IY@K(BX7A6L3,DQ&7\0M;:"9.L`^5&IB,N0O0[O`RK`1.L:88_X!KH:_[ MHJZPZ-JVT%LY6>\NO:DMG=U59+QR$&BPFF&A:[G1"U)&'9`8VDN%3:#@V2.6 M6H50>=3=DUG#GUW_GSYDZTJVS:ABM\;'F+39;B37K&1+ZR_E`'_^5'?!#[KT M\93ST!6=?,Z"4>;\,+0GDT)NYIG?LI0OYK/8PO(LJ7<^_I5C@0/ZTRP`9U4E MV`8"2!\$U965T?.?N\QLBJ2PEK!G%\MN5#<0?I6C MJM)NI1!(N*C\00*25DBD734IJ$+]`9LT1((FRB90I#X,S\*3]?O&,[;/V#[> M52,J]1]D?9TSGOL%-,(>"[K+,G!Q@N^(JY7,)82OW+C0_=,Y8B""W+O['S(O MFLIB0L\M+0J4_[%RMJ\A&8M.$IC[SNXWZ%L)62-""UA+,4AJ@`.5@*(H4`Z! M1?)*F$40=;HK>!92+Z85H\K5=QIBT(EDB3.0D(E!BQ@D`X".H1VOLK.19Q^?@:"1;*C6.)49< M*5(>>8F3DB,_@JXK$L;F,N35H[V3U?+R3-)+2=F>L.D3FUSPHH?)L)-9XX9, M4UZPRQEKDGF*.I&? M5B"6UNPI0E),U1>@HSC;<:/-IX4:\Y6)BT,D6S20N!+ASC:`C$/Y)=6'E/TA M<<(Q`*/_-9PD3+J'B*!5/Y!#*==ANTI^W-/+,^IHE0`;-JR@X)S@\^8U$@UA MA<-?I8>+-APE#,#=T;<NQ!OF2:)]7-5,$+0$83&9T-EQ.*[G[Y MG..!J)+A,^'"+"44$$X_%MVCE$VANV)/WF");#S&7,%G/8&_Z\MA:5N^_R(KJI5\0ZSQZQTKRP6[D%Y*(T&G@`9QL4/A^8F MY!_:1I/0CHSS,9-%@D1,\?LP&[<([38'20H:7CUG+OLSOLS?B^,D>I3('E`E M)AH+]PI\R\_=UZJ$HZI^PZL#L2`4.UFR5#6HPYRHF;4^JWDC=@N7(N\/DWV+ M=)%.Y1._QDM1,J#,V;<8YO%/=JT""8H1Q:H:MU^_."M8,0@!%*E^^2!NJRL] M-G7UFV37I\1Z+1)%`H1.MQ!_/WLO138\3P[A"`8_/-ML,E0'[&&3.RF_J@7F M3)S@.)T]]WED&T>O1\W/,;%RYG7)5L.E)KTM?L&;D@;VP&K.WJV^&^:_'NX- MWQ9X>%/[')W\Q>Y[Q?K/4.T=77\NX9='>P](;&"-8!Y%@',VCDU]B-A@E6#: M[9'D3;"WE,'2SR#@G:&>`S0U@!WJU3$J$6%-\D4/Y_V_N`>WLQ1#V&S1;>&T MV'<12WT'8FQ/VZ^8@J@NW`P8>A`.D]5^7V:I[>UE\E&6VZ^N$HFA"X9L^1`#JW9AC7M%$3-J[`701JW/AGD/&]WP M%E(]+5N$^7L&#MS;;S1JL.U:;^6.UD:KUSJ#$7Q[L/Y+_CAP[V\/=Z"@0S$L M0OS00FI[L/91?J:*$HWG]7+-!EA^5>'MP!;M^"26>K!OJ9?GQQZ\1@G!Z_?: MKP9?&=WW*!K$Z7Z"6URE&VA<>/S38R%SAP+V*#)"X>'Y`LJ**.(%68L'66]!A>`Z"YI:'FQ,_B*SD-+F M_WRD>:G&[_WO,Q2WJJ8K_L"8``UJ8`B"?-76*D([7"N9_ILV]&G1F@.%=NOW MC!8MK-_(8[1^$=]W4VY<^*2!YLCZK8P6>$@F\KH2D5QI.HV.`C\__JEK_>)_ MG]VO?YB(8!U,USKR!>'=<'Y`?7\X91;:Y3'3*ZD2X[&,TS+\;+P>UJ]E&].2 M+X5:0I'N6%$AOX;@9X&8YE0+KA[+$Z+U(S['F-3B5XR`X:KB,3"BXT7YZO)!/ M^*-X5,@[<73&UR4'LAR:G>NCJ3@)&Z>.%/"FIJTFAJRXI>74[/$7A#8FLP28 M"(7.(JW@*PCDPT.E/R_09#^O4>NSN4][?'W]>"Y7]3-N,,Q_@S!56@U`^:5B M&D0,,-)/Q8.?W;.Z<[OWJ@,F=C;VU-CY82!1PT/;8:=Q!!L(;J/5W1IGZ2+( M@#R[>1U%MH:Z)I/D[D-:'U9#RHW_.6#9;4/^K2'+)4?V48Q`T,@LCQ3]I6$X M9`V.2HELHH- M"9$A34"=#66R*?-UP3&S)YG>[O=5ZF`'7F_3E'OMH3?3.L5H^Z8D8&=W5J#9;=O)\8GXN*>D& M1VFL,+EKI`MT'*Y+&MK06&>Y/I:8%M*R2.Q,6B2T1"1M#CM-]4<'B67B?G-4 MI42F(:M'&2#4MB5FW_,_MJI#MA:+SH+6`,0^P':BY>C\;N,2?JTE4O2B+M.$ M0OA@@0-U!M6$7_N:_IC&TA3KB(!1)/!CPQ'.1:!I\&(PT^K[\=M7W M".BJ3G M8"YI?&8UNPX]JXD!)&)OUTN49K3X?;RD-?7Y8Y29]U&_;@%;^^JD]Q70V\\G MIC$+G6NN8E@R_(W0M?B.[:]^6DFH_(A,+8ZO$B!4:1#LF<&;^Z M`;#U^&:[1H=Z1K)DT6O@L%&T%JE*)"]M525ZG>L)=4FJSM9PD,HO@.`B5U`3 MK7MWES5*:WX6@.$!'Q*?@^U'O/0AK9FUPYG%/*R3M#Q(CO*04I(A,$BL8#/A M.(^QS)./W<0RY;@'2&K]=>OE)N#U0"IR9OV`_5'>J?^U=V@C8ZVCM^;;O+3? M[=7JZM$_````__\#`%!+`P04``8`"````"$`T,>D*R@*``"J4P``#0```'AL M+W-T>6QE0F3FOJV,%Q]MI#_.]\WOC;FR:.Q\3)P$6W];=Y[_.^SLP;CZ^_>UD%QEIMS.]N?OZSZTWR M&GA?GCPO,4`BW$S,IR197W4ZF_F3MW(W[Z.U%^+.,HI7;H+3^+&S6<>>N]A0 MHU70L;K=R\[*]4,SI7"UFJL06;GQ\W9],8]6:S?Q'_S`3UX%+=-8S:\^/H91 M[#X$@/K2L]UY3EN<[)!?^?,XVD3+Y#W(=:+ETI][NRC'G7$'E&ZNP^W*624; M8QYMPV1B6L4E([WS<3$Q+TTC%7D6+0#B5__<1LFWOTC_O/O-NW?=OW_S[5__ MZ"W^]L.O=^_]\(W9R=DPFK#!89KONP?)XG9*N9-)<'.]C$(F2`]J(FU=/8?1 MCZ%#]^`,$(\>N[G>_&1\=0-11$L9'`RI!/7`G=E9<^,7,#_R'VZ;&E MN_*#U_2R11>$8V3/K7R8B2YV4@[GY?-`:'*91@1#DJE/5[A,*XCDTL7#,KG_ MV".3Q&M0S^L8_4F\A!2'Y6J-UZY?[.CP&%Z%K1B?^/%A8CH.F+T&LK-U89ZQ2ZDSS^9'*) M\<<&/;L?!,7`KC^@H0^NW%QCC)EX<>C@Q,B.[U_7&/B$&`Z36W;2YVJ>?HS= MUYXENG^U!ILH\!>$XG$FAEM9=S>[O'-F=X(O0Z:*HH*HX\R&)R!Z-QW/VD-(AOSDO,&C%/?8CB!59K\B6(7A=S MQ/3:S77@+1/,2&/_\8G^)M$:_SY$28*UC9OKA>\^1J$;X+"3M\C_'FB)U1\L M]$S,Y,F?/X.95%Q(=9.R.!6'(NO9-)NPAW9W:`^LRW3"UA+KE;?PMZM=Z0K> M>_T2:B3=U@O.=!@63#)W*`M<';)"9C[%%L+4PM**#>`3N4LHMFA#QK+8JRHC M:Z$F(VN@*"-KH2HC0F=?<.6:7$1;+#R^-;#CC+I=,>MK["_["3+@>SRFMLVN M/FN;[-%H;1M5G>;*0W[9B8VI13\Q.MXC:4V+73EK&NR1LJ:%JHRRW^R5N"A= M4'K>@^2-OJ7'#\'(4CUZCKD7!%\HE_]E670?J,C<7+\LV5(SUO]I+996LND0 M9<_L,.TJTA-@K&ID538RW/4Z>/V\73UXL2->"A`LQ%4JKY9G4]''E>D;FU#`!=^I#>-I$@)EIC@!&T(&`7B?)=`#WU($`(_X<`1RT M1``X![SBF#C$0+E@"1\H68+_J5@BQ^122BQ/*&55^@7_`U(Z4OH]2LTLW\+1 M2S7CY`"`HUA6I5A=*8:9'9%6J@`G!U3@H-=MI\OK5>5\;0IA21<82HT@#1S2 M2'M>R7(N>)8`#FMDVN(XA#D%I2+=$`!'"P1FB)ZF_K?',6CJ@;DW:.J".02I M#SYC3'!+2#VD)@S`HR4JRG%"3^HQSJ@&!D%7AF3>8.E*D1R#KAQ9FL+2E2(9 M!%T9DEM"5XKD&'3E2&8*72F208!&M&1(;@E=*9)CT)4C2U/T=:5(!D%7AF26 MZ)\X179XV30MHK+Z*;A7ET)AH'SZ_]96+\O:0FJO:M($6GGS=/:4SAQA"S&7 M8E-IVL#CYK53XRF*_9\PR:2-/',44[W8I(U?B3_G5WZ,W?6]]X*I:+ID\;(\ M2L`:3"5_E+Q-X[S,:[F)B71M,?R-->0"=ZU5:D%0044W!O+D#,/_@5NV#K&I MEU+DZC89.DGM&$[I-K5QPYC385;OQJ$T?I$S:67N;.H!C#G-Z'+N_;>#:9F] M`Z>AO)NE=5'^RL\JH?&T3HNDS;+HJ='5FHFEMP98]B?9H_4GEHR;*?!XWZI5 M$7>FM@<%C9@S3SX<1[(A*EVW"7.FY[HH4HN;_Y;YV[GHFQ!NGSD/B_.HG<6D MNMHK0O*T^JASA6,3JFI"J-#885_1H['#F.3(3=<%:[N@)J'$O;E_`BPM=H(0+92&4EH6C;L9+41V4UJ@D-&B$BBCA4%14UI@ MG]+J0UI&"V_C-::%LG1&BPK4)2X;(\6FN-`DHR7K?J"H>WN?'<523HF+1%;! MQ6F5=J24S&A!Y*:T2CO"<)P61&Y*J[0C$#):-I@TI57:$5;@M.!N36D5=K1A M.$9KH*C[R[UVE'V5ZJXJN#BMTHZRK_85?973*NTH^RJ)W!17:4=09?JR<:,I MK=*.,M18]/J92VPQ'3$8W`57244BFM)GMY M7]'+4RJEO63_MA7].Z526@KTF$0V;JA+5-BH+VO75M3NU%WD65=V&$M1)?CB MUGP;X$MH$7U'3:PKX#-=7"!:1581:/;DS9^-&5X3+PC)\4#=J`JANY=UX(9N M$L6O!JTE%.1DHP\4R?TVB@H=R10LG*H`^AV^.H7"F[*GO_:]1(DA,S/+X$^UX1!1C7PK2S:<-=M'AK[&-_8GYK[OI M<'Q[YU@7H^YT=&'WO<'%>#"]O1C8L^GMK3/N6MW9OZ$R^HCE%;Z">,1'(L7' M++%>VK.O-@$^)1EGPF;@OY37)B8[2>&+;4Z`C?T_N1"=3?&1S9O_````__\# M`%!+`P04``8`"````"$`^V*E;90&``"G&P``$P```'AL+W1H96UE+W1H96UE M,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-)) M?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\ M_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ( M[]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\! MW8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6 M-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1 M+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P M]?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS) MBZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F> M"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8 M>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20 M$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3 M>H<] M,9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P:3?$45*&'=`X+&(_ MD%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G? MP9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW M"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8T MO;>$#6C\S210*:D M`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5- MX*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY M"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:+T5';:S76&A[R M<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]3 M1>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_ M((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/994FRE)")J(*X,K%B MC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL M,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q; MK:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$# M47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;, M9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TP MP:&PO=V]R:W-H965TKATPP5K`R'8VNV_?,0XLAVU(;P@XGW_FGQEG MLKY_*7+CF7!!61DB>V8A@Y0Q2VAY#-&OGX]W"V0(B&;E/$"2WCD1U-4G."DWE3DIF-9 MOEE@6B*ML.*W:+`TI3&)6'PJ2"FU""K+L60<'W+P_6+/<=QHUP\C^8+&G`F6RAG(F3K0L>>EN31! M:;-.*#A0:39H]V-=@._<2$B*3[G\P M4HI9#@'`U2BHZ@Q("'ZI/\\TD5F(7'_F!99K`VX1W8-HC*H=*-FX4W7 M[F_9-X0J'UAJ?4&VNK[>KU03OH)5^,U[MWH!M%L_3O^]NS$1#`Q'8V0@LA\3 M'9&>'?=_["@X1$$G>F_N]^/?:@:NK<,!L9LDHDEB?XWH^9OW_:DV=.&87B^; MVA0B2&+K81$,;&ID4;>D;<^7_G)HLTLX;N"YB[Y$U`5<9VY9WK",7<*Q%TO_ M3:)G$L[7[3VIX+XYSQK$OM7,M2).$M$DL;]&]/S!^;_=GX*GFE0SU_Q-$M$D ML;]&]/S!B;K=GX(']7.'W:D9W9V>YUN!U>^]71>P'=?Q@T$+1%WB/0D8BRJ. MRPD82&AW>NSIJ5`0?B0[DN?"B-E)C307SDZ[VD[;!T?]6`[6M_8*?L+'ZQ%, MYWK=;#?`=*SPD7S#_$A+8>0DA5=9LP!ZC>OYJA\DJ^H9=6`2YF)]F\'?(`+# MP9H!G#(FFP[QBD-R8::%XS-N M>U*,1+YXJ%JIZ+:!O%_"A.9OW/WDC%[P7$DM2^,!G>^$GN<\]^<^,*V6!8<, MK.U(L3+#M^%BDV)_M>S]^ZYI<0HWVDCQ1\'"@]4CB0ZD,!X M(`DC+[HF(9E=P!(?6&"\6(KOTNI=NJ.&KI9*[A&Y1>GZ9"A$^4P\!P\ MF(T1FRG$R*5DK'':'0O.,#@P[$N2>+SSVF&N^P*G*2'S4VD3@)$RN"&7NV># MQ@KC9'ZBT&&FW',(TN<0!U%`HOE[>DZ9Z[BNEPBF*K9A M3:-1+G>VFT9@_+`Z-/K;R-[*D_5UN(`K:GOX\`$:<$"E M4%3E6KB;&-GU'6PK#;3>_K6&/RV#6Q]X`"ZE-&\3N\'P[U[]!0``__\#`%!+ M`P04``8`"````"$`.&LQ%(D#``!>#```&````'AL+W=O7K&Z>BMQ[I$(R7D8(CP+DT3+A*2MW$?KYX_[J M&GE2D3(E.2]IA)ZI1#?K]^]61RX>Y)Y2Y8%"*2.T5ZI:^KY,]K0@!9QA)ZQY-#04ME1`3-B0+_ M5(KDB%R!1$/A^HJX44%$EN6,_5"29VH$M5G:!?C!YE MY]R3>W[\(%CZF944L@UU4F3[G>8T432%RB%/5V3+^8-^]1/<"B"(K`$=1/XY MA;D-=12_#=,]/X6\K\OV57@IS<@A5]_X\2-EN[V"2%-(@\[&,GV^HS*!,D"L M43C5J@G/00*.7L%T/T$:R9-QQU*UC]!X-IK.@S$&W-M2J>Z9ED1>('=I)GG7>\7C"W>8DS#CK&SK$F:0;J!L3-2 MXCYR%K%&*(8U;7C6:MIQYPS!3<-8]ISA$K_`7/*G9]_!5<5FKN[.;J$S#C<- MT_47.D,F?H&YY$_/TAU_>K$>0T[_L2R9N=WRZ;37!ANFZ_/LH6Z$N$&F=8N& MP6*^N)Z?.\&N,^C\AT_]EEWOT!W"V#"O^GP-L6TZ*\;`=/:7CK"7SM>6AB:= M!C'IQ./9N7.,1[-[,YN1@HH=C6F>2R_A![T;PU"%]FZ[O6SV?>T#V*A59$>_ M$+%CI?1RFL&KP6@.JX,P6SUSH7A5;W6V7,$6K3[=PSZ>PM8A&`&<<:Y.%WIC MTOXS6/\%``#__P,`4$L#!!0`!@`(````(0`WLQ^*0P4``'<:```9````>&PO M=V]R:W-H965T";`ROSI(:/Y=&J+B5-]LU!^=ER;'MFY4E6 MF")A53Z2P0Z'+*4>2U]S6M0BI*3GI(;Z5Z?L4G5I>?I(7)Z4+Z^7;RG++Q#Q MG)VS^J,)-8T\7<7'@I7)\QG:_4XF2=IE-Q\&\7F6EJQBAWH$<9:HZ+#-2VMI M0=)VO<^@!5R[4=+#QGPBJYC,3&N[;@3]RNBUNGEO5"=V#DM=S_0^[1C0[GFKH[BFTB#=LM?_P:)6" M48@9.5.>E+(S5`!>C3SC0P.,)._-_VNVKT\;?VF`!N/-.J#C(>:1KI M:U6S_#\!D39*A#AM"`RJ-H0X(V5_`9/%=R_0[IC@FZ@L]CB'R:L".Z0R)1(#J-GS>^ M*;#`5*\+>O)6U_U1U%GA,+?2G<85!9!]HVDFUVUWCYG+C#=D')GPA\1<<1T, M$24D'!)J2#1$'.4\\1`9+Q=]=26[XZ_8Y?#&G$LREWUN,WQ M2O@H$:!$B!(12L0Z0O(\^8IG#F],Z,7>X<2V%<^"6317_GQJPY\,[&Z!YGL% M\`0`+>C/HO24CQ(!2H0H$:%$+`C15J4IDF1X/#Q^J^"P*EFY:[F"T2C:M83= M](,]4@(\-,!'B0`E0I2(4"+6$9)D>.0\+IG#JF3EGN<*9MH8A$?\G:$L"$TW M>"CAHT2`$B%*1"@1"T*T5KEN)]U MDE'"1XD`)4*4B%`BUA&29;[FN)F+Z2<7'%8M*U,C5S`:BSN4\`317A`V6<`E M(?>ECV8$:$:(9D1H1JS+D#S#//?6,Y_SCF%AH??-#U)]*U,=5S`ZWRCA"4)S M`_+1C`#-"-&,""5B'2'Y)B#WZ\*;HU3CRJ3`;2&=3YGK(`<5M(JUWD:!`/3_%Q)&B1 M3OM,>:*'>$2$([$6D;7S!<^-=OUMA8CED:Q;&3EN"VE<[G#$PQ$?1X([R,16 MUEWA'4BY:BX1D-8YBGAXBH\CP1UD0I39?7@' M&CA'*QQK4V3G?"'T^#@7RR9IG!/E4G4)NOK:X8C7(NTC=#%>PC1>F;+@*0&> M$N(I$8[$6D0VSI=%CQL7BZA;XV-ES+A\)Q2N!.T@1Q&O31'"%XX-*PG5-QH2 MH"$A7MD(#8FU(;)MOCAZW+982MW:)K8Z/X2-;E0WBGAMBMB!6$SG8^4R\F5@ M-E.W3`,)[$CGM#S2'3V? M*R-EKWQ/GJ\/^]+^]X(GA^^H*N4N6<'N\;#<(RO8(1Z6!V0%V\!0;O5!L.U_ M28[TKZ0\9D5EG.D!JF"/YC!V2_'#@?A0LTNS;_[,:MCP;]Z>X`<>"OO&]@C@ M`V-U]X&?H/_):/L_````__\#`%!+`P04``8`"````"$`4*`PW#H"````!0`` M&0```'AL+W=OGDVCD,LXCBRS>W?=QP#A675\I+$Y/CS.3-#IL\'V:`= MUT:H-L=1$&+$6Z9*T:YS_//'F-JSBT" M0FMR7%O;98085G-)3:`ZWL*;2FE)+2SUFIA.*;25OK8=HWE`+_DTM.G.F2?8(3E*]V78#IF0'B)5HA#WV4(PDRU[7 MK=)TU4#N0S2D[,SN%W=X*9A61E4V`!SQ1N\SIR0E0"JFI8`$KNQ(\RK'+U$V M3S`IIGU]?@F^-U?/R-1J_TF+\HMH.10;VN0:L%)JXZ2OI?L)-I.[W%]PP*"A@@GCD2$PU8`"N2`HW&5`0>NCO M>U':.L=Q&DRB,$TF0%EQ8Y?"(3%B6V.5_.U%T0GE(?$)DH#[T_LX&$W")((S M_P,AWE"?;T$M+:9:[1',#!QI.NHF,,H`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`OV($5#=J!$SN;@PX0^(/2&0BS")Q"$D(:0A9"'D(10AE"%4(=0A-"&T( M70B]`UZZY43]%>E6W;P[ETG5.>"G?GYO#C'J`VT(6OHAT1`RC`$D@:20#))# M"D@)J2`UI(&TD`[2N^(-B,R#OV)`5#A6D^T8''1N1(608$4@" M22$9)(<4D!)206I(`VDA':1WQ1L128\W(N.78V;J5]'[Q)N$W6@Y7+&I>3R" MQ)`$DD(R2`XI("6D@M20!M)".DCOBI=4^6STDOK*#UK5C9]M+?YG[RR89X8@ M,T@Q)(&DD`R20PI(":D@-:2!M)`.TKOB#8#,U=X`'#^J5;2?9RW.40V)(0DD MA620'%)`2D@%J2$-I(5TD-X5+ZFJ$G6NFH?OQ\[[L6DKG?7GO,YL$4;*.&.9B4D%)21LI) M!:DD5:2:U)!:4D?J/?)'1%5$/S]YJ$N[,/&:G"/=1%F*20DI)66DG%202E)% MJDD-J25UI-XC/\NJ$#HARX>Z2?HS1^F-ND6B$F]3&I%B4D)*21DI)Q6DDE21 M:E)#:DD=J??(S[(J;T[(LJZ&W"R[!=+^[D>D;BKYB8])"2DE9:2<5)!*4D6J M20VI)76DWB,_RZID<;.LYO"Y3+NGSN&Z]''3/U1#[AR^".?P(^1G654Y)V19%T5NEMTZ2<_AH'@"2D@I*2/EI()4DBI2 M36I(+:DC]1[Y659ECYME-8?;WW?\_&\<=/GDIG^HJ-PY/+@'&$V&*#N'@Q)& MI:2,E),*4DFJ2#6I(;6DCM1[Y(^(JIG<$?G!'*Y++#?Q;M6ECWM0/`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`ZM)"QMU&.W%4HXNYW_!B5S: M>+.BRI![GNH$6&H8U1JR)V6GR3M/=5_[*&]8YZ<5Y?MPOR@W)*MPAC.X>HAL ME-GGF)1HTN?I=+Y83-Z$@\G%,E)NR=DJC)R-.HQ<^!!L:0/,9E>DVI*SLF5P MC=/8*--7:\E9,-S*SD;MM]*_Q]_;5NG6']OP5L#QC\LY*WY#_JD:',^1C3([ M%I,23?KCH_\\R>\I:`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`%RTQ#-J41*28EI)24D7)202I)%:DF-:26 MU)%ZC_PLGU93+EA3&G*SS)J240DI)66DG%202E)%JDD-J25UI-XC/\NJ(@SG M&K\/<)9D$[2#$I(:6DC)23"E))JD@UJ2&UI([4 M>^2/R&GUYX+UIR&;TH@4DQ)22LI(.:D@E:2*5),:4DOJ2+U'?I;#^O,'H_\+*M:+YS#EZ^8PW7-Z,[A0QGIW`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`8^?"O=S6IAOI8N;%E.U^K^B^04+3-IV1=(:)E+ MRWQLF97T)O/A2&\KZ4W.X;$6Z4V.NY&6Q7*M?J\UUK*2EOT?I8;;MKB6EOU? M;Z#EC;2\&>MM>27[LW]]6KC,4K[.3^X!CFV!+"//"XVUR#+RW,I8BV1'GK48 M:Y'LR/,!8RV2'?F=]EB+C*G\;G6D92[+R+/58RVRC#P//-8BN99G6,=:)-?R M+.58B^1:GO\;:Y%87E2,M4CI##WQF' MO4TE!U+AC2PSDV7DD821EHDL-)DCR:8TGQ:(8GDBWYL@1ND=R, M6JM;36,M2VD9VRJYMR`M8]LE=ZC6Y6B+?-OGA_',RX:-K/U&AFHT7AW@(_$? MYNL/\@'`W;A19_B(RWV_M;H'PR7D]M]:W=P;:UE*RUA*Y-:-M(SU)O<$U^J6 M#7N36X-K=>>&+?*2A[5ZA0-;Y`T-:_7^!;;(>Q+6ZBT(;)'W$$AO8ULM;Q60 MWL9:Y*__I;>Q%GE_Y5J]?9'KD1=4KM5+&-DB+T!<)_*Z0;;(VPNEM[$6>3N@ M+#.V/_*N/UEFK.5&MN!F=`OD/9_K:+1%7O]+E6KZ[D M_L@+/]?J#9;2&PO=V]R:W-H965T M9TB6W\*AWU-1:\+3YJ"PH"X(9+;FLB&.(]!@.E64R$0\JV9>BLHY$ MBX);6+_)96T^V,ID#%W)]DQ"N3Z&E7*3]%DYY M\L'=/`SH2YEH951F?:"C;J'#G)=T28%IO4HE9("V>UID,=F$T7TX)72]:@SZ M(\7!'-U[)E>'KUJFWV4EP&VH$U9@J]0+0I]2#,''=/#U8U.!']I+1<;WA?VI M#M^$W.46RGT+&6%B4?K^($P"C@*-SVZ1*5$%+`"N7BEQ:X`C_*WY/!LO)'%BVPMA'B93$2_;&JO*O`X4ME2-A+0G\MB23F7\[#R8A:%X@H6Y! M37X/W/+U2JN#!YL&)$W-<0N&$1"?3P@R0>P&P3&9$0_6:J`*KVO&9BOZ"LXE M+>;>8>#:8<(.04&T4P:U\,;F':]3 M=ABX=@G^MZ"7X/0:901##7H)#;QUH!'2L!_&>XO@1KHSUT4F34LU&"\%(+[4BXRS``/Y-';'<%]6A<9TBZOH45PG]9% MAK0A6'6\7#QVIL'2A_I<:%3\L*_1<,7D>/,PMCQO/F[#8]T+8H@^$7.A,QE= MU?5AV^7N'&SZO@V=8<:^'%W:$-$G:W:A,\PGC=P<_@MP^((M74MW?04C"E5[ M-9@$)S5P0\@=TJ70._%%%(7Q$K7'`_'P*.W@"W7Z:4_7@` M9=K]H5G_`P``__\#`%!+`P04``8`"````"$`C9[#[>X$``!1$P``&````'AL M+W=OW+LCF>.3XS'GLPJZ]O>>:\\K)* M1;%VV6#H.KQ(Q"$M3FOW[[^B+W/7J>JX.,29*/C:?>>5^W7S\T^KJRB?JS/G MM0,,1;5VSW5]67I>E9QY'E<#<>$%C!Q%F<7R03GGF^7RY=$Y!>@ M>$JSM'Z7I*Z3)\MOIT*4\5,&<;^Q<9QH;OF#T.=I4HI*'.L!T'F-4!KSPEMX MP+19'5*(`-/NE/RX=K=L&;&YZVU6,D'_I/Q:&?\[U5EPW!.("`-;'MX#7B60 M4:`9^!-D2D0&`N"ODZ=8&I"1^$T^K^FA/L-_X\%D-APQ,'>>>%5'*5*Z3O)2 MU2+_5QDIJH;$5R3P5"2CZ0^3C!0)/+62Z<"?3]ADBE+N3#]6GO#4TP_&_F0V MES'<<01:&3P\]923P8P-%Z/9_1FGRA&>VO&^5J])NUS%(*[CS:H45P>V!B2V MNL2XT=@2V/3R-:+;!?V_]82%1)(MLJQ=\(>EJJ`(7S<^FZ^\5RB<1-GLJ`VS M+?;:`JL$:8,N$':!R``\B*@-"RKA$\)"%@Q+"]IIP(BS$X.VT"Y!%PB[0&0` M5@Q0B)\0`[*LW9FU-`M;]*ZQP6W;KM_4-MFW)FU@!`D)$IF(%1MLE4^(#5F@ M<*$(6MVT[I31O>!:DS8X@H0$B4S$"@ZF,H/K/PKUUD%C&8.>>Z>0YK3$?;`G M2$"0D""1B5CZ8)^:^CZXYY'%%JX0ZQCPAYU":HUTO`%!0H)$)F+%`H5MQG(_ MUVAL2U:(D6N"!`0)"1*9B*4/WW.,\_6^/C2V]2G$T$>0@"`A02(3L?0M?D0? M&MOZ%&+H(TA`D)`@D8E8^AB\D9@)Q&*%IJS[\>,="GEL[9(:(""['1\^:4K* M\19B<'/4-1Q2*+(@.R;L6@\7!1YO7>4*NFG::ZL;%%`HI%!D0;9,;$R&S`^> M$ZSI;S"/SM9.0W;F_7C#1076[3OKK_J5 MJ5A!<)H8I_6X6[G*:M0>-@'V%#-I_-9K8-WJ,5$VR+ M)M#F7MSGOB>9UGE).(%[[QL`6PMW%S(=VP"-W)9'F1D"B/RMD%&9C`R MPYBZ(XLE],X>G`W!0U[=NQX,OPC(Q)(1'T;\7K81C,B<$I\QC(Q[?.##P[:? M"QQZ['

:\]3-TW\W:\W#8?-KJ20%&?H!WDO3?MD/7>I$/.>U,^7\+K%%9` M.S%\T+C$)_Y[7)[2HG(R?H3%'P[P$E\VGT2:'[6X0%'`9PU1PZ<,^>\9/EUQ M>,PS7\```#__P,`4$L#!!0`!@`(````(0`R;K"ZK`(` M`(\'```8````>&PO=V]R:W-H965T&ULE%7;;IPP$'VOU'^P M_!X,[*U!RT:;1FDC-5)5]?+L-0:L8(QL;S;Y^\[@#5JRJ4I>#!Z.SYF;A_75 MDV[(H[1.F3:G2113(EMA"M56.?WU\_;B$R7.\[;@C6EE3I^EHU>;CQ_6!V,? M7"VE)\#0NIS6WG<98T[44G,7F4ZV\*4T5G,/6ULQUUG)B_Z0;E@:QTNFN6II M8,CL%`Y3EDK(&R/V6K8^D%C9<`_^NUIU[H5-BRETFMN'?7X3,B2/F.F!@'3#)@&`@.BB#VG1E!*,RIA9=N0Z&4YGT;9G9>V00G-/5 MB?-ILAAX@W+`P#H$N!P0HP#G[U%&,-1@%-!9;@-H@C0TU?3<(KB7'I(;++/^ M2IR6#"H_G1;!8]JC!6[?D+HT^4?RH`;3I1`\E@J6\PAP($]N=P2/:8/EG/;R M/;0('M,&RSDMC+21NSAVT@54YS_7%(^-%7JFG)ZV3IJL7O5M&']A/&AI*_E9 M-HTCPNQQM*5PX0?K,':W*7;):_L\VX9QS(8O,`X[7LE[;BO5.M+($CCC:`71 MV#!0P\:;#ER'H6@\#,+^M88?GX1+'T<`+HWQ+QM09L.O=/,7``#__P,`4$L# M!!0`!@`(````(0#UI5B>E0H``&!$```8````>&PO=V]R:W-H965T&ULE)S;;MM($H;O%YAW$'0_%HLZ4#(L!\D&V1U@!Q@L=F:N%8FVA4BB M(-)Q\O;;7=TM=U=7B:R;(*Z4_CY^76SZCQX^_#@>1M_K2[MO3NLQW!7C47W: M-KO]Z7D]_O-_7WY=CD=MMSGM-H?F5*_'/^MV_.'QEW\\O#67;^U+77-A4A;%8G+< M[$]CIW!_&:+1/#WMM_7G9OMZK$^=$[G4ATUG^M^^[,]M4#MNA\@=-Y=OK^=? MM\WQ;"2^[@_[[B>*CD?'[?UOSZ?FLOEZ,./^`;/--FCC#YG\<;^]-&WSU-T9 MN8GK:#[FU60U,4J/#[N]&8&=]M&E?EJ//\+])ZB*\>3Q`6?HKWW]UD9_'[4O MS=N_+OO=?_:GVDRW62B[!%^;YIM-_6UG0^;#D^S37W`)_KB,=O73YO70_;=Y M^W>]?W[IS'K/S9#LR.YW/S_7[=9,J9&Y*^=6:=L<3`?,GZ/CWNX-,R6;'^MQ M:1K>[[J7]7BZN)M7Q11,^NAKW79?]E9R/-J^MEUS_-LE`7;*:6'7/F^ZS>/# MI7D;F04WV>UY8[G<.VEU$G3.RORT:JLQXOQR+3?FJG]_@@5/$R^ MF]G8^IQ/+L?\^9YSS9B8WER[9+H1=XF?GM"R3;8MV^FR7?GD`G$S)=_,-&W& MCGPFKD9HSGYH/:[B053O^JX'+L?\>1WH@N_!+.W![8':9+-(\<#R.79)`YHV M`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`-1J7#&;-*8A'-%<.X9AD,V MOJ.B@/D57?8[DDJ%+&:3/DO(5BID,9LH.V3M+P.BQQ_AS4.EPABS26L2QI4* M8\PFR@YC9NY5S%9YZ?4A1IDPB_O?7@%[-DY>@ZL`;[0&*^$,JE0\8S:9*8EG M>W.)>;X]#,Q.E7THGZFEBEG,)LH2LTL5LYA-E#W&R?Y?":\>EBJ.,9NT)G&\ M5'&,V419*KWV0%:LJ@,T/M50@#O5EH19W/_V?77/QO$%-WH#C4JVB7C_"Z\@ MEBJ>,9O,E%2#EX3GGF'D&*,`.U,J9I<.T&0-)&;MV[;AJXO9Z6R$4+K_A5J3C&;*+L.,[/GI6*60=C[M6+% M/:Q4'&,V66B)8RA4(+OT5#O$\DF"0L6M2Z?B$KE0$'0M!O;1[_;V<1^CC02( M8PZ$5Q%0J,!VZ;0]"6TH"-M]@W$`QT>VD^!H@$*%L$NG/7=<!T!A0INETY'(Y5D*%1\NW0J[J#GIDJ%,Q0.WG211:"I/\MB`?TO1R'8 MLJ+'HQ`SN_7]CK82[L=@^JGU?[;&G"F+1]+UT.X,P,:L:*&>XX2SK?E8\P65CJW..N6CW'B M.K(Y]Y9LWT+7530M^/1D7^+VS4]>PX%Q%D(=VW0 MV;Q<.ME=WOO%<*%S>@%C]0HQ3MP6YN'KP;B]0+1[`=JU%.+,DSGG^"H+X;X- MZ-A2-.B(3IY*1-,7H&E+(__7"?H_LT M/*+'7`AW<-#YOUPZ;4]\:D<'5S2J'LB]X2M9;!]CN-"YP("Q@848)T[J=U_/ MW54[[;F/Q?>^LI#NWSHO&#!FL!#C1J.KVXP?#$1#&*"A2['(#-&B)PS0RA6) M(Q?V[4[?@C!H,[:PLI#NX3I?&##&L!#CUL,2&HVJ;S!,_1;-88#F+H4X4[]% M?QB6ZKCG>.\;\/]$@B\LOH?[6%J_I7NXSBL&C%DLQ)CUT-G%@/&+A1@GKJO? MC&4,?(P3UY'-F,4@Q-)S2KI_Z_QBP!C&0HP;C:5V^-9E/&,@FL8`35\*<:9^ MB[XQ0-]7)#[TG`I^L80+IGZ#=/_6>.AL9,#ZR:\S]S^[XO[J" MSDKFTLFCA_>7<5W7%7#&108AEH`!TL5;9R0#QDD68MQH=)@S9C+P,4[<5N1H M[_94(\9/!C[&B1.D+1A#7MPRWC+PL:1@@'0!U[G+@+&7A1@W*ET!9QQFX&.< MN*W(BO5@"K@WGC'BK,UL0`'WIK+D"=?'TO6@%W#W;0[N*Q..]>6Y_F=].+2C M;?-JOZFA--]U<(U>OT;B8VE-7S0^N__HOUYB&PO=V]R:W-H965T&ULG%G;CN(X$'U?:?\ARCLD=N)<4-.C MR6UWI%EIM=K+-CUW&Y?'`_??FH=\9[ MV795LU^:9&Z;1KDOFE6UWRS-?_[.9H%I='V^7^6[9E\NS1]E9WYY_O67IV/3 MOG;;LNP-8-AW2W/;]X>%977%MJSS;MX5>?5WA0,B_8>CF:]KHHR:8JWNMSW@J0M=WD/\^^VU:$[L=7%/71UWKZ^ M'69%4Q^`XJ7:5?V/@=0TZF+Q;;-OVOQE!W%_$#O\;=?_U1Q_+ZO-MH?E M9A`1#VRQ^I&470&*`LV<,LY4-#N8`+P;=<53`Q3)/X;GL5KUVZ7I>'/FVPX! MN/%2=GU6<4K3*-ZZOJG_$Z`AHC,)E23PE"2$/$SB2!)XGDC<.0T88=X#4W$E M"SPO+`%CKA?X]P<$R$$5>$H6ZLQ]8H?.`R2>)('G:2KAG+CV'>%88I6&14_R M/G]^:INC`3L)UJ$[Y'Q?D@7P\M5V(&=NKS8L,^_SE7<:N@*Z@Q1]?R:N]V2] M0UH5$A/=PO@J)KZ%"51,<@L3JICT&L,0378-(*%,RDZ];_$K&D"I>EP#W@EK@-8P$AA-A/$D(A&(BXZJB.DD M0:9#*#)`41S+H*\&'(S#9^K<(H$14Y^16RD@$!J!DDE$.CE*IN-0%/!5!>ZK M"+P35@+M]TA@I!(TX`%$0X,G`FYX..>&@2D03I\D%" MA%JN>WVB)M,DZ30DTT)4/;C;>EP/X=%4/;"3)`(D@J4T"!`@5@#D:E43V:X1 M-%4H*/$]-$:FY5"5@'%^0@G>"VT2#[M)(D":0&()$6(QSZ8.*KK)F81;J5F` M3NKTW'Q)45PQM1!5"VZ\1EDQ42B$35.S`9F]B"ANSR?$14L52X0H%'B+)^?6 M3^-+KX:@:(A,2Z(JP#W72('[C`2_>[C*!FPI)4B;#8)'5M5;94)G"675G(1D MVIFH[L;/HUAIG/D.RJ;DW*[)AC'_%4.F95!C MYX;K_MB%/5-C1SLQ(CH/)WYD2XA(@9GCP>NJ(DRRI-,#95J(*@2W7/<+(0R: M*@0*(2**SPL\QA`BE@C-;DFF(>GD.)F61)6!^ZW[91#N3)4!.TDB0'*_LS!D M%)TAL81H==`905D4)B&9=BZ*$/0A.SF@\4F)[:0$G:Z?7!^.=(2)%8P3^@$J ML(D*4.UHJC12)Z2.1U!UR13,C#+7860T#54$9"CUE9'>,)(^-I(2I%GJ6$)D MPH1!2*EW)8,82V)<@@IP.CT,O[OGY]GMF0@9Q-V\N*8]Y)ORC[S=5/O.V)5K M\,KVG%\9M^)F7GSIF\-P'?O2]'"C/GS<`7C=-?_K"[_[/_Y-Y M_A\``/__`P!02P,$%``&``@````A``W-18.D!P``D2(``!@```!X;"]W;W)K MWYU^^'_:S;WE5%^5Q MY8B%Z\SRX[K<%,>WE?//WU_FD3.KF^RXR?;E,5\Y/_+:^>7EYY^>/\KJ:[W+ M\V8&$8[URMDUS>EIN:S7N_R0U8ORE!]A9%M6AZR!K]7;LCY5>;9I)QWV2^FZ MP?*0%4<'(SQ54V*4VVVQSC^7Z_=#?FPP2)7OLP;XU[OB5)^C'=93PAVRZNO[ M:;XN#R<(\5KLB^9'&]29'=9/O[T=RRI[W<.ZOPLO6Y]CMU\NPA^*=576Y;99 M0+@E$KU<<[R,EQ#IY7E3P`JT[+,JWZZ<3^(I]5UG^?+<"O1OD7_4UM^S>E=^ M_%H5F]^+8PYJ0YYT!E[+\JN&_K;1/\'DY<7L+VT&_JQFFWR;O>^;O\J/_^7% MVZZ!=/NP(KVPI\V/SWF]!D4AS$+Z.M*ZW`,!^)P="ET:H$CVO?W_H]@TNY6C M@H4?NDH`?/::U\V70H=T9NOWNBD/_R%(F%`81)H@"MB;<;F0D2_\X':4)3)J M%_@Y:[*7YZK\F$'5P#'K4Z9K4#Q!Y//*D$>WUFM+A37J()]TE)43.#-810WY M^?82A\_+;R#IVD"22XB@B/2,T)D`=AU%6+A-<5CT,Q,-UDQT$C2U!'^`V!TU MR8Y[B0C]#D*8@$#3F6CPR@FM`\=1%Q:Y(00^.VX!1:1C"$+-NX>:!J\<6'=W MW-BE!TX0$K6Y%'X<^Y++9B/FR@U=-U1=$,(-:MR63=>8@CTXGD@]B&(!2A=.^GJ"=1&87+=42,W^JH0"6>8'OG[HQPR0(F"4G(`M8"LWGM,6S6EY74J0E@'Q MP[:#J1E$TK'TPBNB"=V'K8S>X(5=V^XEPBH5PPM!>&BI_8HQ3]N#KAQ$>)Z0 MLD\W2:G0W7HZ.^SME!W;@DD;$EH2JR2C&D9`8BJ(K^Q/H1OU=%K8UBFM"\,\ M]WYMIWVN#"T<1%I"A5[#UF"&/`$P9*7&!"D ML/-?(7C_-2!![1T^+0I,IL2`;)X]"5.'&&<80O5\R"C$ M@%,(UFP3`SH76Q!Z3/&4(F*I_%YNRO(ARQ`#GB%8BTL,"%E"@Q,>TSLE".7Z M7M0C"$MYEW6T:&8=HG=SW#,&--P$S2!2]T.A^@Q07G=9AQRP#L$*+#$@Y#47 M/L^L&4=JD7"O^8;4?=QJT-.V23N+2\<;M0$A!>G[0<`6D1+$7$:Q=9I(!=1M M_7Z6>A9GV;=;DV`$&98JO%32!@0JBBP$).>6Q%I"X076-05V M'`J)W=@*0FDR8YE(<\!@)"NZ1%]O@^"HY1RV@^]Z;$.E#.."308]AC)E5C-N M@1(MAK1NV;:LJ;_!#2R`6S2\>$XD@5%!`J3&) M4P/@_8CR>LA2Y("ER+ZA&?T0-,(/`>/\F)GQR!$/WV= M9N=UV@YI9[%N(_O*1OT,B,N#6]@,&G&E!]GOTT\9,D.9R'#`6"0K_T0AR)#0 M%"P2AB="^"(H0^8KXSE6&LVUXWYB0,AL#K<4!IAAG'%FNI]/WK4*NS_=M=Q# M#(@?UJB%$9"VA-M!EIY4,N8?-R0;\`W)?4,1WY`AG`+22^.4(J+0ND:EY!YR M#37@&JJO:;,G;->`:S:I>%&F)DY7E(&,^YU%>=[E&0I[/7*"D9A[ZHO+"O4$J2V<9XBKT!NU#<+@P(R2G/91TH)>/" M<_OZI:(%T#;#3<1# MD%'2E7#SB(F=&@CW&X@UX";^A MD1@0B@B7Q2*\>+)@(.,,F8M,%''`3?CS@\1#D-G-[5D,+=B4(OPP=J_T1$]W M=JL8;VQG]`%2A/Q62]*&O';/UPPB];$S&>\N*VG1K`EZ_9+12@R(9PTMS@PB ML=`+E&63=',P%YF85W03JAQW$P]!1AP979PE&`!?`>$'#^M)1J?Q:V=Q`;F+ M&!`^N0SLDU#4D(SWIVA(#]\`P`?DA[QZR]-\OZ]GZ_)=/]V7\(2@^[5[\^"3 MU`^;V>\)O)'0/KY?=@/P0L`I>\O_R*JWXEC/]OD60KJ+$+9[A:\4X)>F/+6/ MY5_+!EX%:/_&ULC)39CILP%(;O*_4=+-\/9IEL"!C-*$H[4BN-JB[7CC%@!=O(=D+R]CV& MA$;-J,T-8/C/=[9?9$]'V:(#-U9HE>,H"#'BBNE2J#K'/[YO'I8864=525NM M>(Y/W.*GXN.'K-=F9QO.'0*"LCENG.M20BQKN*0VT!U7\*721E('1U,3VQE. MRR%(MB0.PSF15"@\$E)S#T-7E6!\K=E> MD14!4I&5`CKP8T>&5SE^CM*7!),B&^;S4_#>7CTCV^C^DQ'E%Z$X#!O6Y!>P MU7KGI:^E?P7!Y"9Z,RS@S:"25W3?NF^Z_\Q%W3C8]@P:\GVEY6G-+8.!`B:( M9Y[$=`L%P!5)X9T!`Z''X=Z+TC4Y3N;!;!$F$ M1XN-&^AHS;]24PME4[8>);[<`8PV,#_P$.ZP@#$%=: MN\O!6WCZLQ2_`0``__\#`%!+`P04``8`"````"$`4]II1Y,,``#J1@``&0`` M`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`"4$BD!@D`4E!,I`IZY*+,:Q`7Q0'R0`"0$B4!BD`0D!=\:MGHQJUV`D#\E'"I!"I`@I1DJ04J0,*4[M3,3 MSTF9Z2)*DHOD(?E(`5*(%"'%2`E2BI0AY4@%4JF1GF56"-V0Y7/=1/V)6?K$ MGI&PQ,N4+I%<)`_)1PJ00J0(*49*D%*D#"E'*I!*C?0LL_+FABSS:DC-LEH@ M-4\_ENRIDIYX%\E#\I$"I!`I0HJ1$J04*4/*D0JD4B,]RZQD4;/\BS?1%B]] MU/1SNFOG_9)'.:VXHIVVT#MS?:'W9)2XA'SH*@`)93/E5<3L/))1HO-8[4I/ M%RM&?D>Z6#_&2QXG-5UG4M/%@^B'?%T0E8HW)!"7E>HUR$GNH]3 M4F@\2EY:;90X,1?)D\1.S'*,7GRY7=T7)!'V%1)*6OV4P?D+@S:BSW MJ">3%0@W))/7$VHR.>GST7PV8+51XFQ<)$^2>H+&VN=W1BDGV+RP!3)*[#%$ MBB0I>YP;5T+<&:7L44\I*P]N2"FO)M24U>3K9F+&(91=UKR;+-BNGR>MB$ZZ\2@I0[1R07R4/RD0*D M$"E"BI$2I!0I0\J1"J12(SW+MU5!-E9!@M0L0V'D8I2'Y",%2"%2A!0C)4@I M4H:4(Q5(I49ZEF^K@FRL@@2I68;"R,4H#\E'"I!"I`@I1DJ04J0,*4R`7HSPD'RE`"I$BI!@I04J1,J0DH\4((5($5*,E""E2!E2CE0@E1KI66;ECCJ7V1KNT*W@)RL' MKY*46V6;D_*,@),L[%T1I*_KQB&`>>M4&BZYR+_MQB;KQ94,@HT;!4N])'C-5OZHA],E*\W%-'JJT` MU7,QCFEIMU'BF%PDCQ/=BK&B^VYZ9]E3HR6"FL_)-O53P8ENBD3WI1:E#Q6K"V\8*EY&JD/55I9* M4N;&*(0R"BQQQ`IDG0>+'.LY';12R)(N:Z0 M,J1Q#!#'G2"EDN3.G)$Q>S(9)?K*)74HXZ6NX<<>Z=-HHN88#>1CE(P5((5*$%",E2"E2AI0C%4BE1OJ( ML')6'9%/YCVO?M7$7Q; M'=Z$ZW6X("7+2"Z2A^0C!4@A4H04(R5(*5*&E",52*5&>I9OJZ#'6$$+4K/, MHR2Y&.4A^4@!4H@4(<5("5**E"'E2`52J9&>958'J2O&+[Y!2O]1WWP'29"^ MAAM/7I-]R^=O2'@:V^(K$LPMSG3![H\HI[#ECK8T M[X#`EAEM:6IVV#*G+?.NWL8C.H+F>Q;,-F/V]0W-*XNYQ1XOV%N7'<=F3VA+ MDQ)H0^=#;Q%UM'$<.K;F^9[9QJ']4+W3U8;V0_?H'5LH!9T9H`1TGK]%YT__ MH:"C)XO.__RA=?.X+!HU^N!V5QLZ%_JP,6ZA-VD6["T8W$+?DO&ENR_JJB/^ MB7;>&<_2V!'_9;SX0I,5=_Q$V>U,+N6V,[4T@IT#2/.QZ\3HL\T+]LEEW'-( M6]C'CG&+:TVH3=?>Z=.YU*9K"[WAMV!OYV%O]&[=@KT7AUN>;!IV^@15UQ8: M=GH4U[6%9;XSDS;EGI[-4IMA.U?HFT;>5Z]5MCJ\;O;'WK9ZH45@-&!?Q'`X M?U?)^8]3_4[W%O1](_6)OF.D^?6-OE.FHO_D.AI0\$M=G\0?;`?MM]0\_@T` M`/__`P!02P,$%``&``@````A`,Y2PKLJ`P``9`H``!D```!X;"]W;W)K&ULE%;;;MLP#'T?L'\P]-XXCN.T">(4Z8IN!39@&'9Y M5FPY%FI;AJ0T[=^/E%+!MZ;.BQ$S1X?D(6EJ??M2%MXSDXJ+*B;!9$H\5B4B MY=4^)G]^/US=$$]I6J6T$!6+R2M3Y';S^=/Z*.23RAG3'C!4*B:YUO7*]U62 MLY*JB:A9!?]D0I94PZO<^ZJ6C*;F4%GXL^ETX9>45\0RK.08#I%E/&'W(CF4 MK-*61+*":HA?Y;Q6;VQE,H:NI/+I4%\EHJR!8L<+KE\-*?'*9/6XKX2DNP+R M?@GF-'GC-B\]^I(G4BB1Z0G0^3;0?LY+?^D#TV:=L]4`HH"S606(5,B"@@`GE[)L35`$?H2DQDX MYJG.8Q(N)M'U-`P`[NV8T@\<*8F7')06Y3\+"DQ0ELN$=D\UW:RE.'I0;T"K MFF+W!"L@'HX%@D#L%L$Q61`/W"@0\'D31N':?X:DDQ/FSF+@Z3"!0_C@U'D& M;^,](Q@]HRH8RITU--W,AMV$;3@BE.Y\H'HK)=2.),)H[?AN!Q<#3);IP MB%:B\W8$YSTC&&K13*ROL06-<`U],5YC!!O73F1K"4T#-4L''="D':"W];1[8_@-JVU]&F7E]`BN$UK+7W: M`*1JAFN$_[B;S;&VAY.IV4)A]$[_8C,VO9[7WJ`[SI``QJ[71\%%WP"#[C#; MS\``,T[GZ,(&B.XP6],`T=PW?_P(ZO MZ9[]H'+/*^45+`/.Z>0:2BCM+<&^:%%#C\*F%QJVN_F9PVV.P3J<8OME0NBW M%_#LN_OAYC\```#__P,`4$L#!!0`!@`(````(0!(&PO=V]R:W-H965T?G\O"^.- MU$U.JYV)%K9ID"JCQ[PZ[\R__\+?UJ;1M&EU3`M:D9WY01KS^_[GG[9W6K\V M%T):`Q2J9F=>VO:ZL:PFNY`R;1;T2BIH.=&Z3%OX6I^MYEJ3]-AU*@O+L>V5 M5:9Y97*%33U'@YY.>49BFMU*4K59&W'YVH:939YL>YHG5Z*,#W.UJFV:#=?9G(EWE6TX:>V@7(67R@4\^! M%5B@M-\>:"[W_4N?'W_**0+1A MGM@,'"A]9>B/(WL$G:U);]S-P!^U<22G]%:T?]+[KR0_7UJ8;@\<,6.;XT=, MF@PB"C(+QV-*&2U@`/!IE#E+#8A(^M[]O>?']K(SW=7"\VT7`6X<2-/BG$F: M1G9K6EK^RR'42W$1IQ=9P>C[=F?AK#WDK?0J%A]19S!.VW2_K>G=@*R!=S;7 ME.4@VH`R<^9"?/@X'EZ_L@H>F<@+4]F9T!^Z-S`_;WO77V^M-XAIUC/AE/&7 M(A(-"(L@TXV'!Y^Z2.R2#,30!?,'7>@L\/@P"N$;&WT^=8,?!C,_@VK('X#V MPZ`C#B2:$KXG(O$4D422*2&+X"GB?+Y'<.R*CMG4+K],VL$YZ[0S_9%1UP]$ M'R%GX/,1C)5(1%HBUA*)EL`J0HC$4HR$>NX9O#,AS)_NI#P-.;+N$MV6K/,V M&-IG=Y&(%;T3;6_\O+=@%R9Y?JHS6+3KKB5/(6<\OK"7*QM)`8DXH#*MDTBT M$EA%"/YA'YKOG\&R?VF3"3G#_2//=@)I140<4/G7221:":PB!/^P>N?[9[#L M7]J60LZX3_-]:/LZWP>"'0M29B5#VY>]\4"(O06_K,P:G6'JY]$W&[5)?S-N>KQG!,8)Z9/[\=K3L^?.$[.J*L(>>O[Q#(CT2ZY%$ MCV`E(@:"U3:C1)]WHB->$<$Z>IQ(TR.]AY0!X3H*)-:K)'H$*Q$Q(*P8D@+" MJE?U#H!X"34^X=VUM![#'E*XC?1(W"/]R;%$4AXF>@FL1,1HP&#E:.@+/L1Z MR>O%ES;$'N(^?-OW;%M:SE&/*`(6ZU42O0I6(F)`6*TT2@]-6O#*2DP+:3,, MD;9`B_1(K$<2/8*5B!@(5CJ-`C%SX^`%EV;C4%5E_4ZJ16+V8QJ24)$\B1[! M2D0,"*NEI(#,V#AX!29FB%0*ADA5IO4!T2)QK\(7G+/T/!1(16FB?Q%6(F)` M6)DU"HAFJ?"B3`B$+XTO1!Q2S&FD1V(]DN@1K$3$0+!";!2(F4N%EV^:I:*J M\?K,T"(QTB*)'L%*1`P(J].D@,Q8*KRZ$S)D/5DJJA*P#X@6B>'BC^T=_1F[ M=@(G0-)IGO2,(A?9_>'76Q"/"+\?Y-=G):G/)")%T1@9O;&[/_9SX?'T<2_Y MXK!+).EYB#9PUS5]'J,-7&C!<^O1`:X1K^F9_)[6Y[QJC(*&PO=V]R:W-H965T94\&YVZB[/#"$)=4)(`;-] M^].R)4OJOPXS2>4ED)]:+:E;6[?QIS]_[)];W[;'T^[PMO_[G_2/ZW;K=%Z_W*^?#R_;V_;/[:G]Y^=__^O3]\/QK]/3=GMND8:7 MTVW[Z7Q^#3N=T^9INU^?K@ZOVQ3@<]^LS_7M\[)Q>C]OU?55I_]SQN]U! M9[_>O;1K#>'Q=W0<'AYVFVU\V'S=;U_.M9+C]GE]IOZ?GG:O)Z5MO_D==?OU M\:^OKW]L#OM74O%E][P[_ZR4MEO[35@\OAR.ZR_/-.X?7F^]4;JK?T#]?KO4'<4QWW1N.J3I\Z?['8U`F+UUW#[MF1M\I/PP)?#X2\A6MP+1)4[4#NM/+`XMNZW#^NO MS^?5X7N^W3T^GGC9D45)SY?>%ILWAF3I`?UO[G9@:9)'U MC]NV3PWO[L]/M^U@<-4?=@./Q%M?MJ=SNA,JVZW-U]/YL/]_+>1)5;62GE1" MGU))[ZKG]X?7E9(+%:F)JG7ZE!7]X=70Z]X$0T(7*@YD1?I4%=_<:UH"5>/T MV>CXK5[?R(KT*2MZ_:OK?K\WN/Y%MSWR;]6F^-(T^E9S>^2L6HOV&AGB@KF\ M0-6@+[+=_I5_W??Z`^'G2U65J3W3UK_C(V^H&J4ORE#=BX;JU+.SFNSQ^KS^ M_.EX^-ZB'83FW^EU+?8C+_3(86J:UQUO)OX_S7N:\$++G5!SVZ:!T)0^T6+] M]CD8]CYUOM$"VTB9$`I(`28%D0'(@!9`2R!C(!,@4R`S(',@"R!+(RB26T^@,_0BG M"36T6=):;1Q"9ZKMDI$4NN2U1J3Q&I`$2`HD`Y(#*8"40,9`)D"F0&9`YD`6 M0)9`5B:QO$8FM+SFOGZI8TA(5\Y11AU)4M_0Q)D2`8F!)$!2(!F0'$@!I`0R M!C(!,@4R`S('L@"R!+(RB65X.LLMP[_S8B#4V!ZIB5_=OJM3/I(RVD=Q0_0B M\P.V-2:-D')V"B0#DC=$JPZ\P%Z_12.D5)Q$V_='V$FHL>U4$]-.4L:P M$Y`$2`HD`Y(W1!O%#ZZ941JAQB@FL8PB@N`/N%4*-;91)!DVEYBH)E4@6-\9 MI0A-[&:#]GM=>RQ)(Z3&DG(]&0=Y4\=4S*ZP12.D%)>&'LM&%.18-KJ\LPEI MVQ22D'ICG/P"UPBI[L1`DH:(:SLS5-H4FJVPY9(U0JJ5'$C1$$:("HW, M%MD-I'1)F2W:)A61A[E>+\]%S;RFZJ64@.,$24:F0-DNE*7E#G` M:C/(M)1J,4=4:&2V.+3WC-(E9;9HFU3$#F\P:1UJ4!.JGR.1C!!6MF;I#=MO M(BVE*L:($HW,`;(-/M522E>&*$=4:&2J9^=UJ:5(O6TL<6E_@['D'=\TED3F M_`M\MIE%(ELC3'K=6#E&E$CD>U4>P^O=^)1Z9:I2K)T.T&?>;4 MTJIF6TI:B,N,*N:@`Q2(+;J^S!%&**$.4(RH0E8C& MB":(IHAFB.:(%HB6B%86LGTA@@_3%^]=5$(/NT37R(Q/Q?,#DC)0C"A!E"+* M)*+]0BV^7".]9@.?W=(*+:4JEHC&B":(IHAFB.:(%HB6B%86LOTF`J*/\)O0 MP_Q6(\-)D;AB=^.Q*+50>G187R(:(YH@FB*: M(9HC6B!:(EI)5(_/\AE9]$-\5NFQ?2:1Z3,EI=='K)&Y/M@E/]%2:GVDB#)$ MN4:&^H"[4DLI]26B,:*)1J9ZMKJG6DJIGR&:(UIH=$']4DLI]2L+V0[G4?,[ M-U<*-/@BE8C:5OV(E)3I<%G1O,0$/@N[$JR8(LH0Y1J9)F-)BT)+J:Z6B,:( M)AJ9ZMETG6HII7Z&:(YHH9&AOL>FZU)+*?4K"]D.YS']>QV.P;Y?(\OA4LIT M>(.,,04LODJD+F,+3A%EB'*-3/4LEU5H*66R$M$8T40C4SV;KE,MI=3/$,T1 M+30RU//$[U)+*?4K"]D.YWF)]SH<$Q84(+,S-Y+(\%NLD3&F@`7KB9928TH1 M98ARC4SU+*0OM)127R(:(YIH9*CG'IEJ*:5^AFB.:*&1J9[M3TLMI=2O+&0[ M7*0F/N#>Y0LM MI:Q5(AHCFFADJ.^QF3K54DK]#-$:*UQ208_M]*66 M4BV.$4TTNM#BU"4%+9%C*S/2,LHT,:($48HH0Y0C*A"5B,:()HBFB&:(YH@6B):(5A:R'2FR M1&]8^#*I9&[*?$`QH@11BBA#E",J$)6(QH@FB*:(9HCFB!:(EHA6%K)] M(?)#IB_>>YVJ\TSFPS(?4D^11-9U2E8TUUG08ZLQP8JIA>PQB>3&1XRI3I)8 M8X(<3.1+*7WZQQK]TXT!ZJ2Z#M_W`I[$N'Q.5N)VKD(A,G5S3@8]%M9%6JK9 MS332%?&@E%)R5Q\.^_T;ME.F6A&,SA6Q"_%?C!(#]$`BLJTQ2A;+1%I*C[*I MJ%`BI>A6*CP8=/UNWXJ!F,T;$J-H_?&">&7O362'6YLWP'5SDMI^8#`8T-QJL7H`9 MA'=T@Z'NL1)ZNA6*!S2NDB&55&E65N?.)VW4+T<=*A$'K*N$M-%VCR7TFFGFG&L]9%/BESR`;WDX^!WO?"NWMBYHEZXZCDJC/KARFTJ*G!JHL0? M]"$)93Z M#$7\A"64`0U%?M-5XE&)RRV44Z$2EV,H^*82EVLH5*,25P\HZQN*T!%[0,G? M4*1V724>E;CZ1NDD*G'UC?(.5.+J&T6I5.+J`66WP\+9`TJ#4HFK!Y0OHQ)7 M#RBQ0B6N'E`83B6N'E":/!2Q-MJ`GA/1''7-@Q'5&3GK1%02.4OH,0'--Y>M M8QJIR!9C#V(:J4@KNDH"*G&--*:1BFP%UJ'G#32O727TV"$4N0NL4P["TK71 MQ+2L7*LJOP[IIYBH9T2V'#EM&5&)>!*&=>@A9BB>?F$)/;@,Q4,P+*'GEZ%X M%H8E]!@S%`\#724W5.*J,QJ$(]?HHT$8N7@\".F'P-A".@CIY\#(LT%(/PI& MG@]"^BFT@P_#HI+O--LOO?KXNG[<3M?'Q]W+J?6\?:!CJWLE7ML[UB]/UO^< M#Z]TQ:`7(`]G>NFQ^OI$+[ENZ9?YW2L2?C@&PO=V]R:W-H965T`X?N)F/]`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`!)"(D@,22`I)(/D MD`)20BI(#6D@+:2#]+8X#2_WJ"3J'PX(F=:%9 M4-\F(E),2D@I*2/EI()4DBI236I(+:DC]0ZY>5.]2KN'?_@>H1YL_?0,9!H^ MT%&&0E)$BDD)*25EI)Q4D$I21:I)#:DE=:3>(3<7JD-Y1"YV_4^I3Q_>UVI@ M3*7'-'Q`"DD1*28EI)24D7)202I)%:DF-:26U)%ZA]Q(3<7JOMGYT+=6^9R M.SCVWC)T(^TD[7N6]KW%'^=20\!^WD`1HV)20DI)&2DG%:225)%J4D-J21VI M=\C-F^H]VGG[Q;UEZ&S:Z1G(OIZ!0O5DX*8G(L6DA)22,E).*D@EJ2+5I(;4 MDCI2[Y";"]5)/"(70Y_2SL5`=BY`H?JDP\\%*&940DI)&2DG%:225)%J4D-J M21VI=\C-A>HW'I&+H9MIY\+N>0[W%E"H/CKRS*OL="4F3(U#6;>'7%8U'3.9IRV-2K_>&=F@7U1F2& M[#4NW*W/QZ+L-;I->ES_;\K^GR;WJ/0_G351>F]"4F3(WD&OKG@LRM[![=4S M,5%ZC2DI,V2O\=)OTF&WW7TT272;5'69[/O&X>[`=.AA6;<'3N5=?`(3 MI7M>=:(B2,THU MWF*QO+A$TZ'NQ-2M5Y<:.K"ZS%W=9#J;+B^]*T5N:L)QISH(1[3FT)^P6Q-= MC&`*"DD1*28EI)24D7)202I)%:DF-:26U)%ZA]PC6TY=)Q=O_$QEJNKQ'B0' MDK-_?[^?3?'(M(_2QV"HZS(=D8@4DQ)22LI(.:D@E:2*5),:4DOJ2+U#;MY4 MU^"(^D9R+1R,`6%I(@4DQ)22LI(.:D@E:2*5),:4DOJ2+U#3B[41Y!. M+M[8O]_6XR9)DWT.37$.F:C].42*2#$I(:6DC)23"E))JD@UJ2&UI([4.^3F M[;A>X8R]0DW6.40*21$I)B6DE)21?0$&4H9%1$BDD)*25EI)Q4D$I21:I)#:DE=:3>(3<7QW5^ M9^S\:C(-'Y!"4D2*20DI)66DG%202E)%JDD-J25UI-XA-Q>JS_OZY[/9T$6V M^CB:[%P,489"1D6DF)204E)&RDD%J215I)K4D%I21^H=KYV+MYZ;QEZ MT':2=J2>TZU[BS<.&H?<7!S7GY^S/Z_)-'Q`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`E)(BD@Q*2&EI(R4DPI22:I(-:DAM:2. MU#ODYL(?P_E%+CA4L]P/PNB3(""%I(@4DQ)22LI(.:D@E:2*5),:4DOJ2+U# M;B[\X95?Y(*C*$L,F02DD!218E)"2DD9*2<5I))4D6I20VI)':EWR,W%;QKY M6'+D0Y-[;_$ZHH&)TJ=52(I(,2DAI:2,E),*4DFJ2#6I(;6DCM0[Y.;-'\#X MQ3G$<8HE!B4"4DB*2#$I(:6DC)23"E))JD@UJ2&UI([4.^3FXK@QAR7''#39 M]_DARE#(J(@4DQ)22LI(.:D@E:2*5),:4DOJ2+U#;BZ.Z\\OV9_79!H^((6D MB!23$E)*RD@YJ2"5I(I4DQI22^I(O4-N+OS^_!M'U9?LZ`]D#[+J*).WT)`9 M/YK-O8\:(Q.E[T"Q0^X^^?WBM^X3.\S+'3G[Q`[S$"6?%*A7@XP,')L`LSMV M->[N^%W+7]Q&V(-<#B2KV`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`````/__`P!02P,$%``&``@````A`)M1?82:"```H"<``!D```!X M;"]W;W)K&ULK)I;<^(Z%H7?IVK^`\7[`6QSKR2G M`KYSK:ES9IYIXB14`TX!W>G^]V?+UG4O)MUT]4L(GY>6I+TE63*^^_/;8=_X M6IS.N_)XW_1:G6:C.&[+I]WQY;[Y]U_Q'\-FXWS9')\V^_)8W#>_%^?FGP__ M_M?=>WGZ?'XMBDN#'([G^^;KY?(V;K?/V]?BL#FWRK?B2%>>R]-AU4;)ZJ0H=]V^]T^NW#9G=LU@[CT\]XE,_/NVT1EMLOA^)XJ4U.Q7YSH?:? M7W=O9^5VV/Z,W6%S^OSE[8]M>7@CBT^[_>[RO3)M-@[;O MN]DJ[^H+V!]VVU-Y+I\O+;)KUPW%/H_:HS8Y/=P][:@'(NR-4_%\WWSTQFO? M;[8?[JH`_7=7O)^M_QOGU_(].>V>YKMC0=&F/(D,?"K+ST*:/0E$A=M0.JXR ML#XUGHKGS9?]Y3_E>UKL7EXOE.X>]4AT;/ST/2S.6XHHV;3\GG#:EGMJ`/UM M''9B:%!$-M^JS_?=T^7UOAGT6[U!)_!(WOA4G"_Q3E@V&]LOYTMY^%\M\J15 M;>)+$_I4)O3O3Q;NRL+T*0M[O5;7[PV&51,^J)8:6+6=/F5)GWHY['F]OFC\ M!R7[LB1]JI(W=YIF4%4[?4J/;LOK=GY4]4@6HT]5=?_G&NW1X*AS)49)G0?_ MYF9[*EGB'^GR"RGW5-K$8),VGM<:>)U1,+@:_'8]\JJ!'&XNFX>[4_G>H-6! MQM;Y;2/6&F_L44;4$*[SIP?U_QO3-)B%RZ.PN6]2>1JN9YJ(7Q^"0>>N_94F MSU9J)JCQ7,54*<1,$;8A!Q$',0<)!RD'&0U1LQ1+>JS%&B)S@&0"$@,)`&2`LF`Y$!F M0.9`%D"60%9`UC9Q$D)K&8S_+L7L^DU4+3BBU'US8(4VZ/?+$GT(-\1G0$(@$9`82`(D!9(!R8',@,R!+(`L@:R`K&WB M!)66"B>HO[C1$39NM"49Z#OOM":!!J&44,+UL/>#D;M:15JD\AASGX2#5)?Y MP#C3(F6<6SY.C,2Y]#=L!H6-&R-)K!C5Q(J1E#@QZK(M9*1%JBLQ]TDX2'49 M*T9==JO.M$@9YY:/$R,Z.C@Q^GAR"K4;"DG(WHR%+ELGIUJDFA,"B301NVT6 MJ%A?M&L)W!&7:)&J)062:7*EEEQ?O%Z+$S=Q@+HA<)7 MA>*NS(:A0NXXY#=CHU(=#!%%!MD=9.M;?%5E=;`Z\25&I6I,$64&636.V"3( MKZJL&MV0B@/##2&MSQ=4A6KG1)SI192=\3EB*\W4J%3!$%%DD-U!MDS$1J6\ M$D0IHLP@V]X,MBH7N5&1O1LLL9N_(5AR\V\'RSX/5-5-/4`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`6\G=7"E$5>AY$:AVSQ#-#3*5!1TV>A9& MI;R6!IF"T,J5456M=*?^VEPE6S>YMQW`Z<[#)Z)"]D0,.FQ3/C4JU;$04201 M?8A>>$,O&/D]OFABN011:M`'8(9H;9"H+.NQ9S,*HE-?2 M(%/P2G)EU(=56%@\UL8#DGO;HP!:#B"Y$IEU?JI4!H6((D0QH@11BBA#E".: M(9HC6B!:(EHA$J_?5,&Q[F7UZS3U6PB'XO123(O]_MS8EE_$JS(TYQ[N-%;O M\73'C^1$B6)7Z-0Z%L>S:U=Z=*6JEI?Q??5:$+M"&^&QV.:B&[U)]'B]?JKD MBGXBJKC&@S']$HK^$^K&M5X\]L:/](#@2@'JW=7.]NM'4FZ/VHM\U+ ML=B<7G;'&PO=V]R:W-H965T,JJ4X2_?XMOEAA)1:J4%+RB$7ZF$M^MW[];7;AX MD#FE"H%")2.<*U6'MBV3G)9$6KRF%7R3<5$2!:_B9,M:4)*:H+*PW=DLL$O" M*MPHA.(U&CS+6$+W/#F7M%*-B*`%49"_S%DM.[4R>8U<2<3#N;Y)>%F#Q)$5 M3#T;48S*)+P_55R08P&^GYPY23IM\S*1+UDBN.29LD#.;A*=>KZU;VU06J]2 M!@YTV9&@680W3AC[V%ZO3'U^,'J15Y^1S/GE@V#I)U91*#:T23?@R/F#IMZG M&H)@>Q(=FP9\$2BE&3D7ZBN_?*3LE"OHM@^&M*\P?=Y3F4!!0<9R31H)+R`! M^(M*IB<#"D*>S//"4I5'V/,M=^D[?@!\=*12Q4QK8I2+ESX;EZ*QZ%;=5 M@6>G$EC^8N8Y_R$R;T7@V8J`W"L3@%2-#7BVL4MKZ?OS8+GXIPN[*8FI\)XH MLEX)?D$PM>!9UD2?`2<,,.I*V]2A+_9+M8;R:)&-5HDPQ$,5)%E3U#6QI%6VK2VC;`;]]CESN M.D87LA\#AS$07P$##]Z;>-`J$5Y%WS8KV='-!BFI.-$=+0J)$G[6^S<`K1[MKX:-B1_A6[@RS'X= MXVX(!P(*,,:]$*9IBF_FX<;L_#%_'D*#@&_W7\"54),3_4S$B542%32#E&>6 M7IZBN52:%\5KLQ>/7,%=8#[FQ_@4``/__`P!0 M2P,$%``&``@````A`,(G7S.T"P``WD4``!D```!X;"]W;W)K&ULE)Q;;^,Z#H#?%]C_$.3]-)8=)W'0]J"S@]D]P"ZP6.SE.9.Z M;3!)7,3I7/[]4I1D2105FR]%2S.4*/&C+F%]__O/TW'VO;WTA^[\,%=WQ7S6 MGO?=\^'\^C#_S[^__+:9S_KK[OR\.W;G]F'^J^WGOS_^^4_W/[K+M_ZM;:\S ML'#N'^9OU^O[=K'H]V_M:=??=>_M&9Z\=)?3[@I_7EX7_?NEW3WCAT['15D4 MJ\5I=SC/C87M98J-[N7EL&\_=_N/4WN^&B.7]KB[0O_[M\-[[ZR=]E/,G7:7 M;Q_OO^V[TSN8^'HX'JZ_T.A\=MIO_W@]=Y?=UR/X_5,M=WMG&_](S)\.^TO7 M=R_7.S"W,!U-?6X6S0(L/=X_'\`#/>RS2_OR,']2VT]J5N^:=4_GK4(/KQ(/OT%I^"?E]ES^[+[ M.%[_U?WX6WMX?;O"?-?@DO9L^_SK<]OO84C!S%U9:TO[[@@=@)^STT''!@S) M[N?#O(2&#\_7MX=YM;JKUT6E0'WVM>VO7P[:Y'RV_^BOW>E_1DEAIXPM[-KG MW77W>'_I?LQ@PD&[?]_I\%%;,.SZ9"P,OF!TX.?@Z(KOP3+NP6U'M3),4NB86B\' MPZ9IHS2A:7!T^AAK96QZ&&0C05:BJ8,(F&Y6*\=FK03(&H8N]#%J"N9@>E-: M.6[*2%(/=+8->+@])UHY-FLDJ=E&8E8KQV:-)#6K8*C"[B*^S6@4X\?B%JPH M#!VUKH?PBH9>!V'8ZNU!0FW2F#8`Z0LS4XB^$K&/VL2RP9^QK*FIDQ_H1DK0?3)GM8K3`&,IE+ MB4!';3*:!G5F-$59+POS('*2HHP$N`^JM7-CGB=D$/T8Z;YB/Y\!ORN(Y$/%=2._7"B=;+D5@3ZVZ&,VL2TP9_I-`%;A_)J>3>:3RK#$>X&144R!1P/<+F,I`AZUB1\& M>-ALTURR%-&-VL1TCNXEH1M!J:N[]3@H%NM@AXK&H.$8E,R!=RF"'[6)3R8? MI/#7!/[;4XS:L64G2B>B%M&-VL1TCNY:1#=JHV4/KMIX=,UNT6H!>,,"[U4B M*FH1W:A-_,K178OH1FUBF:4[YX>([CJEVXJ8H!+175N4`SBE4K43\HS:Q;);R:!4,/(UPAV]D!(L@:I/&YJ5"'W4)CZ9;,#X1-"_O0BN M!MS]4J$V_F+#K"=6:PHG(OQ7AO4PI5E1ZI>^!)X>!:@=CY@519R$KD:@K$6\ MHS9I+;?>KT6\HS:Q;'AG0%F+Z$9M8CI']YK0C;O%=3/A6(6?)*T,I`R770%;$!!2!_S8HZP'XL-/^TL2`8K4F@+(6)0#4)J.82P!K40)` M;6+9Y@0`;M@^JL:[&L^/"/AU"KP5I?.S$0&/VK$?5L18%L&],22'2-A;I8-=H16$DJ29S![01<8_:.%+A]/I;#1/)5BML/[/UWI#<<)LC MU";S9/(!,YHB]C1JBH0L2\4:<-F@U".DNJ$&%OU*EQ`SYG7$2Y*@S3X;+B9)QQ`CIN M^*?40EF^@YV,*HP,V@^B+W,N5H4H#1AU.F2Y1*`*D@EN!ZY1I\9SB[PJ1+0; M=6K9I=BIA5W(K,4*B^8$`<$DA'S= M'=;-"8PS]-O2NVCG&GH<+/TR1\E*[XPZ M(=/6XW%=U\P&73?Q74[8Q"JF%&^00?`.:W)99`[&2E:@9]2I9VX/D)!+:_1& M@/6U>6'/_7'2`F35I@"$!7C!T(YU@,D8MH:/FS=9>F#*\925$8"\QP0@LE$8 M\X9)![9RC_-&MAG072:WL&%6TTK8[I.*_-P`U774P!BRO24 MD\4`9<[C"BONIH>8*]"+/,N>`V05>LJ7Z(4`^=7%`F35I@`D*^13OI+/+^Q6 MQLV;;->`97TD]U@9`DW'>R-(!4ZZGG(P#2,8^4[*GK(SK M.F$?`:KPO^O&-EE,`9]RLAB@W"F=EO6-9#57N!<"9&6,9[+*/<64[@TR9E)D MU7O*E^]Y.JR,ZSJS+2@G?8&MF$J]019/2NZH+JO?4TP!GY-QGLFXM\5Y^L`6 M;&C\H=9FM:&&SVOE\H"LJD\Q97U.QGDGRP-,89^R,I+5O,=Q5J/E?F,`,=L" M6^3'>4-2PYAQ9EO@ROP8@&15?"Y!5F[(MD!4`*J8"T,FX>9.E!Z;@ M3SE9>$\<>AP#A%5\T[=PKN@OBL+LU2'6\0F,Z^Q!-CG94D"%Y7L"XPSZM@*0 MFP>"/IY+)]P3,X5_RLK"V"J5OQJ)YT-6#:A\.:!G9ZC^2]B15?LIIMS/R9@A MDQ7\*:;BS\DXX]R&8,+_SS*E?OKU#>9;P#`CT#L"\X(&\Q:$4WMY;?_2'H_] M;-]]Z)KO&^>VW_L;N\'L[][-B^P/P7>+Z^F-=SF#^NW3O$!;QBH[O" M:S7PUS=XCTH+KYLH]+^SO73=U?T!32^&-[,\_A\``/__`P!02P,$%``&``@` M```A`#3[NGL&#```7#P``!D```!X;"]W;W)K&UL MK)M;<]I,$H;OMVK_`\7]!Y8`@55VOC(ZBV-M[>&:8-FF8HP+R)?DWV^/-,=^ MM3ADDXO8?J:G9^;M.35"=W]^W[]V_JJ.I]WA[;[K]6ZZG>IM>WC'C>OA[?JOONC.G7__/3WO]U].QR_G%ZJZMPA#V^G^^[+^?P> M]ONG[4NUWYQZA_?JC4J>#L?]YDQ_'I_[I_=CM7FL*^U?^_[-3=#?;W9OW<9# M>/P9'X>GI]VVB@_;K_OJ[=PX.5:OFS/U__2R>S\I;_OMS[C;;XY?OK[_L3WL MW\G%Y]WK[ORC=MKM[+=A\?QV.&X^O]*XOWO#S5;YKO\`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`W?'3K21&DL*)`.2:V*[ M9KM3H8V4Z](FCDPB[?L-MS3AQI5)$KK4ZFW4'S,-(FED20ZV#LZ7=[*A+4KAR3DWY)CXO8GTD:J/S&0I"&^5U^%/6\R M&#,O*=3)@.2:6-WQ^6K31N+6[?=8.Z4NIMXZ6HE,Y@JQ:G-7+86H"4NN6R:7 ML=)Z(4HD\@>U8L,;\<]UE&*M#%%ND-4I$,U8"=4HR69SOC0&H)NXR-N+\?(D M$U<4-LL49:3_Y4%Z5 M1A<32&-CIK%]L:_CF*!5BBA#E",J$)6(9HCFB!:(EHA6B-8.+'B!)$ M*:(,48ZH0%0BFB&:(UH@6B):(5H[R`V1R#/L$'UP@Y%IB7UVV)F*/#L`Q1Z@ M!%&**$.4(RH0E8AFB.:(%HB6B%:(U@YR5199BJWRKYX=,MNQY6^07S]CDO)+ M*RM)\S0R:\,?L%,G,59J=:2(,D2Y0;9[=H,IC)5R7SK(E4PD*[]#,IGTV)(U MR)%,6MF2:62/B6TZB;AJ-IN.&E.**$.4(RH0E0YR]*'>_Q9]:C]N+J?06%^L M(XG,9RBQ,K)W6W_($I?$6&EYP%4&)#?5+.V'+),IC)5R7MJN7+E$6F)/I\O[ M'&7K=5BM6:.0K8JT,BB65M0/U:<$48J^,D0Y5BP0E4Y%=\PBI;ABS#(#L<T>^DCUASR?\K65&G.,*#&H3G!80F]*[998)IX9*]52CJ@PJ*6ETI2VM^1* M>%UJ1-C&BQ"`Q,,]C@4A-N=T6B*A[9$0$5+3[ M8M?BLMW*M.B*R3.H#]:@3&;L^2B1.Q_Y)<_75FJ`,:+$(%LL=B2F[59F@/6) MFQDKU6*.J##(;I&=*&6[E6G1E53D%UU7F$_@-PC-M54(!-$*:(,48ZH0%0BFB&:(UH@6B):(5H[R`V1R`;L$'VP M$&3R8&_$$IG[T0+1$M$*T=I"KLD@-;)7% M0AC0M?T#M65&8:LMD;EG1GZ#[`NY-+)7@C\RYT9]4B6R'GU(HB9^"JXR(+FI M9I:9/V*WF,)8*>(YH@6B)826;U?(5H[ M%5V5KTO%!IB**40[CM[TZ0NG;DH1&2L5^1A1(A%E4?6=>C`)O!MV)4NQ6H8H M-\CJ%3P?,U9UQ,%;-PAP%]1JVS-$4>5FM32F[=V(H\VUZR'UQ*9%IN+U6)W*7* MYG,TT%9J8#&B1")Y7([]MM""HPP=Y09=$*TP5O*T=&4K3;GJ]`S1W""K+?X- MX86Q4KZ6!ED5,;)ZP*V1U:40V>L^CZ!WD/B'-PJ9VWR$*$:4($H198AR1`6B M$M$,T1S1`M$2T0J1>$&K%J=6HED_S0M7S1LN^^KX7$75Z^NILSU\%2]3#0,Z MU366;WKYX_"!/%&@6`E]SA"*A+JM9$(E];>P>)U!H%X,!3?8VCQYHVH MI!X$J_/@!>$#?>K25H?:H2>\;274:WHJV5+B4YU6;_2VVT-]P+#VI_067+VG M<.Z3H[86!C3X%OXP#!_H2S8M72)-6B4A1=H$F7K40JNGV+\-1:*+;5`>&XHL M%4LHFPQ%KH@EE*V%"64S6$*Y5RB2+2RA'"D421&6T*/24#SHPQ)Z%AJ*YWU8 M0L_::#RMWJA$/`9KJ^-1G;:`T6,EJM-:$H3T?6WTE8]#^H)R"Z>AM$W\,@C+ M-CZE$4Y;1QA12=1:$E.)>"Z-K<<>1;FU#CVT#L536*Q#SZY#\3`62Z(@I.\V M(X^#D+X>W\+'(7T?O(53=]O\I$%(WX)&^RP(Z;O0Q/MZ7=&[G>^;YVJQ.3[O MWDZ=U^J)MJN;GGB9[]B\'=K\<3Z\TX"/_T7``#__P,`4$L#!!0`!@`(````(0!W/SMT,0$``$`"```1 M``@!9&]C4')O<',O8V]R92YX;6P@H@0!**```0`````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````"LF^03G56MJ1+(<)6!$*Y79U>AILTJO M4>(#-Y(WK8$:#>#1DEU>5,)2T3IX<*T%%Q3X))*,I\+6:!^"I1A[L0?-?18; M)H;;UFD>XM'ML.7BG>\`%WE^A34$+GG@^`!,[4Q$$U**&6D_7#,"I,#0@`83 M/"89P=_=`$[[/R^,R5E3JS#8.-.D>\Z6XAC.[=ZKN=AU7=8M1HWH3_#+^OYQ M'#55YK`K`8@=]M-P']9QE5L%\F9@_9MK$N_W%?Z=55*,=E0XX`%D$M^C1[M3 M\KRXO=NL$"MR4J:$I*3<%(26!2W):X5/K>D^FX%Z$O@W\01@H_?//V=?```` M__\#`%!+`P04``8`"````"$`Q2,N"<`"```B"0``$``(`61O8U!R;W!S+V%P M<"YX;6P@H@0!**```0`````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````````````"< M5M%.VS`4?9^T?XCR#BD4I@FY0=#"F,0$6@H\6JYS0RQ2.[.="/;UNT[4DH#K M;;PY]CW7YYY[;(>P9F8?ER6N%$JOF<5/_9BH MHA`<%HHW:Y`V.9Q,OB3P;$'FD._5VX1QG_&DM1]-FBON^)G[Y4N-A%-R5M>5 MX,QBE>D/P;4RJK#1Q3.'BB3#18+L,N"-%O8EG9!D^$DRSBJ88^*T8)4!DKQ. MD"M@3K1;)K1)26M/6N!6ZLXJ)CG0K"N3WDG6 MY!^`'/P%DUEFP5G-4%70&_0KL_\%F3-3TDLO9)O;I"$XXX5L%`BE]0L11H2L M<>AE,O(&NLXR4?G+[&3XUP"ZQ"NY87@O;AOK[JG^U'M,%=QYI\`=F]U;>/S8 M[^/O23N:N7:H%W]N9]'4^2[IK-\>79K+].D"M\6G7EDLQ+)A\AW\2\7W!_ M`_?]+T]Z<+0_F4[PH1_,D>3UYR;]`P``__\#`%!+`0(M`!0`!@`(````(0`= M?[]DX`$``+H6```3``````````````````````!;0V]N=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A`+55,"/U````3`(```L````````````````` M&00``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`.C!R>??`0``JQ4``!H` M````````````````/P<``'AL+U]R96QS+W=O&PO=V]R M:W-H965T0,```L+ M```9`````````````````!48``!X;"]W;W)K&UL M4$L!`BT`%``&``@````A`#4/6S'="```.S@``!D`````````````````Q1L` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`!;(?O*E`P```0P``!D`````````````````)BP``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`'#Y6]>E`P`` MW@L``!D`````````````````*#L``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`.C\F8@]1```B.0``!0`````````````````E4L``'AL+W-H87)E9%-T M&UL4$L!`BT`%``&``@````A`-#'I"LH"@``JE,```T````````` M````````!)```'AL+W-T>6QE&PO=&AE;64O=&AE;64Q+GAM;%!+ M`0(M`!0`!@`(````(0"#5N-_'@,``)T)```9`````````````````!RA``!X M;"]W;W)K&UL4$L!`BT`%``&``@````A`#$%9);; M`@````@``!D`````````````````<:0``'AL+W=O#```&``````````````` M``"#IP``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`#>S'XI#!0``=QH``!D`````````````````0JL``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#"AF>S]`@``%0D` M`!D`````````````````TL8``'AL+W=OX$``!1$P``&``````````````````&R@`` M>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#)NL+JL M`@``CP<``!@`````````````````*L\``'AL+W=OE0H``&!$```8```````````````` M``S2``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``W-18.D!P``D2(``!@````````` M````````RN(``'AL+W=O&UL4$L!`BT`%``&``@````A`%/::4>3#```ZD8``!D` M````````````````!.T``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%W*EFOM"P``>SL``!D````````````````` M8P(!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`)9]#'P*`P``D@@``!D`````````````````G2L!`'AL+W=O&UL4$L! M`BT`%``&``@````A`,4C+@G``@``(@D``!``````````````````;DD!`&1O D8U!R;W!S+V%P<"YX;6Q02P4&`````"P`+`#F"P``9$T!```` ` end XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Details 1) (Fair Value, Measurements, Recurring [Member], USD $)
Sep. 30, 2014
Summary of derivative liabilities fair value measured on a recurring basis  
Fair value of warrants liabilities $ 556,070
Quoted Prices in Active Markets (Level 1)
 
Summary of derivative liabilities fair value measured on a recurring basis  
Fair value of warrants liabilities   
Significant Other Observable Inputs (Level 2)
 
Summary of derivative liabilities fair value measured on a recurring basis  
Fair value of warrants liabilities   
Significant Unobservable Inputs (Level 3)
 
Summary of derivative liabilities fair value measured on a recurring basis  
Fair value of warrants liabilities $ 556,070

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details) (Stock options [Member])
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Stock options [Member]
   
Weighted-average assumptions used to fair value calculation for options granted    
Expected dividend yield 0.00% 0.00%
Expected stock price volatility 112.00%  
Expected stock price volatility, minimum   105.00%
Expected stock price volatility, maximum   108.00%
Risk-free interest rate 3.63%  
Risk-free interest rate, minimum   2.68%
Risk-free interest rate, maximum   3.44%
Expected life of options, minimum (Years) 1 month 21 days 4 months 24 days
Expected life of options, maximum (Years) 9 years 9 months 11 days 9 years 10 months 24 days
ZIP 16 0001213900-14-008252-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-14-008252-xbrl.zip M4$L#!!0````(`&&";D53>^NI5)4``/M$"``1`!P`87-P=RTR,#$T,#DS,"YX M;6Q55`D``\9Q9E3&<694=7@+``$$)0X```0Y`0``[%WK/-Y M'"/>Y';W5CJ/F(-GB`.4>"_/P+'TM$`^D[@(O_A_=&O7R^'YM$_ M/OSPMW=_'PX'/T$?8CN"[B`.2?W@XJ_A'Q]O/RV:#XQCTOY8&OPW`".@CF0) MJ`/).M'`B68,3C__[V`X7+SJHQV2UY`VR0OD8["J2TK.`R>>0#\:?"90QH@\ M^XRB1]KCA8NB``]^2_L$29^`ONH2(]>>_3CX$CS!R3>(!T#]<;`$H9RH.@&1 M]O/R#7OHA/X[(`SPPQ,[G#Z_/WJ,HNG):/3\_'QL8Q1&]C1XAOC8"28)-9*E M$/[,&WC(_YYI0%]V'.`'\J2DC&CU-T+DXG%:ZZ)E`_9A?32O7#ZZ\>IG)7D6 M6)8U2FJ7CX8H[T'R4C#ZX_.G.^<13NPA\@DEOI/!@DJPKS^/PD"5@5'68O[$ MHH$?^'X\R7_>C?`HFDWAB#PT)$]!C)QEN^V-L@U<.,70H2I9",X:V=C!@0=' M8]N)AO!EZMF^351H=DE^7[P(PW'A&_01J5U"A%%)5TD_Y)&,U*-.'X&F45E(E5(82&"I@V2S&F`S8HG9I;:*]V88N1/EM2$7. MX_#%>I35#.XJ*FY%*C+[%$0R99E3'P]PV M24U.7R]>R;#\XQ-C*^((EV@NJ3VBAI%:EY,PL1NW<#Q(K,U).H+*;=)HBH,I MQ!$B.!GKE[R`HG]_%*+)U%N6/29CCMK=X<*V'K^$[M%H,4>F#]Z?A_?7X7@'WY]"YIY+\*DGW\[]?KW/+CU8O)),-BF:K MWY%+2\C4@P<).[+4+Y3F[.J?1Q\D8FY56=55Z=UHO3%]X2B_!\(L%+A,CXG9 MC4A!HH5D0"E@U7I5NRA9M1]E>%*%29)Z?P>GE!ERADEYY=UE$C$YUE!2^3/I M+`ZC8'(O@0/E$N$"CL[)O,CRB5$FMGX)VEUOH+(=+FIY:)\BY?,UK[Q3?-W4 M/D5J:X@"Y9YXLIM,RBOO,I.H*5/:8I*\-.I9)N65=YI)\E!NP=BG=@R8!\JE M#3M&_YIU[-@:8SG;L0+MRROO%%\WM:\]5Z,.D^[O(B(=NO"_^#,F%)P%DVG@ MDU_#TQ<4WI-?)X%_%P7.]\_)$E\,4U-=@P\4V*+`)5V2M21R4#3',G`1J9_O MHZ1._DDI.4N6^:GK(NK^V]Z-C=PK_\R>HLCV7I7\ M2VGL=6&I"[%$X"8:X1>'WPYLERBCI)PV^'@-9(7LT&N*&T#+[2LI#.SD[#3_.V)IT,\T/ M8R\Z&#UJZ&U4[J M;4MZN;6YL>FU4=[EX2!H7W@[D_IS(6$#XU!DWI\+];K0GPN]#>GW>Z2O59;] M;M?KE_$M)&X_?!Z?.6[Z`FYL>W-U^>/"(ZOIS1YE##E>CQ&#L2'H0RY M!#$K]&+*!&P#JW6W@=7U.";N\=`Y*E&@*OV6CACCL"'SM@+\&LN\W]+I=:'? MTNFEWR\C#D;RJT39S_9L4_2RF5>>ZR,N=DX.0]@%;F$2#Y"E1(P;J-5U`[6A M;/[`W0U>JPUT$IX_0_XB#YP/9$2Q3B4UJQ*B%7E&-!\_5VOLMW>!JO]O2Z4VY@U"2?GNF5YZ=E:??S^G5)5/> MQ_3TPN_S'GLEZ"/!>J5@RON\EUXUZGL,?=YCH>)4[N<0\AY?C?;V,;%O6AGZ MT^]>52JJ2A]UVZ&HV]>C5OG'J^<(0R<*7D=L;I:87AU*O9,'#)-1--^0H2,) MT2\YW,38>;1#N*SOMF8D?FF&EL4Q^C:*>O4H50]"J8N\F*YF5ZR\>'&\V(7N M)0XF=,*/B0]`Q'`]7NR#WT!\]VAC8M+S7W#@&S_M,:7?1NJPPA[4+I00)>TW ML:JO_.)O(>&GC6=W-G5>DG&=KOKH=B&\\6R'F9=>R\R\7"<6T<^N$?,8T62+ MJW<+]A-4Y#_1[X%]\V#>LO_5:7;5D*12KO1J_LK4_,VK;:]`Q2'JU_Z!Y+ML M"1A?TM'KP4YZ\/41'TKFT[;4@14EO2Z4Z<*M[3_,SP(_VR]H$D\.0_Q+V*NI M(8._%WI%H2/_L(7.XG]30E^_S/?`4EK6\X+%W'C<9ZATZ3Z0`Y%YGW#2ZT*? M/_(VI-^G@[Q661[N^6X'`OL[*^,^3O^M2+H/NW][8?<'HHQ]%/UKDFT?%/]6 M)=_'N'J/=?@J><>X]SRKL<*P+`$*A=8%*_..C$XJ"1/OQ].!S\ZJ-H M0):]=,-[,!@.%^4__.WJ_\#_7/YV\S-\@>>:;IC_OH5_H@]7C]_AT\5WA%^> M3A,%!E M8)R0NOIONR=\O$_2\9;O33+>X0?FX2_QA'Z%*L`[=KW1GA:>0S^8(#_OM549 ME'G%*(N^G/)IS!"<[996;>,C5:0++QE(&1U[YT)T$76[B/7CV`R<`8]L+X;SOS.L7?9X1UX,6H="QO7]#&U_,(S4Y M=3^\<_;EZQW.H^?Y4K[R;++]9_I: M![)BS24I"3E"R8)8ZRE[XJ#^(.7NB`6M'D M)>G\.'"A@PCP\/W1U9=+*E#+L$S#R-B4$F#"26CH(VYE`%!TJ0[Q2[?-#A]+ M2*SS158&)/4Y&(1TQ%F&8FKO1FR_=7#4B6\OPZ%H"M#U8ARGCA/$\R4H1$\V MD<<7&*5F6@B?=$U6&3Z5X>&!FQ=?@:H`2:F/FVC[U$;NQ]>1X\0 MGX8AC$*1;%=DS9!6\"O`XD@%-R%(P`#&SE1<$1OD$\=X1D0E@NFJI2N`T1FV M_UUP\6)C55P)-\]3:WT6A%$HB'&F+!D:HZVY0!HAY<7*VDC%CWP`9%EG+5?1 M\!`_G"V@2:I5`1HSKC\3#Q)ZGNW#(`Z_!+XCCI7`D!5=7A-V*2I^-'#CN6(I MJKHK#5<^<;$>J!WZW$?&Z?@H"]QEYGA"EUA1)8PW8=E@\R>`E#%DQ M+'UW,FYP,"5.]>R&R"PBLQ_UO*?4!1=DIG5+TS1V-BZ&PP,V/[,CF5)]V'.9 MB''6#$ME%Q/SKNN!X::C9.4IZQM&.L\WO[%GU!$6.+D!8&BR##;=\BR49F"Y MN5VF`2RY#M9/R"<+V_$9\260R$6:;JJ6Q4P2>3B:X.3%44L%LFI6QSG_,"IU MT*9!B(2Z8<3H2(S1*4#2$"PW"VF:6CVPBRRM-(GB$[*_(2\)KA3)8U57=<9L M;@7%C0)>C-=4@W75:Q&P6'7<0K*:BT5:85U1`&.#\X$T@\IM>PR8EF'4P;IF MI9>;#(Z#X_TINB09:N%,LA5C6_3QVVR3R<*0&WW[$Y1JZ1+(NB;FI*AR M%K#ZD M++QEWSN!XL4X7=$-K0389G;QGBRS(K-N7AD<'K!YL7<'R)\"_^$KQ)-S^$WD M>"BE8H$9$LW*X-D&"UX M8U@'[`Y)/I!F4%L8Z=MAYMH"L:PU=%EA]TBW0.*$GMM\K^F2LR(2DJ\497V+<#XT<& M+PD,94U5M(P;6(^,9`P\!IX+<3@/H:S$?;F`^TQYW9M>2Q5--5DMVP3=!9+* M+S(M)X],C*9D=)W"@NLYRQ54,71@:*!EVIJ:`Z#KIJQ(>T?)==BL3$C>?%:@&,/26^-[FQPAJK#"[25(30["^ MU.LFA3L9@HTU5#=I:\\0,%MQI[Z['Q=\(_QT&RA>!+06LEJ'@%//"YYMWX&7 M`3X/XF_1./8VD[T$'M6QP1AUL+5"5`O'4#L3E1V%\RS0TSAZ###Z"[K\15.0 MF:I)R9^B3>%U7'PHV$T.;5-P8^-KG)A.-]G-77S6NI5APES3P1"D$-TZEB2Y MB)@BB'R)VGF8B")J+M.K,(S%C)2RKL$M7#5MJ&N2BI[T0+3 M>QU07+5L:,BJQ9['[@B*JW8-@:'(FLZ94XU!`5EA\TD+0-W"$-)[HD]]]YS> M`QTDUQ^DMRJUKV4ZP9@)FRI!TPPV5SU49$E1@1#<7%55V@.K]P#Y#GH>O3<% M^A#;'GG\U)T@/[D,EL;?"]-N55=4]M:':K@X4<)W>C=ET]"4/9'"=0R0@2LK M1B>$TC15FOB#LM)(*-=3>A,U:9/6Y2:ME-8!7OA-,(,V(%N#<`KK,4_0>+FR!7!`2&X<*[H'F2`E;X@"QOF+5@#HA=,')5 M2@V8JLP?(U>5!-0$22WSL:D55W056)4Q_NIC:'OTZ.4G&_E46Z_]54:I`)-) MIAR-W:?8`J@I=LY3NIG))6\9.V==5BV=-5Q"&=]4R655DC1Y)_`KNWR)@PF% MA_R8V.O4<-/OML-Q@.'\N:_V"PPO7HBG&V`7^3:>745PDN0"DY8X2!SCQ1@3 MX6!(*K'EF0L^6R-GGUSCZ_`HP%`T]HK:5\HUKA9"(\ZVI+QZGO%=H^@2D-A% ME%"FD>;I-/^1+-7%;.=+Z[1N@-@5)U\30,2B&J`UL'R7/LF'282PM:F^:T"K MA?0+C,0NR-?GRPR`>L@XSTF2(4F&P@49;[NOZWQP<=8UR])D>2_`^">F5*=F M>2E=-FZQ_<'#7C*4CV%7F%Q'4GLP^6ZORK)I"N)H0ZBFKFE&+:@9Y3U]LI%' M$RR^!DR459H=\]$.D;-WP[\=(F_J1$X>XJGC&U9C`84-ENJ4Y)H[3+*E\R%N M,=LLPG/;&EKY$<0R=?Z/)6:$Y>+9#7"ST5(&F/VR`T?`S09`(6#"8%D`@WGB M-6O@_1VBA\<(NJ=/9#7\`+_$U&VZ'F\$Y+:BV?F9(H:Q%N=<"R-?XAJ,@H(T M&%67+R_S!E=$\,==3CH*AD#Y9+>ED;_-($4K>!.YM+A%%(._Y1+9DU;14 MO3,$\IY39%715,/D(\%S.,7DYJ M@&J!B,81')*A[T[$PM.FWXJ=T&WX8MB<@XS('_:2I%P<.R+EJB6Z)FEL!@I7 MI'RWXBV@&D)8VG1;PR"R!W60TCQ7>D,+<5GI'@=1Z-]MC&T_"B\#?`?Q$W*( ML<%GGHTF`HYCV/.V.LC:)*FY'0%F`[+F'\9AK,SU./TX.M.0(`]C+VK!ZRCY MBE!E3.V0T7@+T-!H7.NNM"3BFZ>)G\>8U!#7&`4N(T4BV]NB2Y>X2H2X2,9" M*I5AM4)(\VR@^D0L1E96AC3"\AR%R6531)X3%$_:GWQ-7<_<++\-47/X?/TV M%A(E2#+Y MJ-):.&I%=*W1U/Q*!D63U,8TD<<="-TD;V^U#\"$Y0K8-I%5;>T2_2V8>!/` MSRGC`#V;?D`&VKP`DDKQJ2:[011"9./SJ8U/-[1!ZA5!@&SO)O[F(>=Z3)J* M.D2LC:HM4AI;N@J"ZAA!K7W#BC\S/B$?AL1$$147D:$L&\7X,U!XX6W'ME>" M>@NG]HPJ03@_7A+@Z9B&I.4C7@?#$733`2X;F6/=JJ@+')Y+Y)-!(-C%)+.) M+EO;O;$<<*V1U'2"5`Q9D?6F)+'2G)]M)$M"4NS&M`$4M7->,))+,+5#1E.Q MF%J1_:Q(2H$YA*'II)FU5KQQ8K1'#5S2[$42;$#>3_D=]ARN@:Y&JQF>OA@G:(NJ42!WC&1%P\E697&K6OUT"LO3DE)=' M@Q@`L)$YE8!QI60I`;E`,G)5R6CLL8QX0I:LEPM$4I$0PY2U/1.2?J1962=D MH[Q<(CI@0XWVH5J_Q/FF;*.\G!!IZY`7,D*:WB"J2ZK9C2&RH5D;Y>5+0<6W`6F)+IO=4'HE4_CJI+5-&$J_2RP^SN*'I-]3*%;DSO@ M:H^0S)U,SF*KD_!:C=V\?`\->(R MP*=^A)*\4%)]YMFQB"77,O^G#JS6B&D>-@,,0]^5I&6BW2IA!8C8S#,L]DI8 MMO<&J!I?99W=.2]"E4UK6.[.T2^CT;2>18Z#B(O#U_;ZJR)KB1I^)P%U"$D4 MGUYM2YS!:WQCXRC]Y=0AKF&8C(>T)'V1[5WC^;'1:@XA%(7(32_3S0Z>]N5H MJ+I"MQ=:)Z4K_/K_]M[TN6WD:!S^[BK_#WC]<_+8521-\!)I)ULE7WF<9VTI MMG:W\LD%`D,1,0AP,8!DYJ]_NWMF<)``#XF4<"6;C4@",],]T^?T<:2\BE.C M*O(!QUARF45B1H/BN7L M)1QED??$ZFBM!?JN==ZMU?-NW]R."_C$UFYEX7$;"T[KXO;-W3`"4]J(-UH#:_/^9N48&TWF!\LKTZ%E@'[Y4,QSH% M5`>X^$Y`6AO%^HH(V-U(2Q_HZ\5E/)(=[G/`$)`FGT7]"'I#^>^7EG+,\EQJZ M.]FE8YCL8?*FUSQ]QUMZ4;%QNEC24V)R'^+[PF[IEX=)WQ-^R(/6]3B`W$,/ MR4J4>L6&^CXAT\-!;WR"K1>URXCDK:XW$ED7`//;<[T7LGQ(D@D<*=C!S"'PSV(I,ZVV6&`?E5WH>]-&M;!T=W[2T\]&#WBP!"46 M`F=W8#?#4;?7W^UCV!/(')TT3$5T4=+ZLCZX2?S39L_Q(7H M1MWD0Y?X^/`=URC;DQ&7$Q?W4.#@G/1.?$X$117RH.19<`?HDQ<'?B?SAD"%)Y[/.0IQ7T M1_"?=45J3YCB*&D9Q/*>F0[\8%VXL8YR/.AWY**+_JK[K>>!5WXZ;^/!4*M] M?AMR+"K`WS-N^O92]C_!QF:X_FOM?]'UZ7=-]H,AFW/C(7MK%YK_Q/8"]@`E]UJOKQ;V_)NH]%O/=^*UT5CP>JG/VP8#L?D@>_] M8&UX*9C+WR4N?!:8\WC8A>%?VZYXY-E?KX,WN!U3_..+%S!-U_YJ+)9O_M^X MI^MOM,39T+R9IHZ,9KB6]BUK7$OYX^J=DQ*,RFKYW*SM!VY4&@C=='W3IO4VFH-8T3Z[9T5X$IQAKN*OM'?O-1N#:[9K@E(\'P# MNWP"A7XV0)O6^MV6UNMV=?A9PX%(*43J_0+[^&_/_Z'!JQ_#(/29]L%E_O5* M^^:)'"4N%X"2%][^XMV0;HC#C350U-UKF`@K$[O&@FF!I_T!V+V"OWWMG5P) MC-*!06`M*WA-UUNT!@E!YA@9"+B"5^AG\;RV\&"MAFF&"*JSTD#?=)@)8^#8 M4]\S8(M1%P`@$[-%.L;9&PZ[889.!AIT5Z?(F+A[UUX0N*D8'!0]A[T$LZ-::]PE!: MPR++S"*O$AS$!KL`C-,;YF#>10M)E%T#6_#@;Z1$'BZ7C@W$"+S`I/+E;8MQ M`)EE4"E?<;"7N7C3B-YM:?(57W)"0);CB#&Y!T9OQ`+$^YW$*8K^NLIA1$M@ M82XR;&)XR+;?LP6MG`;3@!$[<%R0NR]#8'$S.%?:`OO(+9V8]WBA;](SLFF0 M6%<+ML2U6MHL9(YF,LL"X-:NC07[854!,^@:H"D$XD+8PJY2 MEC936=H(FK@YX-K,WE^8F8Y3H_ARDK6T:VHN$H?N/\_/+E)6+(A\U/-]>)!9K MNXAFT1X;13Q7=%C#4U95"4^PF-PA-K_RM30S@DD@,!9D96ZTBP/$!I( MK0KPYSC*I$Q.Z;,_0[RITJ8K#5=,JT1,PSE#<]`-88T9J$5\1O<=C5E8`$II M6%R96=PGP5F\I>U*_W1LVK6(>(TX^T=[86+=":I1"T:70U=*8FCB(3Z&G9'- MDGCI)>P@F%D<;1LD)<,UB7T`4U[!&[8;[U"6 M^:Y$RO]%.$X`(9'Y'C`F<*D3+OL-LR\`SVB8?9F9?60X?F;!W+-(@XQ4T,9P M+-)^-8169D+;,!SO822B=91M>B7N_&`)-@E>3M>"4\_[(42T'%E\G;D*+]*D M?+2YILJG%!NGC>0MP+EJ&$*9&4(D>7_CI/5_X'AA$S01=\7:JX;(RDQD*'67 M\4T(TEFFQ!-V+BX;[T4C(:M\DCQYNPTF^<+X`4:Y(EAA^'(>+I;218IWLL9L M!C:[-.:7GH_FN[$0]6=1EHH64/BJDVC?BY\ML'P=CV,@$=ZV>R1Q<>:\=\0L MEHQ'VFJ?YRW'%YVPQ4/H;G#Q.MD*Q75S]!+YIQ];_@F)38J( MY]NP")@.1*:J4T!BWF<8PNL&<_+^.YC;(ZX+3,4*Z`\6LX)=$75K/H/<<5!? MFAKN#\T"K8#;@?(,`,BP/>:<5!(ZC@MC!>H$=IW49LR2E]@P?HBN#<<&=2NY M*"VYEBES;-!*<"D8GHAW)J"8>'B%@^'#\`1/I"Z9HL>O;W,*Q#:D$D*J%CP* M9Z<-B@O=-J,?9;I:TY/PCML.1+AVG=62HE/@J=GDTR?--AU3+9&W"5S[RDP& M_&/JL$8A*=)V-0I)M$T%)JK4.<)`"GNV$ML4$9@?$1@:ZT(AX9&-;X5,F.`B M"AWU$'D=3\%:&(H!X_C"%SF5"8DM]/V#O`V7'@9:W'BV&;L-6K"UD7P%N>[= MDF3%^WO+"Z?!+'0BO2!3\?B#:0P4BA#]%D8&%'^&0"[,QY@2%],(ELQ$::^> ME?<2`<:CHR(%*R9X7*8TA!VK0A6!^3X/Y3\M9Q[@7?C.8$!RI`/95!"$*> M/"V6NNEPQ"0S2F!#WP>L[0?H(JA,9$OSI%_!%/5Y*!G0P,Q$D[0-R_;QOD8D ML\D/(D'.EBU9M\4O`K#AS#`#<6&2"%1%CPQ]9Q,:/2LT15BG0=ES-#5!E[MN M.]H.(T\GD?O$*'[+-V[1503T8#A*_Z-;'$][WA^,6DJ)@0/T`\YB&Q9E4EV8 MU)/ZL-OJ32:9JXH/B(T*VXW-;F'J6%W+5LDHTMRC_1-(^YPNIAL=K$C[U!!8F0E,T)4* M^/#1I8,QH$('0K4D4T*^1[^/:8MK*)M+OPE`AC@B?*E@SALFLBSH'DHH4U2# M149F6%@$`'T7CHTW,#(EPV<._4;%!DB>TU]SSP'=:`%ZQ,V6;)I?,Q^E40C' M8BQ+K)FNM=J!)Y-JQ*(1#3(T!;27N,8W/X,P:LF#! ME`Z5#(SQ64(KW',T4&XPBU*HJ1AB9/MB9+I#8R[Y@6CD.197()=40B\T>-;J MM7-04*]A`+K1\T!/(M<;-QSTT\$T6,N3;AS1GX+AT4"&>=VF4Y_U6 M?S)"K0?OY/".BXH'.H;R'N6A+ZLX8#S9+0-$@7)H8!4(`M7!5&E,=5[;XM23 MVNPN8`XR]S#SK_H2?V%(O>'19>;1L2Y$)$OV"_"U7SWWNOTK&)B-`ZFAN;)M M4]%ICHC+(>)*>9'D90U5@(JI$;TI#!41<@60PT?4"!:I4;9OA@N`WA7%,:E8 M"1-I3BAX3+K"ZIJH;_@VCQ6X;B5C,&,84NYESA0TP& M.\\^/"A*/IHS5(2J7%>^8^!E1>NV2'KF&$%J>@!L^";4Q!RD1)%R&:HL"T%23 MAZY4TP]EPO(Q?A@6$MW^63*`##8E&\-X)P@JK$$MM>A]CF5BR==&%87$_:$1 MR&RX'726%%XDJSKYHPT!%Z&35*"]:LHX8")5F@3-)6_B[9= ME1&D3Y_4DM(4@5&8161W4R!*HJ3US,,L()2V6'+6EM$>("VY$=A\9C/K=9;E M^D)_B:_[-/R2^3PT.-:#9=05U&3*>^'[Z)9!-?F-]J+W4@3Q,/_&-BE"1$88 M:W.#JSIR'HY@J6L9E?X%;_?EVQA#N.+94U-IN1N2#* MTR;24:.`1&2PJ/#FBDE`?56*_]IG$'@E)D;K#:4H8 M;RHN`NI+TH4AX(;SEIGS)G/;0BX+[B.[23:3R<_-(PV-=[3WD8]&U.4!!N"& M=$LB-#FN&M1)ND]V8!"-_"*&VXIX3UI5CNZ"!*,57->*URN9_"VJP=-5-(AH M(ZD M!\<2A^0%-V[@-[YY%RB0LP&ZXL9BG0B$&D%ZT$1,&%YA8E2ZK?"85+X[VB27.JR+O4#OB\&3U:>1&"$(%2W9X(%4XD(W&<6D%I,H\)NA^[FYM!% M<"R?%-;4A+3$R'XQ:$A5HW(E*SC%$QH\7BD@]H#YA/P\6"*1#(SI0B`'65$C ME!JA5,9M*KI0.@\RKMG3!?'FD:Y\-Y:3"$N=C%K82OL%QJ=F)PGW7V+[:UME M.6ONG_$U:J MBSFV38.#2EZ"@IYM"PPH`<5"=N3:CLO-6B**`Y[!L`>N)+V,[=A9;TXZ*D75D+7;1]`D$O.N M^R4SO>@YZ1=XN[C9>2C:/54(#34X6-!_1"R$6H,H7X*`O:)K7"H"(OH]HUL& MCJD;B'1D^@3]I`MPSCJ6Y* MR3REN*@<1:'"3^'2,J0/&5E#LH/\%)"$+,.X,6RJK$>#4PZ'&54J%GE-Y%J* MIKRU00V>,BJ!@CHMEN>3-8)%>`]L_NJ_=(\BDH8V\"H;14;>*X&>J7@E>1)><-_87LBI&HIU'^YLYQ\IP:OLP!!<5F(5G,8=6I:)X5=A=K)HF M,!`=`XEKB0K2J]+SB(&CAIDX8BBZ221;8XI$Y'1UX#3"-V=+)EB+DG8D`9+G M+4[4AG$CYY\(.[[Q,$A0I933NO"L.60VT&R-PE8`5M3(D(K(D!1A)D+09#0^ M6<%"/-AQRB]P/AX*UBZ=Z(9J60LVL.7Y*AA`6&\XR+4']KYP-`C&CD++H:H" MTO!7(5Y`]BA8AMUA>]C-:5QK4AN<:^GR5Z441*E-D@JRL,"F=,@')ET)05KW MS/`=6T35O;!?QDN(6OAB!)-HHH=2<&%3+T":/Z.!78PL3,P0J)*)%N9<9&N\ ML+=/DQXFM7O1D.DB:(EE)"+N.B#N98D)P??WW>76OHA="R>,1#PQ?57T([J" MB>./6PA(7/)6.':PW@2*O$1'X_JRE\(PDT8*E%D*)(J>HB=.NS)^LF)Z.6%(=C4]%0T`]4.='(:$LF3X(\C4+M M8=#H=;JH<*.J8DHOBBPPZ2''5U`6P]",RH:A?&:+I>=CJT'+GL'0XHU?@%"3TKU:13]%LF?HYH5M@20V>"X(CL@ MKB)/P;&T*[C!HNDR[1J.DN\GB9:8@"]VZT3=*ND,1!>]X:M01\TG=$DMQ-]LI7I%07?X:C*;XP1&@C'VO0T,248 M_!G:%KIUJ1\$R-4IZAYD"%I>"+`94]!'-[(Z/\FHCBP M(04A'$,8YS:[H>"Q<#:S31N^=RC-8V8'E&.Z!I\WQ9I#=*L1V\7R!*8R1?_V M*E_DHT*@U(GWL,_O;6X"3D$K;+2"2K.KM%;0UZ(CK[_1\"`T:D%Q-JQ1"\I+ M9Q=N0IX-2)SUTL(9:Y>)*TS,#\.R91S%&U4,PM+,*MQ,6(I7G_^O_>'+50N# MX#M"?XAJ,5/-,NWYL-LESP(F.9*$$DU"\=+8O2)NH M,!:BE1)U'$T#+VJN^=0B7B8Q9@(C5($(!_#:\[,A_2WR!"G#U!2+Z.EB$7>; M-S6?G(/FTUL]\2DWMMY%GDNM*AC/6M&@H[WU?)_J?6_9`5ET2LS9U<VH4,8Z6H$V4`UJK2DQY)>.(([]*5CW4/HX MD73,K%YX_X$42C6$T=*I()8]E@F*NN^<^RS'X_29!,QN+B(]$3)%^15B3J$2BL7'?V(;J), M\$TL=$B]B0<3-5BRUI">12`6A(:L0JR2@=>&E_GERF"$84BZ M"D,ZJ)F=&'$\;)WU>_+O46MT-HA&$TWR]AVN4UO5I3"*RC[Z9:-I%EW3/"=% M2W7`LL6=$K$*NF"/TEA>UW8'"[-?!QMTP@$D-PK'%UA^)0;?O3MR>?IP=)9_ M>C=/>=XF9"!EBK+:;V-'%6/)`9WJK\31:!O6?T(>J/FR\;0#N\\TDSF.G/OO MS[KB\Q)=8.)SA#)?X8LN!TW#44=BZ@6!MX`E@Z9V[8,,M=KJ[)LF8[-9["$) M+#6(PF#_;!)A4([GL%D@7B'!]B*ZMTS;:FO*&/J"*<'X)6UU8.7/.:"OO^TCP8G7A:EQ=G:V.K35YXY/LJD&Y,N M?D']AN/(1<(XNK@:QV9-Q&#:L3E(.3:31R-AB.?AXC2X8$*,Z>;OB MZ*G]`K'(O66(ZUDK=J,\I]&$!T^5S]B(V8KGVM>A923#ED0L$4[6[?2Z&'"4 M6D4<)_KB+%I,=G#82^%DF($5WR9?EO(`*3>-](;!%+/0<40(F'*&M5*NN7") M'_78@;<98[LVN8`K&B`%U3`!!0P[IB1K.PCE@#85+/%\WI'16>J>63IAE`-A M\T(Z[2X3R.EH'[!PH)@-%K`>^F6C\P%FEYU/L#5Q[*Z.BKO`BY._1%T%US>`^L$KB`KRV$I0P/KTCFK;>:C+_SUDCUC)@#AA%0K>)HW1A-[8J^9M%B924\M:]Q!!OIBS3US/8Y M:KNSD!O"]QG_AO7[;-->"N\6'5<*2(QNL=>I37;G2:UW2#YL=6X%G\E8T0*+ M$LZ,&P^QX*K*.E0X4N#6C9+^UVLQ9CI:EQ%*Q;9Q3W,\O(SG(G(OL4G"Y9=$ M>D<[C^@,'7$"K`TOV;`EBF,J<"BD@IR(B$)Q-W%#MR^NN@Q@?Z(30!X=^9VM M"@5-5V)MT7BJI=K4`U9"`*';V=)(F!BFVI9U6+'RA6\#,''9SD14!9P9;H.L ME4YVGDTMY"95""7GO.A+A+F"B8#VM5T2CN%KF%N$0JC#%*<,&)'&U^N^(?8' M3YIS%I6@Z.EOUB809BDQFHC8UNX7-DN)`[4GL43AM\0X5$D.VQ?7!8`LNB;) MNBC86DY)O#SO>S9UP?Q54F4JTG1-ZWQV;@U''6CG%@,SHE: M5D7D(PN#*#H4,G,@Q91P65,0K:%9R(Q\9R.O!4DR'G%_1:NJ<'5$8#;%1 M[2NFVMLY=\A)]BNN/=<9^YIF\\]0*D[GX36P9''?E!6?N)8L09J.-.P%*Z8: M;W23F.0KJ.=N2[N@N4=Z+_\N._4T*JQK>F\KXJ-K201*N>VWNJ.UN_*D-B9; MS9''?A^1`P(U-%4D)ZRE+V(0THO*S![8VT^6BA&,?KZ8)8L4?A4U%*F0/F6( M4&W52ZEE-RZW2G.$M,MMN.ERTYI*NXU$+N\V%9W^KM8T8[#MC*ECBAP5D7ER: M%B026RP=;\5PYT6OG@3G98?D0I/L@D.VOHKZP_R.YM_JMX7"; M/XWZ)1`>TH^1Z1#%^5!Q2(H"`Q3'BQ`,[F*YO6M#AC(084QJ*C:9-#)K$`#3 MN]W(,94;^Y4&0UAZED'V&:TU=T%J=I$+@C8[.1(8:!J@-435A)Q5/*JP904* M@DWZF`JLH^)9>P3LI6]Y-^Q83+3G@\G+7UP)@+]]#,=/NAK482&*-9J^,H_K\-3,L+O^0A8ZK`[ M3(<:"A-I=Y1@7W1;WS-$L=_*`HZJNY-EY6V(ATR@4^ZV87_2FO1&D5&W@4XC MKB-/CBX=P#V;9+8>Q()DPKV7-_6<.:)G.R7R,3\A'%^AD8B-R3'HDS,'3J0G M1,8MK4&*US5_.LN*T;S&S-HDT><20%U?OWK[5Y./PX5]O27Z#N0<[AF9. MB_`94!470*J$\(VLX_L>F)(KZH="LUNY,G69&OR`*7 M-_%)XRDRM.D<;AMCB]FY]I*:E#88=SJ%`?3.^K((W.8TJDG/SI8Q"2))01]= M"1+Z4S/'S5P2P`K*(>=#=,&W5KL@F1/O4V)=JDXNIN!8>"4>D*U*Q6GC,!/A MG:8P>;DRKDC/I22R<&N''!%/3Z66Y)%NJR.=ZDV#S#&JP&"[ZXPM44LNK8I+ M=+]NI'-AI7.^"I6*V#]R^/UA^WQ8L/XQPN\E!G8%X">?C6+'UT]E?K1XYIOJ M4$X]QSKX1&_L]P:)9)[E@[:C:O"D2->D7'8\)!Z>$??OSWH$[QLO)D9*M+9```W>& M500S@T"4DB`@5QER4W0CK/^FU!O"S=IO$E#N.;:U2721]S%&IG)#;D%J]J9H MY*#'1KLK5_ MV0/.89G@/)Q"2P7>$2A4'X]+"_&!%%J%K=VDT'OK)71EL4TO+2VR(C5$IC+3 M[71\J;M3.2P^X(>JN\6'Z#XLK90P)FL9Z;VJ0;>?;E$6T"I^%&M&;@@-#E0V M>-9V2.\.VWIW3!N%X\0%RZJS:R=5@+8Z9@J"KJ=/[HJPK]GQ9A4X(17G5`TW M+@4\M/A^9]1?VZ4ZLN+R@59Q^FIX2"G@$>5Z.Z-QN]\9#&K+/AI7UFY7UEKH M?`6.1\794\U8<$=L['(P:\:H!7=S.I!5(==JZ06U$'V,8GW*68CU=>( M]HT^BEL1-"E814O!%KU##R8C\/1!6P4K]S M4#&(GSZYP]G_0Y4&.9=U%#ZHLHFIBC3FSKO4PJ.G?@>B@3@'8G7HV]&ICSD^ MELA6!5FNF+^H"T[J=0K6V>!Y9/)\@NVW76Z;"0;X.U:-J21:DNK](^0`WG=) MA1SY*)EZ#68*N/YFY,+MYH-DK(X'9Z5*J]D'IQ>)#BA&H/W3<$/L`Z;O+`51 MSES`HY%)9^[@/PB`1"3J'E9IW!4\[S0.!D3[.Y00^%QPPJ*2O, M3<#NG0G_(ATXH%DAM1[?86"4&2GW,;W+"?&Q^'\%<+#+[51DL]#D+#][?R M_5+GIU0XR__H@JP6E5D.PRO]3Y:_/M158&*C4,?!-E4^]I6R_6K[#39P52-) ME?PJ.,?VZ[V'F#7C.K.$P#:W MFEGD/LC'Y5J\9-0C2-NC>U8E$5)Q-6#06"5'MDH&N3:)Y853A]W/*.FU!L-A M2Y]L"[HJVPXTI[%X/"FZ62W^.:BF:;*!@NV&2;_J@KEA"(V2LM^][+AS5IV* MAQ MX4B-#GBX8V#4:('U(8H&\FV.@5'C&*@XY(U0J(]C(#=J0"K60MENBO%7I.*W MTQ1C+^C6?/1\JK'O`HR:X5KP`5N4+N#M.=<8K-[*FU^+811Q:Q+QW"QIO5SO3]I=?4NK>#Y8-@:#OLMS>`T MHH'A]8$'#TVZK?%(%P_UX.]NEVXZ[P!!OZ-]2_0-$$OCFK'P0EHB3!&@V'K5YW?,A[_9=X#!RF]89ZJS?L1CB[83Q1E2"8&X&VA-/O63#1 M:-0:#\?KCQXT:T>[FC.?:;?X+QDR'0V8F>=P"#):"J@^X5&-2Y/%@Q^RX([V MQ4N/PV0MZ,-6AA!EC%YC1E48MK3&-SM#V\U4!.JY3467)]C<1>`!Z,Z0E:MG MANUK-UB@.-$Q<;WBRMZD>PMRX7FWHT^0$VH[;*4"]WD%Z.4@F*!^B4V!C*"V`*X!2@+;:&9T/0 M#[EGV@;RD%L[F-/K/EOZ-@*'G*8W3.D=QJU!(P*+,)`I+&!R$WX(G0#V[Y47 M!MRV0#,!'9`S![#I:38<$>\6U$J-+9:.MV)LK2D5*20\-.=JG<2>HL4?HI,T MVD=ACG+#<,JI?5RXVGMF"K)"A@)DU15LY:T'M(^T^QZL&#/P?&`'RZ7OW:": M`O0*8]O4UUFTDR/=1#`,9!J2/%`@+L9LVEF,0`LR8!YSFH@4ED`P`N*(6`01P$K59DU[0@9)<;>S%GCJ5- M5QF;,`-*TLZ!X3NR)KB..$I^,>QHYT)PX)K`+I^,)A)IREX&R%)#M,B)H.OC M5O]LK)[UJ?>*YB43;.`IU"ZY.6=6Z`BY@F.NCSAL&'L!^$/#V$O.V#\;P/JT MOJY<2^<68U/MFS$U2.5RC060X+NYS6;:!3!,@[C*Q6QFF\A/R2\8:Y=*%9S; M"]`2NZ0F2E('/I%@08K/$B<"[LM#%`Q`Z7D,L-?MCK4/?X9VL-(^N=C+QP;V M=^D8;L2E;<=1C((!=W1F&C/@>T\PQ)GMPT^X8`Y:)#(9UX4A?$["07!>6GXG MS9Z%OW53)[:EXBN=FV0@G_5:PZ[PMM)JIHQ4UFL73JDE)%"2-TOY(R$A]-;H';G5A=-P7M_\,8='Z2"'W6\"6 M<^9J;WWOUDT<>$,TS#5,&DP<_X^V:[BP4&>OX_]@IQ^&%ANCIV:48MA>`#B( M7&<5+=>/.IX-4J_`_\5;F]#X)+;NL7F3>^]=(T0**T2:K2GLUARC)_C3)[FL MB^B&&V^PYZ>-,6_#Z=#$L0#72"XF'/,JB\-/@XEMU:2H`C43W%/[[& M'%TT/B=@IUGBO!*-3Z/X-W'$*]?V-BF?9*/;DY#_>N/'+R&9"-XLC*:T<&U"Y`]70S4GI1K4A5UW(L\GG(]XT_"ZN&(+L1_Y!-RKOP0"O M*VD]2!M879^4JG.=8,Z>VY9NH.3Q.2A%N90-#*O>GW$CS+_R+5MSLI?D=6*S MP27O+EEQ\'+VLX(-4W/HM-<9;\NOJM*F-H57[X*UOV*0??TR0/I"M6HQ+8[H3WAF'R7 MD5A9A>-S%%]L&0`]:+>K"[JL4W&JZ]L7>G_>F0.OC*I9S+8.K++B,"8LQ/ZXV^J.>U6#L**[6#V(ZNB4 MZ4^J!MWA+ID:E\4K<\Q[C;:I#+DIJL7_>U5R-O7AK%\_=[FIN/QT&<7LV22W%/OF;P9>WK_\P?((U^@4+J2">O[+9WY^] M$W]_GWS^\+VK?_^GX7Y'\*ZZW>_BGZN+[_WN=UA]^OMGOS1'OU!'/PK#_^(% M3!MI4;J5_D931R`_(+]&&UF8;6M$39GI[2J1HST'(2!KN=Q*4D-7!P@"VX_* MM]B-8GC"8+.6%\#71:=WI=6ZOFX`Y:#-^"XVJE M8;3L&QO.H260G)K&`&`68L<0(O&*T#JH]BLS?,R'Y]HU<['&!988PR(XGJAX M057.0(%PO2">#M23*8QLP2[@?%C]#!-M([5"%BM"Z-3*N*K.X\*$LL!1+KAQ MWJXJ_-A6A1]C<*16)$XJIOO+8A=Q94C3<,S0D4#@VJ(=D84BZYR^6W3&U23O MGB9Y-W$JDVT#[M\KHO#9-`V\&_E>FSC8R')$"_&SL!`_H(582;34[1C4#=[F MV-_[&!QV3]P(H(82]Z'$$P1Y[$'=D9,S1O8>M_QI:$JR!;4\9'6#M^!$M2V0 MO1Y$U23J'W:2MW7L^[#A]"+G8>42H8_&URH#_K%:NY:T$$`^1C*Z.SY]$B-E MG_SC.AR.OU0N#_OH/*+TX!^=1U1%I-ZY`VR=CL8FAVC"X^^OJ,EBW[YM,NW& MPPLYQPY650BD/*[M65*(C\5R*X"#K4P6H<6)R@:O*#?5%ZXQ?#.*S*KL/MY5 MBRPSZ+4EVH9Q59EQ3?KMR;AA7:=2;ZM1:^-NZ/R:'>18T?-56][8R(] M<]9OP[^&C8QHU-M*0=RPKQJPKXX^2*10]3JC;L/'&E?NR5RYZ[DM93Y?3Y\T MXJ(1%_GBHOS"8=#1V^/..-ZV%3-\W@B(>ASF^D&\SZY7&G(9`5I^SI6((1VV M)YU^P\+V.LQ-G9ZR)[VO6#,S`6\JS MJ+[QQ;#)\WG4="0U#VI'6_3@W)Z]LB>O]I4M#!OKGZ2+3U5A5P@M]#^)SUQ# MH7HGLLZPEX<:USL!:Q]^,M^T.=,N,5:X,CM2Y]-89]B+2XE)ZFM'Y!<+0RRW MZ1MF$!J.=L7\166VI#F.13R.ZX+A_/K:9]=86NX3G$/;Y;8I>L%79B^RS^%# MII0_?;)74OEX<%;VO*\-K%Z$`0\,4?[1"+1_&FYH^"M-KV9'^":1O$DD/TJ< MU%EK=*:W>J.SYHC4D&9J#OX>YZ&"/>WOR"E`I]&;C/)[55\X196\K$-XRGD> M")SL:38WZ*'PF$$F986Y"9F],^'_L7;QJUFACP9'15H)-@%G39CA`0J!WAJ/ M>JUN=UNAF0H@H=8'H7X0W],HJ`#H6ZF^TQM6&_HCD?O)*F*7?>03ZO`/JK67 M0%&O7AV'O%N^O91V]G-I^]56VN]U^U1>V(MW"UH[I;%X6[!5C7FAMWJ#;JN_ MU:=YOSUX^J0H3&"/,_FR0D>QSISPS@>@?MC8;N8,*^?5./&IR#$>CDJ'%9QC MN]7P$+-F&$8E!+:YU<@B]T$^+M<"IE(]XBMK&FW!1R4%X+&U\D&N3FYYX=1A MC5U4^!W8?J3JA`.[B@!FJO:@QF,S`NG(BR-_Z&B M#+=PUF_M-+S"[<".OJ;ZN*7W)ZU>1>]?&I.COLRPT3[OX8&H7-1IPPX:=K"? M!V+0>"`J#7DC`QH/Q'$]$$V5Z(3=4;!ZM$Y3*KB@6X.UH6]E`37-D/739H;M M:S=8IRK9(D>S.0_C5`(L%.T"9K0%S#3G&@-(K;1+2T.?EF:X%O[1AX&X]KS3 M&](WSSL#O:7YC&-#'ON&.:M.@M*CO]X?-EE+PPS-LS%F:,8+OV$7.18=[8NW\>5!4W1J3"B%(8LUNNT,;3=3 M$-5SFXK.SS[N3VXQ9TKSH5:R!C[\8J+CS]),^(*YW`ALSX4//*!R^<\'KN=PN# M:6RQ=+P58R_72O)G\DCBX6J^.3!QF"I@+EE0U.@,.)?V7._TNL"59&':)1:F M%1P->:$V@R.90AHL.)AC2V"RP\3O5`%"LXR`-9RJ``>^X50UX53]')8$.@9P M)&SAX06``="3GH]0O^EK!N>>:1NHX]S:P9Q>]QD2/3X%/&70Z[=T4(2\1$1T MQ$,,^,O:GVG=SCU@<]H:Z]J'0MZ\-8_GZ/1SC&P/9/3]WK8^@[E)5UNA9A!:W]RN; M_?W9._'W]\GG#]^[^O=_&NYWG/*JV_TN_KFZ^-[O?H=%I;]_]DM#<86B.-R. M*?[QQ0N8=J;]->XWJ\4G0OO5-J:V8P+<,C7`[)8K$S!P&-D.?Z!R#<>A9]3ZL$U^8A4'HHYKL@[1S0*C: M,QO])%RS8G[AQ/Q"*-3XM,_(?V+AR,P`$0?2U_,#%+.D/VN@M/.$VFZ[IA." M3'VAO\RR'?3)9*)]#K2O;UO:K[^^P_6!B/I/Z)IDCI",]T+0]IG!45A:L%!3 MF"KPST M#&U<@SU!^TAO?@M='[?LH^T:+B@KCO8/WPN7+>V3:W9P39]A$WMZ>LFXGYH) MSS/'$2O_9PCJ@3Y)F'0O^O=;^I*V%LZ2`X2"Z^5B'F>E]:/EG(?7(=A-(_&9 MYOUL^+!"^9E-\G*((U2_%D?=OKXGUYWI)^-SJ@R<".NJB*NKA+R8@X, M7[+SV$8*I.A!=HZV#C$:#8C5L?^K7-9O,:BL_9(Z M-H[#;3A!A@\?+&!>_JH%NX7"T5@N'1@,PU(3\R($L.\+9*1Z)H01\&Z-'(X><3M`:G!DH%@-%*A'#1X#6K/3J+?L&S'!8"J$O M-29(BW`ACANN5;PB](%@3BJ)C_UQN';-7#PA:&ZC\)'G!045:C&HB473@1H" M*I5A`7YQ/G0.8$_1R$Y?&BL2[@"*6EFD2+GHBA0B2\`6]R-59[NMSG:\=B[$ MO:`I(<1)*XNOI^!\F:$C5YSRNZIJM0@^#Z<<5HV+$WH9O?"ZX<,EX,/YF]3T M,CU.+].JM8FJ&CR947(;#4'12?I9.$D_H).T]&!7;1NK!L^AQS(-^M377E%& M5"W.ZF&I5.SL/0R*J MAF=#)`DBZ=>52$Z;Y:VV2I^4JY_81O"Z3.]>]\R0[VK+T2EE6[FJ=\W+WMR# M`"Y9(\W-?)2=V2=5VMJ_[`%GJ7K\W:L/6_'!.PJ%EE?@'$BA5=C:30IM:M_N M5D-X@+&,%-*2N(6K0$IA!7-E[\'22@EC@HDA-#A0V>`1M5L&O;8^$+4B\>TH M6+1">[6?IE06T"I.6`WS*`4\M/A)MZV?]6K+.YH*@EO0]34[3*H"YZ/BS*EA MP*6`1VAOG1&H;V>-^E8>T"I.60WW*`4\HD)?=]S6.P-]%_=X^J1LX#5NN/LC MZT->''@%R+GB#*H.3#A9;['47+C7F;0'G6&\4W'ER.IK=)4ZG]6#J`Z[5DVN MTND/@:N,DW5H:\U-&E]==#2^A%1[IM'HB@U1[7AOPJS6!ZU)KX=5,*L&9$4W MLGH0U6'7\L@/"\U2D=BJP?@PJD(%?$*BQ%]F'>4*G(F*4W)\RBO1@R"'20V' MHU;WK%$0R@%C]2"J(67Q4Q]:HW1'8IR^#:7 M-2]%X2:L3@EX#IBJ$94L-<6Q;E?H^LP0A9ZNL5"H+&65N3A9+BN["F='.ZRV M]BV+BTZGU^%XG-]]'8FRW#U]W)J,QK+VU;[OBT*B[075.1.U1*D`&&`77F1@ M4*T2=44!G[8G"EY%I=FBNJAK]<7*2>)'(?#"D/,^]2&;"F7%Y\BX'=/(W*=" M\MIG0;+(ZVCGFAKB!=FQIBAKV4G-QC]^5T4%=]UE&%!;JO@=JJ<+WT@%.:%8HZ)M\\2@ M2]"-L=;_?U$MCX>SW:C/U=3W#-#X0:MVR"(1%6K!F/@5O])T]0HJY7^&'IHU MLEG`B]`UK/^$V%'P)=59ID9BB,(?+!!E:;$:#%U^8'5;_-+STQ:+F*27/PF. MHLHWRS$0S4ES87-JG%GB#:O^XJC>%(CBADJG*@N/ADNN:-72F`V_X#Z`910X M*S%2]`DPYH77+.:=@P/83/!#G3P`I]@Q>X<`L:&"L:.VMET!>Q)37 MF'4%X):-AEEF,9>N32Y*3%/W#DL*CB2S,`W?MX5?9I,@B;(-]"R%/O6P!7*W M2;(`_]MTH;VN\:$HS!&X`^TV5<@?I9YM\D0?I2QF;_/#'?<!\AC1S3ALE(&_Q6W/X'4S\'S8/7P"QU81V_"8C-96P>[7\!.L*0I\3ZQ]XCPD7@<&3<(5DI4?3V;0#CY8%FS4 MIJ)I=6%,,+I^J]OKMH:]IK1I?;NC;.)MF^7UA07)6HLOL.CCRZCDXBY&6(5C M=E^S]`2V784UD`9O&5>>"0[^(JK?>D>[O&30)T[-9M!ZHZYF\*>!XDX?7"MI MH^?5-*DBCQZU+:9_@VV[A!XDW5`RPGV?<)O_O8JY.UK MPUB^CI-+^+EK8?4,RJF_@HG>.I[YXY>G3_ZFGOW";L]-$]@V%M"^]#T7_C1% M?0UX]YVX>?SD)I^Q01-=.HQ'XVDF``P?OK+9WY^]$W]_GWS^\+VK?_^GX7Y' M1GC5[7X7_UQ=?.]WOP.K3'__[)>:73,6^-XZ7=3YBQ%FM/,RZ.:[9%A=F0K?6!,[:FY%M1,+S+DX$U:^W9*G,S-$4, MO2'^=X>)\\G5SL-K&([T_A9%ZGR,W#8)IODM,%S+\"VNO?7@_[07SSZ>?WO[ M[*5F[F6?ZPND]OZ,.;!K?1#5%SZTF<<`!0! M?6"OQ.O[IOJ2<*VM_/BY7J/GLS]#V*131-:ZC M%B=+T$%MD^(-EZ24,,`JEJH5S4$T)@(,&6"24;E=_!>CDJ]Q^5Q290/-F'JA M:O\1V,'J?[@FJ]#B2*B#V&Y(IIBA71,(I@`!IV]I]DSC7DO5568B+`HC(CO: MYWC-M[;C:(;#/6W*8J"2*T58HD'4LFU`W!),09C;<=B-C0_2!+3T#'P!A&PV M8Z)8,98+-EPW!%!%"Q/JU8(0&+,@&4'P'D0PV9?ZD.S+D0CEM#'0P5Y$+\M8 MSK4AI]'-\JY1.]H'PW=6FF%Y5#L85[O$FKW``ZR.]@<#L("V`HW]7`((HH2R M>E8&K<%!1;3-#8#/2!7PM6'_X25/=,2!/2+_$<6JQG[.J%$.[S3\L(S\<*>J MT>Q?H?2(6B^LAN&O'@&FXF"!)!E!H(O:>]@ MB=Z"^3Q+LK1P">9`M/AS$+6*?@1?,E^VIR$HR_GP,95P%R(]UR'P$C0 M'P&;`@_B)[$DP6QIV*F4@8[H+,9^RM9'AJ'FFP$WV0Z@2&+!#G"T-'\5] M]DH([;%2$?5^V()0#,?.'@RD*8IQ>(+#9XYY&T(!V#RHU`D!.[I)G`?S+4C> MKIF$>!L9DV@Z'.TL2U=`U2"A+R1ICQ![*YHYR`X+SZ@O`G`XW^-+,>^S:+@6 M1JU'>Y5*#F M8[P\:HRRZ5PT812FGZ7+1$0H7DX38730!,DM@+1@8.(5BFB80S33Z$2EE*F- M3E3N_0.=Z)\A,.D36OA?O$Y\2H11W\M0L+#?"W.YD`IM&`;=\,DOUXX:O43> M`TT.^NQE!Y6XC2EL:@DD6H4"NP.NYCD@""Q@EZ"+D5"1:X<-,`(RFJG=S1SY MFFCH8MP22,`(8RT&!1Q77)H>4%TEE.J5E'D!;":3>I(A58`;)L0Y+,"Q2(,P MYS:(.TO8LS0PR3;@GTSI/9(]KPFA7=;W%J-:J%=W-:V'\4\X!VHU"(B4,M\+0%CBX4!2Y)CZV6>**'$&G'^]OD\;73,:Z2 M\&K*X,O;U^\9-WV;X+F8O<5D5\;Y)2S*7#7W3M6^HU`NS<01P".M#D'6-5.3 MHUB\6XS:)2*7D-;.?3"1#>W2NV5^2_ODFAWM!8J"O\8=#M_X/=,]_#`/L/_?!9?[U2OOF M.2'9['(!0O:"(G0C)"<,-Y8IT!;YV5UC0>;W'X#=*_C;!\DE5D+V=NRXTEM) MN98Y1@8"R"#&GZ5/98&N(E![0@356:7=-M0RD9'DEZI-5B>^F6>&J"2L/->B MAZ*E2RHY&X#FZ9/?`6LWN(&_$HT90:+*3'A-(XP'`>RU<%4M!08' ME=?'KHHUIKW"4%K#(LO,(I,:-[J#-`N++7A+Y!=H(EP#6_!\X8;C(2GR/O(" MX?EM6PP5;I9!I7S%09M6Q5BB=]%!2:_XDA,"LAQ'C`E*N>%'+$"\GS`7X[^N M]99R!R1KM_2KO$5(ZHY\TJV6[WV;;R0=5&!_P\8"5&[4'3` MK^%M:N"9BSF>7*E`&AA,2^!S`?HC.6Q=`-S:M>%)LD^9.7>!?JY7RM_N`#-E M7,$!7Z'!!-LNR$:8NU9H2C>;;YMXMVQZ7+:P==`H56^'0&-)Y"?/";EZ!01$ MC([#DYO)T:H63FQLJ@H_F-X"A($PLFB/+W^/]S=A:NUM&B5#_-YB08^+6<+N MHF<;8ZH&W"LRIN@0(`^Y],6%!?J(&DNJ0/O5J`EE)C1D_^@;)0&`TB=T#1". M*&N!L<+:>8XK3?CEZ%)O2:0I;I#6+^\2?M?HVII+^8IWN?`[)I]$MT^_N30W MV5]$]^<@8&S3T%XD;#N\&D\9=M2H7?H]DSF'Y)GY M$1Z#(]3^5Z92ZB6N\Y)11%-9T19?YM$K$-)RSR!.; M@5IU)2?LPAK33F$HI6%Q969QGP1G\9:V*UVRL373(N(U++QK$VSM!46TB!L; MNCN'Y\70*F)!UIM+O/02=A`L"X[J/-W*B#)UR[6P57'1P\$L(0I$3^\$V_.9&,78CJ*DQ%KF$FS)IC[C+7!`D%^#3"Z>!C$QT189[(V5)0G M2$$!R`L5`N!8HQ_'-D4"^!K4,@2([GUP[;``3\2AKEU:R951A,7,YB:`MV*& MGV(>R[%4E4/XOPG$" M"(G,Z(JM+R)2^IF74_L90='UTV>*O=A\_A3FDF7?9`8""%;U2A+-3A:78K3K MW/*^M?\RN$HF+]I5QR]EDP@DDW(2H7EG$M%C8$:$"CP(;O:)$*GJP=C0H>^A M+U/49Z86FO#X`VILXD*<+@6FGO>#RUP%&EE\G;D*+Q(K/JJ?4V5>QWKZ6HS6 M*TGFTHFSD\$D/3B_<78Q^R`K.O.&]=R?]0!&<;@6CKB,LD]YTKD/"MK"^,&B,NQ2#>(\7"REN1R'-DG5;NGYJ,R)$''! M3#B5A<974U7AXPPDO$?%RP9*?KK&F?/>$;-8\CIVJ[:6MQP96RP+S/_$6#/X M8(6^"EX5+\FP;(RZRG8#!,@QE2HKHKDL&S#AB_L&$6$582Z7CV9SQR3??&?P M.88>P?]]@#VZ,1R$L='DCLY.$<-T*NB/!*X;OEI?O@K&VTZWG+8,_260.U\+ MU9#9,)1.B=:GCU/YBY8VMZ_G8!H[-IPQ5/PP*%1P+F+(GF\#QW;!`[R46E8D&GS,%06%R*2L``!NUQ MF1\!3R3C/DT8$!X$3?B'2)<5S)A$#CP*AZ:=#,:5"3KI(G1V(*)VMJ4B5/5D MYY'UIFS:2P(E1186V;"I`74CIXXOIZ2UQ;48S8V$.JV$RLS$*/)ABJ4(PP_X9EJ_TY%?)(9F[X<(4ZL`,)%(?ZO+O30,CGJ4G. M^PET"3?P_!,&QM26[T:X;;AM?>V!Z!!H\FH0LW3!:*>[+JP5`]R)RSC**;HQ M%E,']7>D_>QX140"A.L% M&``;8HT:X6-)W'2B\4+?4>49W[-"61K`H'A#V08*H,M=MQUM1U[Q4K5/C.YH M?.,6K2HX=(:CQ"`Y?CSM>7\P:BE>#D?F!QRN-BP*KS+7GM2'W59O,LE<57Q` M;)1;-S:[A:ECJ94MF43Z'AE.7!P?;PJG`F-#8A"/*9E<3PU'`BBZLMXIA_(D M3'3K^-'^R:QS"-SDY$'5E#C@58X!UTV'@J<=FA MWRA$742;XU]SS[$P3=?';*A"V2%<<-A,M5: M%D4ATPY')#'"38:SD42:B>H;D:&W$0DD?Y`E06C7;^@ZR/C!J$"`ES2NW_%G%6N_C)PFQ6$^9: M9BI+$)?4$:09I"Q#%##<0U6`)6+AI/6.GR(%)$/CF$6W_V)B=0>52"18@@;Q4P8MH''IL&M#O-K!>,PX MTC6*<547:SG!K>C,\PV+H34M`0@\7#H(SN==&N5YO]6?C%#64[$349Z.5")I M-^:A+RN1.I[LEFK)+E!_P$)@`*J#4;88);NVQ:DGTP&]^X(YR-S#S+\RXE-W MBO24_*>%HJYRX;^W^=(#)>9B]JOG7M,+I[8@&V95&&85JP31D4`"QZ/0IK/0 M*`B-@E"R;2HZS1%Q.41<*2>"]%=2#EU,C6A,,Y3(9`F2O2\*BXB`0MLWPP46 MZA(9]93P(2NB4>U7P_#!@#O3Z9DJAK^IW42X] M#BT4,3!SY@@E(D3S'TS=!3-$U,ETI6KB^C:/-9EMRX(A9Z+`BTOM#3%2$1]B M,C1F1O4_H]P5L0)9*""N!DMCM1(U!E`5P4($J)A@]"/%TE!B7Y8G>:;Q$$-K MXOU1(471E+%>0`F'\8X%GD(IE53=0`@M3\`-GQ)U>C>1$D'"96"/J!I#64UT MJY!^*!.6C_'#L)#(`6[)JV1L%)F)872+@RYG4'%B>I^*WRYE97D9P.X:@8PA MW;&,N^E^PHD>^G0QBTHT?HI;9Q[=2U)?ISJ>SM_5 M48[+87Y:ZU/:^-IKZ6N_RN:+R*9:63$JB2^7QHIN,67^H(^54Z.@)VEW[[07\;-I[#O2&APS+QG6**:VC`(&R?N)?%&>]%[*6YZ9:UI MSU>A.'&G!EGDVE)>3!4N"F_WY=MX`QDUE9BB:]:.#`WU.*YJ1A?7&`DIC0"# M&KRB@'PQ>"E[A3AX1YEP.B=&)[Q)F;FB9+2\^]US$9$:?R''I1K5-AH"GD0G M"7;L'I+9-$2HV4)8J\M30$P$E$R)R$TBJ#[-%8;"&L987L;XD>(7.*,2O)0= M*FI4DCLC:LO3`KL[T2E&1)T(HL7P=)'"B145\2+)PR0J-IN1LBSJ-"1"UZ.( M%62NN+,'VZ,8G<2-%(9;4MD_6<9)-D&BI'>T=_LR<*/-6 M%(B2X9..,<6*FU$P8HNNO.98F43>CV$08!B@OR<:DVI&\2UI73*`$-F\#/&? MVHX31BZ)\L!M"R!.^()X((^(18NG=+)R*4>`?TP%&+'K3&.C>F3%" MGQR`&L:H/@DBTG$E@E=$6Q@6M>#S!.JC>C?7/I/8(P$IXELY30GC386KL*X$ M71CR;;AN>;EN,O@[Y+(N![*:9+&^_.!UTLQX1WL?>2=$CB<0OQN2#U5H<%S5 MO)4TGZQQ)6H#1\RV%;?_2JG(D:=8M9-#CFO%ZY4,_A;5W^DJ&D14IE4!!Q%K M0LB<%+\F/J:&%5$"<3,X6K2L]B18&2>57$4\PMHI5)Q1'Q4J'D#Z;RQM2%9P MXP9^XYLW!0(Y&Z`K3BS6B4"H$:3O2(1.X`4'ABS:"H])I;NC?:**+N$B="*I MI5SYJ1_P?3%XLIH#`B.$H/*M"_:K.H7A!0FJPS0J[';H;FZ.;&6G9)/"FIJ0 MEAC9+08-J>H^K&0V<#RAP>.5`F(/F$_(SH.E$>F$UG;O6^]AF^B"N&9I;PF/= M$GY-&J<)1).=UUP0UOB"\-QQ)$=*Z(.YOHR]TE2^YGM">#J:-[Y.S`CH3;ZY M)8`W1[E7=;0^>U,,.OU*^3%X52F>_Z:J4F`(=59;?'1U5>&Z&XL:@ZAL#_J!MZ-C<4K8&T(/2GH'[+7DF4N*]<(9B[ M"%9@0(W5#,S2`S:''@>IDHIF.C&_:T6IYC`->:!#0*4OH4-W#-FG8"NH+O%8 M#KNU[L-6MW4X?S8OQM!-&%`"BN4(R/\2UTZQQ!4C-A&B#K>2#(4%_4=G.1YB=^EP@]B1\%8?-7_R5GGXA[W<"KK!"ZWCHW6S!O ME;2IZI:)=L]?A?)$TJ`I'7!T^X7Z:[??$O-(==FNKN"MM2@]4#C&08N4<,`X+AW#S:IN?O[MG7:FCSO: M;S2>_"CX<=067EHW2<.*EM860G!IK.3M:L)A'N4.YC523]\E$%C"Q9T1TTZ@ M9TJD5/OZ)?)S+^24\B?7@7@,J;@G?$@B5$DQGP3\C-%]B2@7@_WII6R7/P$S MWBF`Z>8&E_L6Q-J/]C=SCDG_:OLP<`8Y^\*SF".JD,G8&W5A'LOL!`:B8R!Q M+5%!`B<]CQ@X*B&-(X:B9ERR6+1(,D@7OTDC?'.V9/*$J%9`'"MYWN(D#!@W M,EE%L-"-A]?[*EV$UH5GS2%]BF8K4N7/AN<]-,]+':1D=S+A$2!U5K`S.PZ7 M!DKEH6!%TE5AJ*+CH,Q:GJ_\ST(-PT&N/>QC0Q:#8$1<1OAQI<&K"T7L(P*, M<-@=MH?=O3J0J;0>4?6#N)AJ,[/!S?*!26?E2#6=&;[J!/O"?ADO(2K"CO=E MHOPO=?^TJ8HQS9]1>C=&%H;_"53)<#YS+F("7]C;ITD/D]J]:,AT9GIB&8G[ M76JP+=*=!)_:=Y=;^R)V[?(Z$DG$I%0"6N3HBB-=6@A(7'U'6&B8^\1XJB;] MKI*]^ZG5Z7HL:%I<&3\;U?L$I2,1MQH@M^G2T8B>#'7;%@(ASH2.MU&NA11Y6BPR]YR:;'*?UHJY"V MUF%+G61Y#;[;FY0GFI+BZX/AHSG#+YG_;0XX;!+6:A`L$@E8[(QHBHMYVPF1 M?'_%HWZ)MY1X&IKLM>+L7!.=55Z"$W3&)*]%:T3C\T1JE(R'HN98`E_(_/'Z MZ5IX>.:B(Z&PK52*`UX64)AIW(5K2^\M1>$9JQ`U,A;+4!2X3'J.XG#DQ&V7 M7(X(_*0>7G%@UARSX[P/)0?. MI1SX)M:;%!E9_EB1;;/GRI)3N\(6\7OU(2BN&*RD[+ MT`=CBZMHOUGH6JH("1KRV-6'3&VUDLPXXQU64RIX#IVTH<,N9I^CMG2BFM$5 M\Q?OV32XPH"$4UA<@>P$<5?_D"1A?3@ZR^<8]_((3?'&SV]CAKFQY,!RU%_' MCFC23#B+U[<&S: M2F*8)F.S66Q:!98:1&&P?S:),"C'<]@L$*]0I/Z+B.:N/O]?^\.7JQ9>!7=$ M<7ED4;)M'Y-7MR_I6`96_IRC',FWZYV<53[?^?)`7W_;1QXD7M=;7>"=9V=G M.X<9YJ\A%Y)7@1__29W=TF$U!])@-OT2I5,*KU9*=_[3Y=QDE])F$9OK&((TO^:TH*IEB#D>F],-4I\/XPC$H M76)@%ZTGG[62?#2EZ,FQ,XWTK228.;+2`Z>>8QVL1&ZPQ8W%9JJ/AVU7`Z\Z M)ABI@\5<-G&`YQ7.H/OW9SW"QQ?DXI\]JI;X`:LE5A(M=3L&=8.W.?;W/@92 M46D$4$.)1Z1$J2Z)4Z/,DBG&&J[_IA2]SA`7E_Y-@LW!EK7VH>[(41,C6WEL MMB`]#4U)MJ"6AZQN\!:9'"+@?090>_*-SB*H(U'MSB#HEF=)(3X6RZT`#K8R6806)SHEO$^?G`)B<0O>%ZXQ?#.^ ML*[J3MY5CRPSZ+4EVX9U%8!UG8QQ3?KMR;AA7:=2<+85]) M&QWOC`>4!%C1\U5;WMC(ARK+![USUF_#OX:-C&C4VTI!W+"O&K"OCCZ(TDKT M-[W.J-OPL<:9>S)G+A5,C2N\\HJ>K]HRRD98I')_2BT:!AV]/>Z,XVW#JCB\ M$0_U.,SU@WB?7:\TY#+^L_R<*Q%!.FQ/.OV&A>UUF%,*;IQ-*CYO3:S,2C@] M1M)HN=)1/RR6CK=B++&2)C7U45)3JQ:T7S5X,L7.EAPZA''J:Z_(EJQ$.EW5 M=K1J\!QZ0BN2Y?D(69R5.SE2KLD\*)4=53DP'RAS[+C)EVN;HI4#UY4[.PV) M/!*)[)%*64T2>7S!=9PWU[?ZH>J)IO>G4'T\+BW$!U)H%;:VB1VZBQI2 MV43/"EZ?WX.EE1+&9#U?O5Q=/DT-:9X"H2BJ)WAVV]6[U4 MP@=3@:J1*IB-KNJF`E:<3S6\N!3PT.+[G5%_;9?JR(C+!UK%Z:OA(:6`1[2L MZ8S&[7YG4+UJ-HTKZWBN+)7F)KM^5>!X5)P]U8P%=_1!>](Y&VMQ/D2%`*WH M9E8/HCKL6B6UH`ZRCTG5TZH./IWE2Z#"SJ+,Y31($T(*_4]B,S??NFJGL;Z0EX<.-QJM?U!- MR"\Q"J$%PM`5*M]PPQ"P]&P1W=%-J0YBL4[BNOB MX/SZVF?71L"T3W`&;9?;IH8F9K4%P7Z%CA+F_5'B5S*#G\>#LU)%/^]3-NHB M#'A@N/B<9@3:/PTW-/R5IF]D[%8A8>/.=;0J"OQ="ZEEHZ,>_?;.6J,SO=4; MG37'HV;44FO@]S@+SW=SB%KTVP/M1=^)BG+E49V<.230L>D#/Q81)H_?Z69Y M$%"R)]G>QH0B<"IDMZHWHW,U9V`=HW_AP4+0A_-B:T&1)EQ M&H]ZK6ZW6V44U/@0U`W>>RG]%0!\*[5W>L,J MPWX4,C^^`ESZ<4^FHS^@5EYP17R+)[^4A)EW+[>74LY^+FV_RDKY/6Z,R@MY M\6XM:Z86%F\#MBHK+_16;]!M];=X)LNV`W=FC2\KCH(ZD-^=-[]NN-ANP@PK MYJDXZ8G(,0Z.2'\5FV&[57#Z.3.,GI(!VMQ(K.-QD(_%M5"FJ,JZUN^V*FKV M;,%&!07=L77N0:[&;7GAU&&-S5-P_&^_C1FW>I->:Z*/*K,!681?SZ-(T#U] M4D,F>,[$-=:Q4_WJ+1Z6#W4 MXE=7_;!8.MZ*L<3LR4JK2W66E,>E2_\Y=(,W#LT]CV9>;=;,L^CYR[GA\M>: M$09>^ECQP/"SSI7X9J-(+$6ST*R)98.IY]U&HV?4>]U1U#6'SA:&?VV[R6.. M9W2)?\EZR36N<;MG;XDM+23BLWA@1?'"%[.J&CQ;,L3N4#[V8K^&&U7`2OW. M0?T@WK]@:XR7]=*ME45._8Y#/2&^8[742N.D7J=@GT*E,4;62Y96!RW[V<9W M:=.VERI]WR458:48NS6Z>M@=X4T4Y%R?EKP]Z-S*I#/AW=93G M(:0>M93U5G\\:NG=<7-$:D@S-0?_P.O57$Y1BYK*G9&^!RYJ6U1Y#X2<0LL] M56'E1P;GY,6&U<1Q<=@'++#\R%`W_>GO3/KR]FQ'G>4J(>4^QG@?A#?TR:H`.C;K0!]4FWH&W*O+<095+"&A$EG'']8 M#[NO*EKJ<1`:OK^5[R.T.%'9X,TZO#A`'!=?U>V\HR`[[05D*?%*_SNPI*ER M%)B&B^';S-(\?T51T(] M2/#.!Z!R2FX>$G:491_5!0]'DD['+6M>FSFV7^X]Q*S'*]&^:]JG3TX);G.K M><1B[=6U30XM*E%%R!N[I`S5S7JMP7#8TB?;PJ[*M@/-:6QXTE%*W508!=L- MDW[5Q7+##AIVL-^][+ASME'[K.JXJ-NL-ZZ! M*D->5^VK7*Z!LU[C&*CN66PX4J,#'NX8:8'V(HH%\FV-@5&C'P-,GS3EH MQ$+C&M@?![E1`U*U%NKV07Z`N!ZZ^%S(BNA?&:#7-@-FT;B_N7;`J7KY"\S8]9I4UM$ISN@C5RBE:NL$(% M+W3N(9E*"6."B0VZW:H42ZS!+E8/HCMH$:4$+4%RG5Z_:M`]C*90C8CGW=?& M";?DNXQ"30]T>)X^*;XOMG+[75W093S(J:YO7^C]<:LWJ41]E(-.3)5*(]6+ M(G9N;465H)/Q@$Z_?N3?>&8.O#*J9MI8'5AEQ6%,6(C]<;?5'?>J!F%%=[%Z M$-71*=.O1`>)^SEE3A1^?F#`>#(6'8.%*%;HD[L,X2W.6<#_%0+*[0#&OH'O M,9:;IFG"SLL:=A[30-5B\:H&3U9LX6;\+$RC?89AYUS[`"=\I\>R\&!7;1NK M!L^AQS([[+0>9_4PMT`MN783*'[:0/'(!1,C202V18\ M4&D2:7(B]K?X/_Q<,LI0`RO5!AO3TE8V<[8I-Z6,*6]R(FJ2$[%/H'45MO8O M50LHKV<2Q&$46EZ!Y0"'A'`VAVW]7"O,VD/.L-XI^)V#]7GR)4ZG]6#J`Z[5DVNTND/ M@:N,!UK#31I/W5IFLZI4WFAT18:H=KPW6DV-N=+`6#V(ZK!KN?4= M6_UNM]4?'MB5576#*S*437G:0RB:VB[<4-N%1ETH-D0U++\P'(Y:W;-&12@' MC-6#J(8DI[=Z_5YK=%;-FFD/4??D[L5)LMMMO@=8;NC%7VUCBA'2-N/G033- MR0J<1$T`E8.D2_\Y=!,V-O:>QR>O($KF>?'\Y=QP^6O-"`,O?2!X8/A!7AT6 MTN]HCL0B;VW+NXW&RBBILJ-N2L[)WZ]7(YZU1*O"IK3,HQ0I2)[CXY0G32QE M/=MWKU&V)?`^NQ?M_?=S"XZD7RBSG1?NM/9$.%)B?!? MH1.+7]D-NDP0SVC/0N]P[:4K4?)L]Y5X ME?:UN@>YXN#5GD[;A=K1IT\*0J.E4B0J#MY]:+02Q0GWH=$J[&AUCW#%P:L] MA>ZO[59A7P\/3,OJMG58O%AF6RT1LR:O_:T+]RLS0]^WW>NW!K=YTTRK3A%/ MA7>1-2[%C0>@'<,UF092(C3\ ME:;OC!TKI1>D]W6L-=DA=6WM,PFWK997E]8 MH(6NS^#Y_X+)\.+:L-V7FN-QKGGN3D98A6-V7[/T!+9=A360!F_;^/>+?JLW MZ+:ZP]X=K?*RP1Z?F!.`\6;/KA6TD(W."JN!Z5YE1\'I^$S@UPN M8WGAU&&E)[5MAG^#K3M<;F4=T'*"?9Q+KD,OJ)*76Y_<&]`L/7_UU;C];`2P M1,/AF3=8Y_S[Q2SSKBKW#@M475L,\MNW]\]`O35M0!C'ZYM?^H,1/!L#D;F0 MS)7^X?D_/KF7OFIJ>_H:"BB(S+T#?G!F?1[^+Y M!+HX09/$V*"!CHPWLA(&-N\1+ZZIGU&ZPV'O5(@N'X MY^!L2.68UC%Q$'`%P.G-+YE/XY\OO-`-CD-J]US*VU7V`(3W#XNEXZT8(\Q<+'&$ M?3'>&PR'^D2/,7X4E-5P#_X0%5GW9HWCWJ0WT4#+YZ+%AC+P>DZ3SB>.KIK.4=?^CTUGLFHVQW?;?F_>N[U%?,7[]DT`,-1 M;N57MC16=&ER,;L$$]BTEX;SR?T":[^Z9+>#PG8$QE,%J"Z3=@8*HEX(TZ_NMD*Z+ MWD/6=P*X]/[W+][-)EQ9WY<)KE[D$$C#E?7]5KB$KG0:N#[)WK=?08=Y'Z(3 M"IBG[65;3^]"'G@+E"]W.8C+T&=)R'K`"COZ#KCRUK<+KL_&3WL1+A[E'.ZS M7WGK.P%<1SN'>N^$@'WXN;1]DN/O8:NS;3EY_O3Q`0#]@A*@K??:/7W[PM<6 MD+?>A_`,HB@:YB'Z+@L[IHS>^JB.9\8B-M:F#%?0 M'Q>>2T;"[P85F1-EKC[;+A[C$SB1OB^9_YW4TS5FJ'?ZX[7%[[G*PZ$31/JP MT(UZAT(G5KD!W>\@#[8+JL/3>"[U?Z^M+C5+M`94""]FZIFC3=Y5LZ?'/^6T MW\]O#=^Z6BW9IJWV_2MS@`E:EX8?K*XP,\DPD3/RMZOD+\K!P4,GB.V\QP+G M0!?5+Y?#':O$"SM1N8ZN[78L^-BL=MR?`$.3*\Q=2E(:H*'R*0I#^\TU%IX? M8`#;>YN;N1Z#(\NN<0_]5;&$V+FHHT%P+,S?"X(-AZ[P013*27T/;V[FK6N6 M(W<+!B+ZVG@R_H($0.E1E2L,NYV>HNQ=2,C1JJZ\#.GYFVLQ?V-EC\->=ZMK MV_2U`\"[/X)HAXYXXDYV9H;WQ54,:9)G748.+7I5Y7R@+^](LOE;..6V98-R M]\W`+&_!%Q`[EQ1*S2X=PTR@Y+@<:HU!;0,W.DR@]F&:JG'-T,V79`SO##Y7 M7@DUU&.?FTS72GVQ5SKJ%=K1X4R>7RSUAP!=&Y9-NZRX23D`1E[*"M( M!,P]!X[YH[.M?$?.,%8,]@<',6"#\L0#BE#C`4ZJR/O#3^""-M];SN^^Y-MF M0._M%$$]<+\U'Q6Z1W0/E!\S7PWW6F!%>J@.U./Z98!,>!;OH*'N#UED,3H& MWAW+YR[\KQBW?1$&'$X-I7,UQ;*#;GO]K\QUUB%0;];K<_3%PI[`+B MZ`#OL9W'!%@?3'J]M*%?0(A/S[3RSD.OK_>&!4?.L05UOSOJ'GPDUH3ZNBU; M`OUDI/>RU)-MD*2:8U+<%$QLH2^*P3G$]\_QY6M:Q]M5_(BTRNA<)Q-(P@6% MM`%373(SB'7!KWGFUXFTFVS+,W$D3@YMZ5&[3Z1B@^;C:K`-:H^)VN8$TV2_ M>Z!&4"Q)`T7M51O7^L3"G52LF_0?%.!3PQ=Q\_+++C MX,)J(/ONW+U!_"-Q=[US]L`5&\I.]J/ MR5L&>H/YAQ*@IW*D5Q+51W2S/*B.N):V?)<)^4[G`N:L/IC5^3PE!MS^3+PE\O!Y][@?2W1>$_."JC[M_YYU.#NGBZZ7R[USSV]4FA\*,/A ME\O)O_N?]?$#(._A!,ACF`*(2+W[,)RP@)B\-R<<_WM2VV-X5%8X040^!#,\ MHB(N0.")F/HO(;4V.4YICSW-&XYKRRA5.SK3>Z.S(^C:>6"6$(?W*$2K]\]?$HG4=W7!#+A;Q[ M,`654>^P?GS-OQ_A1 M[G9KBO'[G_>C)!F?$/O\(*/OX!TXH<6V'>^#0R))CH>$XN+^@;A-K\'["0W# M[;C7)PWN3V]-5G\/,NS8!7QF,'\'&/8TS;!?VXRB-Z>[YI@?/]Y4M#!O;AR*F?<,,0L/!Z(V3=-O9 M&9:2CN]Y6(`WCOH]IL^WZ?*F[SU$#-501I,^(I@5Q/*V4SW^]_BSWJL.R@^G MJR.U_MEUL&6,^2/"64$T;SO9HV.?[&.@_#ANN$\PB^URVZ3PQ@?7`/,;9Y\, MQA(C5//`Y!;'-V]#KC8PC((^*H3'MV.DK:<2E]R"5%9?;L M=UK,*8,1[\C?!FL-VAX*!8^!]KO1RXGW9<>5]C&J.AT;30^S=Q\]?\;L8E*- MWA_W)L=(6SH<"P^*_!"`+R'5]!]R:_;"T>DR?_[A>WR?:Y#39ZSHH^&P=\R, MR`Q`'Q^/IT^V.''R5(1'<86EVBPSZWT(5O>U>(C&XXFE2QE1D(,V&@_'Z@[N M,`!."/@#I.$,]5[49_;.@&>>)GPH&N,HP#[[Y8.-'%.S%PMFV<`-G97FN1I\ MIUE8_]B;:==X,C7/A^^9%GCPF\^8MF*&S[69[RTV'^YLK0B0@B*"&//]7;*4XW]WE&_8([']#BD=64'V+W^DVMA M6ZG0<(C$WML^,P//5Q="RLT)QTNM2>.T1LT#V:T96G#+G!O6OF7LA[84U``' MU7J2#)S0$QS,"C/LKZ/A./WP*V MG#/WK>_=[I\$W(T[,9X(ZD?!ZL%'4W(E0F2*0UVX;#_&/QQ.1I.2H#*JKN+A M3)_0=.1+>L_'R&&@_W@&^0GF]I](F[S!.C,M(9]ZF M':U9ES1ROO[?WX8N_?MGP]_KB+Z;VVQV`2+%0/Q=S&:VR?Q]];XU)]V=@#L1 M>F(B_FRL-C'4&V=]GXDA)9P/$C#%1\MCR-ZC'9BDDLEE+^XK+^N5TRB6*3KH M=[N]45IGWK&FH_@+A("\F`ETG8?!W//M_^;8A(=?K^RB_OYP?3>/#<@IL'1C MV`Y>YH-:3/Z'!T+6B5"U#DV"-!*1T/"KLK=PC".9T5\\S6'`98*YX6K`\_Z" MQC`:QC/#]K6%X?]@@79#GECY@S)2R+J*3.[5AA&];?'),Z$8\UOFLID=H#69 MC=C3V\W#_F322[AW]U[:\>!Y4'U@$P-GJ`T\*@(>0.)G.$S2/M%'!?ND$GT3 M],G=(2][CBRI':OY[Y+/ZZK;M(=8^F( M!UI[&NWWU)@&P^&P_TAHO^?2]?ZDJ]_AR"C%\,(T0]_'B]/(-7HQD^\\P*'I M#S$1;N\5'7OYQW/A[NEA/C9*\PWAPYSF1W.PK-WQ1E>[%S/E61<&UD.V2=I1 MAT(_DKME7]"+B.L'K#U1,ERK\81#6!@Z#WEX\WRN?3#R[X_.+.@>#6TI3N>>XXGFFHGS9FD"SYY(?HNW3Z7!I^L+J"[[EA$O&\725_$696 M)!+VT+3[@TEWE,A?WP_>DV#H?D?F9!@:3)+M#O?'#YW+Y/&*G)#O&3=]>[FG M^^`1T?++7YW@#=AQ?[T.WB`$%*'P5V.Q?//_]%'WC6N[3%O`HN<\,Y1!Q#I@ M,$,'!WHE1Y(DNPLUVWRQZ/LA?,GS4%(?V,I1R17O; M.EN\1V\#Y=2&-?\`J%R.,>NU\N>QDMF\J.S$=JR$J][`"9#X#+K`Y.CXS+8Q_,P5IC MRE,C4K'7K$6BG_Q_F77-^*^V,;4=.[!S3+?U2\E32<<,IV&OWQN=)6ZW]@;D M=-"?2D9F7.T-1]VS;MF`C\[GV]5G9G"0_#CE1Y_]&3+7%%I>]$SB"=!2T<$+ MNGZ#FAVH20X4_?F_-O,-WYRO?F4WS$F/]I:HJG7H&D?-/4? MBE:S`/G##N:_N=Z4,_]&E,G`=0%TGFO"$*)`903L6X/;T>BK8Z;P;X]..,-8 MY0Q+YYB`E`53#R,$3"P)'8.,XUL*# M;$:_V^L.>T<@@#LCZY0[18[@3Z[IPW`,.`S]?XEVI]WO#;JP/Z?;GDP,P9;` MIOQ_[;;VT?,"UPN8]HV1&U9KMW&_'-O]\7HF?_L5/F@_Z:M@M61_?P;X9*[% MK&?R6]]SX-MY$"Q?OWIU>WO;^3GUG8[G7[_J=;O]5_CS*WSP&0[]:F-L^A9? ML5_CO^'C_P]02P,$%`````@`88)N169V'"RI"0``QH```!4`'`!AVCN/-MF^3V;3CV,F.9[+KC+-I>]?!TG',%($+DC_VUQ=D M*;$MA-`FD9$[>Y&LPX%SGN<`!SC@#[^M0N(M@`O,Z&6K>W+:\H#Z+,#T\;+U M\.6F_4OKMU^__^[#_]KM/Z_&M]Z`^7$(-/(^R3)3#(&WQ-',N_[:O@YPQ+CW M^Z8NKWLB*SOI>O+7&XX#M/[1^\P6$$Z`>]WW/WKO3KOOO=/SBY_.+M[_[/4^ M>>VV:H=@^O<$"?"D7E1G9YVL8&M3\F(E M\$[IY5E6MMOY\]/MO3^#$+4Q%1&B_K.4JD8GUST_/^\D?Y5%!;X0B?PM\U&4 M(%6JEU=80OVOG15KJX_:W7?ML^[)2@0MA0%G!,8P]9+F+Z+U'"Y;`H=SHM1. M/IMQF%ZVD)@OVPK'T_.S4R7]0Y_1`*B`X`H19>;]#"`2#Q3%DAP(6IZJ^F$\ MW-$?<2Q!F;,E\!.?A1U5IE-64T; MN`CS=UHBBA3&=[%)&TJ0GR(Q2>"/1?L1H7E'8=8!$HGLDP3%]FDW9>&'].._ M>D+(YOLQY]+ELP8(F@!)FOU+7ZY3LY9])&8&Y9(_[_/5X[OJ(>YG5G!:HB/B,$QJ:TMRPDQ^REEH@B=KEVG4]!@/@,N!2(Y#L9`ZL+FJ'Y&6MP3\ M.(ODGVK'M^?[+*:1&(,/>($F!#Y#9.$4)C'W^3!;G?+TSB6>[CC,$0ZN5W,U MA/1H,(IFP&W[L(VT^ZQ989"2=^82>4.ZD+HQOI9>9F!IIYC[=.Q:E>+^WB7< M$_\8P!2D'4&?B4B8"="7=Y^)`CM32GYRB9*-/:7AAM3KP)`73AW:X:9D3J_= MZ3=:?L+"!R*#36"Q^,RH7SI16`@[RXR-X793>[US@URT/6(9@FQ4ESWW>N63 M6*U2/S(6+#$AQCG#0MQ9RNR,MYO2ZXW&V!QXM+Z3+A;)0.3ZGQC/U=:!>7XQ MBCE+DME8NWF_3G)N,9I@@B,,%I&QIG"]VF9+D3NT5NL0^Z77GL`!W:<8\*)U MU[ZQ[LVBMYB"&$W[,J#"%NMA;?%&4*(WU+UYLA^+B(4JS)TS@6T6O442C:"E MT%SW)L/K<$[8&F`,$E$(*@V_Y;*-8,L"`O?FR6S!.`:YCH\M9IX"@48P5&2L MW1KY@`'!TS:7[_.X8N^J7%4CJ*P.4$KRSTZ1_"UL-IRV$G[^_QK\Y`\.U2=/ MK3,A^HQ&'/F&J*Y,PFF\2\U-T?[E[=$>X`4.@`:Z_3Y]N<8@NV5:BN>Y.Z/+ M`#A>2)L74&F`,8HYS8R=X4^K3'>8NF7T\0OP<``3FU6FIG0C>-&:F='AU*K_ MR2*K[7)]^<.YD)W2>@$W'"EO@\:(U$NH@Y-H;?`J3>&ZS[72;9)$D]\1 MB<&@KJ[T`=VF&&I-(E'>3/?FCSX+0T:MJ,@5;00/>0/=Z\"](,`;'>X0#H:T MC^8X0J8C^2*)1E!2:*Y[YPYCB!"F$%PC3C%]%')E'H=QL@$_@"GVL2G"LA!N M!%\V(+AW]+`U??=H4&F.+!5U(W`QFF6(9IH4G%6R45?2-+6RRZ7E%7YUK=,RMJO.?'S(V="W'$V-0[+VZ7J M3DV]1P1$>CYHSN/:+WG0#&$-L+F^MV^9BS=15-[R:*JR_L2]'":,P>YN2=?A MSUE6/NZU#Y`LOQDCZ&-ZO\*T_9$O6W?H)T`2-9,ST$"Z-6%)/F*JC#'J,\D= M<%8M!#\?[QDM=V\1>P^$J&Q>H-)"(M7N!2&F6%32!/%LLW%L% M/YDXI#+2`'6N;#,\;)5V@9^\\OL,[8SFCD?B%*CE'%3O58C,CAMIK,I; MP#262C]'KUP[TA1,$5\/)5S)=K#*>&!)5QO2"#@(\ZV[ MMVOU@-Y1`YB%7K;MD.[-2)D9:5]0YXA&]\B7_F_1JL7+P>'C@7)`!'^%X"/" M5$$THL\'D*;YJDSRO\5W*8[N;07+1:U58+);[H"T:A7.=[PWY-[%<3DU(QUH MKF28;-XM*I)H!K$:2QT<57<,ZBT0)BKI^@O;.KM+=W6OD,"^;>>SJ,D5%NV- MWN=YSQG:358B%;:E'HAK#EZYU1:&JL M\XA"TWS-&Z#J"2"IA%S]*T<(KM8/4L4A?5K5]'P9_Y0EAE6HI.X-WF\-D@ZX MN5Z=DE<9@NOE90!S#CY.\)"_$TA@ID$O9#S"7Y//C;FB%N(-9]$.(A??[;J? M(0YRWE'O\H0JV"NCLT"@X006P>#D:UU"Q.I]QM$T"0"DF_V!.$=REKIA_![X M`OL@1KQ/$`Y-XVBU>AI.<$707O>UL*);:%NCPVB:OAZWI9:,0T1,E'T:%JO6 MT%#^*@/UNH^*%3"7^)!R*0@&,9?MW@''+-AR)>E@8\/E3?L*FLQ;!9CLKD#7 M_!;4!%LG=;NF"(8Y#P^!:+MM08BN`8W=MNN;),Y1C!U=KNM%T_W6O M2N^:5:JGX5Q7!,WN`O<+A^#G"3T_D1>-ND:9AG)D`8;=!?!Z^^%;'H8UDL>J MIUNF6^('R,Y[5E8EM1OJ<7^4R9M785-)Q=6Y@L[IX?@.0A]:5SJB/V MS<\A'8.(>.Q'272GZ%*^[QY)WPE](?-6%1Z=&]C!F/F$4YM@ M!7#<8(JH_\*,'ETEM7\)A0\0),G!SQN46UEO!J/*90^;T%>1-LU75I1!XUXR MIE[IW6Q$V?LV'X#Z`LEO(KFTPB-DOAQ$]ZYW95MY6^WOXS#DM==F:/A<0\*]]XPVE9V#'.T3A.92^X3&L6. MAKT\(.Y]T8(R5TX%ZHFN"OJ^0XR=;"91D^'2$`L``00E#@``!#D!``#M75MSVSB6?M^J_0_>S.LZ MCJ3TS"0UO5.^]JC6B5V*D\P^L6@2EC!-D1Y>9*M__0(4=25``"3``\I\:K<" M`N<&X.#@PSE_^_OK/#A9H#C!4?CKN\'[#^].4.A%/@ZGO[[[_G!S^M=W?_^? M__R/O_W7Z>D_+R:W)U>1E\U1F)Y\(6V>,/)/7G`Z.[G^X_3:QVD4G_Q8]74R M>$\Z>S\X(7_>Q-AWE_]]\C5:H/DCBD\&'__[9/AA\/'DPZ?/OXP^?_SSR?F7 MD]-3.DZ`P]\?W02=$+K"Y-=WLS1]_GQV]O+R\O[U,0[>1_'T;/CAP^ALW?#= MJN7GUP3OM7X9K=L.SO[YY?:;-T-S]Q2'2>J&WO8KV@WKN\&G3Y_.\G\E31/\ M.ET,#P=#=Z_)OZ&+M+&3S?#[';PR]GJ M']]1<;FQ%TSMK0`WY&X74:$Y]].1F0:J1MG+?FBB-YBX. MS1"ZZKH1G7D7I_-\NNDD3YY90NFQ\^C3[DO:P7X_/0OPY3G"['X5,4S_,EZMW)(7>4*C?& M9`%\CEY0_-Z+YFE!$;"Z?W M44#TA8C>4A<'*M3K&:\QTX]IT=4#>DTS-U#BH/2Q#FLM9L+UOS,RA]7ERN_# MR%2J22"W'Y-$#G11.3!*YE`7F4.C9*I/&*GN-*VF-51>^E0O*?4IT4R(NN(X M'31>?&.\(":P0+?8?<0!3FMN)!7=&"11Q;2J^S%(I,I:4MV/02+K;+WBWG*" MR7$1AY@N,[>$NCVZ23,4^M1I7?U*.V[H9>>AC\C;&R:@P88H9IXP\M/%DYL\ MYD>,+#F=NN[S&97;&0K29/U++LG3#X,BNO"GXF=GXT,3WM"8_)FL1PG<1Q3D M8SO\QLZ'E8P@*,Y]5AEJ\X;.X%";Y_$^S>2(M^ZM..TIA4^>XF@N(:[UD)&` MV),H)N[7K^_(%UE"*(ER-Y=:^.H$^=F+PI38WW60?T;F$)K2/[;_'D1DE_SU M71IG"$Y)*_>1[M512/XW.7_%4A;&^LX9FE!A1?RA0J4;-0G4R>&#J]VV%75` MW]5>,(NA(&9[9V1",;P06X56>-)F*XG'R[$IQ[G:#7@:4])^Q-:TEC9,6:.M MRRAA-\*7ST8CF6)'ALM:XDX2M+3$KFO65 M(._]-%J<^0BO5$7^.-00^5H3-"4.&3V(?'7G+.>!U]3Y!5`',HY$!>%K MB0]`1'Y)Z([=8$S\Y-?_1$!8Z@>]XD-G`'E:573:!7QL#TYL_9SM7PT8N2R0!;GT]P;] MO4%_;]#?&W0K--W?&UBLG/[>H*5[@XT7(G%3<-"V6W<#9>*MT8+BE0WS<@/R MCD!1%QSZ=5\5U-?'N>_CU=#W+O;'X:7[C%,W$"JF\CO0"P5%#8D8T7V_4%]5 M$PJ:"I%_[<8A.3DE0AVQ/P"]AU!4#I<#W?<235SI0Q!WI?]\V-CZ&XI*TNU9 MQV0B*]RVP/<7+,%RE,"@W)JM/6=DG"09\J^RF+X`R>.>/]P@0W?IK'*I$GYK M_ZV'$BOV["H<<@M+JZ>VG8^A;TQD=*&DQP/>K)E]]W'D(>0G-T0(E&KZZ'I, M!4X_$#?S7UF24J*3AXCC!ZZ$B@GBH/\TCV'_78X!AW5`+,_OH5_22_TMUD%;B M>_OOCY39T8WH,+2G-E#A00?.`!8M*:N7&OOK'H_6[+%5+*]^OHGB;RA>8*_V M#"WUXPQLAV?69DLW%LC0C-6@6DY'S@`6%*JJKQHSFFVJDWQHKAI1,.K&" MY/]VEU.67+^BV,/)%I>DN&HP^W*&QQ`5X[*F&REI:'70I.:*SIRAK5$TONYJ MS'PN[W;-]@EZSF)O1K.CG(?^!*4X9DA&9`!RO3C#KD3:%)G2C%J3^]`9VAXE MD^=#A+)N<<9]1>DX]*(YNHV2JBFUU\X9VOXVF$OV1O2<>_)V`.X5>1$A+NM+ MM)S3`/TT%_+%W-B_E4'!-^X<`C7OS9"?!:AX?5!%?L*C7PBX MUS4&!%9?AU)Y&YE&N73[6<"*%3**X!G`7CL;8/\Z-<@VDD.6[3F1U.9XRU+H MWP=N2--8"#'L)H:#?I]0TBUGG3##>F]).L5IR6,*4).R[^W%]?PYB)9H-UHD M1"]SOP%]BV%J$6#;1Y4,K%$N:_?=97PWJD>#"BN))4DV7_V6[[PT%>@%(?)W M10>V_D"PJ:9:]F<;BD%&!$!?AE-59*F[ M8FN=;.8>Q;FR9.(ANH8`C8HT9$(^-*)C((#XB$8E"Y<)32+J>*BDF1`NENP. M1($7UMB+'8: M@7W1E^.!.,E,P0[#E>J%R2!C'?45\BD,MR)P-8(BWAKM*`CA3UD M4A=%77#HMV>#,5<0&C3GL/*4$?*B`X#+>X+?Z%Z`7G)D;G#^2.LI>]P,IUH' M@4U,;"Z4;$92]LSV\R"(7FA*UYLHOHJRQ_0I"PH6D@GR$%Y0Q[FHJ5L5@5'I M!R;?L2%5DX4O)'TO)^[+%^(`QM@-JHZ0S/8P.8];U3"7;WLF M]X;$GU'\^SC,DW=79@AA?P"3W!A&F27&[7EFLZ%Q`Y*9H`3%B\HT2OR/8-(= MPVB5R;P]16_&\V<7Q_2D??/&/DXO7$]'%"$P^H08W!@5%J0J]1+F.`I\'[WM!Z9)]/] M5J!H(UEAEDG644J1(\4;%\=?W/AWE.;E`,4"Y7X`"NJ1E6TE]5H*Z''D?.[_ M*TO2/.7=0W3N^WC5\;V+_7%(CA0X=0.ZQU.`]I:JGSB=3=`B"A9D5K%<6YZ6 M#`T'BM*1U;%!WD5U_EH\-U!YC$,BB(QR^CUTYU&C/$D"0 M(47:AQNZC_'"3=%]X'KY5B"1,X/U`6RN>JDIQ-8:EQUK-%2O*(V1T*.%N]XA MU_;:A6E^X:Z\9EBW9@4X"DNR9&,'-2G[MO]Z&3>M+G59<[*S M[>"0;\V*2Y#W?AHMSGR$5SHC?QRJBOSDW**I&UR'*=D7.5X`HY49,)Y%/@"; M9]W0+ED=K8C@KJZ'30SAZH1[*T=H9$`MD^ M;P./N]27&\$@!UFVQ[@K+%%J3G+?LC#&";K!H1MZV`U^BZ/L>1P*1%G]%0P2 M4%*V8M(M.F:170/].Z.996F"'HF#,N<+0Z!"B_9+"0'8@ZYE$"D^N?"^,054 M5`H,\T0NK:0M+]:<'W1KR9)3HEYUV7?L.Z!6>/QCMH0EL MG@V^RMN,Q=T]6,U,H8&%FSI'/E5"W%)L+OQ66XK`6V\3<;80#][FGUP_N-N0 M(0ALBCYTAF"OG%F&R0IPRK!@S3:IF$3NK80Q]UBV)]>N>A:TH3T9YZ32GPTM M"D#6D;8E1S)UL=MWZ*J7=FYH2]ZYH63BN:%%(<)ZF>>&MJ2>JQ#Y(<$&CT?E M!V*2J>B$'SI#R,QTJN^/Y'FRY\;7;(&+(=A;>#DU5$5]!'Q9LX25J%TEMJ^G MP<-OG2'82W>M&F3Q97!%+(V__2%/N\);$$7?.4.P!^EUU"'-DST9Y.`KP(S` MGJ\WGW'*G.J`R.A,C#,""[;4GE]E#EI+,/<0,=)+?0_)X*5($$_^M3MT1F!I MZVJKJA&S+22\4Z8KG]R5.YJ&KIT16&*\]C6]S[8]@;CB[4=2[.'KQ$&TP$Y5 M)+7J,V<$ED>OR4XG8LE@&KU[%'MD:'=*#J/[N^REF\S629?7!/*FI%HOS@@L M\5[MV:?.H<$$?337VD&6M<(;8BX`=^%OM`U-TG1%8XK_:RFS&K<&< M@9O:M1O">`HKMW1&G8J,5'"A)5N@KO0+D8>0G]#2?]O,=H=)":IV*ZD.G%$G M8R+RS&E)[\%37N36+S9Q?CM/E[A1\3?5Y6AG<5O] MZJRN\>D,76^"UZ_$R\$)]_@E]Z'SL5,1#WFF-BJ#1Z=?!BXM1EJ0>A=/\'26 MWF5IDKJAC\-I50!1\*GSL5-1$!6V-@HT@27V$+>-6)H%IX\Y!J_/63S,B7\.WX1@0Z4UU*)6S MP.J42[?SG];+^&8![%.G!ME&F6LTZ88;VW))WBM`1B M"VI2]J%UK^?/0;1$*/="[W(JA#!2[C>P*5\-+0)L^ZB2@37*K>V;;6XKSLG! M:9Z3GQ#AK)YL1$$T75:`8EL<';1ZME'/MQ79V0/@ULS\M)MK'K"OH5L M;6S0PN0M65(+9LP1[7&NMFMF?T0!Z8:6K(*PXOW1[4[RVCD[+@GWR)?C?7[Y M96?;)P*D1OU;,>RMC.W!Q[?!-K=:;_M$&$HLW-OWOHPMRI2ID^T)3GZ_B1%: M(P[;=$188\/D(#X^<^;)UIZ$>,;9;=D)J2`!)OGSVS#J'1'K>'[2%=MNUP&I M(,%0&NW>MO=%;,\SFYRE1S'7CRI>%WTA6/4*W-R@IE*%=\5^C0G5X".C.E)+ MI"CG^PSM#`R<8QO"&ML3K,$75`;IY^[T[0QL*)GX6[;(K6`%3[_`$:J#'J+: M0U1[B&H/4>TAJCU$M8>H]A#5#EM2#U'M(:H]1-7X,?=\.HW1U$UW*4OR?!?( M%R9;U=/]T0%'-0OG"*!(!6\[[W&_9J*:=KK'`D%^ZC8%S3<;%;*R9LMIRMQO MJU?'X3V*<>0;M+C]@4``FMTPMY*@CF>%NWY]QG'^31L6QQ@-!#[9#;-C2^L( M@)`;_O*$)33\87QW+8T%`FOLBMV5974$\,2R[_`3T:0K1*0+%+M3)$HGU#(% M,%#%;IBH@@@[A$CDGN"9?H@IZ]5'!0PNT1(+UBO&#F$/18PSW!HH4U8D!0:+ MV!%[KB%+RT"'>EPF(*="D@(8.*(E)JQ/A*;!AW50DT(N)H@JB;A,EU&8BS)S M`PH8XF;Y`R`%!J!HUCXA9:D#DPB,ZQ:Z_#P!#$7+;;O4P"`=6UQZVQ>GCM3V M=EBW^O0V\IRA/C7.X,BOJ]H7IT5U!33&:\:$41PFV,LQS.V$V?;'=`;]55KO/9TO+ZL&@SN#(K\&,24U400+\C<.P?^/0OW'HWSCT;QSZ-P[] M&X?^C4/_QJ'#EM2_<;#QC<,$$1<_N2,J?-_`;/^&WC;P^+=&H;7]L56E MHW%(^,MRL=VE,Q0_S-RP.$M]C?*R8?BU"CNY=!9@8CP"? M+,^Z.>RH*@W=S-5=V\C`C/V(WGS(,WUP<[`I\;Q)!P([`X3D=3,!>/&$(8^/Y2HZ&@R=%NF0#V!'\$K)5G&LQ@E=AXB5`CL:,KUKLT2:5T( M'DN!(_0>2)\9H:8KL[G'Z?4XO1ZGU^/T>IS><:&K>IQ>;TD]3J_'Z?4XO:[@ M]!222I<3*5N-=M.J2!;O.B`(G`P:Q3&5$/C3C?,L2USM5+:W&\ZE14,B_NVY M0W_`*75MQZ&/%]@GQW6!=\YL;P:#9)N7SF/='M1/B<*?.)U-4+!*'S7#SP_1 M=9CB="GTGQ1[,H3!D7:RN:J1U*20.VOV1D`56^+]FM:U?0[N%8Z11_H6.D/[ M#4$1/S6F&%M_)9[,EB0YE3P&6RI^D/^JZ$RN"UBNAQ5?P5[Y:UL=!1SJP!AR)M^ZDE'U_-IO!7N#K&<*E3G2@7#C):U, MT?,,A1=Q],(/A7!:PM:DUB-L-E?V(*5RAN@A,DZ7#^2`F;A>SM_%8ZLN08;$Y9 M.@_`/,^=$$I&<(7N^4$[F!2#`M-F^=D,NJV9`A273)Q%P:ZTT\I0%CW;MIT# MCNUYGU,0)ERN]MHY`S/A'^G=Y%"``R6[M#"%C:&6;96P!?,);$NT#::HBW)WVSA`RU*4NW@/2#88<]X=]B53D MNV[M#"%#3S6DNTNXCM,6-]C!`I,7*')A#6J9CYUA)U\PW(I*3,OR;L]-=7TG MKJLUVX9P!5BDS8/M([0L)6L>&8YE-E=?XD^=(5R%BT8ZDF/-X-TJ3=00)NCN:8*>B>]!AKU8 M;N.V#U$9OLN]Y%;NR1G"E4EOHK5ZG.JXK^5-+C=PX^4FO\!#=)_%WHQP1YB; M$THHL]S9)?&M,X(K%MYH>DGRIB,)@]*ZIYI112:)E,GAG!%A`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`=+1%MLT5N!6M!O><#W%,/>^IA3SWLJ8<]];"G'O;4PYYZV%.'+:F'/?6P MIQ[V5'%FS>9S-UZ2G3)UTRRY>Z+LN>&RH*!XX"3,TJO4R]%!B^K)X`CNI(OG M.S+)G(R-!0(!JJEQS0'9"I%8L]0W96X_*:=!P]H?"`208Y55E>1Q/.L5?`9G MN+0#EE@76RA'`&/9\)?GTJ!!!.-;8FDL$%"*9>95%LD18$C*&[ZI"@EZ*(!! MD%AEB0J2ZA`0Y.C*>(#`0=HU5+W2LJ=8;V/&&;X(E,4JD@*#%+'+;&N(3`<& MQ`Y/8,?/`?($)"F`09!8Y0DH2$I'*FZ-!OHH9OI1V?V9(*HZ\OME%.:2S]R` M(F.&(F-MEQI:F/X8#+=]J5F4'KRA`/@SER>`@4$CKD$-+17^QHVXIM1T9#>W MPU78F<5CPB<.$^SE",5VP@3[8]("Z\=@D*9D8UO.=CT3;Y_/EM;(@T&=P7'< M[!@3CBBM.P`>N4@VV<.2>UAR#TON8PY!Z6W&%+ZF')/2RYAR5K M4UQ1!.W>C=/E`R$Q(>M*Y6.[^B\!=D._$#(#9-E]"21[V@`-WB1.N[N7& MAN#$TKN\FM3%FMMP9>5DK:4@2S9/4YJR;U^\PC'R2-_"C7&_(6A20_8<8&NA M1+:Y]S8_<1!@=TZ6[SE._^`*E-L6-)^>C$RK*->Q27#D^@5[,Q<%_\BF,Y14 MBY71%#2+F[14V83KP$QSJX&M*_542_2P'6SB,&EYLLC6`1+F3?TBJ'U0.HD[ M^]G-.YJXJB+`*>+6X*K1]`[OX"9YD_3E[FG-SZJD-D_';8T/B!.L4BS##MJ4 MB,%=OACK)TYG$[3`A-8?*$EQ.+UBIYJ6^`H00:>H0S$?-D[I-=645%04OM<^ M;UF#`"+,VIJ9W*LV+0*Q*,OJH;R=]!)3\'Q!LISC$%ANQY+W0>Y)TC3M7B MH@IHU56M5`>`V!UY+:JS9#!)ZNZ(M'9Q<39ZB/:]H8=H>Q;B'_*4NW(&8.^< M%6==3>8,)A.E"-2MT\I3RGXK9P#V\%=1WF6Z[7GRT!/%#EJS M8AD3?>H,P=[#JB]@,LSHP/@+SE#%T6'ULNL*)5Z,\S%$IRC>=\X0[*EGS7-4 M%216`@EO>F@`G+PAED30>9/#`J#I6S`,SDIN6)#=AM]OEZUQ2%;>C%)& MR\`(X'55GUD`SC>MZZQX8730WV'JQ%E2NH?ZY=*UMR(S8=KA9`O'8@R^O?&-L1[)'D.&VHX7((<'H1VW56P$?08;=CE8AAWP5<-S&O1&P/6@;K6RS M"OBV9=.LL4&?8AR)*7/DVJ&4O9K*JT,:\DZ%]]Z@S4%SMG'.B0MA&L@`*!X5Y$&6)\1J3J$$TH#G"^:Y".P/#O.N",\7V MI&H0&VF0?NX&W\[`,*_1CM<5D8L6)*)I0$9#LB==!#4GM(:@])M0$KT4-2><9]L2Q$06F[ MB1%A,?1$B1\EOGZS`%4YV=B'V6(1*T0_2GP-C5J5U(=`F97\O25E6H)H-:]5 M^_"M++*3S>HEA+W*?`Z*AI6<;/(Z97!GGS(OEIL__X%13&0V6]ZB!0KD]^"* M#BQ(O`R^#5>+QQZ<+-.$R\376L>Y_4!G;Y;7D\*\KV#6O@6@76W;MW^WH7:+ M-_-Q^)RE2<[R0'X/+W]E!UQ7=A8*M,IDSVK=#6OI;FA!CFJ#NMNR9^$NNT/G MJ);R1A:DPC:HO"U[]CS!V(;;=_+4;G_\BM**)-'JG;Q5***:A.R9VRW?T4'" M^115U/BZK2+@;<5EV["_;.LOV_K+MOZRK;]L>YM1OOZRK;]L.S9EVA>LZR_; M^LNV#E^V5>])^2;T/8P>$Q0OZ,:31T/(/T>A1[Y:Y3IW`R\+\C\G41#<1#%% M-RP9IQM%I0B;-DG[5D7Q!K62WSOA37K\;CV9$GQZ2] MR"^7.H1IW_JJR""'O_LL]F9N@I)O;H#R0A(T$7'R#:7IZGPG=5QJBQ8[+MZZ M8]5-!-W]!9G'?9Z\?!QZ,>D.7:'5?ULT<^;X=MQ+=M^T><(57*Q!Q]2+=/%] M9+V/K/>1=?!S3A]9[S.K]YG5^\SJ?69UBT+C?6;U7;[ZS.JRZ5"8;O=!>2:& MH*6_?6-!816YV!-#^$YX=@/\!_)_(V*]C9+D+MPR4>7`"+X$";0JZ8`]_\1L M6;,DM@LU!*OBW$R?*@P*IB4C%G)&QZ0)ALC__#]02P,$%`````@`88)N12/: M15-280``Q!H&`!4`'`!A1@E;5YS]VU;[^R^O73T]/WS[?I=&W27K_^KLW;]Z^+@=^)4?^ MY3D+=T8_O2W''K_^OQ\_?/8?Z,H["N,L]V*_GL7!=,T[?O?NW6OQ5S8T"_^2 MB?D?$M_+!:5ZUT64(_B_CLIA1_Q71\??';T]_O8Y"[[B-$B3B-[0)1&?_TN^ M7=-_^RH+5^N(+UO\[B&ER^XU1&GZFL]_'=-[+ZOU7XF*%US0-D^`B'K;4O=E.U_PY]])\Q*H;\QVM M^S;)O6C0BALS':WU$QU&VVJ>*YHR/4B'T;2>.>%:\_8ZK0E94Y!K:O[S!_;] MG971YYS&`0W*M?&9&FTI``LM*Y1_XN\`B[BZ3=)=/+UL_73$K<>;=V_?"$SX M;WXO#=-)S,0^#_/M9;Q,TI50UR=W69YZ?EX"$DL7X'__\8I3*^SE)NRNS+O[_:=_^>F'GX[__O=_^=]_^\EB M9=RP,3#'!`YD31FDB_EW/_X5[F8"K>3='<_O-0O%\I^ M[$&N&/':3YB]7>='.W@NTV0U:@/*=26CB/7:F.L*-`6*2R^[$WANLJ-[SUN_ MYMSXFD9Y5OY&\.?1F^/"JO_WXM>_,]6>4[ZJ6^^NEM\&.W[_X_&[?_GNI_?' MW[\[?O?SY=N?__[C3[\K9CO@P1]_>GO\[OLW?WO[X_';X\N__W#Y\:)96:=;U\%^)APQ![,F&#/9@@7/RY8;)YEJS62SHV,%0]V&A@; M!G0G4WN+.$]67AC;VIAN(-"F1H5:GRR1+W(H/M6MW2PC#:[;*7=,=Y;$3*_D M(3,BUPPL35/*#K")_\='$>HQ5>5]8*"4>3]Z^RS8F$&J*43,(5_DK.E5>]XX M;,Z%F#-DAM@I>W0^TS2D&3DA0S8,S&89BIO6:IG)&H`O^"&,Z27[LYMJ`:!%I>FXQ)U>,('PAJ5R9? MO7.+T<=`G2:BAWOF9?0S)EJI%UW&`7W^.]V:&@$U`"@;H$-)P3W%0")&$C84 MA1&8`Q$P*]#+:%HCT,=E]._42R_BX)RY33;*7`D#4I]K M$&M%`.10(L<2/IBPT80/1Z/69\('5+OW,5^O@N_AO+F$IKRJO&5@353\SG@( M#;^W8.6%,_\[N'X?LU@0[=[%#DKEWL$+<[-IE5MEJ]B[`4!J=15*2B:1`_&I M\ZD1`=7C6D;K5>(Z+IM;-&K+\9[]IO657T7,R2R0<+ M(B>2QDPT%L0EDAAN#`Q8U_3ZH)]O`5(OKI;OP]B+_9#9O20+;1Y-6,$"3\K5 M([K/L:=>Q%\+,B:E5"2PHGDI,60'S7)9^[?/'7^>9!FCNX83M?D>>[.A4X): MR+1NFL0`#9>!J'OSY7_^?''[&8WVUO.04<9/)P.YYO[B4L)6'7=/AM*_*E2Z M16!!RCLG.%D8A4:Y?$^,1V,LM`REM0XZ;G*8;.YE#[9&0,R!5OW%PEMLPGZ- M2L>[7.>Z]5A^LK4NR"F]#^.8N=2D<.%F6GY=GV#"Q5^(PX!JY>`&M2F%1F:T M(8(.C:?O)YLXSVZH3\-'_LCQ$\T+!69L0W4PP$RI'K&612V&DWK\@K`9E8W% M85A'(T5>133+B!=%R9,XLRV3E`3)YBY?;B+BE1.2)?D?;XB7D\^,_64UFK=O MBFHT_'W\.0,H?WN\8+]\^\WT;W4:Q39@=GQ!1-D./&Z)@:CJO9-^.76G>*Y3 MNO;"X.)Y3>.,GL3!5?Y`TQT'RM:',0$)[>*8H=WQJ(S/(L4T(8)B(MD[":!R MD\;A2N6T3"";"&1][7EA7I4#N:N`FFBTP-EX0.8"[$Y/7<:/[+-)NF6ZTM0A MVID#Y0#M+7R?^:H_"Z.'PKLQ73$"7\.*N-@ M)5F>=4NB5E-U`X%V!E2H[;.3-`KE0")&@HCM)-A4>`3T+B=!F`FO%)UQT_*= MD3G3,1U0>'Q06!Q'.+P_#(["B/6M69@"4$]VMF7C"-C;!^IA3)IF_FC$ M2$V33?:)X3[LZ&L`$86QZT.ZV_*5RIFF^O69[(@KL_KD)USQW;,`!5@L+VK3W(-J.>\KA"R(FR(++Y11\Y]J! MV`FT:(V63I%2;*U?#2H5>SN@[6V$5I M@,,SRK@,"D=0N4:IT9#%7RS7"1QPL8BT.!>D#Z%W%T9A'E*#S&"MHM%`@O:[ MM$CN,U)C,(;$X>D0*W&)ZDGHK%4_.QK9JEY>=)\X>.UM>2;1P)3!O=G0R8(M M9)1)8\5(9'=O(XA#0VHDAL=OL_99'FRXJD!:_YRU/9N7C4=K/F#$IVVIR9',BZ30U%8 MS0G7#]?P0,]2^D8'6GYRV)AGM8Z2+:4W-!)M5%N^KJWIZ0<(;8=,4&Z5ARCF M'*5R$NDZV*$R44.P9!Y0NF'(,0>5?1]?ZK,QLYHU*3+D5'?"6*:MW=!'&F]L MCW>*V5`62HF,,C6Q&(GK>&>/1BI'HC%3>J[26BDM2X&%/:HW"E)=C;=9UO"A M3=@`@O2=Z)L/80HSX,3&:=N#.2""P/3)2WD[D2WQ><(P*CON#$MPZSY4RLW* MI0P3<:DJ'8:%(.1^14#,KW4W'S*W#[1Z9[).4OXQ'ICVNG#\%HWG8"AE6@?!3,3& M:X'S\#$,:!STYAEU3W)MPU5+5TE!-0;46-NN.IAMU7UR.\^RG=M@+8=WVET= M>[N,M*7A(]N;1SH^>J"%!1TIZ$&T'<0JAU>NWQ;CV=\2K?=>F))'+]J(V]?B M'(SKG#]\HZ*FCYX],.M-&&%7:*RTC4-!,YAND82W]\R<1@%.LEU._+ M;:N$ZX&`&U+1:H)Z!K7JX-5J5I026I`&L8V0Z#9@/QLD<7J]$`07AVO^$M+!6>Y2;[1'6"IMZ:3.SP3I1`PYS:16((H-( M#P8NQ:P//;/XUHPUC;0AKNF1FM,_'Y8]-\T.M=T-^!Z'ED+6DVAG(F'`#OR( M@SLF=\.0$16..R['PA`7>?:-3'QV',?XJ;"!]R5,5,(`J@`JA`'G=PRG=;V( MH["6^M46;(\JIVSDBC$$"&S#`0"-4!/_CXODY-NA534TD*"MLA;) M?;YJ#OZ:R.'D),_3\&Z3BV3V/"'7'N9B&R/P?1709>B'>:OH([BQZ^=4(XO7 MRZ9.&^;(%S!B3;_R#`)3\],)4]+\6`Q?D,LLV-$!A(6T1 MR20B/RS>O'G#_T?/OFS7=D[14I(O^3'"^^/_Y! M/(AY0T*!O.R'4W?#5G3I2M*=)EW\EV\16.DIME\1K!N-C4'=P1EQ0E!B<$;L MX*L)&FM&$R=,K5$=EI%(5JLDUEH#?8/*_?G0CE<'0JU$&3'$C5$8GA)HC4BA MV87.1^4;FF-2FC=IW"P,W+O%3^^^6WSWHVPL>?POBW?OWBY^?/=].=W*ZNWW MIA1F;T$8G#7U>4PS&%S&9]XZ9$)B>E)230=[MZI$I_4@HQI)^%!R&9-B,(K3TB!$>#/( MHS`F_DR(#'BX.G@_PFH_L!U?IL$)@=:>$3MXG6VEKDR.,'I5YTYCW]#<"V,: M7'@I9Y_LQ/158QXY5\1B`0]" M@]`\DT-XV@4O2LD?_*(Z$PU"JO@+?\9<#IY>0?+R?8QLO[I&KF),6LQ"=,:: M4]*PGL#FQ1F!I0?$'MX3&&O[;,YSQJ84\@[:]'#7,1/J7->)Q(B[911G/".D M9")&MH,:%8,1'.\&8Z"\"`<[U1FA@D"5CU@\LL.86C%ISV%*K02247<2!T8* MUC33L!L>]/'+`&%-@E[5+FT&G351"JXI5JVT.($;O':&P+-0X>A<.E/IM$WA MU8FFPX!]%"5/7(^_3]+S9'.7+S=162'SAOHT?!S27L@**%APWQ+U5L"RG$^6 M24J"`@(/,0@0*'S"0\-QU-DY-S2#T)E4>TQ!UZ[UC"<*6%Y<$1EPMW"6DFE7^H&F_@=D8/5(U=UAO0PN]X&@\.@=Z%G MRIB-60C-MQUFNXHDF1&S:5Y#3;1O>&,=,Z&+-)IAJ',LW#*5P@%Y1S4V7*$# M!>V1Z='4OV#`':48A-G!Q"<,V-/V:09X9**QEK%A"1-08)VQC=#4BQZ/1B3. MHA'V->)&X2B$4!V$`/'.QB.$,:QB(7'Z9N'&X@9HP(=%4U1@T!ENYG@;WS M:2V__?!,_'%!V)]1V-S^)8L1&%[K6!$76Z]P!6?KWXITLK5+[SG+KY8_)TF0 M?4ZB`2?LW>G09J"-3ML?R7)RM21B#.&#D)VCC1!(9D5@S+'9?OEX#\F=HF%X M..Z2"W=B_7.:9-EUFBP[:VUT:J_F%"CCNKOL?=81?R7RSR@,J\ER/\Q1[,+> MLIHL]:.7LB/GZU=\R2#UGWOYTL2BMOG8G=@5IXGX_N)Y3>.,9D./66I`T!96 MA^(^6U5C23D8:\7T<5C]!9WMZF5$(RO6QX4N2TIEE-'EX20.SIFS'"5K?H8M MEF5JX?1`H&Q>'VKM$Y`<7U1&K6:4W(C",HY"*F@@10O.0V!"I]XH;,=7(QG3 MFEX3`7,8:*(1@WG_,XV9%HO8FDZ"51B'7(/QFEIJY:%O0V$&%=I,&R/?"@7) MB0M23!7R*4 M?].%0K]+C<*+,5FZK$."R$T9OV@P#T3)[5JO0\7J`%(J[]AX_&3P@;\!`MJ' MZ$9++;MR&.F.'^$XWFLQX;\FG$5)4MT*([+XTR$!;L`U`F,7F&A)BSNA_Y3$ MR>XR"OVCB?EU:KU^0%"FVP3%??YKSJDT0C'M&\#PWY0('M48IO+J]O6KPICB MB9L;\Z?6N)HRI\M$IIPR_BC#"N?T;D`24QL$M+'M1FN?^\U<9@!L"[C-HY-XP_TTE].YTUR]Q2KV(/]#[ MV0MC[K97>=Z\W6\9\B?)3'SWC;,@:N3G4_I,DFI''?K/=/LXIEY94?*[M"5MCX3N?TIA:9):JID.YJ6IT%#J7#2V/>>15,=IY@'L:5(30DE=^ M2H,PGS)*/\*WG!H),%^R1TZT/J1>2!R&M6D^_!9K=S*T?[:/2I==V_6J'+5B M&MY^T02EPCS+XR8J7\YB];Q,?!S&E*R8_7O`Y'N-W@)P%ZE3Q(V: MSL/',*!QD.W6FS-U0U33H=P0-3JM5J/ER`79*S6(H%R4.1H?*#M#K'<+7Y*@ MG(["%9D+&3"7I$=FM"Z)7F"`7)*31R^,N'V^31KU%8J.1Z=>%OJCG!8#\*C< M&B-R&#@^)1CN]31+=A20%D3`PNH)C::"#,U[32KX1>D97KFC@(35"P%"'Y4WK0N@8S9VL_$;#^P?F"IZP??7NZ:?-ZHZF M5\M64:9![H,=<&CGP984^]Q;SB<%`"(A\-OKSAKOR+R&R=#W"O3C"OVF!&>- M$G60TCPAX]K8SB$B`6P3$X9O[LKSDU?+,RQ[>1\F3K@9.=QD]'0RPLH]ZQ/1%1OD,(J8`%QFU MI[>)<3+8,*?!8KZ(ZS3AP>O@=/M+1H/+N'HQ=N+GX:/(JQU:FVG`%Z#MU""B M=#E=@I-+,.1T2UYQ2.0R_H;4[T!K:%C+/4U"CQIAKQJ.SA@-%P?3*.DP67"G M$$Z"_]QDN=#%M\D-Y<0,([H3WKU-QJN,[E;Q=.MDS?@/\7M;Q\@()K0K9(AX*P6G,8T_]2PF MRN))C:FHW)R!N#;_7!3DJ^$@?+`[\Y9B?-/KAD^)^ ME`9GR8IOA$H'=Q_BNV>#A4M4R+0")7S@T1T?29I#47AGYECP=)`""W].+(3. M"!_G1*/HQ215ZXLGY38@<T@[0`";*S\O63T*EO7GW]HU0:/PWOS?Y\&IY+;FP M\<6S),XV46[07M06G&MOS1Y=K+4DQG93S"0-`:@B@7MW$V*HTE%]!F%%/ M!XF_X1&HSC,"..+?@OM6`P6YT]D:)L4C%)#03VRA[&W8=5$#4TA0":.$>#9-KAK>N.ON3%]L[#S$\V<$GK`@@IH>"JM3$M`<*:`)X`@<:TCN)]L_##`,8?X?W7 MT8YVE,,HX*`%`!)BZ$&IQ7IEX.MJN1M(**;`1Q&&(M2(Y.VXK`CB`^-1VL$( M20C`1)C4AWX#27+8TKDJ+J2H?9.LG"TCTMP1`!AU2`4%GR<;CSQS-L&L>63H_>!-G&ST5X@C<(31^-&_8:0@.L(VJ&;$<9 M2S&!O"JG?L/S;7=FDV(ZBE#`>$P9>E'R5+[IR]BA(B4K+_V#YB3M1A2RBJ<% M#_<5]31G8$@IK5*3S[QUF'O1T+=1%I"A70HK(IA(\&7<>')0@,#Z`&H4\K*S M0[;W1$#&17CLO=&[`N2YP%0<:A4DL&5\2&DOKB_/BZI^94>O.+C*'V@J(QO# M;;01=#PVVY`8AAJ@3(`HRX5S>1"`BL`A4G,^D`BO2DC"?RFS`F@#]T3@[F]2 M>2DY#PWLDTAG98.PGPV`WA0`*+&ZWLAOHT M?.0E$,>[A!TP\3F#G8@;&H%R+JDG(_?^C+`MA[]^%38%G7DU`=-P)<[I##A/ MT@5Q%,YD(,X(_5VU2`_T=)7R#*FX+N-'9F*2-#1OJZ@'@L=CW47-T"-I3$)0 M-'XP4@R3L!BYM8TH(?&U]9A6"J>)*4J/>2P;XO:!)]@E1(YLAS:T]%?;JA!2 MNY]MLCQ9T?27*_H4PQ;D;<:>X#PN-HME$TM/+E1%+, M1.J)#<8O*/%+N_%#9/D5;&II_;MY%/3&4H3)?#_=,+5<7SA-<&&I`(S/'U"3 MP)"-BXBTA$`^S-%R?IZ[RK&(>P7*HO29Z+#K^?C2AJR9?NA-I9;C,42?K[TM M#ROQ$CTF$F^H&HV@X['&AL2PC5$7X&39*WA5X)X8[7#NND&22E7,2)(IHC'3 M$L24.W#'<$;2Y/6K8#HF0>02VFA52S_10J5B+`ENZSU:0(9V'ZV(,$'I;U0N MY&CD15W<=8G\W?;UJZ)([C>=57(1%<>$1AW_ M+,`XYG4)D3/1R514[#,UY?V`H"RX"8IZ%[190$;.(V(B@D/S>.2:I;O+#K9\ MXD(TV>(%="//%RTS1>HR'JMMS+I:8VW*M]`B>9T6:2UE77'Y"\K^J))3XX.+ MQ5>@;?5@XIA+>`5,"KFX-*OAS23Y4YVT)Z1)4S&L*YID7>B#&_)Q,F-]*K<6 M&%CM<1DS)\.+KC=W4>A?+=GZ#!H"V`/$9.!5*!NJ@6(ZD?-)"0"IP3=%5NJS MI!C0;#V%,,^9',Q(XR$ MW="UMQ6=?65![R'VO`4#@PGO0$PO6J_J&8P7OQ&%ZM&9-1.L*B1B48P>1:;B MJ)W9N;LC??BA,-`JL3*VR0J9PACCGR^V#VZHK8@P02P?E3T?C7SK^FYI$,T? M?QB:.G%P9H3!W1M[29_XVL*Y;N/K.HD#_A]>./B1V1>>P2TZ">UG>)LZ1%8P MH1PD2\1;93`Y?_-`IOBA`6%1-AWK>%R!PH<:B7B-UL[[B%D:'=H_C9D(N=?] MR('Y5D,D5NMK#1!7:/UTPO1IFFZ9ZOS5BSJ?WVO5O!E0:(_+%'4+U73"W3`Y MFXCIJ+RL,0@O".45)I=%3T!$KM0,V^CM;^/D+_$*K"4Q/^=>FKO'_8C\-6NM?($;91O.YLS.?->AV)A`POXDM['R5/ ME_$R25>B@Y+M.QE3<%">KSFZK9NAQDRIEOAS3JM")"MZZSW3[-H+`UM';W\ZM$O71J?C!,)&$#&$7'=LT#VZO%<)B6ABF0U)<"CKC2YKE M"BE7%#=HS($KU;*S\#8SR3_/(\O#RJD`+GA(L1/SY2J.08#5-]I,W5-3H\71 M#J^Y&(9,?]>O:N*@BE!?YG0U_`6+,6!H^VQ#@M:MAYS;>(/&#^_UU9:8C_:% MRCC$CP3FX0[F71<^^#I"63.]V86/)<>/Z!A]3E-VCN:/6"]CWEU.7)0S:\Z[ MK`2_A?F#2.5ZD*Q/VN"> M?V0WZ=_4OS`'".57V*"L;+)^M23E1*F5]M[3((@03()GW4P^DP)XK7\C,[OB M@4,51-F,E#$3_\A68DO:C\"O\N#=XGZ4FXZ-C.*F%XG&,.#NFJP0+AEY1I3N?=9AR7%;,&FU?RYLHF&W%:,P7F]CD*_ M0KEJV\)?RI"@F`ANU(9RL_8>P9*51[C91:3S*KWVTKSXQXG_YR;,A%DM?E.L MP(NN4I[WDV_K8,-9$F=A(.KF)O&N#;:*`\RZ$-#XP/U%@"5LX)N]O'>YVV2V=]T5'%.5P3)G;!TKBS>I. M=G7=/Y9X&?D2%VS'2<99L_CW?_`N/@U&$XX8N=MD_&EQQD>+7O/,#V/K8Q8` M673%A0KMC\HXT)\.GW77#T9#_N0J#K(A%=CT4,">=O!K@+;0/PX>N51*RAFRNAJLPH;&H?/C$?UKZ1-&-3A6QW>2RV\VTBO\SKE M'2+RK6W<0@$%.H*A1*Z5`]D8**N?R:$(_!UK7&Z9$L^6TB"OBV&=<0XT%M6, M%\T>*^@8T64,T,M%9O;54HCU0Q(Q*YM)\VO]-L$(&-C+!$-4VV&X8A[GT^;, MK_GCVV7HA_DWKXOCB3H!"RZ1WV:']6G\%MOKTBY4-NDCY?Z]O4G8!P!O#=HH MM0T!E%LUZ=+)%SD,5\+BV`U`8*`40F%HF[HEPF7EK.9]O5*N%>6!.N;"5@R)L445(IX!%H\YGDDRFMTH@6NHHV8TTA=FW"F.Z&[H;D7QC2X\%+^ MN#ZS4]Z*V5#J6XE,B_%\?[/:1+Q>'RD.!2AN.*=$`,P*Z5E*:X>T_.3PF/W@ ML1V_VN19[L5!]U,)?1)%"P"TQ>E"J75T%F,6I#$*E7DQP>'4BW@^Z8)\9"S\ M0-X>+PC;Y&/R2DZ>ONS6V+(H1DA5M4\J]#(Q#5D%%*L-ZL8`W-`K9=\L"4HA M^"!I@N<;_DY#%N\2U51$IT/S\&`?(+C08#^*NJQ"(F<5Q?D69=DD,16%&S`$ MP>9[`L;_[+-YR),.]Y]N\8@]JAIVQ@S;$^TTXU9P02PTA$(235,S51#!W0P3 MI&UDL_))((1S>E1MI12OF33F;MOD83UKCWH%])^;+!>7Y+>)XA2N>H_$WT72 MZ[)76Y\)G?IS0.^')B17._)3`2>W"=F+;Y$ZOE5W#>IX^B@^0ZKOP+_)GI5F MZA>#ZX(2Z]DH,>15DB/VR1/B[<8121U'7.PT6NNA&II735/K*=V3IXF5%+A_ M)3R^3_1)_,6Z"8,94*1>5@OU`8<@-ET.P%6I;2C&N_Y6G?DG'KE4ZJ!\YMCS MMA.KT]7-\F/\KDY^!Q=MZ0WJ9-OF@+D/#5DTHXWLD&/3C.)LG\P[&%.5%&,. MU@S'RD@WE5L,[K(,D]DAL9QN@0772D)75@_%/]/T,?2G=3S:P#$[(%VD&."( M7-9/HDI`B!+GQA*@*?LRPB,PC>@].\-D"GQ1^Q]*"1CMAZC8'USRI4(R$7U[ MC0DB\_;:>*RPEWZ*"VF?W+A/)NB'99! M71;9"==H/\)4LL"5CMS%(5K'7IFC4#?V!F-J/5/Z(?@4C1O:6&J8PW)8K%7, M'#1'HEN$)I1U?-<\G)1=/-/4#S/S"CO#/X#9<5&19("S4M2*EK!(!>Q@[E/L M2)$4>/*@I0Q?^LF*U[835\4'Y8IHQ6*T^Z&3"7"U(+68J5ZP5\%@"L%>E1NS M/Q]]=.?QQO5G#98G)SQR?R_?H-]M27-<69WDY,E+F<(HOK*HE$3&4Q>NYVEN M.7GX8TH]<5@.A9&BF(J@(!KBAJX9?SUPICV)@QN:\UI9+94VR&4P!(W"63`F M0S?/-Z8+OB\`=/H-V,(7@U&70ZL*'(@C$G9,;NX`6'$X-L&6&V9E]$UA@II[ M<\1'R7(WO\,9[^%H=\DQ3C-MR=/]!MJ.H<0,B;1.C6&)6X9HX0'%X)=A1VQB4R#(< MUWM11F2E6(UEL[^>JJE@.JRU(FOV<8661*$?4EU#S^X:Y6H(8#7Q=4BUQ2[S MTW!=5F8\+2L$<]O^>;-:\;JHW.Z%]W&X#'W>**^&3\H/8"PAU[^W^GKQ?1OK MCDO+36GL%;/'IUX69KP((\U*!79+G_-3MA#C=G$CO@!],!U$E-8K_)+=FV+` M65_`X6^MFI#(%PZ+"&"X2K]-0HQI5`$:ZS5>>HR.NH-%9X2__',B.E==*(DVZ0BV7,'&V1'&ZW(]!]G=/+BSCD\IW=Y37+;XXMB-M31 M18E,VU>YRS&9`[/=T!XXM%L!Q4^#3Q0J,-#'!C5ZG2S64&;HK,HPE-"H8$.& M,W+"]=SF3GB&=2!`TFK`H*=`TF@C@+=YP(`N`<#M`-J="3XE.9U`#9L#AE;, M-B30,6;)EWSV0:COJ1`O)1*=@K=F;O,4`PO.=NA!56O@2=!U3DZ;2;P9GBMZO24$HKFJ*UHT-G;B63* M[.`UB4"-"'N7M=CL0V!]TT&N1;3H*/LFJTW=W#(X/P8P-SO];*6^W^GEJ0G8 M?=@-3WLVZ.U.%S)J#L%F::Q10'278[+LW7N<<@:R*QRE//1?WZB$P9WS^]X+ M4Y$#7Y/:^ABHA0%UR.M!K!V6%D54PT=*/H3>71B)I\*8;(+-CFF/9P;;Y?*J MIZ1[=A('U=)&W/GTP`,_/O4CK.9-F0C%)\F72O@LTB1H-D40C:ZWY5C#2R,C M=H7(1CY[X$]G^;(NTC1)SY(TI;YX$#D\/]D`)GS&LA'B[2^C`"!Q$8-4=0]:[AJ/&OX M(J<20(&>!BNF(BD-8V-L*GCQ!:2YO"MF7RXLO?Z;=NO2?1O M<,R@0KL=QLBWN[GRYV*,4>NI"U+H%P1Z9F:DKU.Z]E*8 M](\T?TB"]H?L['D_%!!C;H+9&NYBZB!+&I5DP82M$73(MD5 M<"T&8Y*[Z1`LW*:,U+/0V;E^MC2R>;T\Z4[0+N-')N]):A#)Z51$ROE05DZ# M4*OY5#D4DT!-AA0:6]7'8EKSU,-?(\(H[\-G&IQD&35Q]]29AAHPH$FT6O3V MF48,)G(T!B&8`2U$6;8#<4DK0@QS8"!/YOI0;7E.M9O$IB<5U-)8RXF69\+]T2!.QJ;;L7*9L^(#/C893"7 MG>$W](;ZR3WS,]AQ:71,MP\@M-4V0;D=X15S2&,2)O%T@2\Z6VO,NH9Q7S.^ M=2F:&65TXC=`YVQQ4;+FBN+BF1=LH'8VU`04E`4U0[/-H'*6N`ILS"/%1$S2 MZ0)M4;4#C=6T8%VMS33G6Y=U_QCMO32X3I-@X^?%D_2M4B![ZJSI@$%;RCY4 MV^5VY'A23"@K$*"ZQ)D4XW(`G/R-8"\;\VC"J`XS@Q1EBX;F!AF"`\L.,D:W ME2VC*0Z&1R0G1AI3U:]1_&9B(NUXU^6-C9^LZ*WW/#8PK((#;1PU"+:O+/A0 MPL9BDKKIL4.8_=K'AF9!5ST/.JQ5[J5Q&-]GUS05%?H&VKL^,S'O1V^>] M<@9O8BNK76*2L(F0Y(^7?'GB"Z,-M^`?DJR!,AJ[9LB>^JKN1KSI\+CG/]!@ M$]&KY4V>P,(TG+0"A#\ZJ,&4EUX M0YM'Z%NCL9VC'9 M1Z7UB$4P*A]`OO`AN'R)OM7;RJM67!>D00Q^L+AFWR*?O)6*-.`N1R>?&OD3 M74SJT%D8K`_J=<U*'3C'M\%-Q^1HV:$ELDG51GE:!#KA_T,N,1KY"'RZ"XQRK+-2OYNJGN22;X.[5E,3LQ69AH-[Q]R&AQY3&-X]Y0_ M4RXGDR>:4K+)PRC\!Y/*,";Y`R5+_BSC43S+\+W(WT2>'+Q,TLK^W_.L+QI, MKM5RFHZ^@X$@9).&.OH]E2VQYB+@--=8("3DAB%/%.0SX3YPYW,>S6AY6S:A M6L1SE]9<_HF?AX]AONVU(X,N!`R^A/7VS(A(W1?/3'=E0OEGN9=OQ(TS_Q>' M[L7;KS/BW=^G]-[+^8CF01#$$+BFCKB6KRE34Z50YU#:'(0.@WD"[1V@N7(9 M=?EGK%GPJ-T;FN5IZ+/-%(O_)0[S3(8?376PM;T<\WF,SOPXR^8"2D=9[M'?`G:3(\BDJ:(B02WJ$HT-4&2!DSLEG=2 M^C2,[),N_,/^;A,X$RD%V>8NHW]N^$U"2A_+J`8Z4SU>*(VL\FB)A#AWU(U\ M&[V+3_*ZH^_(((\E?/C0CC5!=`F"BN[L7K[;"QM:&\U.DEH'!35%H@9%&JIG M13W>VCT@3%%[3*_XFS3ES8KN>.LH-([)6`DRC&0,$A\`=TO/>8F2$-[^'6+X8;&X!4I M>54:\I8LJR)V#>V"UR&Q%!L[-\1.9B"I`Q]O3?)5>$=E(N+IW)?F)TC]#5)^A'!^)XW/B`Y< MK:?@B!\E3,9TRW4FB?#_8-F3&,A^Z#)OI]3 MR7QPF8L_IY;ZH,DXG\PM_`";=^Z&$1R:EGWN&]'YZYQF?AJNY7=.-QF#G&4G M<5`\VZ:),L:F9D-DM5-Z\FZ^`Z2[O6S:#1UI_LYU!E`R],;[^FCE],T]")K M7ZH;"+1CI$)-T_DT]9YX.3`Y%%5X'1TR>9)[D2M4V$A2#5V06_YM=(ZD5I0, MRYZJY0A`)?R6I']-5*YP^ M)$\T%;?129:3)&76-/V#\A0X,87_)50U&,?A+-CM7*K8+SR652EN=N95)6L@ M'5Z7W?UG(]Y=TMCH&H(#L\+&Z.K[D:K;+XOY"!Y'3H4I.PT&E.L;H7QPN"`3 MH1;6F^@AZR=M)Y5Z3\5*)%UV\F%:,,U$M$(\&A(!Y4S^.J?!L:T'TP\0VI$Q M0;G=QZ><(V*%?-9"WF9DI)J(R+$9@N.G#7\ZP_%;,P:C:5H]8_3E-"&C3%P3 M]HO5BI%"/#]&Y>H,P?N&YEX8,V1I<:V"SN$Q%E(CO\=40ETK(<%?UR7K-59V MF64;&ORR3N)ZZ::NT!#0<&W&AI"A6U5)8;W>%>1*94E09,-@D1H8`G]I&A+4 MFJRIJ.2[XHR$#>3]';V^1RXTCL@(^>CI7394.`XF(>1DQ6]8'&>#%!^%=G2F M(MU,>2`+(K^`RH&8BV8-,B6;/./=//E=Z=-#Z#^0BIC\Q>5RDV]2BM<9F50@ M763'[$BC.\5U&D817\9ES%9*L^QJR?M"?F*4WS`]VZF3.I5_+QPH=\4`P58G MM6(*OX:0DV01D"Q?D'HBBO#&`.P*C!AN:='I]:X`@L:3,&5*K=M@R)$CLM!^ M3AC\,XY?&O?GE'6JJUXX4-;9`,%]QA*C23$<11K7S)@YS[&:%A]?#@=)@!HF M#";FV%"BW%G89D^ZTVW1K6YKFGQJ"`7*NO8BU[Z>;+9N7)#3;=G;<8LEWW,P M;EB[-`YA*!,+:\23,()6-X6\H6M9Z)8Y`-=I&/OAVHLNXT],*]P^T>B1?DSB M_,$Z!6+2W5-4Q>;K"$*H-7!5SN@'+(1((F$C8*#V$N*G&^ M):_8#'XBS,CMQ[\?77RZ79#+V/^61/RU"8\%IC0(>;I&\966EP%^M)Y$SHR. MU%,(&43E@(MGGBV]";,'>95:M:,UM?8FH.#?^.O0U#W7WN(9^7=EXD[76X+&4E["(!P(D5"(!(/B MZ#(1WL7E4%ABF[*IX`9X#%/K[Y?M.1I6A(MPQ"R&6PD;H^'6$,)8I,NPU0$: M;@OT2RSORK&+0[38?8P_V&+W<#VLN%\\K\-4Y.J=,VW4]0;56$_N@\)DG]MH M&LMP/96<=Y@J-*;8',7"`J_*G+4`NP56,*FUX>WF4!@!'&-/4=E+;2K5KE0A M>K;=@X%\R5);M(QLXH"FHF6XWK:A,>2]"F!!/(GEVMOR!`[45GJP%1X?T2U[ M=\I'FD;!W+TI(''4+6;%4/7D;G+91@7SC6%A5T=?NYD]`ED[;K8UC.QJ^*E]*]>NN5'Y33T:5;<+9H:T4&P09\MV1-" MR6`E"")A%)5&"BA$@B$%'!36;&H"=.H(\E@08"T)L"HNWE_Q5].B?@&FMU%` MU$#VKFJ@=NA_:S5,-;C0[UZ_!=""A\K7VDE*Q7#`2ZG)L0D<<" MD?4\B(SW=P9B@M1OZ90:<^^D2V1&R#)_E7:U+($;N1A[4T`\B-:R]WE"O,Q. MEN2I&`)O^^&7;&^IK=>,Q,9V<[7:A':R]`BIXLVA/XIRY:)%M%;`U!I##074 M4NJ0Z^RR+@?+9NN\<=9O0#(Y(4I%+?JJ,3J8S#K`"9D=[96M?EO:)U@C)/\D M^,]-EHM'W;?)21"$?-^\Z-H+@\OX3"8U\CBIQ["OO_M;F#_61H9Y MKF^#6/CY"-FZYJN_1&X34G^+\(^1RY@4GR/E]YI*C/!/DNJ;\K+SJI5"`%CL MU3$Y*R+MUX/E[>Q*G2)*+WI5H4%>&C;R-MGTB17V/@\,X^4)\6K&6W/&"^,R M"WHA[H=*HE8T?.*8F*#<^:BGGK0@C6FDG(?"\QR'95$YFY?B(H$" M+?#D#6.>->&YWG2_"$)>*^C+*?TL\>KI8A0 M[.FV/;@<9E=29\IO@M7>F99P[0)VY0S>.$S.(?(+I)R[(/PC57\11YY/N=LUK$J2`@JTQE0BM\^3Q4!2C<190R'?>%AO_K]`[WWHHLXYY6$N]V, M'4W2-<6UVNY>=NL!`1]!Y!!`;Z&7>CJ%JZ;V7.P@/Z2T[)TBT)H'I2\[$&C5 M$RKX`=`RF]'01'$H"#_B7NAC?G/W(?+-2JQUS`"Y@]E?=.O-;TYN[@@;@:.\ MFM&:C]^]>T<^YM^2F],%^?#A#$^1-36?J(/;74PR@DL_;^(TS.C[,/9B/_2B MG]-DL[Z,U6RKOJ;M`06:P="+9ONT+":0:@814WC!V?_=LN^9>(]]TR'CO-WH=`6DY$@BAA(^5N%>.K4J M\Z("&CW6,%IO(%C-9:#"8N=@]P."CE#H4#3D.X5'#AJHF`\M\'A%+U,:!ZIU M'`DF9'9%HKLG([%&&G]HC^-F\_'L6W;CPV$"8SH>"RQVU*(TMDXVQF2@WJ=4 M1#EM+C<[9H*>T/:1:*7.E7^?RT,=6=?--_?NIBFBFXU^P.M',. M3+YR:^$:GIW+)1N0[6J^;"R)I-T2V^L200%DO--A8 MF0&R+:M=S:G?YS>X'U_`['!P'&Z7)D<2F?TREDJ#F*"A2`)GKWW0=#+IR1CL MA`*?#*I`SB)Y[0-L^Y(A9#<]*_3NW!B3QN$])%'`SJ,R6[._?8E&%'NAP9HT M`V1;+->84V8&PW<^F0_'KTLDE?U1($W9V`VD8A(V`V8J@P8&S%``W1FPLR1F MO)RQG2Z3;D794?GKG`;&1:?[`4&9,1,4][FRGM/(>"WJSE83$40=A^!VG9:/ ME.3[3[\U)IH4\8<8:5;GZA_(4H\61GI7F"@-MH`58TL797^ M8.-W8AJ"XM,3H+>>!97A]G@<-DSQ-15$C2$R^VPJ??WFV5#T)BM7?9MTU(;[ MA=>MF\8$1W"4H!L2-J`I\A.0LY>HIQ+V3U20PU MK2#0+QH'5'_SD,741ZL+T^+@]KH"0@E^YKQJ[U%-\3T4-3#'$6QRE4D$^)D< MN-%U-F<*PE)%J6>;U$+F5DZHIQ5CRE&%[?=E2EML04%(E=ECA)/)+EDHI&ISX?)FJ#\1Y+ MZ_U'JN#.D@U+:H-%!OPXPO&YIFRGF?:^IU?+*@HG#YI>]E!V'BW78.7C6((& M=6>LR="2N`H`CRC5\))XUBAR=I7]; MI9G+LYKR2'85$P%UGG:HEL5-IR=(JPAR>?*0!XRL2!#BB5'MPP9\B,\A0=C1 MZUXP0E<#68#PGG->Z#AL[M`$28AOO`Y5Q_A&*]`1MH%_5W!']6TK?[9C.JC/ MVHG./EM6@QHJ&XO?:81`W;&E'%WVH47D05IN1:T@D'F!:@GI]_24XN&R`%GB M4QID[QFJ=9WF_9).QH$@,VA@(2%39-O)-G(BX1Q1!X;$R66O=!F"=*+!:#81 MVZV#WALL@@F'3;.?ZO+OB&-D5G*KCY;9".T(7^*<^R?!>?@8!C0.9/Z6E3?1 M"0#4GU"@U*XGSH>1MN,YH"USR15\-SX3JD_XP[=)'$)NR%5]?NQ5)RAQ;\#$4Y>WZ.>5O\ MS-72V\8)1O[V=UGWGC-!>>R]>*:I'V9V*4:&T*"\#6-D6RY]-:.*/B](.0E- MUO9@]*I0!RU1FB=E9XAK-1BIJIUX'1S=43?BO'(7T2)$.E]W1+H,8R'N/V_" M@!\+H/9S0=CZ*9X./':Z1^NU62D>AR_*(B_+JK#457H3WC_D5YL\R[TX".-[ MTXA0+QRP]V3]"+9>5?`I7!J+2;R-C9BV((V)"`)``W#[M.$O[]'T=!Z!2>.O M=30GI4*/3']F72<9TY"/]-;%)E7:,9F1W7B[LRC)-BG5:/TY,0)4]L-4F$F0 MS5`/3G)&WT]#[3F?:XI6F8&$K65FBK;F,->10P]W1)\7U?U;=N@3.BBVR")_ M=A)L4#S.1GP=5MOA'S_U,AJ<):LUC3/!&R=\A??BJN%T6P\ITMQ$B*%*A#AA M:*S6?%9V$@>R35X2)?=;33V5[MHQ#I8"5O?'"9E;!IURPT:#(X^Y>SR[TZN! M(/",\1&%;/(P$NUSPY@LZXPHWXO\3>3),3QGO])E(OEI!E=V4*59A/3,I*+O MIJ4@95(,55`2KI25.\VHKX?E3"T>J-6Y>%Y3/Z_OV6ZZDZ'UE\VY!&CHO\_--29533`KQT@>]ZX$IYF75/<*2Y#MPX_)IPER,* M\ZW"/,SO`RB6\B*.)$HRMU[!KS0K%8:1[92_R5*+:!`2V:$&*Y;ST,Y#I'O1HX@59S40O=*=-K:&".WCJK-3+<@V\9X5K`.4(EBMZP>?1FN@X7`&YG'^.\ZF: M]OV*>28Z(3VO(J24D>E_.?1ZR>?]/<,#?>S?M3H':N)OPNR/]RFE93DH\!O( MS@6]J+.^@N0.[3I?`>%+J`OCN8\VHR,X'W:TY%2I*L:E5+LDG*8">L+^(PY`GKYH`$/M4V"B+NB74#U+H8)NKY4NCT\D]2 MBD@>C@T$L6%W_8C=V80J;VFZ,N[6.^,*0,].14$> ME>$8GW`QN%('!)UN'VA%D35-PR3@Q,K#%25>3.B?FS#?%AZ;J,Y)0EY3KJ!M MGI`[VBPY]"TYZ9KT=7,.%V`&Y)[&-/6B:$L"RG\7QNR/71`7S-\`S_8$(['.ST"0VXF'+K5_(>>`^1PQ"4/" M#?4$*O!%,XGB`Z3X`OE2?N,_#NKX/)1JF]7*2[=;L7&CVT.KS3HHW>FN1,:*&T#B"KIEA_HQZQK`<^>TJG M\L,'E[NI(>$,UXY7I==^U:R;+;^(YY)M9CJZP%V>`3[G7IJCP[^NV2]`9>2& MKKPPYFY[`>7U;]6I=X=8=_0^C,7`.R_B;^MFHMM%'+PDJG73ZO!25?O4_3PY MJ3VZ_G#,I##SV65\+7C<68II]]NI4Z^Y#,GWBEI:W?E6&9V?U6MH+./339Q=)YS6"U?=F"UG"G3=-J-D8 M0[R<_.]-3,G;-PO"9.:[DB3:`^F+.H>:4*QV'5J\HS,D[D.ZX)2R"NTV`+ZX MXZ724C@Y8:K,Q.%8VD:,NNPU=B);C74V^'9X/:I=SJ$>1LW)[>PJM5P'*192 MJ@M*Q%)>Q)%M.-E!287@2M:27#T4^N>[G)V7?B_WFM;$&+FZO#6P1(@,?F85 M%;EUHC[_3;\"LIJ_SIA:9_<.Z$7OWO*_K MR[Q@D_(SG8QSOXCPPOS4[+6'9R5Y7Q_@C3("^I7A\,.[9Y[)J(T[/<]CT1"Y M$N:1?Z='Z(F6A?[X/!GYG=UQ(S-T2,FOOQ2'";`CN.B=VMK]DUSYNCLU3ZIW MQU8VN.M?Z)WU0JL,@K.ZM`8ORI#UG8+!U@571W\=_8?SY_S3^T\O*%^"!]]E9K/O#KZ^-__^'C\=OSK]D:UVR/1*B) M%QUB_V3+8:OB!8O$BIA;LZ5>RB"$CY2L&"(/S&&418I"-I3&)/"V&::J0C!6 MI:?.$(A).8#*^KVWU"H,9=0VP,4F\2A\Q-MA037PB!L:"3:^ M70+1+(=SP=0P7I<,E3#.0E_43G5]I:1>"`HO?282._/%JR_+&N?X_&U'!*[K MONY19(=>K3NC%W8E-#W%<)XZYE2,3BY\^K3B09X@=C&!."CLK^`%G`?:1'7F M]@/;%GC*:E2D+A$!TS,T7*1ZB4<;A=9S=8+I5GGN[,<-S=@">`L&4>#[(QU2 M;Z4;"/0!085:J_UU-:YH.O!%#IV^Q<#PETZFN)Q37_R)'+\5RNP-26OL9`U\ MV<2&:`EU6S7NR*][:Y_;!BPM=^(E? MQO,[_9LDBMXG*9\TV%]MW-U,3O=E%/S1*.BG%[+JI<"FFLA8C%$+Z: MVH&M%D2^\"618DW.U132?>CJ!]-4\/SK4L&W=>T;SWD8-=(M>E">ZEP(BZI><>SFMNLTB"B;TK_4%AQA,-FJ&NS%EX"'O M#CQTI,N)I1*^UD8[^D,H`P*S:2WZU43C)J)!343>](LD,(BGZ+!@Z3\SF9U5 M-?WG)#)`@Y6#)/1+#BL;NY;0P693O_(E./Z_"HR=-R6U7=?+#4"W-@#.:9=+ MF;'+&LX0;.\.:`,VXAN'6%)U8I4!')KIU!^\J96D]"/JLN\N`.`%-M#@Z=CJS4\F%LE85W#V<(,`K[K![]E/KH M`(Q$[P'F?9(N:8@ROM]>VL$Z\X.V`2[B4ZUFQD`_QDQUDUW0>O15TQ@BZMB" M-3Y!([$X(O\J3?*"%/B&\=\!1/ZM5GMP7O_4FP5N`39"J_W_],RQ&V=Q%L!B M0C`K!MB8_P`=YM#0\)(%WZE$S3;F*@G`S2)T:#BJJ3)AM;MRF$*L\R"28\AO?E*A;:O2(B#NS0Z[&DUIU52+WPL/CNAW2TC6Z';*D"N^RW,'VYH)/N4/H3KV^0BSIFW M=9[P,M*FQU-;L%#G2'OT37CVB0$A32C\TD;"(5\D)!".GF2K3#S[8=OOCNO/ MV9'-9["'^=][LZ&U:PN95OV[8@#.^G:]RS]->&T^)F'E2+7_!&X6NAG+R!YT MC3E+DYUVR#PX#YB!;G"%-8(,<*P_K,+\'YC.(&-WD%8[F#1V<%W. M1G)&L11(]9'%3AK'JI#W8>S%?NA%]8=^9?_M5R.=BM(:+I1U'4"`;N:LIN^H M%PX!@8Z9"_6/211MR=]H<$\!HQWS;NRRVMBFUGGD&PNK>J81/!/?9:`TNW/T MQ=JNUC1E+!+?%VLS4`S#:(>/%(S,DW;S3;RLZ&6<$#W_.Z?J! MQJ=I\J2^3.UH[MV>!G)T[5Q^^^)4#")B%*9CF_WJD9S$U%RC:;VN8AF7;4DB M+^>9$&F^O4V]./-\$4\]W3;_,N3:R`(R=+33B@CM'AEB"!%CL%XMV6^S8<\, MRSV&86R[>Z:.F5`^>2<2/0R([2Y(O1%:-U6Y"V-B3XPU-U'N#0LP[4^&C2*U M46F=:*HA^.XVM-MA$![HW@MWVH6_&F*G)X5=[)2#YA0H?;*[['V&*?X*:,-Z M"6>B.=J$=LX72H.C-=*[DZ&=HGU4E-P":'`LR&GCUG1MQ`BS4X"3;U"N8G5P MI'VJ4$P%.5@JT5!QAAQ)V%`,84$['$[6:1B18UZ*\QC3^=AZ$V016Y+$,.$> M8Y;N/2QK16$JZ;QE0X<$+Y5`0)U$#6H],BL&8^K/:8M/(;^BENX/2/W?/L[K M]X-[V&XRJ7A*AMJL>BJ\S6JBTY)^Z.L(8W6<)GL1&&X\J<$ MH^%JB82AX=J7AU'W%(G_1^NIVRU]SGGB]UV6IYZ?6UDQ,XB@)LT4Z>Z78J?M M-[3%5';H+28CRI>9'-E7Q=QO$%U7CD-2OG;V&S.1W6I:26F_Q;<1T0.H*K"+)_'-%2**%$/D"^ MYU/:S_;GMA^`Z-\^4+;WU1NEE#F@X2-CE[BJEI,U"/0"6F7WZZM9ZY>IE=58 M/_(RRS8T.-^DE:%TGP-TX%_SSLQ'H';7/?D+::HE$$/:: M%3\D@3$+&=3D0AH+X)CT]&<.F5XM;^@Z#7T&^71;YY+<)NW"'5;>S@#PL&GN M0\C1RB:70,@5+XU9@"&G6])(/[I-2+/.2PD,C]\S*2'8J2>M"+%,TLH5:-:X M0>03S8?\W99IKXH+\J23$LATB@,EQ6&3`37 M)8:^Q%`<6C`X2C.CB,57LA!'C;-D+HN3GZULJ^T/;AHUZQI@`TVS$=;X'-B, M]9\6L?YBW$ZL?R]4U6P0@JGGDV.RUM7@T[H:?!'^P1?S)`0!9/VX(4H#87FO>]\9O@5_[#9.1,P;$0R5C_&7-EGQ M(OPVZ?I6;[Z@#2@01\\8347H/2-E(0#F=G7+J?,;ESFP3`LLF:U/]X73FP=+ M>R?*!9I(?!L[\53[*E:R>0"IS?(`<+64^O%DDS\D:?@/\_RY^18`[K',0-(9 MDISK$UR1NU=_$$7,TR4YJ_YQ/IO,BR)?LS^3=9H\A@&C'+_ESGDN,/,.>".S MZN:%"^ZB./;B\YGF$NUY^U[VR/7AJ<9'+V34BNC[)!4)SGVNW.S?/[CW'_T$ M=:(?R^\*?2"^?-AO(>S)6M.D"/7QT)6W0Q=Q@"1>UE"F.TGAX%Z=*_&>YZ6$ MF6R/.HXV6L(SL&72#O^X9;:@!A!P7J`6Q?:910XG8CQ/J*FN`L04%-[2*,36 M`K&=7+Y9$!N3Q#&? M?ON2W(OF,ZM-Y)M&)ZST-EZ!`#W\^)I%3]3>=LKA(#([H>S8H58_ M7KM:JF(Q#OW(2?!+2OS"N/$L*UFJ"G(`WI3.A2*R6U(38>R_(S60Q/E?R5H& MN\Q@'L)[6#4[FCV"19`G-1&Z1J\]$3DKCC!&YKA8RO-D[U@G>$.P6:V\='NU M_,PV>Y-=+;G?Y,7;XGELX2II:EUVI.+:@83)^;=%NW50EP"X.I(@^$\%D/+Y M?7E@`JQ\.2/FHO28P#RI,/\Z*Q^=J\Y10-GA@[AGHG`%!/0(&2J@7Z[/W/!PF/[J11MV9BV7+%\RF9T972WF(%^86Y!Z\C?GC5+DY3)( ML0["%T+$2OCIMQ)%N1AXDP](]HI47D&J)2?5HR`5.RZ#U:A#121>V_S)C%![ MY8#Y2XB4KI.TVQ=U)(O0XPKFC\D M01(E]ULD_I)KS3S?ZW9+M3R!9_=;F#_0K:?L,5:(RI>_2T2[/BK=FA^X'>F:M\W>?E"U(.1U+ZLQP;,L_U4),=]YB(7)XAR-Y M*T_`$E%OE6S8WC9=X%V4D?F]EB+<[P#;R:^[)V@GD0!.%:\:BBR?/H_8$AK4 MXS-C9%N=Q,N)RM=FI)B,X-798"S;&?DH7I>-PHX=)E M&(<<]L^;,.`/]=SN'NWF1K!'679J1OLBRTK'3/@NN"?:=&Y=F M=;O]2Y0=4B!S#4?H!?LW8>9*88*;B9U&:^-D'WN9!#$E8S%30U)$N0RF;MM(NO^L6.UA?BEIY M.H8@,3S[ZD?;K/)N-;>9=H+'@1F/K9=EB1\*A,5=9EY%>QA;(G)>QF.Z4X2W MWM=&*`N9@V(GP<8OO\OQW+]ND-+B* M;RA_E\ZL`!OP*8G3\I^G7A9FOY:*XY;Z#W'XYX9FM[PTHZD_X60MT+6Q9R;T MOI0TY-D%YQK5>W;`MN[T MP3D[?#QZO'CM99SEJ=#?-V'VQ\ESV)M"900#ZIJH![%]^:F'DWH\^<)'@XB" M/:%-PNX&.P7!>F=)+%Z;W+)/GB5 M33;12*L:[.#!>TD?PIA>YG1EK%EG7P>4=G9`X!D])/X9(KX#^^(8D)J-\ASE MVYJC\FV-EV6;55$!D/V]\=2F?#@C_L0+!59W1D4=#[$%V>8NHVP!<=X,UJ"Q MPJZ4@]:2.](,,"JWY)ZR:^5YR+O3Q,&-Q1L;:[C07H(%`32JK3%Y4??O+>>3 MFSE>XHSI>30"ZPJ[H,1N&]((I!30-!PX]!!JP-9C7^7<]>=EW^WG9>N6>$O3 MU?'',`Y7FY51A'C^5<"]WIF9N)W/%GH:!I4/>CKZ!9%N;=-H%LX^3XY)L0`4 M[WP<4[@B110N=]X7+\AJ)JH,?!WSHED/R3V!,P7:\[;&@?;$:6:\9X6945^_ MSK\:T$0)%\2&DGVY`"SOBR`HK3,_,U%G>&['RV=%9)DESA1M?U***RT+>YW& M@S-_H\$]CZY4(9HQ=VO=`#%=M*E0-KIUDQW!Y/0%:0!`\"QK#++OW=1F&A)` MGAXM9GN4^X;J_E0KG=:7J3K1!(BEGFX;5QWO4Q%4][>*NWVS()8&))H(JA;M M5BW3>BBIQ@+>_(_>AD%AQ-YM!>#>KA4ITP/T5S4:4.!7H%HTU:'^!5%P+F"J MP.!-L+KRZMU,6%[-JDLWNPKZ5C#1Z%H]XH;LNW,+KZJ&C4?Y&FRVG?;MWVD0 MYZ'Z\6\A31D%'[8?Z"/;"(O<0$-HX$JX#UD=(U<3L.4+VFVEF?(UV4=@_=M> MX+"D0CO@*#6RAA2:)((&0V/-.QRT\<.5Y)F0O&.S/A\F(,#U M<"=:.N4K)RR(F$*.<;0"&8;6_]DD/'HL:DEEO`WFB2]"8Q^]]`_*>P\4.(+T M'K!F)2NKHF1%6,GZ;J0'WP$*C9GH1--XO?OJG1 M:DK;+W&BDK2WN.W;VY'V[2V09-77%8W^"/4O/]'-BK_FT8U6\.2"\_C6I'AKPLM=!A?LOOY!6DL@'SA2R#%&I`Y'@Y)W5"'_@//4!)G M]-U&4J67M@QCCWW"BU#F03C3!6;.T,^[XJ9L+?H5KOG[I\@?GF2:0_,'!_93^S__"GH^P/ M_P]02P,$%`````@`88)N12,45KB".```5W4$`!4`'`!A1E*Q2F[[Z0,4N,_'<_F_OIO]?'+Z M[N=/O_QM_LOIW]^=?7GWX0/]3H##/Q[=!+TC<(7)K^^?TW3]R\>//W[\^.GU M,0Y^BN*GC[.??YY_W`U\7XS\Y37!E=$_YKNQ)Q__^\OM-^\9K=P/.$Q2-_3V ML^@RK'DGGSY]^IC_*QF:X%^2?/YMY+EI3BDI7.^X(^C_?=@-^T!_^G`R^S`_ M^>DU\=]3&L11@.[1\EW^^5_2S1K]^C[!JW5`PX[1\M?W;K+^\8'2\>=/ M\Y_I['_9<>;FW`9Q:L$4J3[Z&;$?E!O@:4LI6Z!?3.C0F%GE&* M/3(F6V,-I$\!55VP)^"5*O!BO*1L7R_,LP2%*$J(!OF6K ME1MOR,?Q4TA4ON<2Q>!Y448T0_AT%P4$"I3H:)=V'VJ)YN>(+$9DP4.QCDJL M3&M-Z<=4BUYD>&NIC+P_MH)S]6=&5+J6`-8FFP#GG!Q__D6T6I-=J7M"<19H M"=;O;AP3H=,1YG)*:YF(\0M!X@7=8O<1!SC5W52L^2V!ND<>JNS!.`K)GUZA M/36@DRP$JKEZUV"F-!G5"P_N8Z`)>CFIDSVL#9!P&4/[61NHHXE=[.T&G..O M`KJ!+E'JXJ"__;/[GD%#0!\%UFP#^[D)+?>SS`'P@%[33.M>PYALW&;1IPY_ MC4ZT7T,`N>MT">2)*2A/.@5S9@K,6:=@ZF\8I>4,'8`-6%Z;:A:4YI`8!D2? M<9P%NC`2FAP'@F4Z!%%'M,3K=`BDCBX1K],AD$V.7OEJ6@"S7-=!'!=?"]&3 MFR*?.JX_48/V*FM&VG-<738DIBYK1=#_3(*QI M'4YM0NXI2+34.D8)"M/<'+HE8%0`).H,A3[UGQ>_T@5:/FCESXZ15_E,0!_Z MHEBFQ^DOCFCQL\ M7'?]D<+^$05ILOLEQ^;#SR?;U\=_V?[LE$\.N7^!`3Q[H+,]O0\Y>!97H79C M;[<>^;/&ONI3Z7;$QW7^*O;!>\9!R?EE'*WT*;F#)9+@\2Z*R9WQU_=D1I80 M$*/<6T&/98+<$L7Q]M02`)]#'FP%&XA_Q9V77C"BD+I:SUYQHL).UCQG!L)= M/HLDK.3@,&[.'B%U&:U<'`HXRASOS(?!21Z'V(SEH3)NAEY$X0N*4TQD^FX' M;NX:^)+'R@A8*YGIG((RFHI>/OH(%TPC?QSSBOSD%";$/7K"U'((TZ_N MBF4&\88Z?Q\&GRKTK_)*`#IWI_5!\PL"=NP&-\3(?_TOM!$2_6BL\V\CHGH= M=OX&Z9;N9P1FG\)]';A/''I7QCC_&`6=CV'>T7?6,WTOLIBB=8T3SPW^'W+C MJ]"_)"AP2,T;[GP:!=4%X.\8,.^9`;NKX0-9ED/TPR'.R<^CH/0QS#ORG@*1 MMW2-"H2;.=8Y@?$;-"5X#?@=Y?\&1/G]9KLFO[!,2L%HYV0@]WI%ZC/`W]'_ M[Z#T+\1"G0,'XYV3@=S(M7APA,"."_\&8C=>XP#%%P2-IR@66XV5D1Z8GBRRE^34T>TALN`LF.B<#N>2JF?$23'8, M^L1FT,?CQXYCQ`T]@,AR9:#<((OE-0X)0)AHDRC!DB<3G>D`KR9G24*(J@!_ M=2#0JXDF,3FNGAHJ5KCI"JRV5QEEAAZ-!WXOJ7-&Q,$Z[%8PDN9WB5SHY)^! M'T.XY.?XR0N(K6#.-K0[H=DA^(6ZE+^B=$L)T6833`-^]-!DI@038QYS4"[? MQ6CM8O_JE<:XHK/07Z3/**Y02L!LA=G`CR*:/%=#B.^K'!/K;\(7@@ZYJA"Q M%O#X1$F:B-G''`_\%J/)1QX*?)?JF!BJ MJFNK2@CVD4?W)#T"G>^1U61<>AB'"K`/"\2^X,1#`;FYHRA+OD:A)^6E?#+P M>Y+J]40)$3LLI1O"A?")AL`4^!(==/7J!1GU)7V.(O\'#@+A,2J?#OVVIT-=4 MD2E<93DSG!-8]U(CW@IPL4)@I',;L"*P:&^5CA^?%F>8^UUW*.8%U M;YDPSI20-.;IA):4)B+!(Q`CQ(V_'Q.W;*'QZ0/&*EE=4\&?41SNS$7JI M.'CLO1GCYJG.OF4)]R@=5"PT2H:V]D\-X_U@_RBM]X10G^?,!I)"WO85@8V: M'8ZK0S6E%)7!GN#,!N.BXG!+KJ6KV%CQEL`T,)38+)GIS`;CJ]+BMP):QMX; M&MUZ.M3GNGK`,C!>CUW MI71!WB1G/N;<.S%>=CPA5(N!_>8&F:@<)6.T,XZLRA0ZL:\)*%A!UA&6>^CPNP[USLWX07[AJGKBA$F3/#F4,786C`5P$N M=MQN[VD%^1#Y5VX M@1HVEC.']F`UX"\;#RJ8Z\X$47FQ[2^)BUUDZV4#JOU2[#D_% M8$P81T$0_:"DOH[BRRA[3)=94,_W5XART5EGW*5D-#&UXC94O>D5):3.LO0Y MBO%?^TTNO>H>3QQ*K?Y&@B!%S8[K4Q5-HH(7<4XW/[\FWJ$XQUQ9!'@+#*78 MOP%1$*!HQY6+)?DW29)I:X)B$G`U'/-:H$3+CAL6"T5Q"47%F4/I$V",\57< M['!MUTI'*IW[@EE#Z3K0B.MBO.R(LP/K]W/UM)J&2Q7*Q1 MG'\$KN#R34A`1"50"FXUS@R(9I1N@))MBJ2X(,[12&!O&)^"O,>'&OA6N+AH M/;W%DE9M2KY%@?B,JXP$=F)I\Z\.OAV.JL]QE"1W<;04OO@>C`)V.6DSK@JZ M#9&.VR,G?-K6F56I2L^=`^Q&TF:G"!$['$?WA!&$B,]GH7])SHL@RDNF;=$5 M1F4(Y@$[C81=IS"-0KIJ')@QU`#[K)0L.ID+HXU6CU`A9'[T<`>G^:G<04%&T*J MOD9A5$5N5]5?;FQ)YP([>K39K(*0'5[\FS!%A"D[.X-F/PK]*+71T$68E5C% MYC('F]:&UJ>"KR%ZRNN=@?#U>Q@C-Z`/3I]='%(]M0CW*8\B+2V9"5V+N06_ M%3"SP[K:'T[7A'ZTG@\.,T*OO>_V'"VC&!7C'MQ7E%R]$N(1Y''HQIN\42#- MF*25@*+<,-WM%:F3M9.O0M>2UCY`.J:%L7=#0(.C1'V[?\_)U4?LE./,@*Y1 MW5`XF'C8\53X%:5*%X+*..@*U/I&XC'TQI[\`'=E66.L&K@D8")G!G3E:6UV M"O!H7WUK""9A15[/7EPB9:YXQ`X3ZAK]GJ$<6+ M92UH1<9MK76@2UAK2X$V=J5TM'?@PI4'.I;]2QQDJ3!TCS,#ND1UZUU_@$?) MV7&_JW(D>HNH3@R?YDK0):M-[7T1?J6,=!"V#QK?1WMR7P?1#[CPOH.PS!(8 MO=39VC2`0#_:_)J`<1=']%KAGV^^$T+?A.4#TIF7D@M'GJBM\,"BO=APDF=9 MS.#;W?IH6A$7T)0@*;5F?\_69+F6O4AND=>%'HX0!5$ MR8W2F(KHXG/`H8\F!:PC\MCQ7G2)"+`>SOE+_@Y0SNC0/UM%<8K_RG\7>0`5 MI@.'77;%?HXK48T@5IQ<.Y<);36_HL\9,FEA3P".U^Q7/K@DL$.=T,0W6OID ML0?2#>1^7MVL2F]!8`C4'N4"QV2V%&4HKH3:'S?)4[R&EQD5ZQPMA+= MIV1S@6-:^SUP5*AA24#LBJC+N'!=W1"VAD^8=J],$I0F5Z]>D%$/,$V+_($# M475@K76@@VA[MEYT20-=)H-S2.VML+KUQ3N71'.@0VM[/(MD9+`C#J[#(&Q8 MUV^_^D*!&.U#[X80H;5'CU9/H+8[#75/-W$BH0&[4%H`-F^Y4> M=9K8$>9'B$BV"TUG*?Y[$]XC0J/,2W.CGZ89QR^B%%NU!:##=7LV691I8DE; MSSK")=VVO2'4RNXH+@(=+0PM32*Z6!*&6$=ZZYJZW**PR^,*_47ZC.+B/J`E M72H+#B`868?WJ@*DBKH5R8UU].NEU;4$ISY]`%',78@)&]'VST[#E(J;\(60 M.HK%+1*%\P80Q]R%'!QAV/Y]:)@"<$$.=7)\QY=H3>LZZDG!\>0!A#AW(0HL M-*%?A;J2A]WQN*U+J"4.1W,'$.3)5(S^:R<]^1I%&4N>9X@K.#-8OVY#%;'G1P-F*T&QUXAE1)LX,UK-J5%;T MT+8C;IN#\[8WAIE#2+"8,QM,PY_VAY`$3^B`;//'T#ZBYZ!*BN(!Q)SKS&`] MKPT9*S]ZN-A:D/3(QK-:48G<^XH?$.W=W$A,9`LZ,UA7;0^RHT(".XXE%OXW M(:&>&]QECP'V%DN"BJS%I.(:SARXG&W7DL/%VKXCZ1:'B%:T((`+ZTIRYSAS MX%JW70E##4L['GP.4;Q':W>SK6DBJ6HMFN;,!UEDH;T(L!"UXZ5'G61&KB_. M?)".UV82HH>VL4D.V0]_/5EHJC^DF7$;QJF"80KTZM16<^1B]HAK( MV?':?]#(X<[%H@*J1R.=.7#3:?)6*VI-SM36<$YA78@-W[%TT(-.S^8DY.^3@F]" MFIV7NS>(>LHH/+_C]#GWC`OP+:-5D80-D.*5"O-]7$"Q`[ZH9'0=Q6=ABO-2W>2?+P(W8_II]!=Q M3H']>FWYK8VMN4!*N`?H@R)7)X+#_'"8\N%%C?$_K;)8E7O\4Z%+K_IG`+'1+8]1+HFCKDG),"@I_U# MZJZ'G&(,G'"BU8'#:7PCI";7CC_"Q92O)0"ZC6W1*?"GU>ZC,'\9?,4BJUTX#[CM M39U%$E9R^$YLO1 M6.#N+ER.\&R4.OA6O%A6?;E2-K*&`_=AT>0D!P-C'FR8K;AWW-)7V)MP6W-! MRD_A/.#^*)J,E:%B1[+"/4H)%9"_ZT4KY3![`G!K$TW6E`4$'J:KT]FZ MWML9N!,'FS4<-K*`MX>-['9%>21Q7K=#[7F7/1>ZU8;V;I4A8T><'@?5K:`W M8_K!9.BV&6J@`95NN87Q5^Q7]R/]%?#-3F`_=M<*4%5%!"#HR MJ`=+HH4`'"T`W4U"G:L-K(H*EE98%B)RE<&QNVZH#;5#;1WH5A*FM`03,1OB MMX2;P(!8%*5VCA*@-H8/"S=.!&"DN#-W=HKUL--!52E2QH$BCB+A%LE^.4W+UBF(/ M)\S(^<9K0;?&,*6AN,A!Y\;VH)<,"8E@,>@.&,TXWT#G<+&WQT:Z1^LL]IY= M@MA9Z-^C%,<,JLK$1VT5Z"X8VMI%':WV+:X')@I^KL;"-VG0ME7KX1)^T;D0U#^E>[)@MU< M&0?=1$)'@=<`MZ3W=]M`J*'T<5`]@VO0F^NX#5VEKE4H%'`#!BT^LH`OV=CZ M"9S%QK[2#B]1XL5X7214GF<)+=U-T_F_9:N5&V\6RV_X*<1+[+EANNVP1PV" M*,`>]1#U';M>@T`A!9$_"2#O<$?B`[H3:I^["4[RK@LE?Q\(/\\#<8:W_F+` M^8M"5G`V7R,DN[-0^]J8GZ.\N$;HH3A4WV8:>#GA4F_2:M+1-$218C!77/G@"@ZJN`J.ASS@Q@I4:_`H(Z/);OEG'H4 M:?X>"I-\\=Y/D)*Z>4^\$HY[%)`KH)\7,,MO>(\4TEU-(963IM7"$">2*L#G MAP`KG5SM5H8^X=HRDG<2MJ;*^'7`+B"\]1UFMY"2,2B98>(^LUM=>I>I#82\ MQPAIPKK-L*`?OU3NRU+?8O<1!T6\4\_J^-K%&RK$CF@9RS=F1DOH- M2^#4[COBJ<#'@H30W.N/%*GQ[Y][Y*&*0SB.0O)GD><#Z!:^>';#IYSP5W$< MQ1<1H:67A[]H.8KERP!LM*_H!X_@M#E2`?)->#@&AQY>!TC)A#.Q_&#AM_A&Q.TU#U1&- M-G+NZRT`7+:RT<.>*F+0U2SRH(V5%3[7N" M%LNK),4K-Q4&D58'`E>P;+([:PC8D;G/Z3.LK(V5Y@.7N6S";E6\[,C?I]=7 M@N-C@#18SY\$7/VR";^%R!A+NP;NL/E"B!?%&K86;PIP#-7Y)\E"5+1QY(9P(4NM2TH(29VY/S=$#:$3S3EM<#S&H:2@-DNH`A=G0 M!3J;"8`26N82E*!+WH>^&_MW<>1G7KJ-1]E(F2^'S+>A+)OWC/RLX!< M_+ZXZ;9H7.$0>$#QJJ2H4EZ-YE+0`?J:*6@-T!M_N!8[VP9HDTTY-S51W&=Z M'`)^1JWXIR*\\'Q3RP8Y^T$L?FF/8E/?@-[F'>7AF*3/N/NP%JB0KTA:)%?& M0;=$-LD]MH`[^!QT!-RQ/'#T2C>8CUOZ MKE;K(-J@PT*FTLZCW#G`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`M\"YXR[W:`JC&1-1RX`JPF'SD8C%RS7D0A.?136M-6DZ.2F=#E6[5WJ10; M8QY@P%W;T@JY58C8,O4)Z$*O(_'V5.AE3$1UE9%.%RWE%P?Z_)*Y@2R;P^A' MP*O+FI2&JL!U0RPKW`=G01#]<$,/74?Q990]ILLLV&*?[-MN7&0Q9:%(]^FL M`U7'MB,YX&@W78I8(4]E)X][]\<7*B"M[W*!Q=S.WQ:)7J_ M1_$?-^%=''F$CBJ24)D`5?861A1JJ-O1B*[$KXQVIE7!XQ=A4SK^)*C*N#`R MP43?COYV!TU#ENP.,P%M'B(2$K45H&KK]BLQZK0PUA@/\$)?^"V2G*JYOR*_ M!B1;=P;R3P1B(YWKG,!X6GL5&"4J&&NO!RXJ#!=7@?!-DF3(_[Z.PCU%FKC_ M^*LY)S`.7P!QTJ:+L09_XW4NGJTHT;OS+!;K.S,8OW2_MVY3E+*CC^$Y#@** MWTU(2$`H3DL5)^G7*/2D'AW95&<&6!&E+W%2(4*'?0_[BH__'!$DB5KV4!QJ M1[MS/."':\H-BR';43.-]L& M(QL%#,03H7LO:+98D2)CA58\Q'+?2N8>K;>])Q;+NQB''E[3'JQ?R29\^(&" M%_0E"M-GD2>VU;K`F2MRSLLEI@G.X^_08"$!2R3AGL>C`). ME*M07L"<$MAQL^>+^XI7V4K*H,HXX$RU(_JSF70,\,C9A$,U-AV.`\Y`4V/3 M$<`C#WAGJ?I;A;!FX;S!9)DU.,ADB('QFQM33%!2C0RN#05.`I,2F^')9&-A MQUV=H+Y87A!8<7KM>K1>TV8;"WH>Q7'T@WH!W37YEW0CNIIK+`.4/";B).?N MK8>4M?)P$Z:(\"J]=U-TF=':3'(8MX49D,EGID1``8R=H3)'B*K MR&"H9*YVG#S,JFH=FMJ099)62T44&\_LKHX"3G-28`(':&,QG]WPX"Z+O6X>!@VT80Y^]%\L=U#R.5$=SA+WO\#M"6%>[ES8&."S3,6)GX MU+$?N2SL\:'5K!?+!V*$)F0OT4<):4]IZ63@\$,AWSBL5L%IW#R_R_MNH;O` M]?(BQPH%85D3H+M!*S&*S60N0E9$9E3ZHHNLZDK_=.#6R[WH\6.,1QX?V45# M=)&Z[Z+_.FPT9DT@.(="-YB/^QAIUL=CX&V+&S*2+3;'F`_H=$F0]]-3]/+1 M1[C@./GCF-'D)^<6/;G!%6WONN&<)HQ1P$7_NSU+V/CRX[6ZY4\!!%=U'P\! MBJ#DT*Q.V"-8N1NF]4/(E_3^\3;PN,JK/@@JUI!%%L9C0PU68&7#H?NW+(QQ M@JYQZ(8>=H//<92M;T()(\2SH((`%3DC!]Z.^%^J2=&?&2'8%2T$JG`!XGT^)@[RQ(%`X_^(19O*[!6\.5$BB"IN4&;M'9=PF_Q%J4M.?.1XJ/%&- M/TH\W2,R9<6_W#AN( M`:?J5%;%W^2,ES!*7D6PB:,@@B_`L MUY$*$E:<5)JUR-Z"@ZB"KK',M['4+9L-IG"94N6RV=A=.\U*E\V&4[MLIEB\ M;&9)E$^S(F:SX50Q$S#L&&1['DAJT8BW"O7,Q!.=&;"3!2X$MT(#8UG#IDS7 M6@*$8BDTZ41G!AQ%(^<%RYA50:`EN MU68H5[+LGI0COBO70GMJBCPVHFG.'+!N6YN#78;40,NVW:'8HV1^0K0%UJ%! M.I`;Q5G#ECHK?'.U\?16$$XDT8;K#/%.:7ASR^\"6#-R0.>45G-.1 M^<,:X&>N[EMKY;Q+0,;Y\RQ5S?/MWU0.Y@=*N?C5*=YQJ5[9F0Q7K\2>Q`GW MFJTVT3D=F3M-':V2W:U=;#Y:XC`7M,\9]JFZ[]]A'KA)4IH:B_@>/SVGBRQ- M4C?T@G./`F+=^KD[*F?!XT$-ET2E&7>K MA4&;=C>O:Z/>VKOE-Z`;@+=E+D?%FZ3/N".(FY6=&TI;<0/<8PO(,;KC9K(- M)>=@,PMJ\L#1*]U@/F[INUJM@VB#4&Z/+'+0I?'OW#G0]4L[8C!;G$14L"+F M5DI.'C5O50+P6R\.75ZU^W/."(UL+\C*HT'YX'9&[I"K'.>$[.XBD2(*HB>5 M_@4]?!VX7*L9&3,LOUK4>]NZED6JJ][3H&)] M&ZI$N7U[@D==8]EJ@&&MG1.J9U-*``)XC7>K-\0!D:$3]\:R,_HUH`0@@!>\ MMWMG[(EL1X+B/F9%3+%''8.3)H.+RI1T]U'PY@#@TM\960>:GMF$XHD2UGQK MIY\/@S="@)#E_DAK+/=T-/+,M5'Z^3!X-P<;Y7E/6F-ILW5Y'D2<^,D4*#X% MBD^!XE.@^!0H/@6*3X'B4Z#X%"ANQNR=`L6G0/$1G7/C#A1O?NL_>WJ*T1.Q M(0^V5I(73D*^M"2\F>4M#-\V3)ZWK>*V9#FH4/`UD[7X-?TMH/AKTW)D6/<) MJ&5*9-Y8AT*+/5#P&%2H]#8&ND>N-ASXO2!8SC M?$X?\LKX&E`@\SB$EDVO*21Y*!8"4(#Q.(2722YC@<*%D7`5^F/5NWD)-GI! M[5QN:]^""@(>A]PRR64LJG?DV,;N::G;%D>A`9KK,IPW7*<)TR7*<,URG#E2D@4X;KE.$Z9;B:D;Y[ M1-0QIF5$*M]UM. MS2[3FC5!&&O3IM%LH1JYC:5*6VK&50DVS"-*$\;1=GT:Z2Y38HBQM.]Q[L,* MX_E'C1:3V`0:12 M/)`U,X+/E%`Q)53(OS$E5$P)%5-"Q910,2543`D54T*%+0D5D-X3C;YQ]4YI M`W=&&!4"%O9#:\ZUO6,1K'YWX[SZ+)>IPO%##_0WPE@9!>R([7K`*;7,;D(? MOV"?W#0EAB5S/'3H>_<&)@_MD2Y+D1NW"7B)8^21M:5'?G4@<'QQ`RZQV5W#"C@9BW.:7SQCM+QZ M15Z6XA>"^!)[**8'&R$_]@G!Q(>[XG3H>-;67-5%%KHQFXC;USAT0P^[P1Z# MW\A_=3BNM@1T_*5!KJLC;(=%ER.]6"-:3#]\VB(MU>2"6="A@\;TN@1'8T'B MC>[KG&V_:T,NWMG54="A:F8V;QTG8P'*AJ[3WU*T?D;A>1S]X'M'.".A@YW, M\(B-E[$(5R@':/Y:=>?&Z>:!W!P3U\N)YOSWK$,'8, MPXN/]-I<'PP=8J+)*SG#]VA!78IY%C7!*@M25VHV'XV#ZG8@(2[+_F5`/F[/ M!,VU(+:;1/D>C((JP=^C=CW"UI@9"\IAJ>:LC(.J)<]C@9!1>Y`'IA"W\!7) M%XM0C&#/8QIHG<]E,W<@:([N+0Y7_- MF4'V<>U:8IO1`]8H'X9@5O?RYSA*.K$&^5]S9I`-6($%DT,/V%N)R!R\29(, M^9=97%ZGM-U"&Z1H;*I9K+;?E4 M9P;93+,5A]60@RY.Q@O/>*4@DVOQ/5H36XV`?+[9O[H\1/7X<6X(A_9*SARR MKV0;GC?#%;IP%F]CNX$;;\KB10_1719[SX0RA#`K@@4E%'=G*\QUYI"]%EMM M;47LC-5XZD-CZY:*4ZFNV>7GG#F,;[FKD\$(08P5-AJ6Q%5K$MZ$UQFM]=25 MP+&_YLQA/-7P\L:GA[$*0;#N&Y$M?I0#F]-%>A%NM*`SA_%WF[GK-D;96*D; MH]')A2&7;$.2'B(6"C*35S+;F8_03:R)W]Z)-FX-T52#%B?S]G$Q.>NB!JE5$*E0@U+*E]<'-`G;'*AR5V./0CG\2>=^5OT\RH0 MI115J-PM[@%Y\)!'`-YY-CA]&Z5SG/E8/;DRK$H.VMBC0UM5./,1^G/E*)5, M'G>/B5UJVCD*T1*GU%&IS7?E-9S3$;IY&V%92D=K#Z_).\XAE'D%P[WRRH\? M_BN=?*9S.E;?KAIN)4<'YMK=WXEF]PSNE879P:")8,;NVT/&9P7W65=V^'VTK*)^HUE#G252Y8 MEKF5!?#R9TR5C`=9R5C.-9[-.Y4H9M5>%8C*5*)XQ$R>2A1/)8KAI&^KH*5% MC2KCWE1)XF/,Q\WOH2?G65_`Q0B-H`OK`R[24+MXJ(N::4Q,T2"8^SJ`O5$``5T&WOK-L2Z.>YS\<1TC M=!,2C%"2`IP;`A"@2^7;LS,D1#:6`FSUONCWS!"``-TVP/)]L2>RL;QHHX4N M&A`@D9Z9#RA>\35_/Q^&[JX`(M?]D=98,OA(I)FKK_OY,'0?"BNE>4]:8XGF M`PFBFV+HIABZ*89NBJ&;8NBF&+HIAF[,TC?%T$'%T(TS?&D*I9M"Z:37Y&RU M:ZJ)65NG$Z3NFL5JKN4#2K'P(*]AJ47-8H\J;CLP;34`&R MRLE`))--%CMZT8_[.`<*>1J4=#*I8BQ"J3C1KT)_G.*YK6E%+WR=BV?M6U!Q M1X,23R95C`4*C5P\#_9N5]W`S$``%2HT*%'6H)6QB)_AWZBL:WH'%#W4KZB; MI1=L2-!`!)UQ38"2=DU0H$*,AB7R#8AF+'C(1TL<8CKW6 M@2Q7/S9;9O^4U;K,W,B-]8.;#)"`*T+@G$#6R1^(@&O0RECCCB$(^*.<9(_: M.N$>T4`,\OM%%.9\R]R`QM'.9,+>+S3.B2WO>_W3S:8&)RVHQU<;/.J==+@' M&D#CG-CREM@_W=YZ.Y6Z!KDA1,)A@KT\FZ(?V[WZ3>=D>H$44\=<9Y61VR\' MN[Y*I9Y4]-%'G9DMKY.=D<=<2QF6Z`)E8&TKO4^)6%,BUI2(-25B38E84R+6 ME(@U9NF;$K'>9"+6MBGPG1NGFP>"7D).9&K2GF\._T5R[*@O8G]BE18MC$5_ MP^B,0XRDYTU],'#.E!ZGY-PND1KW07")8^21M:4G074@<#EK-B/83*L!#JS) M>5=C'`3871&=M<+I7UQV<,<"%U=6X8@(]H$FEW[!WK.+@G]F3\\H$3.%,12X MMJ\R3]B@0V>#<%NC[EH'BOEQ/`ZZF*PR-UB`&TM^&.AE%[@``'0UU5%4`#A( M8KDCQ4V2 M9/PFVGU]'S0P7R05#"'JDR;#E,H=G+_C]/D>O6""YV\H27'X=,GNK:(P"S1. M75,"Y)B`>3A,ZY$=JA0_Y.=CN`V\C7X$-)*[+XW`0QS:O#@T=A/D_?04O7S$ MX0N!DIJZ\^W?5,[F!T9N\:MSD_^'XKA#3Q9#K381-/1972+4D8%M-<'1%!*X MB];U?(-!<3IH-*_F[M9`R88F"6=!OOA6'=6T&BVU'":BP`VU!4!C6=4E0!^I M038$.(3U(DK2K0_F(:J:G`_1WN?"=R=I+P4:YZFYVQNB9RQ+UJRE3L.?]_<* M'DNKHT!C&S6Y58?<6-HFZ/OT1>`F28G8(KZG5\:#2&&!^I5-=68#B(=35[PJ MZ!C+8NSFFKR]&Q9IQY[*//F.3/`@AT-K\HB7(SEZ)EEW_9,3\H3 M@%SUW2#+J2W7J6JSG=EX_%[J&-F4;S;J`G^S4?C4.J8`>.:7Y'BXH"4A@H!_ MIZX-=&;C\8TQ@3>7UE1G25^9(9=$P%[(@B_H%KN/M)4H1OJ->LQHJO(-89]G MD`@>_U2F`625''9V0FER%OH'E/V"7`J?OPCOD9?%,3$FR("O41CO_I>H!9S\ MMCN1'I#W'.(_,Y3($DVZ_"Q0[HDB@SEZN&."C#Q.L-SV-R$A9$8/(=HB4A(K M+)H&G+'2-;O90B8AB"U"LDM%IT'WTEAAT33@'!,9NV1,9B(T;B:/,75$QA`V M&ZU,`>E([=TJ!.IU_6G@=!.8`Z4'HD+'9IL7_.,&JI?X!?OD,G3/CN/170(X MU:4/D9`+HX1`5BC3QJX;$:%^BP*R#.'61B*./7P=.,\'3I+[H>V;[@>C3JEM MIW;8K;!K%P^;9V7UCMB3V%@DH.4;HVCZ#KPQMIWG89/=[-X8)8EA@R<'N#&H M-^8Z1K04%R*2E_9I,[&^#9UF:,D^X)'6AE#3S@G5L[TD``$ZL]+BW7!`8=C8 MV[%LBGYM)0$(T(FF-F^*/86M:>#3I%2IR+3LK,*W]*-0Z:X#$?S.:&HL^-MD M[D5W*//-FWX^#)6S"R?&_='56$S[2$29:Y3T\V&H=&-[17E/5V/Q_8`&2)<) M.4!YS?#&@`IES.42`$H/*WJ*$OJ?R'^BE"K)K1E!R%P#*K<:7IZT2&0N+>!8 ML(80@7XRA:`/*"AL"D&?0M`[$-+SS9845-%=QXB@&'JRJM4*L]]D0+H:72R1 M'!:&TO!TA=G`4>J*/)0(@!`]^P0@*3>2-)1=93IPA+LB%]5%@(&?)3)POBG_ M_"=&,:'S\^86O:!`_001+/"V@]!EI!EY"P3F1JECW.A(X:XSE&AR*6\UE(L` M5TNTS$VXSM(DI\^)^@%3GS64"&Q5[DF$@(F@%;D`+!1GC3@_&T1'APXY/QM, MVX?N6#]OQ/KY(!I'=,CZ^6#:2PS:1T%P'<4T&%Y%Y+OZ]E`>1>%* M;'5(62L<2:Q3C78NK!$EJ5(EJ=)P1^9-OI:FE=#Z>T-Y_>U2V-2-$A/D-"7; MZ[S0_K?4C=-QR3>'/G=9[#V["4J^N0'*NSW1RO7)-Y2F06$1=B#[C6$9RMOX M>/9%&U);]DIOB'*Y`K@)O9@LARY1\=\>-PGS^T.)'!C_QN"1U[*XA5%;1T.) M4!B/M$OI::S`7&$@787^P-X(MPU\II?"`7G1II?"Z:5PZE4S-!?KU*MFZE4S M;B9/O6K&R;?IL2H>2A##)7GOKD',!W*C%O[?2=T<@/\ M%_(_$YU_&R7)(MPC+E)>DIE`KTE:G&,K$#EB5KQ9]AO\#O.&8D`:=%#L\.V" MZ>/]S__].Y?O=Z7D]LKZRRP0X_ZTKH&F@FCCO7(Y,PZ_Z=W[C`9 M<.M3),L:[(*PW8$%EQ><.63QF_4A>*#>F')K\/HW:W]O\-K:.SQZ9JA0/MXL!OP M*9#L#?I?KJ_N]&@3R2[SOQ:HG\;<3>@/^JIY3`1-R%6K(U.&//&;?M28DKH- M"\4-9`S'S0U;>S050&':LX.#P\[.O6A-2G4R*I4RO\L,\#E_9CLH0K M%+TI(?.4:T+$6'/$#1KNWMZ@=S`HL?2(E/5LT,C9.)14)&QV$/J2+XJ`"FKO M3H.'?MRH>CLH]F:'G,.4K^.+6Y%A.I3A/-"`D-,G>X;3JQ:$@?D/5$B<)6I# MM/$)LP7.HYL4RZ#((IB-,T`#0@X&D(LY%:AI=`NBBY!S7M,)M""]<#JIG6AO M^]":66'.J=TR,0FW]=R<$%OVZ-/<)3X!9[6X@-\IT/`7\L9E0Q&U,D810[<,@?/L(SUJB!YBRV5(B=&D]&<`"="I1T1'9:C)P M2_Y;!6I,V&X@0D[5CZP79[83UA(#@T\";0ZR12XAKVG!X!RB\EF:W\OQ;!_%G MPCDL&O&:EO["8=POPYC0;QUL9Y2S!^CG@5XQ,F8NC#&+"[`F'-"#JO=,F*T< M]];!>TMM6HB:>.##I1TE&1'.+30XX*_+@$=2"C%30<[60;]:6+O.$+DY5!Z\ M>9E0V7J57&UC6C26]V3L9O9+?^,V>(M%?]:KB&?[\,-CDCRBC10XQI64L"YV MV5[-+N+872S1\*3J%>@(<921'Q**<;<9\E77RC$K"W+4L MN8DHU([[E21U72MNW.WV&3Z_*54P(]:`&Z62VA8VK;886Q6*E!Z-[`:.926_ MC<*9'Q"ZXIX^R3!Y$8O6RV6["U_KT$'8HG M#N=!)9VLP+F-'KN$7<%)U+3A\%82PRJ\6^L&T#VL4K+80($#CF2/^#;7UCJ+ M)E`'[;C7^.6#CF]1M]JM-.&ZWPY]31AX4,D\VZ#?PB"P"=?2MDH[(6X&Y%UH MLQG^3SR_^D>5XMW2B:5KW(Y4H<[QCF#>W%6U3!HM/OD MN0F)DMQ0;:?M6$8A[C@1$=,4@7F]K"*E1V&]ZO236C6XRBK8H`$T";BT?+12MZ[T-"KRO0IL M+::!1?WJ)7P]=:LWV.\=#':?A!,-;(G^4XV6[#_A6ZY_O)RW8\\)@^KR38?. M&HMJ:_K4_:&,?>I*D=SI9:*Z:MU0I-HT%H0MONYE(I8=`U;WVV40>;[DQRK# MP,J(.XTCSYC^6L$HE6+C+J-(F?35"KU7:Y"[=)]Q19>]3,"R`RC7-'?I/N%1 M%ZMT7:YT[M1WPJ2OENN]K4"_BS-R.2]P*8]TJ)S@X.TJ(^CH"G.]RU5[;JX! M[SJ:O)3S3,AR@VO\6D"769'PJ(OEGL;F"O5.,)2Y5C`,7E>_W"`"_\-SQM'\ MU8+GKYE:%FJ3^.LD>BS-A?G#L9!<3TN5WJG(\*]NY%%XJ;\!<@3WF#^]E-13 MJ<^.16*JXQW)0Q5\:BH(]UC@W&L^)^1QH83/7%>=J4IH10C,3(:J]4\>A/.D M$P;B03NKHM[0MH'3N0J$.`U\W?&I7KSR2C41Y57Q`GC^"5]@RDR(*U!MHK!1 M)DWCJ$[[>,?FU&%RC3J>L0?F4-\15/"ON'1(?`;CB=$^8DN[\7 M`0<;B=!59[#RFB[!M#(&V0PM@>#0\7HPT._`+H50Q@O5`W2CNP=%[BA_8#95 MA^)NB]-X"9X-0$`IHD2.)CDKQHKDE&XFVP`]LZVN2WBRN/:NXM+7(;;SFMJ12!IQF4X*KN'S1J-#Y&O@&38.@X>B>+N(DB MT7,,$(C_[E^3;`"0^!+Y-Q&S$;PB7\8^A_7?(A%8TOG/! M?.B7$7?$H]-AV2.@'#TL=M$XBZCD@'O9;C8`YZ'SWU!([3/N@VP:W<"J>>F? MDCF3Q*U[O)3;H3&+#"%NI$;IN,UE;/`&4U*Y3:H@AUH#=/N@CU1 M9R@$E0UV:R(R3)_5"JCB]^K8QL]ZY9KC@,H>'U>_D%UT+'3L_;P5K?D&]";L^(H*>!!X&;SCL_P5.A/^N@-EZNF<^\T$-TZLP9 M^QEP,J"+CAB_>_C1.G;R]%RM$TX#M?Y$A4PWUQ#=2NWYR9H,Y[OI<$^YER5> MN<&7&XP:]05A_)KPKU1^(FY(404::#9AR_O9B?,M?0CD@7 MQ%9'YA9K2MB$I/5:WHZO7/M:?_8_'ZX6[Q=".2?P"$/G_+=8"^]"GS-! MTPTHS77I5U5H(S1(I^&44_U[^,0*+ZF*][]Q0.+((X=![R+V<,U#/],(8H-/ M6@P"_([:(=0-2L M/FA'IE2_Q,^]QU.?Y;[T)07;R1NRR'U)3P.Q+&-!9\7Y7:/;4LP:61,WW`C$ M`LT9D;04_CY7R`;$QTJU^&A'K%Y.=ZQQ$Z+2,V6+]&S.T%-[9H7=&JQY$Q3+ MTHN<&QH^$NXH%Y7_H#OZ*KN=R2!W7O<&OH.>S0P&Z:@'5BGN'ZK13S7=R2(C M25RL-EWJEH:@HZ=WC\7YTYS:$A2FW*ONBWV#OHS:VWA!?2N[;]^@KTW#=CB% M)5&=*(\.2T6:Z;61.E@NL2Z)YF0<6J5Q^Z08YR:%GA.C9!I`_,2$&L1GRJ8S MI2:D(1"(W5*5(D;O3;1"D'.IR2+*@'[KWHV:I+$B0S\]K5K)S>M)#$K)3V>, M3L`<=JB.)(XF$T@M.`P9@G%U4`K9:U[X-J%)=?4)_!_'); M0>LK8P*)?'$1\`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````"`!A@FY%4WOKJ525``#[1`@`$0`8```````! M````I($`````87-P=RTR,#$T,#DS,"YX;6Q55`4``\9Q9E1U>`L``00E#@`` M!#D!``!02P$"'@,4````"`!A@FY%9G8<+*D)``#&@```%0`8```````!```` MI(&?E0``87-P=RTR,#$T,#DS,%]C86PN>&UL550%``/&<694=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`88)N19O(P``#.<"`!4`&````````0`` M`*2!EY\``&%S<'`Q0````(`&&";D4CVD534F$``,0:!@`5`!@```````$` M``"D@97#``!A`L``00E M#@``!#D!``!02P$"'@,4````"`!A@FY%(Q16N((X``!7=00`%0`8```````! M````I($V)0$`87-P=RTR,#$T,#DS,%]P&UL550%``/&<694=7@+``$$ M)0X```0Y`0``4$L!`AX#%`````@`88)N19H*R#,;#@``B90``!$`&``````` M`0```*2!!UX!`&%S<''-D550%``/&<694=7@+``$$)0X` <``0Y`0``4$L%!@`````&``8`&@(``&UL`0`````` ` end XML 17 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt
9 Months Ended
Sep. 30, 2014
Debt [Abstract]  
Debt

Note 3 – Debt

 

On September 4, 2012, the Company entered into an unsecured loan agreement with TMK-ENT, Inc. that provided for a $500,000 working capital revolving line of credit.  Advances under the line of credit bear interest at 10% per year, payable annually. On November 13, 2012, the Company amended its loan agreement to increase the revolving line of credit from $500,000 to $750,000, and on December 21, 2012 amended its loan agreement to increase the revolving credit from $750,000 to $1,250,000.  The note matures on December 21, 2014. Borrowings under the line of credit amount to $1,018,500 as of September 30, 2014 and December 31, 2013. In conjunction with the line of credit facility, the Company issued 1,250,000 warrants to purchase the Company’s common stock at varying prices from $1.38 to $1.62 per share. The warrants vested one year from issuance and have a ten year term. The fair market value of the warrants at grant date was determined utilizing the Black Scholes option pricing model and amounted to $1,839,250. The difference between the fair market value of the warrants and draws on the line of credit is $820,750 as of September 30, 2014 and December 31, 2013, which is recorded as deferred debt discount.  The deferred debt discount will be recognized and recorded as debt discount as the Company continues to borrow against the line of credit. Debt discount costs will be recognized as the Company draws down the available line of credit, and will be amortized over the remaining term of the loan. As a result of the amortization of the debt discount, the Company expensed $256,254 and $441,228, respectively, for the nine months ended September 30, 2014 and 2013 and $85,732 and $86,674 for the three months ended September 30, 2014 and 2013.

  

Annual maturities of debt are as follows:

 

2014 (includes TMK-ENT, Inc. line of credit repayment) $1,018,777 
EXCEL 18 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Y,C$P-&)B,%\W,#@V7S0S,3=?.&0Q.5\U9&4R M,#5B-&4U,&0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]3=&%T96UE;G1S7V]F7T-A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=O M:6YG7T-O;F-E#I7;W)K#I%>&-E M;%=O3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7T)A#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E8V5N=%]!8V-O=6YT:6YG7U!R;VYO=6YC96UE;CPO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1E#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7T)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D1E#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=O:6YG7T-O;F-E#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D1E8G1?1&5T86EL#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D1E8G1?1&5T86EL#I%>&-E;%=O5]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-T;V-K7T)A#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/E=A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E=A#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D1E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D1E#I7;W)K#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H M:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7SDR,3`T8F(P7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)T%R:7-T82!0;W=E M2!#96YT3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)S`P,#$T,C0V-#`\'0^)V9A;'-E/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)RTM,3(M,S$\'0^ M4V5P(#,P+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)U$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO3QS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!# M;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\Y,C$P-&)B,%\W,#@V7S0S,3=?.&0Q.5\U M9&4R,#5B-&4U,&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3(Q M,#1B8C!?-S`X-E\T,S$W7SAD,3E?-61E,C`U8C1E-3!D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPOF5D+"`D,"XP,#(@<&%R('9A;'5E.R`Q M+#0Q-2!A;F0@,"!I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&=A:6X@*&QO'1087)T7SDR,3`T8F(P7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(&]F('!R M97!A:60@=V%R'0^)SQS M<&%N/CPO6UE;G1S(&]N(&1E8G0\+W1D/@T*("`@("`@("`\ M=&0@8VQA2!F:6YA;F-I;F<@86-T:79I=&EE'0^)SQS<&%N/CPO2!I;F-U2!F;W(@86-C;W5N=',@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT M9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQP('-T>6QE/3-$)V-O M;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N M;W)M86P[(&UA'0M=')A M;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U M=&\[('=O'0M#L@ M=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M=')A;G-F;W)M.B!N;VYE.R!W M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N M-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T M97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T M28C.#(R,3LI('=A2!R969L96-T M28C.#(Q-SMS(&9O8W5S M(&)E>6]N9"!T:&4@5VEN9%1A;65R)B,Q-S0[(&)R86YD(&%N9"!E;G1R>2!I M;G1O(&%R96%S('=I=&AI;B!T:&4@96YE'0M=')A M;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U M=&\[('=O'0M#L@ M=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M2!I2!S>7-T M96US+B8C,38P.R8C,38P.U1H92!#;VUP86YY)B,X,C$W.W,@<&%T96YT960@ M4&]W97(@;VX@1&5M86YD('-Y2!T:&%T(')E;&5A2!A="!O<'1I;6%L M('1I;65S('1O(')E9'5C92!E;&5C=')I8VET>2!C;W-TF4Z(#$P<'0[(&9O;G0M'0M M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C M93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/D)A6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E M=&-H.B!N;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z M(&%U=&\[('=O'0M#LG/E1H92!A8V-O;7!A;GEI;F<@=6YA=61I=&5D(&-O;F1E;G-E9"!F:6YA M;F-I86P@2!'04%0(&9OF4Z M(#$P<'0[(&9O;G0M'0M M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@ M+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P+C5I;CLG/B8C M,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`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`P+C5I;CLG/B8C,38P.SPO<#X-"CQP M('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N M="US=')E=&-H.B!N;W)M86P[(&UAF4Z(#$P<'0[(&9O;G0M'0M:6YD M96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C M,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[ M(&UA6EN9R!F:6YA;F-I86P@6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!L971T97(M'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/E5S92!O9B!% MF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N M93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT M.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P M,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UTF4Z(#$P<'0[(&9O;G0M'0M:6YD M96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C M,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[ M(&UA'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US M<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^ M)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T2!M86EN=&%I M;G,@:71S(&-A2!N;VXM<&5R9F]R;6%N8V4@8GD@ M=&AE(&9I;F%N8VEA;"!I;G-T:71U=&EO;G,N/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M#L@=&5X="UT#L@9F]N="US=')E M=&-H.B!N;W)M86P[(&UA'0M=')A;G-F;W)M.B!N;VYE.R!W M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N M-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UA;&EG;CH@ M:G5S=&EF>3LG/D%C8V]U;G1S(')E8V5I=F%B;&4@2!O;B!A('-P96-I9FEC(&%C8V]U;G0@8F%S:7,@=&\@9&5T97)M:6YE M('1H92!N965D('1O(&%N(&%L;&]W86YC92!F;W(@9&]U8G1F=6P@86-C;W5N M="!R97-E'0M=')A M;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U M=&\[('=O'0M#L@ M=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0MF4Z(#$P<'0[ M(&9O;G0M'0M86QI9VXZ M('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI M="UT97AT+7-T'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO M<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA2!O9B!P87)TF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N M93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT M.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P M,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT6QE M/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!L971T97(M'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/D9I>&5D(&%SF5D+B8C,38P.R8C,38P.T5X<&5N M9&ET=7)E2!G86EN(&]R(&QO6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E M=&-H.B!N;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z M(&%U=&\[('=O'0M#LG/CQB/DEN=&%N9VEB;&4@07-S971S/"]B/CPO<#X-"CQP('-T>6QE/3-$ M)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S#0H@;F5W(')O M;6%N)RP@=&EM97,L('-EF4Z(#$P<'0[(&9O;G0M'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T M>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US M=')E=&-H.B!N;W)M86P[(&UA28C.#(Q-SMS M('!A=&5N=',N)B,Q-C`[)B,Q-C`[4&%T96YT(&%P<&QI8V%T:6]N(&-OF5D(&]V97(@=&AE(&5S=&EM M871E9"!U6QE/3-$)V-O;&]R.B`C M,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA'0M:6YD M96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@ M;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/DEM<&%IF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N M93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT M.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P M,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT2!N;W0@8F4@6EN M9R!A;6]U;G0@;V8@86X@87-S970@=&\@9G5T=7)E(&YE="!U;F1I'!E8W1E9"!T;R!B92!G96YEF4Z(#$P<'0[(&9O;G0M'0M:6YD96YT M.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R M;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/D9A:7(@5F%L=64@;V8@1FEN86YC:6%L($EN M6QE/3-$)V-O;&]R.B`C,#`P,#`P M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@ M9F]N="US=')E=&-H.B!N;W)M86P[(&UA'0M:6YD96YT.B`P M<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L M.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/E1H92!C87)R>6EN9R!A;6]U;G0@;V8@8V%S:"P@86-C M;W5N=',@'!E;G-EF4Z(#$P<'0[ M(&9O;G0M'0M86QI9VXZ M('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R;3H@;F]N M93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N M;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/E)E=F5N M=64@4F5C;V=N:71I;VX\+V(^/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R M.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B&5D(&]R(&1E=&5R;6EN86)L93L@86YD("@T*2!T:&4@8V]L;&5C=&EO;B!O M9B!T:&4@2!A6QE/3-$)V-O M;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US M<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/D9OF4Z M(#$P<'0[(&9O;G0M'0M M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@ M+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P+C5I;CLG/B8C M,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA&-E'!E8W0@=&\@:6YC=7(@;VX@82!C M;VYT'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@ M;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[ M/"]P/@T*/'`@F4Z M(#$P<'0[(&9O;G0M'0M M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R M;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N M="US=')E=&-H.B!N;W)M86P[(&UA'0M:6YD96YT.B`P<'@[ M('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W M:61O=W,Z(&%U=&\[('=O'0M M#LG/CQB/E)E'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US M<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^ M)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T7-T96T@86YD('1H92!-;V)I;&4@ M4F5N97=A8FQE(%!O=V5R(%-T871I;VXN)B,Q-C`[)B,Q-C`[4W!E8VEF:6-A M;&QY+"!T:&5S92!C;W-T6QE/3-$)V-O;&]R.B`C,#`P M,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@+7=E8FMI="UT97AT+7-T'0M M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R M.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M M86P[(&UAF4Z(#$P<'0[ M(&9O;G0M'0M86QI9VXZ M('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI M="UT97AT+7-T'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO M<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA2!O;B!E86-H(%!O=V5R M(&]N($1E;6%N9"!S>7-T96TL('=I;F0@='5R8FEN92P@86YD('-O;&%R('-Y M6EN9R!P97)I;V1S+"!B87-E9"!U<&]N('1H92!P2!PF5D+B8C,38P.R8C,38P.T9A8W1O2!A;F0@87)E('5P9&%T960@87,@;F5W(&EN9F]R;6%T M:6]N(&)E8V]M97,@879A:6QA8FQE+B!4:&4@:6UP86-T(&]F(&%N>2!C:&%N M9V4@:6X@97-T:6UA=&5S('=I;&P@8F4@=&%K96X@:6YT;R!A8V-O=6YT('=H M96X@86YA;'EZ:6YG(&9U='5R92!W87)R86YT>2!R97-E'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET M92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN M.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT M+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-TF4Z(#$P<'0[(&9O M;G0M'0M86QI9VXZ('-T M87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT M97AT+7-T'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X- M"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@ M9F]N="US=')E=&-H.B!N;W)M86P[(&UA28C.#(Q-SMS($5Q=6ET>2!);F-E;G1I=F4@4&QA M;B!I;B!A8V-O'!E8W1E9"!T97)M(&%N9"!T:&4@<')I8V4@=F]L871I;&ET>2!O9B!T:&4@ M=6YD97)L>6EN9R!S=&]C:RX\+W`^#0H\<"!S='EL93TS1"=C;VQO'0M=')A;G-F;W)M M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O M'0M#L@=&5X="UI M;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M28C.#(Q-SMS(&%C8V]U;G1I M;F<@<&]L:6-Y(&9O2!I;G-T6QE/3-$)V-O;&]R M.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA'0M M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C M93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/DEN8V]M92!487AE#L@9F]N="US=')E=&-H.B!N M;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F M;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[ M('=O'0M#LG/E1H M92!#;VUP86YY(&%C8V]U;G1S(&9O"!L:6%B:6QI=&EE"!C;VYS97%U96YC M97,@;V8@=&5M<&]R87)Y(&1I9F9EF5S(&5N86-T960@"!R871E2!V86QU871I;VX@86QL;W=A;F-E+"!F;W(@=&5M M<&]R87)Y(&1I9F9E"!C"!E>'!E;G-E(')E<')EF4Z M(#$P<'0[(&9O;G0M'0M M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@ M+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P+C5I;CLG/CQB M/B8C,38P.SPO8CX\+W`^#0H\<"!S='EL93TS1"=C;VQO'0M:6YD96YT.B`P<'@[('1E M>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O M=W,Z(&%U=&\[('=O'0M#LG/CQB/D)A6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H M.B!N;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M=')A M;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U M=&\[('=O'0M#LG M/D)A2!I6QE/3-$)V-O M;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N M;W)M86P[(&UAF4Z(#$P<'0[(&9O;G0M&5R8VES M92X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\Y,C$P-&)B,%\W,#@V7S0S,3=?.&0Q.5\U9&4R,#5B-&4U,&0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3(Q,#1B8C!?-S`X-E\T,S$W7SAD M,3E?-61E,C`U8C1E-3!D+U=O'0O:'1M;#L@8VAA'0M:6YD96YT M.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R M;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/DYO=&4@,B`M($=O:6YG($-O;F-E6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H.B!N M;W)M86P[(&UAF4Z M(#$P<'0[(&9O;G0M'0M M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R M;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T2!T;R!C;VYT:6YU92!A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'0^)SQP('-T M>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US M=')E=&-H.B!N;W)M86P[(&UAF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@ M=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P M+C5I;CLG/B8C,38P.SPO<#X\<"!S='EL93TS1"=C;VQO'0M:6YD96YT.B`P<'@[('1E M>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O M=W,Z(&%U=&\[('=O'0M#LG/D]N(%-E<'1E;6)E2!E;G1E M2!I2!C;VYT:6YU97,@=&\@8F]R2!DF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P+C5I;CLG M/B8C,38P.R8C,38P.SPO<#X\<"!S='EL93TS1"=C;VQO'0M:6YD96YT.B`P<'@[('1E M>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O M=W,Z(&%U=&\[('=O'0M#LG/D%N;G5A;"!M871U6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H M.B!N;W)M86P[(&UA6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L("=T M:6UE'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T M97(M#L@8F]R9&5R M+6-O;&QA<'-E.B!C;VQL87!S93L@9F]N="US:7IE+6%D:G5S=#H@;F]N93L@ M9F]N="US=')E=&-H.B!N;W)M86P[("UW96)K:70M=&5X="US=')O:V4M=VED M=&@Z(#!P>#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R M('-T>6QE/3-$)W9E#L@ M=&5X="UA;&EG;CH@;&5F=#LG/C(P,30@*&EN8VQU9&5S(%1-2RU%3E0L($EN M8RX@;&EN92!O9B!C6QE/3-$ M)W=I9'1H.B`Q-G!X.R<^)B,Q-C`[/"]T9#X\=&0@'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X\=&0@6QE/3-$)W=I9'1H.B`Q-7!X.R!T97AT+6%L:6=N.B!L969T M.R<^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,C$P-&)B,%\W,#@V7S0S,3=?.&0Q M.5\U9&4R,#5B-&4U,&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M.3(Q,#1B8C!?-S`X-E\T,S$W7SAD,3E?-61E,C`U8C1E-3!D+U=O'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0M:6YD96YT.B`P M<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L M.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/DYO=&4@-"`F(S@R,3$[(%-T;V-K:&]L9&5R6QE/3-$)V-O;&]R.B`C,#`P M,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA'0M:6YD96YT M.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R M;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/D]N($UA2!S;VQD+"!P=7)S=6%N="!T;R!A('-E8W5R:71I97,@<'5R8VAA65A2!C;VYV97)T M:6YG(&EN=&\@8V]M;6]N('-T;V-K+B!4:&4@:6YV97-T;W)S(')E8V5I=F5D M(')I9VAT2!U M;G1I;"!-87)C:"`S,2P@,C`Q-2X@26X@861D:71I;VXL('1H92!I;G9E2!S=6-H(&EN=F5S=&]R(&EN('1H92!A8F]V92UR969E2!S:6UI;&%R('1E2!A;G1I+61I;'5T M:6]N('!R;W1E8W1I;VYS(&%N9"!R96=IFEN9R!T:&4@0FQA8VLM4V-H;VQE2!T:&4@0V]M<&%N>2!O9B`D,2PT,#`L,#`P M(')E6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H.B!N;W)M86P[ M(&UA'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N M;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/D]N($UA2!A M;F0@075G=7-T(#(P,3,@<')I=F%T92!P;&%C96UE;G0@;V8@8V]M;6]N('-T M;V-K+"!S:&%R96AO;&1E3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,C$P-&)B,%\W,#@V7S0S,3=?.&0Q M.5\U9&4R,#5B-&4U,&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M.3(Q,#1B8C!?-S`X-E\T,S$W7SAD,3E?-61E,C`U8C1E-3!D+U=O'0O:'1M;#L@8VAA M'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US M<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/DYO=&4@-2`F(S@R,3$[(%-T M;V-K($)A'0M M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z M(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M2!H87,@97-T M86)L:7-H960@=&AE(#(P,#@@17%U:71Y($EN8V5N=&EV92!0;&%N+"!W:&EC M:"!I65E2!V M97-T(&5I=&AE2!O;B!T:&4@9&%T92!O9B!G65A'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O M'0M#LG/B8C,38P M.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA2!R96-O2P@87,@8V]M<&%R960@=&\@)#$Q,2PQ,30@ M86YD("0V-3`L-3`U(&9O2!A M(&9O65E(&]F('1H92!#;VUP86YY+"!W:&EL92!F;W(@=&AE(&YI M;F4@;6]N=&AS(&5N9&5D(%-E<'1E;6)E'0M=')A;G-F M;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[ M('=O'0M#L@=&5X M="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M2!H87,@=F%L=65D('1H M92!O<'1I;VYS(&%T('1H96ER(&1A=&4@;V8@9W)A;G0@=71I;&EZ:6YG('1H M92!";&%C:R!38VAO;&5S(&]P=&EO;B!P6EN9R!S:&%R97,@=V%S(&1E=&5R;6EN960@8F%S960@ M;VX@2!T:&4@0V]M<&%N>2!T;R!S96QL M('-H87)EF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T#L@ M=&5X="UT'0M:6YD96YT.B`P<'@[(&QE='1E M#L@8F]R9&5R M+6-O;&QA<'-E.B!C;VQL87!S93L@+7=E8FMI="UT97AT+7-T6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T M>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M M6QE M/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Q,#4P<'@[(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6EE;&0\ M+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT+7-T>6QE.B!N M;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R M;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R M;VUA;BF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$ M)W=I9'1H.B`Q-7!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3PO=&0^#0H\=&0@6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA M;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L M.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA M;B3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE M=R!R;VUA;B'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE M=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[)SY%>'!E8W1E9"!L:69E(&]F(&]P=&EO;G,\+W1D/@T* M/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA M;B'0M86QI9VXZ(')I9VAT.R<^+C$T+3DN-S@@>65A6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X M="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UAF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T28C.#(Q-SMS(&%G9W)E9V%T92!S=&]C:R!O<'1I;VYS M(&=R86YT960Z/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT M+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T#L@=&5X="UT'0M:6YD96YT.B`P<'@[(&QE M='1E#L@8F]R M9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@+7=E8FMI="UT97AT+7-T6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT M+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T M3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9F]N M="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^ M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@ M9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@8V5N M=&5R.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@ M8F]L9#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R<^)B,Q-C`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`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE M/3-$)V9O;G0MF4Z(#$P<'0[('!A9&1I;F#L@=&5X="UI;F1E;G0Z M(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\ M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@6QE/3-$)W=I9'1H.B`X-#=P>#L@9F]N="US='EL93H@ M;F]R;6%L.R!F;VYT+79A#L@=&5X="UI;F1E M;G0Z(#!P>#LG/D]U='-T86YD:6YG(&%T($IA;G5A3H@ M)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UA;&EG;CH@;&5F M=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@F4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\ M+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT+7-T>6QE.B!N M;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R M;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R M;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R M:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T#LG/BXV,3PO=&0^#0H\=&0@#LG/B8C M,38P.SPO=&0^#0H\=&0@F4Z(#$P<'0[('!A9&1I;F#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C M,38P.SPO=&0^#0H\=&0@'0M M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H M.B`Q-#%P>#L@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M<&%D9&EN9SH@,'!X.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X- M"CQT9"!S='EL93TS1"=W:61T:#H@,35P>#L@9F]N="US:7IE.B`Q,'!T.R!T M97AT+6%L:6=N.B!L969T.R!P861D:6YG.B`P<'@[('1E>'0M:6YD96YT.B`P M<'@[)SXF(S$V,#L\+W1D/@T*/"]T6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`P<'@[)SY/<'1I;VYS(&=R86YT960@9'5R:6YG(#(P,30\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T* M/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE M=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!F;VYT+7-TF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`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`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E'0M86QI9VXZ(')I9VAT.R!T97AT M+6EN9&5N=#H@,'!X.R<^/&9O;G0@3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E"`P<'@@,2XU<'0[ M('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R M;VUA;B#L@<&%D9&EN M9RUR:6=H=#H@,'!X.R!B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R M9&5R+6)O='1O;2UW:61T:#H@,2XU<'0[(&)O#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[)SXH,CDU+#DQ-SPO=&0^#0H\=&0@"`P<'@@,2XU<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`P<'@[)SXI/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L M.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA M;B"`Q+C5P=#L@=&5X M="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@"`P M<'@@,2XU<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[ M)SXD/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O M;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT M+7-T3H@)W1I;65S(&YE=R!R;VUA;B"`Q+C5P=#L@=&5X="UA;&EG M;CH@'0M:6YD96YT.B`P<'@[)SXN-38\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-EF4Z(#$P<'0[('!A9&1I;F"`P<'@@,2XU<'0[('1E>'0M:6YD96YT M.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M"`Q+C5P=#L@=&5X="UI;F1E;G0Z(#!P M>#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[('!A9&1I;F"`P<'@@,2XU<'0[('1E>'0M M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M M"`P M<'@@,2XU<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0M"`Q+C5P=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C M,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^3W5T6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B8C,38P.SPO=&0^#0H\=&0@#L@8F]R9&5R+6)O='1O;2UC;VQO'0M:6YD96YT.B`P<'@[)SXR+#0U-2PQ.3$\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B8C,38P.SPO=&0^#0H\=&0@"`P<'@@ M-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL M93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.PT*(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M'0M:6YD96YT.B`P<'@[)SXN,S0\+W1D/@T* M/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E"`P M<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S M='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M:6YD96YT.B`P<'@[('1E>'0M86QI M9VXZ(')I9VAT.R<^."XW('EE87)S/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT M+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I M;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M'0M:6YD96YT.B`P<'@[)SXP/"]T9#X-"CQT M9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/"]T"`P<'@@-'!T.R!T97AT+6EN9&5N M=#H@,'!X.R<^17AE3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M:6YD96YT.B`P<'@[ M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^#0H\ M=&0@#L@8F]R9&5R M+6)O='1O;2UC;VQO#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[)SXW M,C4L,3DQ/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B8C,38P M.SPO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L M969T.R!T97AT+6EN9&5N=#H@,'!X.R<^)#PO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@=&5X="UI;F1E;G0Z(#!P M>#LG/BXV,#PO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L M:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT M9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V M,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@65A6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B8C,38P M.SPO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L M969T.R!T97AT+6EN9&5N=#H@,'!X.R<^)#PO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@=&5X="UI;F1E;G0Z(#!P M>#LG/C`\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M M'0M86QI9VXZ('-T87)T M.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI M=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US M<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/D9O'!IF4Z(#$P M<'0[(&9O;G0M'0M86QI M9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E M8FMI="UT97AT+7-T'0M:6YD96YT.B`P+C5I;CLG/B8C,38P M.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA6QE/3-$)V-O;&]R.B`C,#`P M,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA65E(&]F('1H92!#;VUP86YY+B!.;R!S=6-H(&5X<&5N6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E M=&-H.B!N;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z M(&%U=&\[('=O'0M#LG/D]N($1E8V5M8F5R(#$S+"`R,#$P+"!T:&4@0F]A65E2!C97)T86EN(&5M<&QO>65E'0M=')A;G-F;W)M M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O M'0M#L@=&5X="UI M;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M2!);F-E;G1I=F4@4&QA;BP@=VAI8V@@=VEL;"!V97-T(&]N M92!H86QF(&5A8V@@;VX@36%R8V@@,S$L(#(P,34@86YD($UA2!);F-E;G1I=F4@4&QA;BP@;V8@=VAI8V@@,3`L,#`P('-H87)E MF5D(&]V97(@=&AE M('9E'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US M<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CPO<#X-"CQP('-T>6QE/3-$)V-O M;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N M;W)M86P[(&UAF5S('1H92!S=&%T=7,@;V8@=&AE($-O;7!A;GDF(S@R,3<['0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O M=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'1A8FQE M('-T>6QE/3-$)W=I9'1H.B`Q-38W<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M3H@)W1I;65S(&YE=R!R;VUA;B#LG(&-E;&QS<&%C:6YG M/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(@6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA M;B'0M:6YD96YT.B`P M+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA M;B6QE/3-$)W!A9&1I;FF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W=I9'1H.B`Q,3DQ<'@[(&9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-EF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q-#)P>#L@9F]N M="US='EL93H@;F]R;6%L.R!F;VYT+79A'0M86QI9VXZ(')I M9VAT.R<^,3$X+#,W.#PO=&0^#0H\=&0@6QE/3-$)W=I9'1H.B`Q-7!X.R!F;VYT+7-T>6QE.B!N M;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R M;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W=I9'1H.B`Q-#%P>#L@9F]N="US='EL93H@;F]R M;6%L.R!F;VYT+79A'0M86QI9VXZ(')I9VAT.R<^,BXX,#PO M=&0^#0H\=&0@6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(')I9VAT.R<^-#`P+#`P,#PO=&0^#0H\=&0@'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M'0M86QI9VXZ#0H@;&5F=#LG/B8C,38P.SPO=&0^#0H\ M+W1R/@T*/'1R('-T>6QE/3-$)W9E3H@)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE M=R!R;VUA;B6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(')I9VAT.R<^+C,Y/"]T9#X-"CQT M9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H.B!N M;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F M;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[ M('=O'0M#LG/E1H M92!C;VUP96YS871I;VX@97AP96YS92!R96QA=&5D('1O('1H97-E(&=R86YT M'!E;G-E(&9O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UAF4Z(#$P<'0[(&9O;G0M'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE M/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E M=&-H.B!N;W)M86P[(&UA'!E8W1E9"!L:69E M+B8C,38P.R8C,38P.U1H92!E>'!E8W1E9"!L:69E(&]F('=A'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET M92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/B8C,38P.SPO<#X-"CQT86)L M92!S='EL93TS1"=W:61T:#H@,34V-W!X.R!T97AT+71R86YS9F]R;3H@;F]N M93L@=&5X="UI;F1E;G0Z(#!P>#L@;&5T=&5R+7-P86-I;F'0M6QE/3-$)W9EF4Z(#$P M<'0[('!A9&1I;F#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO M=&0^#0H\=&0@3H@)W1I;65S(&YE=R!R;VUA;B'0M M:6YD96YT.B`P<'@[)R!C;VQS<&%N/3-$,CY.:6YE($UO;G1H3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UA;&EG;CH@8V5N=&5R.R!T97AT M+6EN9&5N=#H@,'!X.R<@8V]L6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T M>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)V9O;G0M#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@ M#LG(&-O M;'-P86X],T0R/E-E<'1E;6)E6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T M3H@)W1I;65S(&YE=R!R;VUA;B#LG/B8C,38P.SPO=&0^#0H\=&0@ M3H@)W1I;65S(&YE=R!R;VUA;B'0M:6YD96YT.B`P<'@[)R!C M;VQS<&%N/3-$,CY397!T96UB97(F(S$V,#LS,"P@,C`Q,SPO=&0^#0H\=&0@ M'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/"]T M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P M>#LG/D5X<&5C=&5D(&1I=FED96YD('EI96QD/"]T9#X-"CQT9"!S='EL93TS M1"=W:61T:#H@,39P>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO M=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@'0M:6YD96YT.@T*(#!P>#LG/C`\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H M.B`Q-G!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;BF4Z(#$P<'0[(&QI;F4M M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)RP@=&EM97,L('-E'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`P<'@[)SXE/"]T9#X-"CPO='(^#0H\='(@6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B3PO=&0^#0H\=&0@#L@=&5X="UI;F1E;G0Z(#!P M>#LG/B8C,38P.SPO=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@ M;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[ M)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R M:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R M;VUA;B#LG/CQF;VYT('-T>6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W9E M3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D M/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA M;B#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C M,38P.SPO=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE M=R!R;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X M="UI;F1E;G0Z(#!P>#LG/B4\+W1D/@T*/"]T6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`P<'@[)SY%>'!E8W1E9"!L:69E(&]F('=A3H@)W1I;65S(&YE=R!R;VUA;B'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\ M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`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`C M,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[ M(&UAF4Z(#$P<'0[(&9O;G0M28C.#(Q-SMS('=AF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT M+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T#L@=&5X="UT'0M:6YD96YT.B`P<'@[(&QE M='1E#L@8F]R M9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@+7=E8FMI="UT97AT+7-T6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA M;B#L@8F]R9&5R+6)O='1O;2UC;VQO6QE.B!S;VQI9#L@<&%D M9&EN9RUL969T.B`P<'@[('1E>'0M86QI9VXZ(&-E;G1E"`P<'@@,2XU<'0[('1E>'0M86QI9VXZ(&-E;G1E3H@)W1I;65S M(&YE=R!R;VUA;B#L@ M<&%D9&EN9RUR:6=H=#H@,'!X.R!B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C M:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,2XU<'0[(&)O#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R<@8V]L&5R8VES M92!03H@)W1I;65S M(&YE=R!R;VUA;B"`Q M+C5P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X-"CQT9"!S M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9F]N="US='EL93H@;F]R;6%L M.R!F;VYT+79A#L@8F]R9&5R+6)O='1O M;2UC;VQO6QE.B!S;VQI9#L@<&%D9&EN9RUL969T.B`P<'@[ M('1E>'0M86QI9VXZ(&-E;G1E"`P<'@@ M,2XU<'0[('1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E"`P<'@@,2XU<'0[ M('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/"]T6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT M+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I M;65S(&YE=R!R;VUA;B#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z M(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T#LG/C3H@)W1I;65S(&YE=R!R;VUA M;B#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B0\+W1D M/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q-#%P>#L@9F]N="US='EL93H@;F]R M;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@ M'0M:6YD96YT.B`P<'@[)SXQ+C4Q/"]T9#X-"CQT9"!S='EL M93TS1"=W:61T:#H@,35P>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A M#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI M;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@#L@9F]N="US:7IE.B`Q,'!T.R!P861D:6YG.B`P<'@[('1E>'0M:6YD M96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q M-7!X.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@ MF4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R!P861D:6YG.B`P<'@[('1E>'0M:6YD96YT.B`P<'@[ M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q-7!X.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@ M=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T M>6QE/3-$)W9E#L@=&5X="UA;&EG;CH@;&5F M=#L@=&5X="UI;F1E;G0Z(#!P>#LG/E=A6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)RP@=&EM97,L('-E'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!X.R<^ M,3$L.#8R+#`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`Q+C5P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/E=A6QE/3-$)V9O;G0M3H@)W1I M;65S(&YE=R!R;VUA;B#L@<&%D9&EN9RUR:6=H=#H@,'!X.R!B;W)D97(M8F]T=&]M+6-O;&]R.B!B M;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,2XU<'0[(&)O#L@=&5X="UA;&EG M;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@ M#L@8F]R9&5R+6)O M='1O;2UC;VQO6QE.B!S;VQI9#L@<&%D9&EN9RUL969T.B`P M<'@[('1E>'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!X.R<^*#$L M,C0P+#,U,3PO=&0^#0H\=&0@"`Q+C5P=#L@=&5X M="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/BD\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B"`Q+C5P=#L@=&5X="UA;&EG M;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@ M"`P<'@@,2XU<'0[('1E>'0M86QI9VXZ(')I9VAT.R!T97AT M+6EN9&5N=#H@,'!X.R<^+C4P/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T M>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B"`Q M+C5P=#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C M,38P.SPO=&0^#0H\=&0@"`P<'@@,2XU<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D M/@T*/'1D('-T>6QE/3-$)V9O;G0M"`Q+C5P=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\ M=&0@'0M86QI9VXZ(')I9VAT.R!P861D:6YG.B`P<'@@,'!X(#$N-7!T.R!T97AT M+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F"`P M<'@@,2XU<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/"]T M6QE/3-$)V9O;G0M#LG/D]U='-T86YD:6YG(&%T(%-E<'1E;6)E M3H@)W1I;65S(&YE=R!R;VUA M;B"`T<'0[('1E>'0M M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!X.R<^,3@L,CDR M+#DQ-CPO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N M.B!L969T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S M='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\ M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E#LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[ M)SXN-S@\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^#0H\=&0@ M"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[ M/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T M3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI9VXZ(&-E M;G1E"`P<'@@-'!T M.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS M1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P M<'@[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI M9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!X.R<^,#PO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N M=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CPO='(^#0H\='(@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E#LG/D5X97)C:7-A8FQE(&%T(%-E<'1E;6)E3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V M,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[ M(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(')I9VAT M.R!T97AT+6EN9&5N=#H-"B`P<'@[)SXQ."PQ,SDL,C4P/"]T9#X-"CQT9"!S M='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@ M,'!X.R<^)#PO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@=&5X="UI;F1E;G0Z(#!P>#LG/BXW-3PO=&0^#0H\=&0@ M"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L969T.R!T97AT+6EN M9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T M>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B"`T M<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M:6YD96YT.B`P M<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M#LG/B0\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M M:6YD96YT.B`P<'@[)SXP/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE M=R!R;VUA;B"`T<'0[ M('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\ M+W1D/@T*/"]T'0M:6YD96YT.B`P M<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L M.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@ M=&5X="UT2XF(S$V,#LF(S$V,#M$=7)I;F<@=&AE(&YI;F4@;6]N M=&AS(&5N9&5D(%-E<'1E;6)EF4Z(#$P<'0[ M(&9O;G0M'0M86QI9VXZ M('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI M="UT97AT+7-T'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO M<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA2P@=&AE($-O;7!A;GD@65E*2!O9B!T:&4@0V]M<&%N>2XF(S$V,#LF M(S$V,#M4:&4@=V%R65A6QE M/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!L971T97(M'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/D9O2!R M96-O'!E;G-E65E(&]F('1H92!#;VUP86YY M+B8C,38P.R8C,38P.TYO('-U8V@@97AP96YS92!W87,@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF4Z(#$P M<'0[(&9O;G0M'0M86QI M9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R;3H@ M;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H.B!N;W)M86P[ M(&UA'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N M;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/D-E&5D('-E='1L96UE;G0@<')O=FES:6]N2!I'!I2`R,2P@,C`Q,RP@=VAI8V@@=V5R92!C86YC96QL960@ M;VX@2G5N92`Q.2P@,C`Q-"!A;F0@*#,I('=AF4Z(#$P<'0[ M(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R M;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T#L@;6%R9VEN.B`P<'@[('1E>'0M:6YD96YT.B`P+C5I M;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X M="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA2!I6EE;&0@879A M:6QA8FQE(&]N(%4N4RX@5')E87-U2!D971E'!E8W1E M9"!D:79I9&5N9"!R871E(&)A'!E8W1A=&EO;B!T:&%T(&5A'!E8W1E9"!T;R!B92!A9&5Q=6%T92!T;R!A;&QO M=R!F;W(@=&AE('!A>6UE;G0@;V8@9&EV:61E;F1S(&EN('1H92!N96%R(&9U M='5R92X@5&AE(&9O;&QO=VEN9R!W96EG:'1E9"UA=F5R86=E(&%S6QE/3-$)V-O;&]R.B`C,#`P,#`P M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@ M=&5X="UT6QE/3-$)W=I9'1H.B`Q M-38W<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X M.R!L971T97(M3H@)W1I;65S M(&YE=R!R;VUA;B#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`^#0H\='(@6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-TF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H.B`Q M,3DQ<'@[(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6EE;&0\+W1D/@T* M/'1D('-T>6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;BF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H M.B`Q-7!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3PO M=&0^#0H\=&0@6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[)SY2:7-K+69R M964@:6YT97)E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`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`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[)SY%>'!E8W1E9"!L:69E(&]F('=A3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/@T*/"]T6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ M(')I9VAT.R<^,30L.3(R+#`P,#PO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@ M)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(')I9VAT.R<^-"PS M,#`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`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US M=')E=&-H.B!N;W)M86P[(&UAF4Z(#$P<'0[(&9O;G0M'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET M92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/E1H92!F86ER('9A;'5E(&]F M('1H97-E('=A6QE/3-$)V-O M;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/CQB/D9A:7(@5F%L=64@ M365AF4Z(#$P<'0[(&9O;G0M'0M:6YD M96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C M,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[ M(&UA3PO:3X\+W`^ M#0H\<"!S='EL93TS1"=C;VQO'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@ M;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^/&D^)B,Q M-C`[/"]I/CPO<#X-"CQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UT M#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA2!F;W(@9&ES8VQO2!O28C.#(Q M-SMS(&]W;B!A'0M=')A;G-F M;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[ M('=O'0M#L@=&5X M="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N="US M=')E=&-H.B!N;W)M86P[(&UA#L@=&5X="UT'0M:6YD96YT.B`P<'@[(&QE M='1E#L@8F]R M9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@+7=E8FMI="UT97AT+7-T3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B6QE M/3-$)W9EF4Z(#$P<'0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R M:6%N=#H@;F]R;6%L.PT*(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`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`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M'0M86QI9VXZ M(&QE9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,30R<'@[(&9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W=I9'1H.B`Q-G!X M.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T'0M86QI9VXZ(&QE9G0[)SXD/"]T M9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,30R<'@[(&9O;G0M3H@)W1I;65S(&YE=R!R;VUA M;B'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=W M:61T:#H@,30Q<'@[(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W=I M9'1H.B`Q-7!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-TF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE M9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,30Q<'@[(&9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W=I9'1H.B`Q-7!X.R!F M;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;BF4Z(#$P<'0[(&9O;G0M M'0M86QI9VXZ('-T87)T M.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT M+7-T'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP M('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N M="US=')E=&-H.B!N;W)M86P[(&UA2X\+W`^#0H\<"!S='EL93TS M1"=C;VQO'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O M=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M M'0M:6YD96YT.B`P<'@[ M('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W M:61O=W,Z(&%U=&\[('=O'0M M#L@=&5X="UA;&EG;CH@;&5F=#LG/E1H92!F;VQL;W=I;F<@=&%B M;&4@F4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N M93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT M.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@ M,34V-W!X.R!T97AT+71R86YS9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P M>#L@;&5T=&5R+7-P86-I;F'0M6QE/3-$)W9E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N M;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T'0M86QI M9VXZ(&-E;G1E6QE.B!S M;VQI9#LG(&-O;'-P86X],T0R/DYI;F4@36]N=&AS($5N9&5D(%-E<'1E;6)E M6QE/3-$)W!A9&1I M;F6QE/3-$)W=I9'1H.B`Q,S6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H.B`Q-#%P>#L@9F]N="US='EL93H@;F]R;6%L.R!F M;VYT+79A'0M86QI9VXZ(')I9VAT.R<^-S6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(')I9VAT M.R<^,RPP,C`L-3(V/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N M;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R M;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W9E3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`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`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M6QE/3-$)W!A9&1I;F7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA MF4Z M(#$P<'0[(&9O;G0M'0M M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R M;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N M;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/B8C,38P.SPO M<#X\<"!S='EL93TS1"=C;VQO'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@ M;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^/"]P/CQP M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM M97,L('-EF4Z(#$P<'0[(&9O;G0M3L@ M=&5X="UI;F1E;G0Z(#`N-6EN.R!C;VQO2!T;R!C;VYT:6YU92!A6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-EF4Z(#$P<'0[(&9O;G0M'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O M=W,Z(&%U=&\[('=O'0M#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#`N-6EN M.R!C;VQO#L@ M9F]N="US=')E=&-H.B!N;W)M86P[(&UA2`R,#$T+"!T:&4@ M(D9!4T(B(&ES2!W:6QL(')E M8V]G;FEZ92!R979E;G5E('=H96X@:70@=')A;G-F97)S('!R;VUI2!E>'!E8W1S('1O(&)E(&5N=&ET;&5D(&EN(&5X8VAA;F=E(&9O2!E=F%L M=6%T:6YG(&]U&ES=&EN9R!R979E;G5E(')E8V]G;FET:6]N('!R86-T M:6-E2!T M:&4@;F5W(')E<75I2`Q+"`R,#$W+B!%87)L>2!A9&]P M=&EO;B!I2!E=F%L=6%T M:6YG('1H92!T#L@9F]N M="US=')E=&-H.B!N;W)M86P[(&UA3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;CL@8V]L;W(Z(",R-3(U,C4[(&)A8VMG2X@5&AE($-O;7!A;GD@9&]E M'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A0 M;VQI8VEE2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-TF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W M:61O=W,Z(&%U=&\[('=O'0M M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@ MF4Z(#$P<'0[(&9O M;G0M'0M86QI9VXZ('-T M87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R;3H@;F]N93L@ M=VAI=&4M#L@+7=E8FMI="UT97AT+7-T28C.#(R,3LI('=A2!R969L96-T28C.#(Q-SMS(&9O8W5S(&)E>6]N9"!T:&4@5VEN9%1A;65R M)B,Q-S0[(&)R86YD(&%N9"!E;G1R>2!I;G1O(&%R96%S('=I=&AI;B!T:&4@ M96YE'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US M<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^ M)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T2!I2!S>7-T96US+B8C,38P.R8C,38P.U1H92!# M;VUP86YY)B,X,C$W.W,@<&%T96YT960@4&]W97(@;VX@1&5M86YD('-Y2!T:&%T(')E M;&5A2!A="!O<'1I;6%L('1I;65S('1O(')E9'5C92!E;&5C M=')I8VET>2!C;W-T'0M:6YD96YT.B`P<'@[('1E>'0M=')A M;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U M=&\[('=O'0M#LG M/CQB/D)A6QE/3-$ M)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET M92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/E1H92!A8V-O;7!A;GEI;F<@ M=6YA=61I=&5D(&-O;F1E;G-E9"!F:6YA;F-I86P@2!'04%0(&9OF4Z(#$P<'0[(&9O;G0M'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$ M)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H M.B!N;W)M86P[(&UA2!F M;W(@82!F86ER('!R97-E;G1A=&EO;B!O9B!T:&4@28C.#(Q-SMS M($9O#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M6QE/3-$)V9O;G0Z(#$P<'0O;F]R M;6%L("=T:6UE'0M:6YD96YT.B`P+C5I;CL@;&5T=&5R+7-P86-I;F#LG/B8C,38P.SPO<#X\<"!S='EL93TS M1"=F;VYT.B`Q,'!T+VYO#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A M;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M6EN9R!F:6YA;F-I86P@6QE/3-$ M)V9O;G0Z(#$P<'0O;F]R;6%L("=T:6UE'0M:6YD96YT.B`P<'@[(&QE='1E'0M#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T M97AT+6EN9&5N=#H@,"XU:6X[(&QE='1E'0M#L@;&5T=&5R+7-P86-I M;F#LG/E1H92!P M'!E;G-E6QE/3-$)V9O;G0Z M(#$P<'0O;F]R;6%L("=T:6UE'0M:6YD96YT.B`P<'@[(&QE='1E'0M#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,"XU:6X[(&QE='1E'0M#L@;&5T=&5R+7-P M86-I;F#LG/D9O M2!E>&-E960@9F5D97)A;&QY M(&EN2!B96QI979E2!T:&4@ M9FEN86YC:6%L(&EN#L@;&5T=&5R+7-P86-I;F#LG/B8C,38P.SPO<#X\+V1I M=CX\6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M("=T:6UE'0M M:6YD96YT.B`P<'@[(&QE='1E'0M M#L@8V]L;W(Z(",P M,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,"XU M:6X[(&QE='1E'0M'0M86QI9VXZ(&IU#L@;&5T=&5R M+7-P86-I;F#LG M/D%C8V]U;G1S(')E8V5I=F%B;&4@2!O;B!A M('-P96-I9FEC(&%C8V]U;G0@8F%S:7,@=&\@9&5T97)M:6YE('1H92!N965D M('1O(&%N(&%L;&]W86YC92!F;W(@9&]U8G1F=6P@86-C;W5N="!R97-E6QE/3-$)V9O;G0Z M(#$P<'0O;F]R;6%L("=T:6UE'0M:6YD96YT.B`P<'@[(&QE='1E'0M6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L("=T:6UE'0M:6YD96YT.B`P M+C5I;CL@;&5T=&5R+7-P86-I;F#LG/B8C,38P.SPO<#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T M+VYO#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT M+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M#L@8V]L;W(Z(",P,#`P,#`[ M('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,"XU:6X[(&QE M='1E'0M#L@;&5T=&5R+7-P86-I;FF5D+B8C,38P.R8C,38P.T5X<&5N9&ET=7)E2!G86EN M(&]R(&QOF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS M9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M=')A M;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U M=&\[('=O'0M#L@ M=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M2!A<'!R M;WAI;6%T97,@:71S(&QE9V%L(&QI9F4N($9O2!R M96QA=&EN9R!T;R!T:&4@0V]M<&%N>28C.#(Q-SMS(%=I;F1486UE'0^)SQP('-T>6QE M/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E M=&-H.B!N;W)M86P[(&UA'0M=')A;G-F M;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[ M('=O'0M#L@=&5X M="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@F4Z(#$P<'0[(&9O;G0M6EN M9R!A;6]U;G0@;V8@86X@87-S970@;6%Y(&YO="!B92!R96-O=F5R86)L92XF M(S$V,#LF(S$V,#M296-O=F5R86)I;&ET>2!O9B!A2!A(&-O;7!A2!T:&4@87-S970L(&EN8VQU9&EN9R!I=',@=6QT:6UA=&4@9&ES<&]S M:71I;VXN)B,Q-C`[)B,Q-C`[268@2!W:&EC:"!T:&4@ M8V%R'0^)SQD:78^/'`@#L@;&5T=&5R+7-P86-I;F#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T M97AT+6EN9&5N=#H@,"XU:6X[(&QE='1E'0M#L@;&5T=&5R+7-P86-I M;F#LG/E1H92!C M87)R>6EN9R!A;6]U;G0@;V8@8V%S:"P@86-C;W5N=',@'0^)SQP('-T M>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US M=')E=&-H.B!N;W)M86P[(&UAF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+71R86YS9F]R;3H@;F]N93L@ M=VAI=&4M#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P M+C5I;CLG/B8C,38P.SPO<#X\<"!S='EL93TS1"=C;VQO'0M:6YD96YT.B`P<'@[('1E M>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O M=W,Z(&%U=&\[('=O'0M#LG/E)E=F5N=64@:7,@2!T:&4@8W5S=&]M97(@:7,@9FEX960@;W(@9&5T97)M M:6YA8FQE.R!A;F0@*#0I('1H92!C;VQL96-T:6]N(&]F('1H92!S86QE('!R M:6-E(&ES(')E87-O;F%B;'D@87-S=7)E9"XF(S$V,#LF(S$V,#M!;6]U;G1S M)B,Q-C`[8V]L;&5C=&5D('!R:6]R('1O('-A=&ES9GEI;F<@;W5R(')E=F5N M=64@6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@9F]N M="US=')E=&-H.B!N;W)M86P[(&UAF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T M97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T M'0M M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z M(&%U=&\[('=O'0M#L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/CQP('-T>6QE/3-$ M)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H M.B!N;W)M86P[(&UA'!E8W0@=&\@:6YC=7(@;VX@82!C;VYTF4Z(#$P<'0[(&9O;G0M'0M M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X\<"!S='EL93TS1"=C;VQO'0M:6YD96YT M.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R M;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M#LG/D%T(%-E<'1E;6)E2!H860@8V]S=',@;V8@=6YC;VUP;&5T960@8V]N=')A8W1S(&EN(&5X M8V5S6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L("=T M:6UE'0M:6YD M96YT.B`P<'@[(&QE='1E'0M6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L("=T M:6UE'0M:6YD M96YT.B`P+C5I;CL@;&5T=&5R+7-P86-I;F#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M'!E;G-E M9"!W:&5N(&EN8W5R2P@=&AE2!#;W-T'0^)SQD:78^/'`@#L@;&5T=&5R+7-P86-I;F'0M2!#;W-T#L@=VAI=&4M#LG/B8C,38P.SPO<#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T M+VYO#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M#LG/E1H92!#;VUP86YY)B,X,C$W M.W,@7-T96T@2!R97-E6-L97,L(&UA;G5F86-T=7)EFEN M9R!F=71U#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT M+6EN9&5N=#H@,"XU:6X[(&QE='1E'0M#L@;&5T=&5R+7-P86-I;F#LG/E1H92!#;VUP M86YY(&%C8V]U;G1S(&9O'!E;G-E(')E;&%T960@=&\@6QE/3-$)V9O;G0Z(#$P<'0O M;F]R;6%L("=T:6UE'0M:6YD96YT.B`P+C5I;CL@;&5T=&5R+7-P86-I;F#LG/B8C,38P.SPO<#X\<"!S='EL M93TS1"=F;VYT.B`Q,'!T+VYO#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M2!F;W(@97%U:71Y M(&EN&-H86YG92!F;W(@9V]O9',@86YD('-E2P@=&AE(&UE87-U2!I;G-T6QE/3-$)V9O;G0Z(#$P<'0O;F]R M;6%L("=T:6UE'0M:6YD96YT.B`P<'@[(&QE='1E'0M6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L("=T:6UE'0M:6YD96YT.B`P+C5I;CL@ M;&5T=&5R+7-P86-I;F#LG/B8C,38P.SPO<#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO#L@8V]L;W(Z(",P,#`P,#`[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT M+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M'!E8W1E M9"!F=71U"!B87-I2!D:69F97)E;F-E2!F;W)W M87)D2!B86QA;F-E'0^)SQP('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@=&5X="UT#L@9F]N="US=')E=&-H.B!N;W)M86P[(&UA6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9F]N="US=')E=&-H.B!N;W)M86P[ M(&UAF4Z(#$P<'0[ M(&9O;G0M'0M86QI9VXZ M('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R;3H@;F]N M93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-TF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T M97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T MF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T M97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T M&5R8VES92X\+W`^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,C$P-&)B,%\W,#@V M7S0S,3=?.&0Q.5\U9&4R,#5B-&4U,&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.3(Q,#1B8C!?-S`X-E\T,S$W7SAD,3E?-61E,C`U8C1E-3!D M+U=O'0O M:'1M;#L@8VAA'0^)SQT86)L92!S='EL93TS1"=F;VYT M.B`Q,'!T+VYO#L@;&5T=&5R+7-P86-I;F'0M6QE/3-$ M)W=I9'1H.B`Q,S'0M86QI9VXZ(&QE9G0[)SXR,#$T("AI;F-L M=61E6QE/3-$)W=I9'1H.B`Q-G!X.R!T97AT+6%L:6=N.B!L969T.R<^)#PO M=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q-#%P>#L@=&5X="UA;&EG;CH@7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET M96US73PO'0^ M)SQS<&%N/CPO2!O9B!#;VUP86YY)W,@6QE/3-$)W=I9'1H.B`Q-38W<'@[('1E>'0M M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M3H@)W1I;65S(&YE=R!R;VUA;B#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(@6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@ M)W1I;65S(&YE=R!R;VUA;B'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/CQB/E)EF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H M.B`Q,3DQ<'@[(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I M9'1H.B`Q-#)P>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A'0M86QI9VXZ(')I9VAT.R<^,3$X+#,W.#PO=&0^#0H\=&0@F4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M6QE/3-$)W=I9'1H.B`Q-7!X M.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)W=I9'1H.B`Q-#%P>#L@ M9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A'0M86QI9VXZ M(')I9VAT.R<^,BXX,#PO=&0^#0H\=&0@3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E3H@)W1I;65S(&YE M=R!R;VUA;B'0M86QI9VXZ(')I9VAT.R<^-#`P+#`P,#PO=&0^ M#0H\=&0@'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/@T*/"]T'0M86QI9VXZ(&QE9G0[('!A9&1I;F'!I6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`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`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(')I9VAT M.R<^+C,Y/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B6UE;G0@07=A#L@;&5T=&5R+7-P86-I;F'0M6QE/3-$ M)W9EF4Z(#$P<'0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;BF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;BF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q,#4P<'@[ M(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6EE;&0\+W1D/@T*/'1D('-T M>6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T M3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H.B`Q-7!X M.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3PO=&0^#0H\ M=&0@6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE M/3-$)V9O;G0M'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W9E3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[ M)SY%>'!E8W1E9"!L:69E(&]F(&]P=&EO;G,\+W1D/@T*/'1D('-T>6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B'0M M86QI9VXZ(')I9VAT.R<^+C$T+3DN-S@@>65A6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;BF4Z(#$P<'0[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!X.R!T M97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T M#L@ M=&5X="UT'0M:6YD96YT.B`P<'@[(&QE='1E M#L@8F]R9&5R M+6-O;&QA<'-E.B!C;VQL87!S93L@+7=E8FMI="UT97AT+7-T6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T M>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[ M/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9F]N="US M='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9F]N M="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@8V5N=&5R.R<@ M8V]L&5R8VES92`F(S$V,#M0 M#L@=&5X="UA;&EG;CH@8V5N=&5R M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L M9#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@8V5N M=&5R.R<@8V]L'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T* M/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[('!A9&1I;F#L@=&5X="UI;F1E;G0Z(#!P M>#LG(&-O;'-P86X],T0R/B8C,38P.SPO=&0^#0H\=&0@#L@ M=&5X="UI;F1E;G0Z(#!P>#LG(&-O;'-P86X],T0R/B8C,38P.SPO=&0^#0H\ M=&0@'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O M;G0M#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^ M#0H\=&0@'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$ M)V9O;G0M#L@=&5X="UI;F1E;G0Z(#!P M>#LG/B8C,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O M;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT M+7-T3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X M="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^ M#0H\=&0@6QE.B!N;W)M M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L M.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA M;B#LG/C$L,S@V+#$P.#PO=&0^#0H\=&0@ M3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X="UA;&EG;CH@;&5F M=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)W=I M9'1H.B`Q-#%P>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@'0M:6YD96YT M.B`P<'@[)SXN-C$\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q-7!X.R!F M;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\ M+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q-#%P>#L@9F]N="US:7IE.B`Q M,'!T.R!P861D:6YG.B`P<'@[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\ M+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q-7!X.R!F;VYT+7-I>F4Z(#$P M<'0[('!A9&1I;F#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO M=&0^#0H\=&0@6QE/3-$)W=I9'1H.B`Q M-#%P>#L@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@<&%D M9&EN9SH@,'!X.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT M9"!S='EL93TS1"=W:61T:#H@,35P>#L@9F]N="US:7IE.B`Q,'!T.R!T97AT M+6%L:6=N.B!L969T.R!P861D:6YG.B`P<'@[('1E>'0M:6YD96YT.B`P<'@[ M)SXF(S$V,#L\+W1D/@T*/"]T6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P M<'@[)SY/<'1I;VYS(&=R86YT960@9'5R:6YG(#(P,30\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P M<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R M;VUA;B6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE M=R!R;VUA;B#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[ M)SXN,3D\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[('1E>'0M86QI9VXZ(')I9VAT.R<^ M)B,Q-C`[.2XX)B,Q-C`[>65A6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXD/"]T9#X- M"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C M,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E3H@)W1I;65S(&YE=R!R;VUA;B"`Q+C5P=#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI M;F1E;G0Z(#!P>#LG/D]P=&EO;G,@8V%N8V5L;&5D(&]R(&5X<&ER960@9'5R M:6YG(#(P,30\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I M;65S(&YE=R!R;VUA;B"`Q+C5P=#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG M/B8C,38P.SPO=&0^#0H\=&0@#L@8F]R9&5R+6)O='1O;2UC;VQO6QE.B!S;VQI M9#L@<&%D9&EN9RUL969T.B`P<'@[('1E>'0M86QI9VXZ(')I9VAT.R!T97AT M+6EN9&5N=#H@,'!X.R<^*#(Y-2PY,3<\+W1D/@T*/'1D('-T>6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E"`P<'@@,2XU<'0[('1E>'0M:6YD M96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M"`P<'@@,2XU<'0[('1E>'0M86QI9VXZ(')I M9VAT.R!T97AT+6EN9&5N=#H@,'!X.R<^+C4V/"]T9#X-"CQT9"!S='EL93TS M1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`Q+C5P=#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z M(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@"`P<'@@,2XU<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M"`Q+C5P=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P M.SPO=&0^#0H\=&0@F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG.B`P<'@@,'!X(#$N M-7!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[#0H@=&5X="UA;&EG;CH@;&5F=#L@<&%D M9&EN9SH@,'!X(#!P>"`Q+C5P=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P M.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^3W5T6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I M;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B8C,38P.SPO=&0^#0H\=&0@#L@8F]R9&5R+6)O='1O;2UC;VQO#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[)SXR+#0U-2PQ.3$\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B8C,38P.SPO=&0^#0H\=&0@"`P<'@@-'!T M.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS M1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P M<'@[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI M9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!X.R<^+C,T/"]T9#X-"CQT9"!S M='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R!T97AT+6%L:6=N.B!R M:6=H=#LG/C@N-R!Y96%R"`P<'@@-'!T M.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS M1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P M<'@[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI M9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!X.R<^,#PO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N M=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CPO='(^#0H\='(@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E#LG/D5X97)C:7-A8FQE(&%T(%-E<'1E;6)E"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O M;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT M+7-T3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!X.R<^-S(U+#$Y M,3PO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L M969T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL M93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D M/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M#LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[)SXN M-C`\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T M9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R M:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M:6YD96YT.B`P<'@[ M('1E>'0M86QI9VXZ(')I9VAT.R<^-BXW('EE87)S/"]T9#X-"CQT9"!S='EL M93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T#LG/B8C,38P.SPO M=&0^#0H\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L969T M.R!T97AT+6EN9&5N=#H@,'!X.R<^)#PO=&0^#0H\=&0@"`P M<'@@-'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@=&5X="UI;F1E;G0Z(#!P>#LG M/C`\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M'10 M87)T7SDR,3`T8F(P7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!3:&%R92UB87-E9"!0 M87EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^)SQS<&%N/CPO'0^)SQD:78^)B,Q-C`[/"]D:78^#0H\=&%B;&4@#L@=&5X="UT'0M:6YD96YT M.B`P<'@[(&QE='1E#L@8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@+7=E8FMI="UT97AT M+7-T'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O M;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T#L@=&5X="UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!X.R<@ M8V]L6QE M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O M;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@F4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&-E;G1E#LG M(&-O;'-P86X],T0R/DYI;F4@36]N=&AS($5N9&5D/"]T9#X-"CQT9"!S='EL M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9F]N="US='EL93H@;F]R;6%L.R!F M;VYT+79A#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\+W1R/@T* M/'1R('-T>6QE/3-$)W9E#L@=&5X="UI M;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@3H@)W1I;65S M(&YE=R!R;VUA;B'0M:6YD96YT.B`P<'@[)R!C;VQS<&%N/3-$,CY397!T M96UB97(F(S$V,#LS,"P@,C`Q-#PO=&0^#0H\=&0@'0M M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@ M8F]R9&5R+6)O='1O;2UW:61T:#H@,2XU<'0[(&)O6QE/3-$)W!A9&1I M;F#L@9F]N="UW96EG:'0Z(&)O;&0[(&9O;G0M6QE/3-$)W=I9'1H.B`Q,3DQ<'@[(&9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SY%>'!E8W1E9"!D M:79I9&5N9"!Y:65L9#PO=&0^#0H\=&0@3H@)W1I;65S(&YE=R!R;VUA;BF4Z(#$P M<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)RP@=&EM97,L('-E'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXE/"]T9#X-"CQT9"!S M='EL93TS1"=W:61T:#H@,35P>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT M+79A#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C M,38P.SPO=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[)SXP/"]T9#X-"CQT9"!S='EL93TS1"=W M:61T:#H@,35P>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z M(#!P>#LG/B4\+W1D/@T*/"]T6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P M<'@[)SY%>'!E8W1E9"!S=&]C:R!P3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R;VUA;B6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE M=R!R;VUA;B#LG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X M="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@#L@ M=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO M=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@'0M M:6YD96YT.B`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`G=&EM97,@;F5W M(')O;6%N)RP@=&EM97,L('-E'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@ M,'!X.R<^/&9O;G0@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[ M)SXE/"]T9#X-"CPO='(^#0H\='(@6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C M,38P.SPO=&0^#0H\=&0@#L@=&5X="UA;&EG;CH@6QE.B!N;W)M86P[(&9O;G0M=F%R M:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[ M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI M;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)RP@=&EM97,L('-E'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SX\+W1D/@T*/'1D('-T>6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E65A3H@)W1I;65S(&YE M=R!R;VUA;B'0M6QE/3-$)V9O;G0MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E#L@8F]R9&5R+6)O='1O;2UC;VQO6QE.B!S M;VQI9#L@<&%D9&EN9RUL969T.B`P<'@[('1E>'0M86QI9VXZ(&-E;G1E"`P<'@@,2XU<'0[('1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R M:6%N=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I M;65S(&YE=R!R;VUA;B#L@<&%D9&EN9RUR:6=H=#H@,'!X.R!B;W)D97(M8F]T=&]M+6-O;&]R.B!B M;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,2XU<'0[(&)O#L@=&5X="UA;&EG M;CH@8V5N=&5R.R<@8V]L&5R M8VES92!06QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD M.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B"`Q+C5P=#L@=&5X="UA M;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@#L@8F]R9&5R+6)O='1O;2UC M;VQO6QE.B!S;VQI9#L@<&%D9&EN9RUL969T.B`P<'@[('1E M>'0M86QI9VXZ(&-E;G1E#L@8F]R9&5R+6)O='1O;2UC;VQO M6QE.B!S;VQI9#L@<&%D9&EN9RUL969T.B`P<'@[('1E>'0M M86QI9VXZ(&-E;G1E"`P<'@@,2XU<'0[('1E>'0M:6YD M96YT.B`P<'@[)SXF(S$V,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$)W9E6QE.B!N;W)M M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L M.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA M;B2`Q+"`R,#$T/"]T9#X\=&0@ M#L@=&5X="UA M;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^/'1D M('-T>6QE/3-$)W=I9'1H.B`Q-#)P>#L@9F]N="US='EL93H@;F]R;6%L.R!F M;VYT+79A#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[)SXW+#8W,2PR-C<\+W1D/CQT9"!S='EL93TS M1"=W:61T:#H@,39P>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E M;G0Z(#!P>#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q-G!X M.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-TF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`P<'@[)SXD/"]T9#X\=&0@6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B#LG/C$N-3$\ M+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,35P>#L@9F]N="US='EL93H@;F]R M;6%L.R!F;VYT+79A#L@=&5X="UA;&EG;CH@ M;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)W=I9'1H.B`Q-7!X.R!F;VYT+7-I>F4Z(#$P<'0[('!A9&1I;F#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q-#%P>#L@9F]N="US:7IE.B`Q,'!T.R!P861D:6YG.B`P<'@[ M('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=W M:61T:#H@,35P>#L@9F]N="US:7IE.B`Q,'!T.R!P861D:6YG.B`P<'@[('1E M>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=W:61T M:#H@,35P>#L@9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T.R!P M861D:6YG.B`P<'@[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=W:61T:#H@,30Q<'@[(&9O;G0M#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q-7!X.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@ M=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^/"]T#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X M="UI;F1E;G0Z(#!P>#LG/E=A3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T M3H@)W1I;65S(&YE=R!R;VUA;B#L@=&5X M="UA;&EG;CH@'0M:6YD96YT.B`P<'@[)SXQ,2PX-C(L,#`P M/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI M;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!X M.R<^+C(U/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@;&5F=#L@ M=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V9O M;G0M'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('!A9&1I;F#L@=&5X M="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V9O;G0M M"`P<'@@,2XU<'0[('1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SY787)R86YT'!I M"`P<'@@,2XU<'0[ M('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=F M;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B#L@<&%D9&EN9RUR:6=H=#H@,'!X.R!B;W)D97(M8F]T=&]M+6-O;&]R M.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,2XU<'0[(&)O#L@=&5X="UA M;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO=&0^/'1D M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B@Q M+#(T,"PS-3$\+W1D/CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B"`Q+C5P=#L@=&5X="UA M;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P>#LG/BD\+W1D/CQT9"!S='EL M93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`Q+C5P=#L@=&5X="UI;F1E;G0Z(#!P>#LG/B8C,38P.SPO M=&0^/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M"`P<'@@,2XU<'0[('1E>'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@ M,'!X.R<^+C4P/"]T9#X\=&0@"`P<'@@,2XU<'0[('1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('!A9&1I;F"`P<'@@ M,2XU<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[('!A9&1I;F"`P<'@@,2XU<'0[ M('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[('!A9&1I;F"`P<'@@,2XU<'0[('1E>'0M M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F"`P<'@@ M,2XU<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R!P861D M:6YG.B`P<'@@,'!X(#$N-7!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[ M/"]T9#X\=&0@6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SY/=71S=&%N M9&EN9R!A="!397!T96UB97(@,S`L,C`Q-#PO=&0^/'1D('-T>6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/B8C,38P.SPO=&0^/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\ M+W1D/CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R M:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T#L@<&%D9&EN9RUR:6=H=#H@,'!X.R!B M;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T M:#H@-'!T.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!D;W5B;&4[('!A9&1I;F#LG/C$X+#(Y,BPY,38\+W1D/CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N M;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R M;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R M;VUA;B"`T<'0[('1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T#LG M/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V9O;G0M#LG/B0\+W1D/CQT9"!S='EL93TS M1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@ M,'!X.R<^+C"`P<'@@-'!T.R!T97AT+6%L M:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X\=&0@ M"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[ M/"]T9#X\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!C96YT M97([)SXU+C$@>65A3H@)W1I;65S(&YE=R!R M;VUA;B"`T<'0[('1E M>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=F;VYT M+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I M;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXD M/"]T9#X\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@=&5X="UI;F1E;G0Z(#!P>#LG/C`\+W1D/CQT9"!S='EL93TS1"=F;VYT M+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I M;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF M(S$V,#L\+W1D/CPO='(^/'1R('-T>6QE/3-$)W9E"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^17AE6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B"`T M<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS M1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T#L@<&%D9&EN9RUR:6=H=#H@,'!X.R!B;W)D97(M8F]T=&]M+6-O M;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@-'!T.R!B;W)D97(M M8F]T=&]M+7-T>6QE.B!D;W5B;&4[('!A9&1I;F#L@8F]R9&5R M+6)O='1O;2UC;VQO#L@=&5X="UA;&EG;CH@'0M:6YD96YT.B`P<'@[)SXQ M."PQ,SDL,C4P/"]T9#X\=&0@"`P<'@@-'!T.R!T97AT+6%L M:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[/"]T9#X\=&0@ M"`P<'@@-'!T.R!T97AT+6EN9&5N=#H@,'!X.R<^)B,Q-C`[ M/"]T9#X\=&0@"`P<'@@-'!T.R!T97AT+6%L:6=N.B!L969T M.R!T97AT+6EN9&5N=#H@,'!X.R<^)#PO=&0^/'1D('-T>6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M:6YD96YT.B`P<'@[)SXN M-S4\+W1D/CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T M3H@)W1I;65S(&YE=R!R;VUA;B"`T<'0[('1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS M1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M:6YD96YT.B`P<'@[)SXF(S$V,#L\+W1D/CQT M9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V9O;G0M#LG/B0\+W1D/CQT M9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T"`T<'0[('1E>'0M86QI9VXZ(')I9VAT.R!T97AT M+6EN9&5N=#H@,'!X.R<^,#PO=&0^/'1D('-T>6QE/3-$)V9O;G0M#LG/B8C,38P.SPO M=&0^/"]T3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,C$P-&)B,%\W,#@V7S0S M,3=?.&0Q.5\U9&4R,#5B-&4U,&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO.3(Q,#1B8C!?-S`X-E\T,S$W7SAD,3E?-61E,C`U8C1E-3!D+U=O M'0O:'1M M;#L@8VAA'0^ M)SQD:78^)B,Q-C`[/"]D:78^#0H\=&%B;&4@#L@=&5X="UT'0M:6YD96YT.B`P<'@[ M(&QE='1E#L@ M8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@+7=E8FMI="UT97AT+7-T6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F M;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7-T3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M=V5I M9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE M=R!R;VUA;BF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`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`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H.B`Q,3DQ M<'@[(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6EE;&0\+W1D/@T*/'1D M('-T>6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O M;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT M+7-T3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE M=R!R;VUA;B6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3PO=&0^ M#0H\=&0@6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@ M)W1I;65S(&YE=R!R;VUA;B3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E3H@)W1I;65S(&YE=R!R;VUA;B6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M6QE/3-$)W9E3H@)W1I;65S(&YE=R!R;VUA M;B3H@)W1I;65S(&YE M=R!R;VUA;B'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E3H@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M3H@ M)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(')I9VAT.R<^/&9O M;G0@6QE/3-$)V9O;G0M'0M86QI M9VXZ(&QE9G0[)SY%>'!E8W1E9"!L:69E(&]F('=A3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/@T*/'1D('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E M6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/@T*/"]T6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(')I M9VAT.R<^,30L.3(R+#`P,#PO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M3H@)W1I M;65S(&YE=R!R;VUA;B'0M86QI9VXZ(')I9VAT.R<^-"PS,#`L M,S4Q/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[#0H@ M9F]N="UV87)I86YT.B!N;W)M86P[(&9O;G0M=V5I9VAT.B!N;W)M86P[(&9O M;G0MF4Z(#$P<'0[(&QI;F4M:&5I M9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@ M=&EM97,L('-E6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M3H@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N M;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L M('-E3H@)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X-"CQT9"!S M='EL93TS1"=F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-TF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-EF4Z(#$P<'0[(&9O;G0M'0M:6YD96YT.B`P+C5I;CLG/CPO<#X-"CQT86)L92!S='EL93TS1"=W M:61T:#H@,34V-W!X.R!T97AT+71R86YS9F]R;3H@;F]N93L@=&5X="UI;F1E M;G0Z(#!P>#L@;&5T=&5R+7-P86-I;F'0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`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`[/&)R("\^56YO8G-E6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N M=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&QI;F4M:&5I M9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@ M=&EM97,L('-E'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@ M,30R<'@[(&9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W=I M9'1H.B`Q-G!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@ M;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-TF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E'0M86QI9VXZ(&QE M9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,30R<'@[(&9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)W=I9'1H.B`Q-G!X.R!F;VYT+7-T M>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)W=I9'1H.B`Q-7!X.R!F;VYT+7-T>6QE.B!N;W)M86P[ M(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F M;VYT+7-T3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H.B`Q-#%P>#L@9F]N="US='EL93H@;F]R;6%L.R!F M;VYT+79A'0M86QI9VXZ(')I9VAT.R<^+3PO=&0^#0H\=&0@ M6QE/3-$)W=I9'1H M.B`Q-7!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T'0M M86QI9VXZ(')I9VAT.R<^-34V+#`W,#PO=&0^#0H\=&0@F4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E2!O9B!C:&%N9V5S(&EN(&9A:7(@=F%L=64@;V8@3&5V96P@ M,R!F:6YA;F-I86P@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA M6QE/3-$ M)W=I9'1H.B`Q-38W<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN M9&5N=#H@,'!X.R!L971T97(M3H@)W1I;65S(&YE=R!R;VUA;B#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL M<&%D9&EN9STS1#`^#0H\='(@6QE/3-$)V9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H.B`Q M-G!X.R!F;VYT+7-T>6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T3H@)W1I;65S(&YE=R!R M;VUA;B'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/@T*/"]T6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!F;VYT+7-T6QE/3-$)V9O;G0M MF4Z M(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&QI;F4M:&5I9VAT.B!N;W)M86P[ M(&9O;G0M9F%M:6QY.B`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`G=&EM97,@;F5W M(')O;6%N)RP@=&EM97,L('-E7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@ M("`\=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA2!O9B!A;FYU86P@;6%T=7)I=&EE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,C$P-&)B,%\W,#@V M7S0S,3=?.&0Q.5\U9&4R,#5B-&4U,&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.3(Q,#1B8C!?-S`X-E\T,S$W7SAD,3E?-61E,C`U8C1E-3!D M+U=O'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M6EN9R!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)S$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(&]F(&1E8G0@9&ES8V]U;G0\+W1D/@T* M("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\Y,C$P-&)B,%\W,#@V7S0S,3=?.&0Q.5\U9&4R,#5B M-&4U,&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3(Q,#1B8C!? M-S`X-E\T,S$W7SAD,3E?-61E,C`U8C1E-3!D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M&EM=6T@6TUE;6)E'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)S$P('EE87)S/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`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`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!S=&]C:R!P'0^)SQS<&%N/CPO2P@;6EN:6UU;3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'!E8W1E9"!L:69E(&]F(&]P=&EO;G,L(&UI;FEM=6T@*%EE87)S*3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S$@;6]N=&@@,C$@9&%Y M'!E8W1E9"!L:69E(&]F(&]P=&EO;G,L M(&UA>&EM=6T@*%EE87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SD@>65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\Y,C$P-&)B,%\W,#@V7S0S,3=?.&0Q.5\U9&4R,#5B-&4U,&0-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3(Q,#1B8C!?-S`X-E\T,S$W M7SAD,3E?-61E,C`U8C1E-3!D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO&5R8VES92!0'!I'0^)S@@>65A7,\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2=S(')E'!I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,C$P M-&)B,%\W,#@V7S0S,3=?.&0Q.5\U9&4R,#5B-&4U,&0-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.3(Q,#1B8C!?-S`X-E\T,S$W7SAD,3E?-61E M,C`U8C1E-3!D+U=O'0O:'1M;#L@8VAA'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^ M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L65E(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`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`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS M<&%N/CPOF5D M(&EN(&9A:7(@=F%L=64@8V%L8W5L871I;VYS(&9O'0^ M)SQS<&%N/CPO6EE;&0\+W1D/@T*("`@("`@("`\=&0@ M8VQA'!E8W1E9"!S=&]C:R!P'!E8W1E9"!S=&]C:R!P&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)S,@>65A7,\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\Y,C$P-&)B,%\W,#@V7S0S,3=?.&0Q.5\U9&4R,#5B-&4U,&0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3(Q,#1B8C!?-S`X-E\T,S$W7SAD M,3E?-61E,C`U8C1E-3!D+U=O'0O:'1M;#L@8VAA2!O9B!S=&%T=7,@;V8@0V]M<&%N>2=S('=A'0^)SQS M<&%N/CPO&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C M;&%S&5R M8VES92!0'!I&5R8VES92!0&5R8VES92!0&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S4@>65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@ M/'1H(&-L87-S/3-$=&@@8V]L'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQD:78^5F5S="!F65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@("`@(#QT9"!C M;&%S2P@;6EN:6UU;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2P@;6%X:6UU;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E8W1E M9"!L:69E(&]F('=A7,\&EM M=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)S0@>65A7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,C$P-&)B M,%\W,#@V7S0S,3=?.&0Q.5\U9&4R,#5B-&4U,&0-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.3(Q,#1B8C!?-S`X-E\T,S$W7SAD,3E?-61E,C`U M8C1E-3!D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC'1087)T7SDR,3`T8F(P7S XML 19 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details) (Warrant [Member])
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Warrant [Member]
   
Weighted-average assumptions utilized in fair value calculations for warrants granted    
Expected dividend yield 0.00% 0.00%
Expected stock price volatility 134.00%  
Expected stock price volatility, minimum   93.00%
Expected stock price volatility, maximum   98.00%
Risk-free interest rate, minimum 1.73% 0.14%
Risk-free interest rate, maximum 1.75% 2.60%
Expected life of warrants, minimum 4 years 1 month 6 days 3 years 6 months
Expected life of warrants, maximum 8 years 9 months 18 days 9 years 3 months 18 days
XML 20 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details Textual) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 1 Months Ended 0 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
April 1 2011 [Member]
Sep. 30, 2014
April 1, 2015 [Member]
Sep. 30, 2014
Board of Directors [Member]
Mar. 31, 2014
Chief Operating Officer [Member]
May 28, 2014
Employee [Member]
Jun. 16, 2014
Stephen Brown [Member]
Jun. 16, 2014
Stephen Brown [Member]
December 16, 2014 [Member]
Sep. 30, 2014
Stock Option [Member]
Sep. 30, 2013
Stock Option [Member]
Stock Based Compensation (Textual)                          
Weighted Average Exercise Price, Options granted                       $ 0.19 $ 0.45
Options expired or cancelled                       295,917 23,000
Stock option granted                       1,365,000 1,655,208
Stock options vested                       251,250 166,858
Share-based compensation vesting period     Either immediately on the date of grant or one to three years from the date of grant.                    
Expense of repricing for options and warrants        $ 110,579                  
Salary forfeited to purchase common share             Employees forfeited salary over a twelve-week period to purchase common shares            
Number of restricted shares vested         55,969         10,000      
Number of restricted shares expected to vest in future           118,378         40,000    
Restricted stock grants               250,000 100,000 50,000      
Expenses related to restricted stock awards     30,026                    
Equity Incentive Plan provided for the issuance common stock, shares 3,550,000   3,550,000                    
Number of shares are available for grant as Incentive Stock Options 50,000   50,000                    
Exercise price for options award     No less than 100% of the fair market value of the common stock on the day of grant.                    
Stock-based compensation 59,147 111,114 171,141 650,505                  
Compensation costs relating to issuance       539,926       72,500 15,000 9,000      
Compensation costs for options granted 45,553 20,800 139,010 190,861                  
Expenses occurred in repricing of options        $ 13,575                  
Expense of repricing by consultant to options       25,000                  
XML 21 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details 1) (Warrants [Member], USD $)
9 Months Ended
Sep. 30, 2014
Warrants [Member]
 
Summary of status of Company's warrant granted  
Number of Shares Remaining Options/Warrants, Outstanding, beginning balance 7,671,267
Number of Shares Remaining Warrants, Granted 11,862,000
Warrant expired (1,240,351)
Number of Shares Remaining Options/Warrants, Outstanding, balance 18,292,916
Number of Shares Remaining Options/Warrants, Exercisable 18,139,250
Weighted Average Exercise Price, Outstanding, beginning balance $ 1.51
Weighted Average Exercise Price, Warrant granted $ 0.25
Weighted Average Exercise Price, Warrants expired $ 0.50
Weighted Average Exercise Price, Outstanding, balance $ 0.78
Weighted Average Exercise Price, Exercisable $ 0.75
Weighted-Average Remaining Contractual Term, Outstanding 5 years 1 month 6 days
Weighted Average Remaining Contractual Term, Exercisable 5 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding $ 0
Aggregate Intrinsic Value, Exercisable $ 0
XML 22 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details Textual) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Warrants (Textual)    
Term of warrants 10 years  
Warrants [Member]
   
Warrants (Textual)    
Weighted average fair value of warrants $ 0.25 $ 0.41
Warrants vested 11,878,000 4,302,625
Warrants exercise price   $ 1.20
Warrant expired (1,240,351)  
Warrants [Member] | Consultant [Member]
   
Warrants (Textual)    
Warrants exercise price $ 1.20  
Compensation costs $ 4,962 $ 349,065
Term of warrants 10 years  
Outstanding warrants repriced 423,125  
Warrants vesting period description
Vest from nine months to three years from grant date.
 
Expenses associated with the repricing    $ 62,623
XML 23 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Going Concern
9 Months Ended
Sep. 30, 2014
Going Concern [Abstract]  
Going Concern

Note 2 - Going Concern

 

The financial statements have been prepared assuming that the Company will continue as a going concern.  Since its formation, the Company utilized funds generated from private placement offerings and debt to fund its product development and operations and has incurred a cumulative net loss of $25,435,169 as of September 30, 2014.  The recurring losses from operations and current liquidity raise substantial doubt about the Company’s ability to continue as a going concern.  Continuation of the Company is dependent on achieving sufficiently profitable operations and obtaining additional financing.

XML 24 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Details) (Warrants [Member], USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Warrants [Member]
   
Summary of weighted-average assumptions of fair value calculations for warrants granted and subsequent revaluation    
Expected dividend yield 0.00% 0.00%
Expected stock price volatility, minimum 142.00% 90.00%
Expected stock price volatility, maximum 148.00% 172.00%
Risk-free interest rate, minimum 1.62% 0.08%
Risk-free interest rate, maximum 178.00% 1.41%
Expected life of warrants, minimum 2 years 10 months 24 days 4 months 6 days
Expected life of warrants, maximum 4 years 6 months 4 years 10 months 2 days
Number of warrants 14,922,000 4,300,351
Fair value of warrants $ 556,070 $ 1,232,676
XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Balance Sheets (Unaudited) (USD $)
Sep. 30, 2014
Dec. 31, 2013
Current assets    
Cash $ 353,166 $ 297,385
Accounts Receivable (less allowance for doubtful accounts of $0 at September 30, 2014 and December 31,2013) 143,103 265,245
Prepaid expenses and other current assets 101,717 232,570
Inventory 496,313 496,313
Deferred debt discount 820,750 820,750
Total current assets 1,915,049 2,112,263
Other assets 139,344 172,362
Intangible assets, net 23,796 25,305
Property and equipment, net 19,080 69,555
Total assets 2,097,269 2,379,485
Current liabilities    
Accounts payable 487,192 1,175,221
Borrowings under line of credit, net of debt discount 941,248 684,994
Customer deposits 18,850 19,000
Accrued payroll 54,763 146,465
Deferred revenue 318,977 63,311
Accrued warranty costs 142,504 140,074
Accrued liabilities 442,640 496,011
Accrued loss contract 542,842 519,092
Accrued dividends 63,675 0
Derivative liabilities, short term 0 13,200
Current portion of long term debt 277 11,782
Total current liabilities 3,012,968 3,269,150
Long term liabilities    
Long term debt 0 16,169
Derivative liabilities 556,070 762,396
Total long term liabilities 556,070 778,565
Total liabilities 3,569,038 4,047,715
Stockholders' (deficit)    
Preferred stock, 5,000,000 shares authorized, $0.002 par value; 1,415 and 0 issued and outstanding at September 30, 2014 or December 31, 2013 3 0
Common stock, 500,000,000 shares authorized, $0.002 par value; 19,892,264 and 17,993,694 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively 39,784 35,987
Additional paid-in capital 23,923,613 25,330,474
Deficit accumulated (25,435,169) (27,034,691)
Total stockholders' (deficit) (1,471,769) (1,668,230)
Total liabilities and stockholders' deficit $ 2,097,269 $ 2,379,485
XML 26 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statement of Shareholders' (Deficit) (Unaudited) (USD $)
Total
Common Stock
Preferred Stock
Additional paid-in capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2013 $ (1,668,230) $ 35,987 $ 0 $ 25,330,474 $ (27,034,690)
Beginning Balance, shares at Dec. 31, 2013   17,993,694 0    
Issuance of convertible preferred stock for cash 1,500,000   3 1,499,997  
Issuance of convertible preferred stock for cash, shares     1,500    
Stock offering costs (100,000)     (100,000)  
Issuance of warrants with private placement (2,868,750)     (2,868,750)  
Issuance of common stock and warrants for antidilution clause (151,776) 2,510   (154,286)  
Issuance of common stock and warrants for antidilution clause, Shares   1,255,000      
Issuance of shares for legal services 110,000 880   109,120  
Issuance of shares for legal services, Shares   440,000      
Conversion of Preferred shares to Common Shares 22,881 1,120   21,761  
Conversion of Preferred shares to Common Shares, Shares   560,237 (85)    
Stock options and stock compensation 171,141 20   171,121  
Stock options and stock compensation, Shares   10,000      
Retirement of Shares 0 (733)   733  
Retirement of Shares, Shares   (366,667)      
Declared Dividend on Preferred Shares (86,557)     (86,557)  
Net income for nine months 1,599,522       1,599,522
Balance at Sep. 30, 2014 $ (1,471,769) $ 39,784 $ 3 $ 23,923,613 $ (25,435,169)
Balance, shares at Sep. 30, 2014   19,892,264 1,415    
XML 27 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Details Textual) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Derivative Liabilities (Textual)        
Unrealized gain (loss) on change in fair value of derivative liabilities $ 1,149,696 $ 237,538 $ 3,240,052 $ 218,968
Warrant [Member]
       
Derivative Liabilities (Textual)        
Fair value of warrants liabilities $ 556,070 $ 1,232,676 $ 556,070 $ 1,232,676
XML 28 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Details) (USD $)
Sep. 30, 2014
Summary of annual maturities of debt  
2014 (includes TMK-ENT, Inc. line of credit repayment) $ 1,018,777
XML 29 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Details) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2014
Maximum [Member]
Sep. 30, 2014
Minimum [Member]
Sep. 30, 2014
Securities Purchase Agreement [Member]
Sep. 30, 2014
Series A Convertible Preferred Stock [Member]
Sep. 30, 2014
Series A Convertible Preferred Stock [Member]
Securities Purchase Agreement [Member]
Sep. 30, 2013
Warrants [Member]
Sep. 30, 2014
Private placement [Member]
Securities Purchase Agreement [Member]
Stockholders' Equity (Textual)                
Number of preferred Stock convertible into common stock         1,415 1,500    
Preferred stock converted, value           $ 1,500,000    
Conversion price           $ 0.20    
Number of common stock shares issued upon conversion of Preferred Stock       7,500,000 7,075,000      
Term of warrants 10 years     5 years        
Warrants issued to purchase common stock, shares       11,250,000        
Warrants issued to purchase common stock, share price       $ 0.25        
Stock offering costs for the private placement               100,000
Percentage of Preferred Stock cash interest payments       9.00%        
Fair value of warrants issued under securitiies purchase agreement       2,868,750        
Warrants valuation, amount       2,878,560        
Proceeds from issuance of warrants with private placement       1,400,000        
Deemed dividend       $ 1,468,750        
Additional common stock awarded to shareholders       1,255,000        
Warrants exercise price, reset   $ 0.30 $ 0.25       $ 1.20  
Warrants outstanding, reset       3,060,000        
Additional warrants issued to shareholders       612,000        
XML 30 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 31 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business and Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2014
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Description of Business and Summary of Significant Accounting Policies

Note 1 – Description of Business and Summary of Significant Accounting Policies

 

Description of Business

 

Arista Power, Inc. (the “Company”) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions, Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power, Inc. The name change more accurately reflects the broadening of the Company’s focus beyond the WindTamer® brand and entry into areas within the energy storage and power management industries.

 

The Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer of solar energy systems.  The Company’s patented Power on Demand system utilizes inputs from multiple energy sources including solar, wind, fuel cells, generators, and/or the grid, in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy users. The Company also designs, sells and installs residential and commercial solar PV systems. 

 

Basis of Preparation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q.  Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.

 

In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.  Operating results for the three-month and nine-month periods ended September 30, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.  These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Company’s Form 10-K for the fiscal year ended December 31, 2013.

 

Method of Accounting

 

The accompanying financial statements have been prepared in accordance with GAAP.  Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.  The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.  The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.

 

Accounts Receivable

 

Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.  We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.  As of September 30, 2014 and December 31, 2013, the allowance for doubtful accounts was $0.

 

Inventory

 

Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (“PV”) systems, and is stated at the lower of cost or market value.  The Company capitalizes applicable direct and indirect costs incurred in the Company’s manufacturing operations to bring its products to a sellable state.  The inventory as of September 30, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.  Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.  As of September 30, 2014 and December 31, 2013, no reserve was necessary.

 

Fixed Assets

 

Fixed assets are recorded at cost.  Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.  Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.  Expenditures for renewals and betterments are capitalized.  Expenditures for minor items, repairs and maintenance are charged to operations as incurred.  Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.

 

Intangible Assets

 

Intangible assets consist of costs associated with the application and acquisition of the Company’s patents.  Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three and nine months ended September 30, 2013, trademark costs totaling $0 and $3,396, respectfully relating to the Company’s WindTamer® trademark were impaired, while no intangible assets were impaired for the three and nine months ended September 30, 2014.    

 

Impairment of Long-Lived Assets

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.  Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.   For the three and nine months ended September 30, 2014 and 2013, no assets were impaired.

 

Fair Value of Financial Instruments

 

The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.

 

Revenue Recognition

 

Revenue is recognized when all of the following conditions are satisfied:  (1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.  Amounts collected prior to satisfying our revenue recognition policy are reflected as customer deposits.

 

For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.  The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.

 

The Company uses contract accounting for Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.

 

At September 30, 2014, the Company had costs of uncompleted contracts in excess of related billings totaling $96,008 ($0 as of September 30, 2013). This amount was netted with the accrued loss contract on the Company’s balance sheet.

 

Research and Development Costs

 

All costs related to research and development are expensed when incurred. Research and development costs consist of expenses associated with the development of the Company’s Power on Demand system and the Mobile Renewable Power Station.  Specifically, these costs consist of labor, materials, and consulting.

 

Warranty Costs

 

The Company’s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.  Several warranties have specific additional terms and conditions.  The Company provides for estimated cost of warranties at the time the revenue is recognized.  Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer’s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.

 

Stock-Based Compensation

 

The Company accounts for stock option awards granted under the Company’s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.  Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.  The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option’s expected term and the price volatility of the underlying stock.

 

The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.  Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant’s or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.  This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.  Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.  Deferred income tax expense represents the change in net deferred assets and liability balances.

 

Basic and Diluted Loss Per Share

 

Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.  Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.  In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.

 

As of September 30, 2014, 1,415 shares of our Series A Convertible Preferred Stock, convertible into 7,075,000 shares of common stock, 2,455,191 stock options and 18,292,916 warrants were outstanding which, upon exercise, could dilute future earnings per share. Diluted Weighted Average Shares reflect the Company’s total weighted average shares outstanding during the period, which includes the conversion of the Series A Convertible Preferred Stock as well as any stock options or warrants in which the exercise price is below the Company’s stock trading price, less the stock that can be repurchased with funds received from such exercise.

XML 32 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Balance Sheets (Unaudited) (Parenthetical) (USD $)
Sep. 30, 2014
Dec. 31, 2013
Balance Sheets [Abstract]    
Allowance for doubtful accounts $ 0 $ 0
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, par value $ 0.002 $ 0.002
Preferred stock, shares issued 1,415 0
Preferred stock, shares outstanding 1,415 0
Common stock, shares authorized 500,000,000 500,000,000
Common stock, par value $ 0.002 $ 0.002
Common stock, shares issued 19,892,264 17,993,694
Common stock, shares outstanding 19,892,264 17,993,694
XML 33 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Tables)
9 Months Ended
Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Company's restricted share awards
 

 

Restricted Shares

  Number of 
Restricted Shares
    Weighted Average 
Fair Value at 
Grant Date
 
Non-vested at September 30, 2014     118,378     $ 2.80  
Awarded during 2014     400,000     $ .23  
Cancelled or expired     (138,296 )   $ .36  
Non-vested at September 30, 2014     380,082     $ .39  
 
Employee Stock Option [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average assumptions used to fair value calculation for options granted
 
    Nine Months
Ended
    Nine Months Ended  
    September 30, 2014     September 30, 2013  
             
Expected dividend yield     0 %     0 %
Expected stock price volatility     112 %      105-108 %
Risk-free interest rate     3.63  %     2.68-3.44 %
Expected life of options     .14-9.78 years       .4-9.9 years  
 
Summary of Company's aggregate stock options granted

    Number of Shares Remaining Options     Weighted Average Exercise  Price     Weighted- Average Remaining Contractual Term   Aggregate Intrinsic  Value  
                       
Outstanding at January 1, 2014     1,386,108     $ .61              
Options granted during 2014     1,365,000     $ .19      9.8 years   $    
Options cancelled or expired during 2014     (295,917 )   $ .56              
Outstanding at September 30, 2014     2,455,191     $ .34     8.7 years   $ 0  
Exercisable at September 30, 2014     725,191     $ .60     6.7 years   $ 0  
 
XML 34 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
9 Months Ended
Sep. 30, 2014
Nov. 14, 2014
Entity Registrant Name Arista Power, Inc.  
Entity Central Index Key 0001424640  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Sep. 30, 2014  
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q3  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   20,979,877
Series A Convertible Preferred Stock [Member]
   
Entity Common Stock, Shares Outstanding   1,360
XML 35 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Tables) (Warrants [Member])
9 Months Ended
Sep. 30, 2014
Warrants [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average assumptions utilized in fair value calculations for warrants granted
 
    Nine Months Ended     Nine Months Ended  
    September 30, 2014     September 30, 2013  
Expected dividend yield     0 %     0 %
Expected stock price volatility     134 %     93-98 %
Risk-free interest rate     1.73-1.75 %     .14–2.60 %
Expected life of warrants     4.1-8.8 years      35-9.3 years
 
Summary of status of Company's warrant granted
 
  Number of Shares Remaining Warrants  Weighted Average Exercise Price  Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value 
Outstanding at January 1, 2014  7,671,267  $1.51       
Warrants granted during 2014  11,862,000  $.25       
Warrants expired during 2014  (1,240,351)  .50       
Outstanding at September 30,2014  18,292,916  $.78  5.1 years $0 
Exercisable at September 30,2014  18,139,250  $.75  5.4 years $0 
 
XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Statements of Operations [Abstract]        
Sales $ 250,231 $ 578,689 $ 541,675 $ 1,015,949
Cost of Goods Sold 423,487 1,219,094 654,038 1,740,939
Gross Margin/(Loss) (173,256) (640,405) (112,363) (724,990)
Operating Expenses:        
Research and development expenses 0 63,639 0 320,341
Selling, general and administrative expenses 341,237 463,492 1,190,233 1,828,753
Total expenses 341,237 527,131 1,190,233 2,149,094
Loss from operations (514,493) (1,167,536) (1,302,596) (2,874,084)
Non-operating revenue/(expense)        
Interest expense (111,900) (112,498) (336,419) (518,428)
Unrealized gain (loss) on change in fair value of derivative liabilities 1,149,696 237,538 3,240,052 218,968
Net loss before income taxes 523,303 (1,042,496) 1,601,037 (3,173,544)
Income taxes (credits) (360) 0 1,515 (103,471)
Net income (loss) 523,663 (1,042,496) 1,599,522 (3,070,073)
Less preferred stock dividends (32,288) 0 (86,557) 0
Net Income (loss) available to common shareholders $ 491,375 $ (1,042,496) $ 1,512,965 $ (3,070,073)
Net income (loss) per common share - basic $ 0.02 $ (0.06) $ 0.08 $ (0.21)
Weighted average number of common sharesoutstanding - basic 19,892,264 17,793,694 19,352,887 14,462,909
Net income (loss) per common share - diluted $ 0.02 $ (0.06) $ 0.06 $ (0.21)
Weighted average number of common sharesoutstanding - diluted 29,248,946 17,793,694 24,354,789 14,462,909
XML 37 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants
9 Months Ended
Sep. 30, 2014
Warrants [Abstract]  
Warrants

Note 6 – Warrants

 

The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model.  The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life.  The expected life of warrants used was based on the term of the warrant.  The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.  The following weighted-average assumptions were utilized in the fair value calculations for warrants granted:

 

    Nine Months Ended     Nine Months Ended  
    September 30, 2014     September 30, 2013  
Expected dividend yield     0 %     0 %
Expected stock price volatility     134 %     93-98 %
Risk-free interest rate     1.73-1.75 %     .14–2.60 %
Expected life of warrants     4.1-8.8 years      35-9.3 years

 

The following table summarizes the status of the Company’s warrants granted:

 

    Number of Shares Remaining Warrants     Weighted Average Exercise Price     Weighted- Average Remaining Contractual Term   Aggregate Intrinsic Value  
Outstanding at January 1, 2014     7,671,267     $ 1.51              
Warrants granted during 2014     11,862,000     $ .25              
Warrants expired during 2014     (1,240,351 )     .50              
Outstanding at September 30,2014     18,292,916     $ .78     5.1 years   $ 0  
Exercisable at September 30,2014     18,139,250     $ .75     5.4 years   $ 0  

The weighted average fair value of warrants issued during the nine months ended September 30, 2014 and 2013 was $.25 and $.41, respectively.  During the nine months ended September 30, 2014, 11,878,000 warrants vested (4,302,625 vested for the nine months ended September 30, 2013), and 1,240,351 warrants expired. No warrants expired for the nine months ended September 30, 2013.

 

For the nine months ended September 30, 2014 and 2013, respectively, the Company recorded compensation costs of $4,962 and $349,065 for warrants issued to a former consultant/outside counsel (now an employee) of the Company.  The warrants have a ten year life, a $1.20 exercise price, and vest from nine months to three years from grant date.

 

For the nine months ended September 30, 2013, the Company recorded expenses totaling $62,623 associated with the repricing of 423,125 outstanding warrants awarded to a former consultant/outside counsel who is now an employee of the Company.  No such expense was recorded for the nine months ended September 30, 2014.

XML 38 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation
9 Months Ended
Sep. 30, 2014
Stock Based Compensation [Abstract]  
Stock-Based Compensation

Note 5 – Stock Based Compensation

 

The Company has established the 2008 Equity Incentive Plan, which is a shareholder-approved plan that permits the granting of stock options and restricted stock to employees, directors and consultants.   The 2008 Equity Incentive Plan provides for the issuance of up to 3,550,000 shares of common stock of which 50,000 shares are available for grant as Incentive Stock Options.  The exercise price for options awarded is no less than 100% of the fair market value of the common stock on the day of grant.  The options generally vest either immediately on the date of grant or one to three years from the date of grant.

 

For the three and nine months ended September 30, 2014, the Company recorded compensation costs for options and warrants of $59,147 and $171,141 respectively, as compared to $111,114 and $650,505 for the nine and three months ended September 30, 2013. For the nine months ended September 30, 2013, compensation costs relating to the issuance of options and warrants amounted to $539,926 and the Company recorded an expense of $110,579 associated with the repricing of options and warrants held by a former consultant/outside counsel who is now an employee of the Company, while for the nine months ended September 30, 2014, there was no expense associated with the repricing of options or warrants.

 

The Company has valued the options at their date of grant utilizing the Black Scholes option pricing model.  Prior to the fourth quarter of 2009, there was not a public market for the Company shares.  Accordingly, the fair value of the underlying shares was determined based on recent transactions by the Company to sell shares to third parties and other factors determined by management to be relevant to the valuation of such shares.  Beginning in the fourth quarter of 2009, the quoted price for the Company’s shares on the OTCBB or the OTCQB, as applicable, was used to value the underlying shares.  Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry.  The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options depending on the date of the grant and expected life of the options.  The expected life of options used was based on the contractual life of the option granted.  The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.  The following weighted-average assumptions were utilized in the fair value calculations for options granted:

 

    Nine Months
Ended
    Nine Months Ended  
    September 30, 2014     September 30, 2013  
             
Expected dividend yield     0 %     0 %
Expected stock price volatility     112 %      105-108 %
Risk-free interest rate     3.63  %     2.68-3.44 %
Expected life of options     .14-9.78 years       .4-9.9 years  

The following table summarizes the status of the Company’s aggregate stock options granted:

 

    Number of Shares Remaining Options     Weighted Average Exercise  Price     Weighted- Average Remaining Contractual Term   Aggregate Intrinsic  Value  
                       
Outstanding at January 1, 2014     1,386,108     $ .61              
Options granted during 2014     1,365,000     $ .19      9.8 years   $    
Options cancelled or expired during 2014     (295,917 )   $ .56              
Outstanding at September 30, 2014     2,455,191     $ .34     8.7 years   $ 0  
Exercisable at September 30, 2014     725,191     $ .60     6.7 years   $ 0  

For the nine and three months ended September 30, 2014, the Company recorded compensation costs for options granted under the plan of $139,010 and $45,553, as compared to $190,861 and $20,800 for the nine and three months ended September 30, 2013. Stock option grants amounted to 1,365,000 for the nine months ended September 30, 2014 (1,655,208 for the nine months ended September 30, 2013) while 251,250 options vested during that period (166,858 options vested for the nine months ended September 30, 2013). There were 295,917 options cancelled or expired for the nine months ended September 30, 2014, while 23,000 options were cancelled for the nine months ended September 30, 2013. No options were exercised for the nine months ended September 30, 2014 or September 30, 2013.

 

The weighted average fair value of options granted during the nine months ended September 30, 2014 was $0.19 per share, compared to $0.45 per share for the nine months ended September 30, 2013. 

 

For the nine months ended September 30, 2013, the Company recorded expenses totaling $13,575 associated with the repricing of 25,000 options awarded to a former consultant/outside counsel who is now an employee of the Company. No such expense was recorded for the nine months ended September 30, 2014.

 

On December 13, 2010, the Board of Directors approved a restricted stock grant award to certain employees in lieu of future salary cash payments.  The employees forfeited salary over a twelve-week period to purchase common shares, which were valued at fair market value as of the date of grant.  The Compensation Committee of the Company’s Board of Directors have approved a change in the vesting date for restricted stock held by certain employees from April 1, 2011 to April 1, 2015. A total of 55,969 shares vested on April 1, 2011, and 118,378 shares remain outstanding and are scheduled to vest on April 1, 2015.

 

On March 31, 2014, Adeeb Saba was named Chief Operating Officer and the Company awarded him 250,000 shares of restricted common stock pursuant to the Company’s 2008 Equity Incentive Plan, which will vest one half each on the first and second anniversary of the award. Compensation costs associated with this award amount to $72,500 and will be recognized over the vesting period of the stock. On May 28, 2014, the Company awarded an employee 100,000 shares of restricted common stock pursuant to the Company’s 2008 Equity Incentive Plan, which will vest one half each on March 31, 2015 and March 31, 2016. Compensation costs associated with this award amount to $15,000 and will be recognized over the vesting period of the stock. On June 16, 2014, Stephen Brown was named as the acting Chief Financial Officer and the Company awarded him 50,000 shares of restricted common stock pursuant to the Company’s 2008 Equity Incentive Plan, of which 10,000 shares vested immediately and the remaining 40,000 shares shall vest on December 16, 2014. Compensation costs associated with this award amount to $9,000 and will be recognized over the vesting period of the stock.

The following table summarizes the status of the Company’s restricted common stock awards:

 

 

Restricted Shares

  Number of 
Restricted Shares
    Weighted Average 
Fair Value at 
Grant Date
 
Non-vested at September 30, 2014     118,378     $ 2.80  
Awarded during 2014     400,000     $ .23  
Cancelled or expired     (138,296 )   $ .36  
Non-vested at September 30, 2014     380,082     $ .39  

 

The compensation expense related to these grants were $30,026 for the nine months ended September 30, 2014. There was no expense for the nine months ended September 30, 2013. 

XML 39 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Details Textual) (USD $)
0 Months Ended 3 Months Ended 9 Months Ended
Dec. 21, 2012
Sep. 04, 2012
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Nov. 13, 2012
Debt (Textual)                
Working capital revolving line of credit $ 750,000 $ 500,000           $ 500,000
Line of credit interest rate   10.00%            
Maximum borrowing, line of credit 1,250,000             750,000
Line of credit maturity date Dec. 21, 2014              
Line of credit, amount payable     1,018,500   1,018,500   1,018,500  
Warrants issued to purchase common stock     1,250,000   1,250,000      
Warrants purchase common stock varying prices minimum (Per share)         $ 1.38      
Warrants purchase common stock varying prices maximum (Per share)         $ 1.62      
Warrants vesting period         1 year      
Term of warrants         10 years      
Fair market value of warrants     1,839,250   1,839,250      
Deferred debt discount     820,750   820,750   820,750  
Amortization of debt discount     $ 85,732 $ 86,674 $ 256,254 $ 441,228    
XML 40 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Tables)
9 Months Ended
Sep. 30, 2014
Derivative Liabilities [Abstract]  
Summary of weighted-average assumptions of fair value calculations for warrants granted and subsequent revaluation
 
    Nine Months Ended     Nine Months 
Ended
 
    September 30, 2014     September 30, 2013  
Expected dividend yield     0 %     0 %
Expected stock price volatility     142-148 %     90-172 %
Risk-free interest rate     1.62-178 %     .08-1.41 %
Expected life of warrants     2.9-4.5 years       .35-4.84 years  
Number of warrants     14,922,000       4,300,351  
Fair value of warrants   $ 556,070     $ 1,232,676  
 
Summary of derivative liabilities fair value measured on a recurring basis

          Fair Value Measurements at
September 30, 2014
 
    Total 
Carrying 
Value at 
September 30,
2014
    Quoted 
Prices in 
Active 
Markets 
(Level 1)
    Significant 
Other 
Observable 
Inputs 
(Level 2)
    Significant 
Unobservable 
Inputs 
(Level 3)
 
Derivative liabilities   $ 556,070     $ -     $ -     $ 556,070  
Summary of changes in fair value of Level 3 financial liabilities
 
    Nine Months Ended September 30,
2014
 
Beginning balance January 1, 2014   $ 775,596  
Issuance of derivative financial instruments in 2014     3,020,526  
Net unrealized (gain) loss on derivative financial instruments     (3,240,052 )
Ending balance as of September 30, 2014   $ 556,070  
XML 41 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2014
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Description of Business

Description of Business

 

Arista Power, Inc. (the “Company”) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions, Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power, Inc. The name change more accurately reflects the broadening of the Company’s focus beyond the WindTamer® brand and entry into areas within the energy storage and power management industries.

 

The Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer of solar energy systems.  The Company’s patented Power on Demand system utilizes inputs from multiple energy sources including solar, wind, fuel cells, generators, and/or the grid, in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy users. The Company also designs, sells and installs residential and commercial solar PV systems.

Basis of Preparation

Basis of Preparation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q.  Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.

 

In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.  Operating results for the three-month and nine-month periods ended September 30, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.  These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Company’s Form 10-K for the fiscal year ended December 31, 2013.

Method of Accounting

Method of Accounting

 

The accompanying financial statements have been prepared in accordance with GAAP.  Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

 

For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.  The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.  The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.

 

Accounts Receivable

Accounts Receivable

 

Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.  We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.  As of September 30, 2014 and December 31, 2013, the allowance for doubtful accounts was $0.

Inventory

Inventory

 

Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (“PV”) systems, and is stated at the lower of cost or market value.  The Company capitalizes applicable direct and indirect costs incurred in the Company’s manufacturing operations to bring its products to a sellable state.  The inventory as of September 30, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.  Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.  As of September 30, 2014 and December 31, 2013, no reserve was necessary.

Fixed Assets

Fixed Assets

 

Fixed assets are recorded at cost.  Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.  Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.  Expenditures for renewals and betterments are capitalized.  Expenditures for minor items, repairs and maintenance are charged to operations as incurred.  Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.

Intangible Assets

Intangible Assets

 

Intangible assets consist of costs associated with the application and acquisition of the Company’s patents.  Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three and nine months ended September 30, 2013, trademark costs totaling $0 and $3,396, respectfully relating to the Company’s WindTamer® trademark were impaired, while no intangible assets were impaired for the three and nine months ended September 30, 2014.    

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.  Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.   For the three and nine months ended September 30, 2014 and 2013, no assets were impaired.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.

Revenue Recognition

Revenue Recognition

 

Revenue is recognized when all of the following conditions are satisfied:  (1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.  Amounts collected prior to satisfying our revenue recognition policy are reflected as customer deposits.

 

For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.  The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.

 

The Company uses contract accounting for Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.

 

At September 30, 2014 the Company had costs of uncompleted contracts in excess of related billings totaling $96,008 ($0 as of September 30, 2013). This amount was netted with the accrued loss contract on the Company’s balance sheet.

Research and Development Costs

Research and Development Costs

 

All costs related to research and development are expensed when incurred. Research and development costs consist of expenses associated with the development of the Company’s Power on Demand system and the Mobile Renewable Power Station.  Specifically, these costs consist of labor, materials, and consulting.

Warranty Costs

Warranty Costs

 

The Company’s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.  Several warranties have specific additional terms and conditions.  The Company provides for estimated cost of warranties at the time the revenue is recognized.  Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer’s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.

Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock option awards granted under the Company’s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.  Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.  The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option’s expected term and the price volatility of the underlying stock.

 

The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.  Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant’s or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.

Income Taxes

Income Taxes

 

The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.  This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.  Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.  Deferred income tax expense represents the change in net deferred assets and liability balances.

Basic and Diluted Loss Per Share

Basic and Diluted Loss Per Share

 

Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.  Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.  In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.

 

As of September 30, 2014, 1,415 shares of our Series A Convertible Preferred Stock, convertible into 7,075,000 shares of common stock, 2,455,191 stock options and 18,292,916 warrants were outstanding which, upon exercise, could dilute future earnings per share. Diluted Weighted Average Shares reflect the Company’s total weighted average shares outstanding during the period, which includes the conversion of the Series A Convertible Preferred Stock as well as any stock options or warrants in which the exercise price is below the Company’s stock trading price, less the stock that can be repurchased with funds received from such exercise.

XML 42 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities
9 Months Ended
Sep. 30, 2014
Derivative Liabilities [Abstract]  
Derivative Liabilities

Note 7 – Derivative Liabilities

 

Certain warrants issued by the Company do not have fixed settlement provisions because their exercise prices may be lowered if the Company issues securities at lower prices in the future, are classified as derivative liabilities, and are revalued at each reporting date. These warrants include (1) warrants issued to 1999 Mt RB, LLC in conjunction with our lease modification on February 4, 2013, which expired on February 4, 2014 (2) warrants issued in conjunction with the Company’s strategic advisory agreement with Sunrise Financial Group, Inc. on May 21, 2013, which were cancelled on June 19, 2014 and (3) warrants issued in conjunction with the Company’s private placements on July 31, 2013, August 6, 2013 and March 31, 2014. The reset provisions protect the warrant holders from the potential dilution associated with future financings.

 

The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model. Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry, or if applicable based upon the term of the warrant, based upon the Company’s historical volatility. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life. The expected life of warrants used was based on the term of the warrant. The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future. The following weighted-average assumptions were utilized in the fair value calculations for warrants granted and subsequent revaluation: 

 

    Nine Months Ended     Nine Months 
Ended
 
    September 30, 2014     September 30, 2013  
Expected dividend yield     0 %     0 %
Expected stock price volatility     142-148 %     90-172 %
Risk-free interest rate     1.62-178 %     .08-1.41 %
Expected life of warrants     2.9-4.5 years       .35-4.84 years  
Number of warrants     14,922,000       4,300,351  
Fair value of warrants   $ 556,070     $ 1,232,676  

The fair value of these warrant liabilities was $556,070 at September 30, 2014. The change in fair value for the nine months ended September 30, 2014 was $3,240,052 and is reported in our statement of operations as an unrealized gain on the change in fair value of the derivative liabilities. For the nine months ended September 30, 2013, we recorded an unrealized loss on the change in fair value of the derivative liabilities totaling $218,968. The fair value of the derivative liabilities are re-measured at the end of every reporting period and upon the exercise of the warrant.

  

Fair Value Measurement

 

Valuation Hierarchy

 

ASC 820, “Fair Value Measurements and Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

 

The following table provides the liabilities carried at fair value measured on a recurring basis as of September 30, 2014:

 

          Fair Value Measurements at
September 30, 2014
 
    Total 
Carrying 
Value at 
September 30,
2014
    Quoted 
Prices in 
Active 
Markets 
(Level 1)
    Significant 
Other 
Observable 
Inputs 
(Level 2)
    Significant 
Unobservable 
Inputs 
(Level 3)
 
Derivative liabilities   $ 556,070     $ -     $ -     $ 556,070  

 

The derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors, and are classified within Level 3 of the valuation hierarchy.

 

The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:

 

    Nine Months Ended September 30,
2014
 
Beginning balance January 1, 2014   $ 775,596  
Issuance of derivative financial instruments in 2014     3,020,526  
Net unrealized (gain) loss on derivative financial instruments     (3,240,052 )
Ending balance as of September 30, 2014   $ 556,070  
XML 43 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2014
Recent Accounting Pronouncements [Abstract]  
Recent Accounting Pronouncements

Note 8- Recent Accounting Pronouncements

 

In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-15Presentation of Financial Statements - Going Concern . The new standard required management of public and private companies to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, disclose that fact. Management will also be required to evaluate and disclose whether its plans alleviate that doubt. The new standard is effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early adoption is permitted. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.

 

In May 2014, the "FASB" issued ASU 2014-09 Revenue from Contracts with Customers , which will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The standard's core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. We are carefully evaluating our existing revenue recognition practices to determine whether any contracts in the scope of the guidance will be affected by the new requirements. The effects may include identifying performance obligations in existing arrangements, determining the transaction price and allocating the transaction price to each separate performance obligation. We will also establish practices to determine when a performance obligation has been satisfied, and recognize revenue in accordance with the new requirements. The new standard is effective for us on January 1, 2017. Early adoption is not permitted. The standard allows for either "full retrospective" adoption, meaning the standard is applied to all of the periods presented, or "modified retrospective" adoption, meaning the standard is applied only to the most current period presented in the financial statements. We are currently evaluating the transition method that will be elected.

 

In June 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2014-12 Compensation - Stock Compensation ("ASU 2014-12"). ASU2014-12 is intended to resolve diverse accounting treatment for share based awards in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The standard is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015 and may be applied prospectively or retrospectively. The Company does not expect adoption of this standard will have a significant impact on the Company's consolidated financial statements.

XML 44 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Tables)
9 Months Ended
Sep. 30, 2014
Debt [Abstract]  
Summary of annual maturities of debt
2014 (includes TMK-ENT, Inc. line of credit repayment) $1,018,777 
XML 45 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Details 2) (USD $)
9 Months Ended
Dec. 31, 2013
Sep. 30, 2014
Fair Value, Measurements, Recurring [Member]
Summary of changes in fair value of Level 3 financial liabilities    
Beginning balance $ 775,596 $ 775,596
Issuance of derivative financial instruments in 2014   3,020,526
Net unrealized (gain) loss on derivative financial instruments   (3,240,052)
Ending balance $ 775,596 $ 556,070
XML 46 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Going Concern (Details) (USD $)
Sep. 30, 2014
Dec. 31, 2013
Going Concern (Textual)    
Cumulative net loss $ (25,435,169) $ (27,034,691)
XML 47 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details 1) (Stock options [Member], USD $)
9 Months Ended
Sep. 30, 2014
Stock options [Member]
 
Summary of Company's aggregate stock options granted  
Number of Shares Remaining Options/Warrants, Outstanding, beginning balance 1,386,108
Number of Shares Remaining Options, granted 1,365,000
Number of Shares Remaining Options, cancelled or expired (295,917)
Number of Shares Remaining Options/Warrants, Outstanding, balance 2,455,191
Number of Shares Remaining Options/Warrants, Exercisable 725,191
Weighted Average Exercise Price, Outstanding, beginning balance $ 0.61
Weighted Average Exercise Price, Options granted $ 0.19
Weighted Average Exercise Price, Cancelled/expired $ 0.56
Weighted Average Exercise Price, Outstanding, balance $ 0.34
Weighted Average Exercise Price, Exercisable $ 0.60
Weighted-Average Remaining Contractual Term, Options granted 9 years 9 months 18 days
Weighted-Average Remaining Contractual Term, Outstanding 8 years 8 months 12 days
Weighted Average Remaining Contractual Term, Exercisable 6 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding $ 0
Aggregate Intrinsic Value, Exercisable $ 0
XML 48 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Operating activities    
Net income (loss) $ 1,599,522 $ (3,070,073)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation expense 33,076 48,769
Stock-based compensation 171,141 650,505
Amortization of prepaid warrants for rent, non-cash 33,018 0
Amortization of prepaid warrants for consulting, non-cash 157,593 0
Stock issued for rent and services 0 92,470
Amortization of debt discount 256,254 441,228
Impairment of intangible assets 0 3,699
Issuance of warrants for services 0 137,496
Change in derivative liability (3,240,052) (218,968)
Gain on sale of equipment (5,592) 0
Increase in lower of cost or market reserve    20,486
Changes in operating assets and liabilities:    
(Increase) in prepaid expenses and other current assets (26,740) (92,351)
Decrease (increase) in trade accounts receivable 122,142 305,482
Decrease in inventory 0 57,133
Increase in customer deposits (150) 81,028
Increase (Decrease) in deferred revenue 255,666 (28,900)
Increase (Decrease) in accrued loss contract 23,750 638,850
Increase (Decrease) in trade accounts payable and accrued liabilities (714,673) (90,919)
Net cash provided by/(used in) operating activities (1,335,045) (1,024,065)
Investing activities    
Proceeds from sale of truck 18,500 0
Net cash provided by investing activities 18,500 0
Financing activities    
Proceeds from issuance of common stock, net of placement costs 0 1,245,000
Proceeds from issuance of preferred stock 1,500,000 0
Stock offering costs paid (100,000) 0
Borrowings on line of credit 0 270,000
Payments on debt (27,674) (8,705)
Net cash provided by financing activities 1,372,326 1,506,295
Increase/(decrease) in cash 55,781 482,230
Cash - beginning of period 297,385 78,253
Cash - end of period 353,166 560,483
Supplemental Information:    
Income Taxes Paid/(Tax credits received) 1,515 (103,471)
Interest Paid 3,409 1,402
Non-cash investing and financing activities:    
Warrant derivative liability incurred with preferred stock offering 3,020,526 0
Issuance of warrants with Preferred stock (2,868,750) 0
Additional warrants issued for anti-dilution clause (151,776) 0
Stock issued for accounts payable and accrued expenses 110,000 157,903
Application of deferred debt discount 0 270,000
Warrants issued for prepaid rent 0 746,332
Payment of accrued dividend with common stock 22,881 0
Transfer of property for accounts payable $ 6,000 $ 0
XML 49 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity
9 Months Ended
Sep. 30, 2014
Stockholders' Equity [Abstract]  
Stockholders' Equity

Note 4 – Stockholders’ Equity

 

On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company’s common stock at a conversion price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. Stock offering costs for the private placement amounted to $100,000. Each share of Preferred Stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly. The Preferred Stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of Preferred Stock outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally, until September 30, 2015, each investor has the right to invest an amount equal to the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment provision. The warrants associated with this transaction were valued at their date of issue utilizing the Black-Scholes option pricing model, which amounted to $2,868,750.  The difference between the warrants valuation of $2,878,560 and the net proceeds received by the Company of $1,400,000 results in a deemed dividend of $1,468,750, which has been charged to additional paid-in-capital, as the Company has no retained earnings from which to declare a dividend.

 

On March 31, 2014, in conjunction with the full ratchet and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional 1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the exercise price for the 3,060,000 warrants outstanding that were associated with this transaction were reduced from $0.30 to $0.25 per share.

XML 50 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details 2) (Restricted Stock [Member], USD $)
9 Months Ended
Sep. 30, 2014
Restricted Stock [Member]
 
Summary of Company's restricted share awards  
Number of Restricted Shares, Non-vested at March 31, 2014 118,378
Weighted Average Fair Value at Grant Date, Non-vested at March 31, 2014 $ 2.80
Number of Restricted Shares, Awarded 400,000
Weighted Average Fair Value at Grant Date, Awarded $ 0.23
Number of Restricted Shares, Cancelled or expired 138,296
Weighted Average Fair Value at Grant Date, Cancelled or expired $ 0.36
Number of Restricted Shares, Non-vested at March 31, 2014 380,082
Weighted Average Fair Value at Grant Date, Non-vested at March 31, 2014 $ 0.39
XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 81 245 1 false 28 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.aristapower.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Condensed Balance Sheets (Unaudited) Sheet http://www.aristapower.com/role/CondensedBalanceSheetsUnaudited Condensed Balance Sheets (Unaudited) false false R3.htm 003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.aristapower.com/role/CondensedBalanceSheetsUnauditedParenthetical Condensed Balance Sheets (Unaudited) (Parenthetical) false false R4.htm 004 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://www.aristapower.com/role/CondensedStatementsOfOperationsUnaudited Condensed Statements of Operations (Unaudited) false false R5.htm 005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://www.aristapower.com/role/CondensedStatementsOfCashFlowsUnaudited Condensed Statements of Cash Flows (Unaudited) false false R6.htm 006 - Statement - Statement of Shareholders' (Deficit) (Unaudited) Sheet http://www.aristapower.com/role/StatementOfShareholdersDeficitUnaudited Statement of Shareholders' (Deficit) (Unaudited) false false R7.htm 007 - Disclosure - Description of Business and Summary of Significant Accounting Policies Sheet http://www.aristapower.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies Description of Business and Summary of Significant Accounting Policies false false R8.htm 008 - Disclosure - Going Concern Sheet http://www.aristapower.com/role/GoingConcern Going Concern false false R9.htm 009 - Disclosure - Debt Sheet http://www.aristapower.com/role/Debt Debt false false R10.htm 010 - Disclosure - Stockholders' Equity Sheet http://www.aristapower.com/role/StockholdersEquity Stockholders' Equity false false R11.htm 011 - Disclosure - Stock Based Compensation Sheet http://www.aristapower.com/role/StockBasedCompensation Stock Based Compensation false false R12.htm 012 - Disclosure - Warrants Sheet http://www.aristapower.com/role/Warrants Warrants false false R13.htm 013 - Disclosure - Derivative Liabilities Sheet http://www.aristapower.com/role/DerivativeLiabilities Derivative Liabilities false false R14.htm 014 - Disclosure - Recent Accounting Pronouncements Sheet http://www.aristapower.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements false false R15.htm 015 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) Sheet http://www.aristapower.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies Description of Business and Summary of Significant Accounting Policies (Policies) false false R16.htm 016 - Disclosure - Debt (Tables) Sheet http://www.aristapower.com/role/DebtTables Debt (Tables) false false R17.htm 017 - Disclosure - Stock Based Compensation (Tables) Sheet http://www.aristapower.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) false false R18.htm 018 - Disclosure - Warrants (Tables) Sheet http://www.aristapower.com/role/WarrantsTables Warrants (Tables) false false R19.htm 019 - Disclosure - Derivative Liabilities (Tables) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) false false R20.htm 020 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) Sheet http://www.aristapower.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails Description of Business and Summary of Significant Accounting Policies (Details) false false R21.htm 021 - Disclosure - Going Concern (Details) Sheet http://www.aristapower.com/role/GoingConcernDetails Going Concern (Details) false false R22.htm 022 - Disclosure - Debt (Details) Sheet http://www.aristapower.com/role/DebtDetails Debt (Details) false false R23.htm 023 - Disclosure - Debt (Details Textual) Sheet http://www.aristapower.com/role/DebtDetailsTextual Debt (Details Textual) false false R24.htm 024 - Disclosure - Stockholders' Equity (Details) Sheet http://www.aristapower.com/role/StockholdersEquityDetails Stockholders' Equity (Details) false false R25.htm 025 - Disclosure - Stock Based Compensation (Details) Sheet http://www.aristapower.com/role/StockBasedCompensationDetails Stock Based Compensation (Details) false false R26.htm 026 - Disclosure - Stock Based Compensation (Details 1) Sheet http://www.aristapower.com/role/StockBasedCompensationDetails1 Stock Based Compensation (Details 1) false false R27.htm 027 - Disclosure - Stock Based Compensation (Details 2) Sheet http://www.aristapower.com/role/StockBasedCompensationDetails2 Stock Based Compensation (Details 2) false false R28.htm 028 - Disclosure - Stock Based Compensation (Details Textual) Sheet http://www.aristapower.com/role/StockBasedCompensationDetailsTextual Stock Based Compensation (Details Textual) false false R29.htm 029 - Disclosure - Warrants (Details) Sheet http://www.aristapower.com/role/WarrantsDetails1 Warrants (Details) false false R30.htm 030 - Disclosure - Warrants (Details 1) Sheet http://www.aristapower.com/role/WarrantsDetails Warrants (Details 1) false false R31.htm 031 - Disclosure - Warrants (Details Textual) Sheet http://www.aristapower.com/role/WarrantsDetailsTextual Warrants (Details Textual) false false R32.htm 032 - Disclosure - Derivative Liabilities (Details) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesDetails Derivative Liabilities (Details) false false R33.htm 033 - Disclosure - Derivative Liabilities (Details 1) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesDetails1 Derivative Liabilities (Details 1) false false R34.htm 034 - Disclosure - Derivative Liabilities (Details 2) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesDetails2 Derivative Liabilities (Details 2) false false R35.htm 035 - Disclosure - Derivative Liabilities (Details Textual) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesDetailsTextual Derivative Liabilities (Details Textual) false false All Reports Book All Reports Process Flow-Through: 002 - Statement - Condensed Balance Sheets (Unaudited) Process Flow-Through: 003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 004 - Statement - Condensed Statements of Operations (Unaudited) Process Flow-Through: 005 - Statement - Condensed Statements of Cash Flows (Unaudited) aspw-20140930.xml aspw-20140930.xsd aspw-20140930_cal.xml aspw-20140930_def.xml aspw-20140930_lab.xml aspw-20140930_pre.xml true true XML 52 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business and Summary of Significant Accounting Policies (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Description of Business and Summary of Significant Accounting Policies (Textual)          
Allowance for doubtful accounts $ 0   $ 0   $ 0
Inventory, raw materials 346,014   346,014    
Inventory, work in process 150,299   150,299    
Inventory reserves 0   0   0
Impairment of trademark cost 0 0 0 3,396  
Excess in related billings $ 96,008 $ 0 $ 96,008 $ 0  
Preferred Stock [Member]
         
Description of Business and Summary of Significant Accounting Policies (Textual)          
Number of preferred Stock convertible into common stock     1,415    
Number of common stock shares issued upon conversion of Preferred Stock 7,075,000   7,075,000    
Stock options [Member]
         
Description of Business and Summary of Significant Accounting Policies (Textual)          
Securities outstanding which dilutive for future earnings     2,455,191    
Warrants [Member]
         
Description of Business and Summary of Significant Accounting Policies (Textual)          
Securities outstanding which dilutive for future earnings     18,292,916